Document:

EX-4.13

 Exhibit 4.13 

Confidential Treatment Requested 

The portions of this document marked by “XXXX” have been omitted pursuant to a request for confidential treatment and have been filed separately
with the Securities and Exchange Commission. 
 EXECUTION VERSION 

STOCK PURCHASE AGREEMENT AND PLAN OF MERGER 

BY AND AMONG 
 WNS GLOBAL SERVICES
PRIVATE LIMITED, 
 WNS NORTH AMERICA INC., 

WNS HEALTHCARE NORTH AMERICA LLC, 

HEALTHHELP HOLDINGS, LLC, 
 MTS
HEALTHHELP INC., 
 THE STOCKHOLDERS OF MTS HEALTHHELP INC., 

CHERRILL FARNSWORTH 
 AND 

THE SELLERS’ REPRESENTATIVE  

DATED AS OF MARCH 15, 2017 

 TABLE OF CONTENTS 

 

									
	 	 	 	  	 	  	PAGE	 
		
	 ARTICLE 1 DEFINITIONS
	  	 	2	 
		
	 ARTICLE 2 PURCHASE AND SALE OF THE HEALTHHELP CORP STOCK; MERGER
	  	 	15	 
		 	 2.1
	  	 Purchase and Sale of HealthHelp Corp Stock
	  	 	15	 
		 	 2.2
	  	 Merger
	  	 	16	 
		 	 2.3
	  	 The Closing and the Effective Time
	  	 	16	 
		 	 2.4
	  	 Effect of the Merger
	  	 	16	 
		 	 2.5
	  	 Organizational Documents of the Surviving Company
	  	 	16	 
		 	 2.6
	  	 Manager(s) of the Surviving Company
	  	 	16	 
		 	 2.7
	  	 Effect of the Merger on the Company Units and the Limited Liability Company Interests of Merger
Sub
	  	 	17	 
		 	 2.8
	  	 Mechanism of Payment
	  	 	17	 
		 	 2.9
	  	 No Further Ownership Rights in the Company Units
	  	 	18	 
		 	 2.10
	  	 Closing Certificate
	  	 	18	 
		 	 2.11
	  	 Payments and Deliveries at the Closing
	  	 	19	 
		 	 2.12
	  	 Determination of Post-Closing Adjustment
	  	 	21	 
		 	 2.13
	  	 Deferred Payments
	  	 	24	 
		 	 2.14
	  	 Allocation of Amounts Paid By Purchaser or Merger Sub
	  	 	28	 
		 	 2.15
	  	 Distribution Waterfall
	  	 	28	 
		
	 ARTICLE 3 REPRESENTATIONS AND WARRANTIES REGARDING THE HEALTHHELP
ENTITIES
	  	 	29	 
		 	 3.1
	  	 Organization
	  	 	29	 
		 	 3.2
	  	 Power; Authorization of Transactions
	  	 	29	 
		 	 3.3
	  	 Capitalization and Subsidiaries
	  	 	30	 
		 	 3.4
	  	 No Breach
	  	 	30	 
		 	 3.5
	  	 Financial Statements
	  	 	31	 
		 	 3.6
	  	 Indebtedness/Undisclosed Liabilities
	  	 	31	 
		 	 3.7
	  	 Absence of Certain Developments
	  	 	32	 
		 	 3.8
	  	 Real Property
	  	 	33	 
		 	 3.9
	  	 Title to Tangible Assets
	  	 	34	 
		 	 3.10
	  	 Contracts and Commitments
	  	 	34	 
		 	 3.11
	  	 Proprietary Rights
	  	 	36	 
		 	 3.12
	  	 Litigation; Proceedings
	  	 	38	 
		 	 3.13
	  	 Compliance with Laws; Permits
	  	 	38	 
		 	 3.14
	  	 Environmental Matters
	  	 	38	 
		 	 3.15
	  	 Labor and Employment Matters
	  	 	39	 
		 	 3.16
	  	 Employee Plans
	  	 	39	 
		 	 3.17
	  	 Tax Matters
	  	 	41	 
		 	 3.18
	  	 Health Care Matters; HIPAA
	  	 	43	 

  
 ii 

									
		 	 3.19
	  	 Related Party Transactions
	  	 	43	 
		 	 3.20
	  	 Bank Accounts
	  	 	44	 
		 	 3.21
	  	 Information Security and Data Privacy
	  	 	44	 
		 	 3.22
	  	 Accounts Receivable
	  	 	44	 
		 	 3.23
	  	 Insurance
	  	 	45	 
		 	 3.24
	  	 Brokerage
	  	 	45	 
		
	 ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF THE HEALTHHELP CORP
SELLERS
	  	 	45	 
		 	 4.1
	  	 Organization
	  	 	45	 
		 	 4.2
	  	 Authorization of Transactions
	  	 	45	 
		 	 4.3
	  	 No Breach
	  	 	46	 
		 	 4.4
	  	 Litigation
	  	 	46	 
		 	 4.5
	  	 Brokerage
	  	 	46	 
		 	 4.6
	  	 Ownership
	  	 	46	 
		
	 ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF HEALTHHELP CORP
	  	 	47	 
		 	 5.1
	  	 Organization
	  	 	47	 
		 	 5.2
	  	 Authorization of Transactions
	  	 	47	 
		 	 5.3
	  	 No Breach
	  	 	47	 
		 	 5.4
	  	 Litigation
	  	 	48	 
		 	 5.5
	  	 Brokerage
	  	 	48	 
		 	 5.6
	  	 Capitalization; Prior Activities
	  	 	48	 
		 	 5.7
	  	 Tax Matters
	  	 	48	 
		
	 ARTICLE 6 REPRESENTATIONS AND WARRANTIES OF THE STOCK PURCHASER, PARENT AND MERGER
SUB
	  	 	50	 
		 	 6.1
	  	 Organization; Ownership of Merger Sub; No Prior Activities
	  	 	50	 
		 	 6.2
	  	 Authorization of Transactions
	  	 	51	 
		 	 6.3
	  	 No Breach
	  	 	51	 
		 	 6.4
	  	 Litigation
	  	 	51	 
		 	 6.5
	  	 Investment Intent; Restricted Securities
	  	 	52	 
		 	 6.6
	  	 Brokerage
	  	 	52	 
		 	 6.7
	  	 Financing
	  	 	52	 
		 	 6.8
	  	 No Other Representations
	  	 	52	 
		
	 ARTICLE 7 INTENTIONALLY OMITTED
	  	 	52	 
		
	 ARTICLE 8 ADDITIONAL AGREEMENTS
	  	 	52	 
		 	 8.1
	  	 Further Assurances
	  	 	52	 
		 	 8.2
	  	 Press Releases; Confidentiality
	  	 	53	 
		 	 8.3
	  	 Transaction Expenses
	  	 	53	 
		 	 8.4
	  	 Directors’ and Officers’ Indemnification
	  	 	53	 
		 	 8.5
	  	 Post-Closing Record Retention and Access
	  	 	54	 
		 	 8.6
	  	 Release
	  	 	55	 

  
 iii 

									
		 	 8.7
	  	 HealthHelp Name
	  	 	55	 
		 	 8.8
	  	 Sellers Non-Competition and Non-Solicitation
	  	 	55	 
		 	 8.9
	  	 Other Tax Provisions
	  	 	57	 
		 	 8.10
	  	 Transfer Taxes
	  	 	62	 
		 	 8.11
	  	 R&W Insurance Policy
	  	 	62	 
		
	 ARTICLE 9 INTENTIONALLY OMITTED
	  	 	63	 
		
	 ARTICLE 10 INTENTIONALLY OMITTED
	  	 	63	 
		
	 ARTICLE 11 INDEMNIFICATION
	  	 	63	 
		 	 11.1
	  	 Survival
	  	 	63	 
		 	 11.2
	  	 Indemnification By the Seller Indemnifying Parties or the HealthHelp Corp Sellers
	  	 	63	 
		 	 11.3
	  	 Indemnification By Purchaser
	  	 	65	 
		 	 11.4
	  	 Certain Limitations
	  	 	65	 
		 	 11.5
	  	 Inter-Party Claims
	  	 	68	 
		 	 11.6
	  	 Third Party Claims
	  	 	69	 
		 	 11.7
	  	 Tax Treatment of Indemnification Payments
	  	 	70	 
		 	 11.8
	  	 R&W Insurance Policy
	  	 	70	 
		 	 11.9
	  	 Right of Set-Off
	  	 	70	 
		 	 11.10
	  	 Denial of Claims
	  	 	70	 
		 	 11.11
	  	 Other Indemnification and Insurance
	  	 	71	 
		 	 11.12
	  	 Exclusive Remedy
	  	 	71	 
		
	 ARTICLE 12 MISCELLANEOUS
	  	 	72	 
		 	 12.1
	  	 Sellers’ Representative; Waiver of Conflicts; Retention of Privilege
	  	 	72	 
		 	 12.2
	  	 Amendment and Waiver
	  	 	75	 
		 	 12.3
	  	 Notices
	  	 	76	 
		 	 12.4
	  	 Assignment
	  	 	77	 
		 	 12.5
	  	 Severability
	  	 	77	 
		 	 12.6
	  	 Construction and Interpretation
	  	 	78	 
		 	 12.7
	  	 Captions
	  	 	78	 
		 	 12.8
	  	 No Third-Party Beneficiaries
	  	 	78	 
		 	 12.9
	  	 Specific Performance
	  	 	78	 
		 	 12.10
	  	 Complete Agreement
	  	 	78	 
		 	 12.11
	  	 Counterparts
	  	 	78	 
		 	 12.12
	  	 Governing Law
	  	 	78	 
		 	 12.13
	  	 Waiver of Jury Trial
	  	 	79	 
		 	 12.14
	  	 Exclusive Jurisdiction and Venue
	  	 	79	 
		 	 12.15
	  	 Disclosure Schedules
	  	 	80	 

  
 iv 

 STOCK PURCHASE AGREEMENT AND PLAN OF MERGER 

THIS STOCK PURCHASE AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of March 15, 2017, by and
among WNS Global Services Private Limited (the “Stock Purchaser”), WNS North America Inc., a Delaware corporation (“Parent”, and together with the Stock Purchaser, “Purchaser”), WNS Healthcare North
America LLC, a Delaware limited liability company and a direct wholly-owned subsidiary of Parent (“Merger Sub”), HealthHelp Holdings, LLC, a Delaware limited liability company (the “Company”), MTS HealthHelp Inc., a
Delaware corporation (“HealthHelp Corp”), the stockholders of HealthHelp Corp identified on the signature pages hereto (the “HealthHelp Corp Sellers”), Cherrill Farnsworth (“Farnsworth”), and MTS
Health Investors, LLC, solely in its capacity as the representative of the HealthHelp Corp Sellers and the Unitholders (other than HealthHelp Corp) hereunder (the “Sellers’ Representative”). Each of the above referenced parties
is sometimes herein referred to individually as a “Party” and collectively as the “Parties.” 
 WHEREAS,
HealthHelp Corp and the other Unitholders collectively own all of the issued and outstanding limited liability company interests in the Company; 

WHEREAS, on the terms and subject to the conditions of this Agreement, the Stock Purchaser desires to purchase from the HealthHelp Corp
Sellers, and the HealthHelp Corp Sellers desire to sell to the Stock Purchaser, all of the issued and outstanding capital stock of HealthHelp Corp (the “HealthHelp Corp Stock”); 

WHEREAS, the board of managers of the Company (the “Company Board”), on the terms and subject to the conditions set forth
herein, has (a) declared the advisability of this Agreement and approved and adopted this Agreement, and (b) recommend approval and adoption of this Agreement by all of the Unitholders entitled to approve and adopt this Agreement; 

WHEREAS, the Requisite Unitholders have approved and adopted this Agreement in their capacity as Unitholders pursuant to the written consent
delivered to Purchaser simultaneously herewith (the “Written Consent”); 
 WHEREAS, the board of managers of Merger Sub has
(a) declared the advisability of this Agreement and approved and adopted this Agreement, and (b) approved and adopted of this Agreement by Parent, the sole member of Merger Sub; 

WHEREAS, Parent has approved and adopted this Agreement in its capacity as the sole member of Merger Sub; 

 WHEREAS, the Company Board and the board of managers of Merger Sub have approved the merger of
Merger Sub with and into the Company, with the Company as the surviving limited liability company (the “Surviving Company”), upon the terms and subject to the conditions set forth in this Agreement and the applicable provisions of
the Delaware Limited Liability Company Act (the “DLLCA”), whereby (a) each issued and outstanding Company Unit (other than the HealthHelp Corp Units) shall be converted into the right to receive a portion of the Aggregate Final
Consideration allocable to the Company Units upon the terms and subject to the conditions set forth herein and based upon the applicable liquidation preferences and other rights, preferences and privileges of such class of the Company Units as set
forth in the Company’s Operating Agreement, dated as of April 29, 2013 (as the same may be amended or modified from time to time, the “Company LLC Agreement”), and (b) each issued and outstanding HealthHelp Corp Unit
shall remain outstanding and be retained by HealthHelp Corp; and 
 WHEREAS, in order to induce Purchaser and Merger Sub to enter into this
Agreement, the Unitholders, the HealthHelp Corp Sellers and the Sellers’ Representative have, simultaneously with the execution and delivery of this Agreement, entered into a Support Agreement (the “Support Agreement”)
providing for, among other things, the payment by such Persons of certain amounts which may become payable pursuant to Articles 2 and 11 of this Agreement. 

NOW, THEREFORE, in consideration of the premises and the mutual promises contained herein and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: 
 ARTICLE 1 

DEFINITIONS 

“2017 Actual Revenue Percentage” has the meaning set forth in Section 2.13(k)(i). 

“2017 Farnsworth Deferred Payment Amount” has the meaning set forth in Section 2.13(k)(ii). 

“2017 General Deferred Payment Amount” has the meaning set forth in Section 2.13(k)(iii). 

“2018 Actual Revenue Percentage” has the meaning set forth in Section 2.13(k)(iv). 

“2018 Farnsworth Deferred Payment Amount” has the meaning set forth in Section 2.13(k)(v). 

“2018 General Deferred Payment Amount” has the meaning set forth in Section 2.13(k)(vi). 

“Accounting Principles” shall mean GAAP, as applied in accordance with the accounting methodologies, practices, policies,
classifications and procedures set forth on Annex I. 

  
 2 

 “Action” means any action, claim, litigation, suit, proceeding, investigation,
order or government charge (whether in contract, tort or otherwise, whether civil or criminal and whether brought at law or in equity). 

“Actual Aggregate Closing Consideration” has the meaning set forth in Section 2.12(b). 

“Actual Cash” has the meaning set forth in Section 2.12(b). 

“Actual XXXX Revenue” has the meaning set forth in Section 2.13(k). 

“Actual Indebtedness” has the meaning set forth in Section 2.12(b). 

“Actual Sellers’ Transaction Expenses” has the meaning set forth in Section 2.12(b). 

“Actual Working Capital” has the meaning set forth in Section 2.12(b). 

“Additional Payments” means the amounts described in clauses (c) through (g) of the definition of Aggregate Final
Consideration, to the extent the same become payable in accordance with this Agreement. 
 “Affiliate” of any particular
Person means any other Person that directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with such Person. “Control” (including the terms “controlled by” and “under
common control with”) means the possession, directly or indirectly, of the power to direct, or cause the direction of, the management and policies of a Person, whether through the ownership of voting securities, by contract, or otherwise. 

“Affiliated Group” means, with respect to a Person, an affiliated group as defined in Section 1504 of the Code (or any
analogous combined, consolidated or unitary group defined under state, local or foreign income Tax Law) of such Person is or has been a member. 

“Agreement” has the meaning set forth in the Preamble. 

“Aggregate Closing Consideration” means (a) Gross Purchase Price, plus (b) the Estimated Cash, minus
(c) the Estimated Indebtedness, minus (d) the Estimated Sellers’ Transaction Expenses, minus (e) the amount, if any, by which Target Working Capital is greater than Estimated Working Capital, plus
(f) the amount, if any, by which Estimated Working Capital is greater than Target Working Capital, minus (g) the Escrow Amount, minus (h) the amount of the Sellers’ Representative Expense Fund, minus
(i) the Farnsworth Holdback Amount, minus (j) the General Holdback Amount. 

  
 3 

 “Aggregate Final Consideration” means (a) the Aggregate Closing
Consideration, minus (b) the Excess Shortfall Amount, if any, plus (c) any amounts payable to the Unitholders (other than HealthHelp Corp) and the HealthHelp Corp Sellers pursuant to Section 2.12(d), plus
(d) any amounts payable to the Unitholders (other than HealthHelp Corp) and the HealthHelp Corp Sellers upon release of the Escrow Amount pursuant to the terms of the Escrow Agreement, plus (e) any amounts payable to the Unitholders
(other than HealthHelp Corp) and the HealthHelp Corp Sellers upon release of the Sellers’ Representative Expense Fund pursuant to the terms of Section 12.1(f), plus (f) any amounts payable pursuant to Section 8.9(d),
plus (g) any amounts payable pursuant to Section 2.13. 
 “Audited Balance Sheet” has
the meaning set forth in Section 3.5(a)(ii). 
 “Business” means the business of providing specialty benefit
management services, health utilization management services and care management services to the health care industry (including payors, providers, prescription benefit managers, Governmental Authorities, etc.) as carried on by the HealthHelp
Entities as of the date of this Agreement and as of the Closing. 
 “Business Day” means any day other than a Saturday or
Sunday or any other day on which commercial banks in Houston, Texas or New York, New York are authorized or required by Law to close. 

“Cash” means cash, cash equivalents and liquid instruments that are convertible into cash (including marketable securities),
plus deposits in transit to the extent there has been a reduction of receivables on account thereof, but net of checks written but not yet cleared, in each case determined in accordance with GAAP; provided, that for purposes of
determining Estimated Cash and Actual Cash, Cash shall be deemed to include, in addition, an amount equal to one half (1/2) of the total premium for the D&O Tail Policies. 

“Certificate of Merger” has the meaning set forth in Section 2.3. 

“Closing” has the meaning set forth in Section 2.3. 

“Closing Balance Sheet” has the meaning set forth in Section 2.12(a). 

“Closing Certificate” has the meaning set forth in Section 2.10. 

“Closing Date” has the meaning set forth in Section 2.3. 

“Closing Statement” has the meaning set forth in Section 2.12(a). 

“COBRA” has the meaning set forth in Section 3.15(b). 

“Code” means the Internal Revenue Code of 1986, as amended. 

“Company” has the meaning set forth in the Preamble. 

“Company Board” has the meaning set forth in the Preamble. 

“Company Information” has the meaning set forth in Section 8.2. 

  
 4 

 “Company LLC Agreement” has the meaning set forth in the Preamble. 

“Company Units” means all of the issued and outstanding Class A Member Units, Class B Member Units, Class D
Member Units, Class E Member Units, Class F Member Units and Class G Member Units of the Company. 

“Contracts” means all contracts, leases, deeds, mortgages, licenses, instruments, notes, commitments, undertakings,
indentures, joint venture agreements and all other legally binding agreements, commitments and arrangements, whether written or oral. 

“D&O Tail Policies” has the meaning set forth in Section 8.4(b). 

“Data Room” means the Merrill Corporation electronic data room made available to Purchaser by the Company in connection with
the negotiation of this Agreement. 
 “Disclosure Schedules” has the meaning set forth in
Section 12.15. 
 “Dispute Notice” has the meaning set forth in Section 2.12(b). 

“Distribution Waterfall” means the manner in which the Aggregate Closing Consideration, as well as any post-Closing payments
to be made pursuant to this Agreement, is to be allocated among the HealthHelp Corp Sellers in respect of the HealthHelp Corp Stock and the Unitholders (other than HealthHelp Corp) in respect of Company Units. The Distribution Waterfall is set forth
on Exhibit A attached hereto. 
 “DLLCA” has the meaning set forth in the Preamble. 

“D&O Indemnified Person” has the meaning set forth in Section 8.4(b). 

“Effective Time” has the meaning set forth in Section 2.3. 

“Employee Pension Plans” has the meaning set forth in Section 3.16(a). 

“Employee Welfare Plans” has the meaning set forth in Section 3.16(a). 

“Employee Plans” has the meaning set forth in Section 3.16(a). 

“Employment Agreement” has the meaning set forth in Section 2.13(e). 

“Environmental Laws” means all applicable federal, state, local and foreign statutes, regulations, and rules
concerning pollution or protection of the environment, as the foregoing are enacted and in effect, on the Closing Date. 

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended. 

  
 5 

 “ERISA Affiliate” means any entity that together with the HealthHelp Entities
would be deemed a “single employer” for purposes of Section 414(b), (c), (m) or (i) of the Code. 
 “Escrow
Agent” means Citibank, N.A., as the Escrow Agent under the Escrow Agreement. 
 “Escrow Agreement” means the
Escrow Agreement to be entered into at the Closing by Parent, the Sellers’ Representative and the Escrow Agent. 
 “Escrow
Amount” means cash in the amount of Five Hundred Thousand Dollars ($500,000). 
 “Escrow Fund” means the Escrow
Amount deposited into escrow pursuant to the Escrow Agreement. 
 “Estimated Cash” means the estimated Cash of the
HealthHelp Entities and HealthHelp Corp as of immediately prior to the Closing, as set forth on the Closing Certificate delivered to Purchaser pursuant to Section 2.10. 

“Estimated Indebtedness” means the estimated Indebtedness of the HealthHelp Entities and HealthHelp Corp as of immediately
prior to the Closing, as set forth on the Closing Certificate delivered to Purchaser pursuant to Section 2.10. 

“Estimated Sellers’ Transaction Expenses” means the estimated Sellers’ Transaction Expenses, as set forth in the
Closing Certificate delivered to Purchaser pursuant to Section 2.10. 
 “Estimated Working
Capital” means the estimated Working Capital of the HealthHelp Entities as of 11:59 p.m. on the date immediately preceding the Closing Date, as set forth on the Closing Certificate delivered to Purchaser pursuant to
Section 2.10. 
 “Excess Amount” has the meaning set forth in Section 2.12(d). 

 “Excess Shortfall Amount” has the meaning set forth in Section 2.12(c). 

“Farnsworth” has the meaning set forth in the Preamble. 

“Farnsworth Holdback Amount” has the meaning set forth in Section 2.13(k)(vii). 

“Farnsworth Restricted Period” means the period from the Closing Date to and including the fourth (4th) anniversary of the Closing Date. 
 “Finally Determined” has the
meaning set forth in Section 11.9. 
 “Financial Statements” has the meaning set forth in
Section 3.5. 

  
 6 

 “GAAP” means United States generally accepted accounting principles,
consistently applied. 
 “General Holdback Amount” has the meaning set forth in Section 2.13(k)(ix). 

“General Holdback Sellers” has the meaning set forth in Section 2.13(k)(x). 

“Goodwin” has the meaning set forth in Section 12.1(h). 

“Governmental Authority” means any government, governmental agency, department, bureau, office, commission, authority or
instrumentality, or court of competent jurisdiction, in each case whether foreign, federal, state or local. 
 “Gross Purchase
Price” means Ninety-Five Million Dollars ($95,000,000). 
 “HCCA Agreement” shall mean the Administrative Services
Agreement by and between Health Care Corporation of America Health Connections d/b/a HCCA Health Connections (“HCCA Connections”) and the Operating Company, effective as of September 2, 2011, as amended by that certain First
Amendment, dated September 2, 2011, pursuant to which HCCA Connections was replaced by Health Care Corporation of America International as a party, as amended by that certain Second Amendment, dated April 4, 2013, as amended by that
certain Third Amendment, dated August 19, 2013, as amended by that certain Fourth Amendment, dated July 29, 2014, as amended by that certain Statement of Work, dated June 27, 2016. 

“HealthHelp Corp” has the meaning set forth in the Preamble. 

“HealthHelp Corp Consideration” has the meaning set forth in Section 2.1. 

“HealthHelp Corp Indemnifiable Tax Losses” has the meaning set forth in Section 11.4(k). 

“HealthHelp Corp Sellers” has the meaning set forth in the Preamble. 

“HealthHelp Corp Stock” has the meaning set forth in the Preamble. 

“HealthHelp Corp Stock Acquisition” has the meaning set forth in Section 2.2. 

“HealthHelp Corp Tax Refund” has the meaning set forth in Section 8.9(d). 

“HealthHelp Corp Units” means all Company Units held by HealthHelp Corp. 

“HealthHelp Corp Unpaid Taxes” means an amount (never to be less than $0) equal to the federal, state and local income Tax
liability of HealthHelp Corp for the period (or portion thereof) through and including the Closing Date, reduced by any Tax attribute of HealthHelp Corp that is attributable to a taxable period (or portion thereof) ending on or prior to the Closing
Date and any estimated Taxes paid on or after January 1, 2017 and on or prior to the Closing Date and any overpayments for the 2016 taxable year applied against such liability for the tax year beginning January 1, 2017. 

  
 7 

 “HealthHelp Entities” means the Company, together with each of its Subsidiaries.

 “HealthHelp Tax Refund” has the meaning set forth in Section 8.9(d). 

“HIPAA” has the meaning set forth in Section 3.18(a). 

“XXXX” has the meaning set forth in Section 2.13(k)(xi). 

“XXXX Conditions” has the meaning set forth in Section 2.13(k)(xii). 

“XXXX Contract” has the meaning set forth in Section 2.13(k)(xiii). 

“XXXX Revenue Target” has the meaning set forth in Section 2.13(k)(xiv). 

“Indebtedness” means at a particular time, without duplication, with respect to a Person, (a) any indebtedness of such
Person for borrowed money or issued in substitution or exchange for indebtedness for borrowed money, (b) any indebtedness of such Person evidenced by any note, bond, debenture or other debt security, (c) any indebtedness guaranteed in any
manner by such Person, (d) any obligations under capitalized leases or leases required to be capitalized pursuant to GAAP, (e) any letters of credit and bankers’ acceptances if and to the extent drawn, (f) any obligations issued
or assumed as the deferred purchase price of property or services, (g) any obligations secured by Liens (other than Permitted Liens) on property or assets owned by such Person, (h) accrued and unpaid
pre-Closing Tax obligations for a taxable period (or portion thereof) ending on the Closing Date, limited, in the case of income Taxes of HealthHelp Corp, to the HealthHelp Corp Unpaid Taxes, or
(i) accrued interest to and including the Closing Date in respect of any of the obligations described in the foregoing clauses (a) through (h) of this definition and all premiums, penalties, charges, fees, expenses and other amounts that
are or would be due (including with respect to early termination) in connection with the payment and satisfaction in full of such obligations. 

“Indemnified Party” has the meaning set forth in Section 11.5. 

“Indemnifying Party” has the meaning set forth in Section 11.5. 

“Insurance Policies” has the meaning set forth in Section 3.23. 

“IRS” means the U.S. Internal Revenue Service. 

“Item of Dispute” has the meaning set forth in Section 2.12(b). 

“Key Employees” means Uday Deshmukh, Amit Gupta, Mark Conroy, Todd Shoe and Todd Silman. 

  
 8 

 “Knowledge” means (a) in the case of the Company, the actual knowledge of
Cherrill Farnsworth, Amit Gupta, Uday Deshmukh, Mark Conroy, Todd Shoe, Todd Silman, David Ripley and David Gibson, in each case after due inquiry, (b) in the case of HealthHelp Corp, the actual knowledge of the directors and officers thereof,
in each case after due inquiry, and (c) in the case of the HealthHelp Corp Sellers, the actual knowledge of the directors and officers of the applicable HealthHelp Corp Seller, in each case after due inquiry. 

“Latest Balance Sheet” has the meaning set forth in Section 3.5(a)(i). 

“Law” means all laws, statutes, rules, regulations, ordinances and other pronouncements having the effect of law of the
United States, any state, county, city or other political subdivision of any Governmental Authority. 
 “Lease” has the
meaning set forth in Section 3.8(b). 
 “Leased Real Property” means all of the right, title and interest of the
HealthHelp Entities under all written leases, subleases and license agreements, pursuant to which the HealthHelp Entities hold a leasehold or sub-leasehold estate in, or are granted the right to use or occupy,
any land, buildings, improvements, fixtures or other interest in real property which is used in the operation of the Business. 

“Letter of Transmittal” has the meaning set forth in Section 2.8(a). 

“Liability” means, with respect to any Person, any liability or obligation of such Person of any kind, nature, character or
description, whether known or unknown, absolute or contingent, accrued or unaccrued, disputed or undisputed, liquidated or unliquidated, secured or unsecured, joint or several, due or to become due, vested or unvested, executory, determined,
determinable or otherwise and whether or not the same is required to be accrued on the financial statements of such Person. 

“Liens” means any mortgage, pledge, security interest, encumbrance, lien, easement, encroachment, right of way, community
property interest, pledge, condition, claim or charge (other than, in the case of a security, any restriction on the transfer of such security arising solely under Law). 

“Loss” or “Losses” means losses, damages, Liabilities, deficiencies, Actions, judgments, interest, awards,
amounts paid in settlement, penalties, fines, costs or expenses of whatever kind, including reasonable attorneys’ fees, the cost of enforcing any right to indemnification hereunder, any attorneys’ fees or other costs incurred to pursue
claims under any insurance policy, fidelity bond, surety bond or similar Contract; provided, that Losses shall in all cases exclude exemplary or punitive damages claimed, incurred or suffered by any Indemnified Party other than exemplary or
punitive damages actually payable to a third party. 
 “Loss Tax Benefit” has the meaning set forth in Section
11.4(h). 

  
 9 

 “Material Adverse Effect” means any event, circumstance, change, occurrence or
effect (collectively, “Events”) that, individually or in the aggregate, has, or would reasonably be expected to have, a material and adverse effect upon (a) the Business, assets, liabilities, condition or operating results of
HealthHelp Corp or the HealthHelp Entities, taken as a whole, or (b) the ability of the HealthHelp Entities, HealthHelp Corp, HealthHelp Corp Sellers or the Unitholders to consummate the transactions contemplated by, or perform their respective
obligations under, this Agreement; provided, that in respect of clause (a) none of the following (either alone or in combination with any other Event) shall be deemed to constitute, and none of the following shall be taken into account
in determining whether there has been, a Material Adverse Effect: any adverse Event arising from or relating to (i) general business or industry conditions related to the Business or the industry in which the HealthHelp Entities operate,
(ii) national or international political or social conditions, including any stoppage or shutdown of any Governmental Authority and/or the engagement by the United States or any other country or group in hostilities, whether or not pursuant to
the declaration of a national emergency or war, or the occurrence of any military or terrorist attack upon the United States or any other country, or any of their respective territories, possessions, or diplomatic or consular offices or upon any
military installation, equipment or personnel of the United States or any other country or group, (iii) changes in GAAP following the date of this Agreement, (iv) changes in Law following the date of this Agreement, (v) the taking of
any action contemplated by this Agreement and the other agreements contemplated hereby (including, without limitation, the taking of any action with the consent of Purchaser or Merger Sub), (vi) changes affecting regulatory, capital market or
general economic conditions in the United States or any other country, (vii) any “act of God,” including, but not limited to, weather, natural disasters and earthquakes or (viii) the announcement of the execution of this
Agreement (including the announcement of the identity of Purchaser) or the transactions contemplated hereunder, except in the case of each of (i), (ii), (iii), (iv), (vi) or (vii), to the extent that any such change, effect, event, occurrence, state
of facts or development disproportionately affects the Business relative to other companies in the industry in which the HealthHelp Entities operate. 

“Material Contracts” has the meaning set forth in Section 3.10(a). 

“Material Customers” has the meaning set forth in Section 3.10. 

“Material Suppliers” has the meaning set forth in Section 3.10. 

“Membership Interests” has the meaning set forth in Section 2.7(b). 

“Merger” has the meaning set forth in Section 2.2. 

“Merger Sub” has the meaning set forth in the Preamble. 

“Other Plans” has the meaning set forth in Section 3.16(a). 

“Operating Company” means HealthHelp, LLC, a Delaware limited liability company. 

  
 10 

 “Parent” has the meaning set forth in the Preamble. 

“Party” or “Parties” has the meaning set forth in the Preamble. 

“Payment Fund” has the meaning set forth in Section 2.8(b). 

“Per-Claim Threshold” has the meaning set forth in Section 11.4(a). 

“Permits” has the meaning set forth in Section 3.13(b). 

“Permitted Liens” means (a) cashiers’, landlords’, mechanics’, materialmens’, carriers’,
workmens’, repairmens’, contractors’ and warehousemens’ Liens arising or incurred in the ordinary course of business and for amounts which are not delinquent or are being contested, (b) easements, covenants, conditions, rights-of-way, restrictions and other similar charges and encumbrances of record and other title defects not interfering materially with the ordinary conduct of the Business,
(c) Liens for Taxes not yet due and payable or for Taxes that the HealthHelp Entities are contesting, (d) purchase money Liens securing rental payments under capital lease arrangements, (e) Liens arising from documents or writings
included in the public records, (f) zoning, building codes or other land use Laws regulating the use or occupancy of the Leased Real Property or the activities conducted thereon which are imposed by any Governmental Authority having
jurisdiction over such Leased Real Property which are not violated in any material respect by the current use or occupancy of such Leased Real Property or the operation of the Business, (g) Liens granted to any lender at the Closing in
connection with any financing by Purchaser of the transactions contemplated hereby and (h) any other Liens set forth on the Permitted Liens Schedule. 

“Person” means any individual, sole proprietorship, partnership, joint venture, trust, unincorporated association,
corporation, limited liability company, entity or Governmental Authority. 
 “Policy Limit” has the meaning set forth in
Section 11.4(k). 
 “Post-Closing Tax Period” means any taxable period that ends after the Closing Date, including
the portion of any Straddle Period beginning after the Closing Date. 
 “Pre-Closing Tax
Period” means (i) any taxable period that ends on or before the Closing Date and (ii) with respect to any Straddle Period, the portion of such Straddle Period ending on the Closing Date. 

“Pro Forma Returns” has the meaning set forth in Section 8.9(b). 

“Proprietary Rights” means, collectively, (a) patents and patent applications, (b) trademarks, service marks, trade
names and trade dress, together with all goodwill associated therewith, and internet domain names, (c) copyrights and works of authorship, whether or not copyrightable, (d) trade secrets, know-how
and confidential information, (e) computer programs, operating systems, applications, firmware and other code, including all source code, object code, application programming interfaces, data files, databases, protocols, specifications and
other documentation thereof, (f) all other intellectual or industrial property and proprietary rights and (g) registrations and applications for any of the foregoing. 

  
 11 

 “Pro Rata Share” has the meaning set forth in the Support Agreement. 

“Purchaser” has the meaning set forth in the Preamble. 

“Purchaser Indemnitees” has the meaning set forth in Section 11.2. 

“Purchaser Prepared Returns” has the meaning set forth in Section 11.2. 

“Purchase Price Allocation” has the meaning set forth in Section 2.14. 

“Reduced Cap” has the meaning set forth in Section 11.4(c). 

“Reduced Threshold” has the meaning set forth in Section 11.4(b). 

“Registered Proprietary Rights” has the meaning set forth in Section 3.11(a). 

“Related Party” means (a) HealthHelp Corp Sellers, (b) any member, manager, officer or other member of the
executive management team of the Company, (c) any Affiliate of any Person referenced in the foregoing clauses (a)-(b), (d) any trustee or beneficiary of any trust established by any Person referenced in the foregoing clauses (a)-(c) or of which
any Person referenced in the foregoing clauses (a)-(c) is a beneficiary or (e) the spouse, parent, child or sibling of any Person referenced in the foregoing clauses (a)-(d). 

“Representative” means, with respect to any Person, any and all directors, officers, members, managers, employees,
consultants, financial advisors, counsel, accountants and other agents of such Person. 
 “Requisite Unitholders” means the
Unitholders holding a majority of the outstanding Class A Member Units, Class D Member Units and Class E Member Units of the Company (treating all such units as a single class of units) as of the date hereof. 

“Releasee” has the meaning set forth in Section 8.6. 

“Restricted Business” means (a) any business activity that is directly competitive with HealthHelp’s Utilization
Management Business or its Facility Quality Assessment Business, specifically eviCore, AIM, NIA or any new entity that is substantially similar to HealthHelp’s Utilization Management Business or that of eviCore, AIM, or NIA and (b) any
other business activity which is developed by Purchaser in consultation with Farnsworth. 
 “Restricted Period” means the
period from the Closing Date to and including the third (3rd) anniversary of the Closing Date. 

  
 12 

 “R&W Insurance Policy” means the
buy-side representation and warranty insurance policy issued by Berkshire Hathaway Specialty Insurance with respect to the representations and warranties of the HealthHelp Entities, HealthHelp Corp and the
HealthHelp Corp Sellers under this Agreement purchased by Purchaser in connection with the execution and delivery of this Agreement. 

“Securities Act” means the Securities Act of 1933, as amended from time to time. 

“Seller Fundamental Representations” has the meaning set forth in Section 11.1. 

“Seller Indemnifying Parties” means the HealthHelp Corp Sellers, Farnsworth and any Unitholder (other than HealthHelp Corp)
that executes and delivers the Support Agreement. 
 “Seller Indemnifiable Tax Losses” has the meaning set forth in
Section 11.4(k). 
 “Seller Indemnitees” has the meaning set forth in Section 11.3. 

“Seller Prepared Returns” has the meaning set forth in Section 8.9(b). 

“Sellers’ Representative” has the meaning set forth in the Preamble. 

“Sellers’ Representative Expense Fund” has the meaning set forth in Section 12.1(f). 

“Sellers’ Transaction Expenses” means all fees, costs and expenses incurred by or on behalf of the HealthHelp Entities,
HealthHelp Corp, or the Unitholders relating to the negotiation, preparation or execution of this Agreement or any documents or agreements contemplated hereby or the performance or consummation of the transactions contemplated hereby, in each case,
that have not been paid as of the Closing, including (a) all financial advisory, legal and accounting fees, costs and expenses, (b) any fees or expenses associated with obtaining the release and termination of any Liens, (c) all
brokers’ or finders’ fees, (d) all sale, change of control, “stay around”, retention or similar, bonuses, compensation or payments to current or former managers, directors, employees and other service providers of the
HealthHelp Entities paid or payable as a result of or in connection with the transactions contemplated hereby, including the employer portion of any employment payroll Taxes in respect of any of the foregoing to the extent that the payment giving
rise to such employment Taxes accrues on or before the Closing Date and (e) the total premium for the D&O Tail Policies. 

“Shortfall Amount” has the meaning set forth in Section 2.12(c). 

“Stock Purchaser” has the meaning set forth in the Preamble. 

“Straddle Period” means any taxable period beginning on or before the Closing Date but ending after the Closing Date. 

  
 13 

 “Subsidiary” means, with respect to any Person, any partnership, limited
liability company, corporation or other business entity of which (a) if a corporation, a majority of the total voting power of shares of capital stock entitled (without regard to the occurrence of any contingency) to vote in the election of
directors, managers, or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (b) if a partnership, limited liability
company or other business entity, a majority of the partnership, limited liability company or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other
Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a partnership, limited liability company or other business entity if such Person or Persons shall
be allocated a majority of partnership, limited liability company or other business entity gains or losses or shall be or control the managing director or general partner of such partnership, limited liability company or other business entity. 

“Support Agreement” has the meaning set forth in the Recitals. 

“Surviving Company” has the meaning set forth in the Preamble. 

“Surviving Company Operating Agreement” has the meaning set forth in Section 2.5. 

“Target Working Capital” means an amount equal to Three Million Six Hundred
Eighty-One Thousand Three Hundred Ninety Four Dollars ($3,681,394). 
 “Tax” or
“Taxes” means any federal, state, local or non-U.S. income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall, profits, customs,
duties, capital stock, franchise, withholding, social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, value added, alternative or add-on minimum or
other tax, governmental fee, governmental assessment or governmental charge that is in the nature of a tax, whether computed on a separate, consolidated, unitary or combined basis or in any other manner, whether or not disputed, and including any
interest, penalties or additions thereto or additional amounts in respect of the foregoing. 
 “Tax Contest” has the
meaning set forth in Section 8.9(c). 
 “Tax Return” means any return, declaration, report, claim for refund,
information return or other document (including any related or supporting schedule, statement or information) filed or required to be filed in connection with the determination, assessment or collection of any Tax of any party or the administration
of any Laws relating to any Tax. 
 “Threshold” has the meaning set forth in Section 11.4(b). 

“Transaction Documents” means this Agreement, the Escrow Agreement, the Support Agreement, the Letter of Transmittal and the
other certificates, agreements and documents delivered by the Parties at or in connection with the transactions contemplated by this Agreement. 

  
 14 

 “Transfer Taxes” has the meaning set forth in
Section 8.10. 
 “Unitholders” means the holders of Company Units. 

“Valuation Firm” has the meaning set forth in Section 2.12(b). 

“Working Capital” means the excess of (a) the current assets of the HealthHelp Entities, over (b) the current
liabilities of the HealthHelp Entities, in the case of each of clauses (a) and (b), determined on a consolidated basis in accordance with the Accounting Principles; provided, that for purposes hereof, the current assets of the HealthHelp
Entities shall not include any (i) Cash of the HealthHelp Entities, (ii) Tax assets or (iii) prepaid expenses relating to capital expenditures, and the current liabilities of the HealthHelp Entities shall not include any
(A) Transfer Taxes, (B) Indebtedness of the HealthHelp Entities, (C) Sellers’ Transaction Expenses, (D) current or deferred Tax liabilities, (E) accounts payable relating to capital expenditures or (F) fees or
expenses to the extent relating to financing arranged by or on behalf of, or otherwise incurred by or at the direction of, Purchaser or any of its Affiliates in connection with the transactions contemplated hereby or otherwise. For illustrative
purposes only, set forth on the Working Capital Schedule attached hereto is an example calculation of the Working Capital. 

“Written Consent” has the meaning set forth in the Preamble. 

ARTICLE 2 
 PURCHASE AND SALE
OF THE HEALTHHELP CORP STOCK; MERGER 
 2.1 Purchase and Sale of HealthHelp Corp Stock. Upon the terms and subject to the
conditions set forth herein and on the basis of the representations, warranties, covenants and agreements contained herein, at the Closing and immediately prior to the Effective Time, each HealthHelp Corp Seller shall sell to the Stock Purchaser,
and the Stock Purchaser shall purchase from such HealthHelp Corp Seller, such HealthHelp Corp Seller’s HealthHelp Corp Stock, free and clear of all Liens (other than any transfer restrictions under the Securities Act or state securities laws or
Liens created by or resulting from actions of the Stock Purchaser). The aggregate purchase price for the HealthHelp Corp Stock payable by the Stock Purchaser at the Closing (the “HealthHelp Corp Consideration”) shall be the portion
of the Aggregate Closing Consideration allocable to the HealthHelp Corp Stock in accordance with the Distribution Waterfall. At the Closing, each HealthHelp Corp Seller shall be paid such HealthHelp Corp Seller’s percentage of the HealthHelp
Corp Consideration in respect of the HealthHelp Corp Stock held by such HealthHelp Corp Seller based upon the percentage set forth next to such HealthHelp Corp Seller’s name on Schedule 2.1. 

  
 15 

 2.2 Merger. At the Effective Time and upon the terms and subject to the conditions of this
Agreement and the applicable provisions of the DLLCA, Merger Sub shall merge with and into the Company, the separate limited liability company existence of Merger Sub shall cease and the Company shall continue as the Surviving Company (the
“Merger”). The purchase transactions contemplated by Section 2.1 (the “HealthHelp Corp Stock Acquisition”), which shall occur immediately prior to the consummation of the Merger
contemplated by this Section 2.2, shall constitute a separate transaction hereunder. At the Closing, the Parties shall be deemed to consummate the HealthHelp Corp Stock Acquisition immediately prior to the consummation of
the Merger, but neither the HealthHelp Corp Stock Acquisition nor the Merger shall be consummated unless both transactions are consummated. 

2.3 The Closing and the Effective Time. The closing of the transactions contemplated by this Agreement (the “Closing”)
shall take place at the offices of the Company, 16945 Northchase Drive, Suite 1300, Houston, Texas, commencing at 8:00 a.m. local time on the date hereof. The date of the Closing is referred to herein as the “Closing Date.” On the
Closing Date, and upon the terms and subject to the conditions of this Agreement, the Parties shall cause the Merger to be consummated by filing the Certificate of Merger (the “Certificate of Merger”), with the Secretary of State of
the State of Delaware as required by, and executed in accordance with, the applicable provisions of the DLLCA (the time of such filing with the Secretary of State of the State of Delaware, or such later time as may be agreed upon in writing by
Purchaser and the Company and specified in the Certificate of Merger, shall be referred to herein as the “Effective Time”). 

2.4 Effect of the Merger. At the Effective Time, the effect of the Merger shall be as provided in the applicable provisions of the
DLLCA. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time by virtue of the Merger and without any action on the part of Merger Sub or the Company, all of the property, rights, privileges, powers and
franchises of the Company and Merger Sub shall vest in the Surviving Company, and all debts, liabilities and duties of the Company and Merger Sub shall become the debts, liabilities and duties of the Surviving Company. 

2.5 Organizational Documents of the Surviving Company. At the Effective Time, by virtue of the Merger and without any action on the
part of Merger Sub or the Company, (a) the limited liability company agreement of Merger Sub shall be the limited liability company agreement of the Surviving Company (the “Surviving Company Operating Agreement”), and
(b) the certificate of formation of the Company shall be the certificate of formation of the Surviving Company, each as in effect immediately prior to the Effective Time. 

2.6 Manager(s) of the Surviving Company. The manager(s) of Merger Sub immediately prior to the Effective Time shall be the manager(s)
of the Surviving Company immediately after the Effective Time, each to hold such office in accordance with the provisions of the Surviving Company Operating Agreement. 

  
 16 

 2.7 Effect of the Merger on the Company Units and the Limited Liability Company Interests of
Merger Sub. 
 (a) Effect on the Company Units (other than HealthHelp Corp Units). At the Effective Time, by virtue of the
Merger and without any action on the part of Merger Sub, the Company or the Unitholders, each Company Unit issued and outstanding immediately prior to the Effective Time (other than the HealthHelp Corp Units), on the terms and conditions set forth
in this Agreement, shall be converted automatically into the right to receive a portion of the Aggregate Final Consideration as follows: (i) at the Effective Time, the portion of the Aggregate Closing Consideration allocable to such Company
Unit (which, for the avoidance of doubt, will vary depending on the class of such Company Unit) in accordance with the Distribution Waterfall, and (ii) following the Effective Time, the portion of the Additional Payments, if any, which become
payable in respect of such Company Unit in accordance with this Agreement. For the avoidance of doubt, in no event shall HealthHelp Corp be entitled to receive any portion of the Aggregate Final Consideration payable pursuant to this Section
2.7(a). All classes of Company Units (other than the HealthHelp Corp Units), when converted pursuant to this Section 2.7(a), shall no longer be outstanding, and each former holder thereof shall cease to have any rights with respect
thereto, except the right to receive the portion of the Aggregate Final Consideration provided for in this Section 2.7(a). 
 (b)
Limited Liability Company Interests of Merger Sub and HealthHelp Corp Units. At the Effective Time, by virtue of the Merger and without any action on the part of Merger Sub, HealthHelp Corp, the Company or Parent, the limited liability
company interests in Merger Sub issued and outstanding immediately prior to the Effective Time and all HealthHelp Corp Units shall automatically be cancelled, extinguished and converted into the limited liability company membership interests in the
Surviving Company (the “Membership Interests”) as follows: 36% of the Membership Interests will be owned by the Parent and 64% of the Membership Interests will be owned by HealthHelp Corp. Each certificate evidencing
ownership of limited liability company interests in Merger Sub, if any, and each certificate representing HealthHelp Corp Units, if any, shall automatically be deemed to evidence ownership of such interests of the Surviving Company.

2.8 Mechanism of Payment. 

(a) Prior to the date hereof, the Company delivered to each Unitholder (other than HealthHelp Corp) a Letter of Transmittal. To the extent
that any Unitholder (other than HealthHelp Corp) shall have, prior to the Closing Date, delivered to the Company such Letter of Transmittal, duly executed and completed in accordance with the instructions thereto, the Sellers’ Representative
shall pay to such Unitholder at the Closing, out of the funds provided to the Sellers’ Representative by Parent pursuant to Section 2.11(a), the portion of the Aggregate Closing Consideration payable to such Unitholder in accordance
with Section 2.7(a), which amounts shall be paid by wire transfer of immediately available funds to the account designated by such Unitholder in such Unitholder’s Letter of Transmittal. 

(b) An amount equal to (i) the Aggregate Closing Consideration less (ii) the aggregate amount payable to the Unitholders at
the Closing pursuant to Section 2.8(a) less (iii) the HealthHelp Corp Consideration is referred to herein as the “Payment Fund.” The Payment Fund shall be held by the Sellers’ Representative in a segregated
bank account and used solely and exclusively for purposes of paying the consideration specified in Section 2.8(c). The Sellers’ Representative shall make the payments provided for in Section 2.8(c) out of the Payment Fund. 

  
 17 

 (c) Following the Closing, upon delivery by a Unitholder (other than HealthHelp Corp) that did
not receive a portion of the Aggregate Closing Consideration at the Closing pursuant to Section 2.8(a) to the Sellers’ Representative of a Letter of Transmittal, duly executed and completed in accordance with the instructions thereto,
the Sellers’ Representative shall pay to such Unitholder from the Payment Fund, within five (5) Business Days after such delivery, cash in an amount equal to the portion of the Aggregate Closing Consideration payable to such Unitholder in
accordance with Section 2.7(a), which amounts shall be paid by the Sellers’ Representative by wire transfer of immediately available funds to the account designated by such Unitholder in such Unitholder’s Letter of
Transmittal. No interest or dividends will be paid or accrued on the consideration payable to any Unitholder hereunder. Until surrendered in accordance with the provisions of this Section 2.8(c), the Company Units shall represent, for all
purposes, only the right to receive an amount in cash equal to the portion of the Aggregate Closing Consideration payable in respect thereof pursuant to Section 2.7(a), without any interest or dividends thereon. 

(d) No Party shall be liable to a Unitholder or any other Person in respect of any cash delivered to a public official pursuant to any
applicable abandoned property, escheat or similar Law. If any amounts payable with respect to any Company Unit pursuant to this Agreement have not been claimed by the sixth (6th) anniversary of
the Closing Date (or immediately prior to such earlier date on which any Aggregate Final Consideration, dividends (whether in cash, stock or property) or other distributions with respect to Company Units would otherwise escheat to or become the
property of any Governmental Authority), any such shares, cash, dividends or distributions in respect of such Company Unit shall, to the extent permitted by applicable Law, become the property of the Surviving Company, free and clear of all claims
or interests of any Person previously entitled thereto. 
 (e) Notwithstanding anything herein to the contrary, the Sellers’
Representative shall be entitled to direct that any portion of the Sellers’ Transaction Expenses, Aggregate Closing Consideration and/or Additional Payments which are payable to current or former employees or independent contractors of any of
the HealthHelp Entities be paid to such Persons through the Company’s payroll system (and not directly by the Sellers’ Representative), subject to withholding as required by applicable Law. Following the Closing, Purchaser shall cause the
Surviving Company to take such actions as are reasonably necessary to give effect to the foregoing. 
 2.9 No Further Ownership Rights in
the Company Units. The portion of the Aggregate Final Consideration paid in respect of the Company Units (or, in the case of the HealthHelp Corp Units, the limited liability company interests of Surviving Company issued in respect thereof) in
accordance with the terms hereof shall be deemed to be full satisfaction of all rights pertaining to such Company Units, and, upon the Effective Time, there shall be no further registration of transfers on the records of the Surviving Company of
Company Units which were outstanding immediately prior to the Effective Time. 
 2.10 Closing Certificate. At least two
(2) Business Days prior to the Closing, the Company delivered to Purchaser a certificate (the “Closing Certificate”) setting forth the Company’s good faith estimate of (to the extent practicable as of such date): 

(a) the Estimated Cash; 

  
 18 

 (b) the Estimated Working Capital; 

(c) the Estimated Indebtedness; 

(d) the Estimated Sellers’ Transaction Expenses; 

(e) the Aggregate Closing Consideration; and 

(f) a copy of the Distribution Waterfall showing the portion of the Aggregate Closing Consideration payable to each Unitholder and HealthHelp
Corp Seller in accordance therewith. 
 All payments to be made by Purchaser pursuant to Section 2.11 shall be
made in accordance with the amounts for such items set forth in the Closing Certificate, as applicable. 
 2.11 Payments and Deliveries
at the Closing. At the Closing, the Parties shall pay or deliver, or cause to be paid or delivered, each of the following: 
 (a) Stock
Purchaser shall pay to the Sellers’ Representative, by wire transfer of immediately available funds to an account designated in writing by the Sellers’ Representative, cash in an amount equal to the HealthHelp Corp Consideration, for
further distribution to each HealthHelp Corp Seller in accordance with the Distribution Waterfall; 
 (b) Parent shall pay to the
Sellers’ Representative, by wire transfer of immediately available funds to an account designated in writing by the Sellers’ Representative, cash in an amount equal to (i) the Aggregate Closing Consideration less (ii) the
HealthHelp Corp Consideration, for further distribution to the Unitholders (other than HealthHelp Corp) in accordance with the Distribution Waterfall and Section 2.8; 

(c) Parent shall pay to the Escrow Agent, by wire transfer of immediately available funds to a bank account designated in writing by the
Escrow Agent, cash in an amount equal to the Escrow Amount; 
 (d) Parent shall pay to the Sellers’ Representative, by wire transfer
of immediately available funds to an account designated by the Sellers’ Representative, cash in an amount equal to the Sellers’ Representative Expense Fund; 

(e) Purchaser shall repay, or cause to be repaid, out of the Gross Purchase Price, on behalf of the HealthHelp Entities, all Indebtedness
which constitutes indebtedness for borrowed money of the HealthHelp Entities and HealthHelp Corp, in each case as of the Closing Date in accordance with the payoff letters delivered by the HealthHelp Entities to the Purchaser prior to the
Closing;
 (f) Parent shall pay to the Sellers’ Representative, by wire transfer of immediately available funds to an account
designated in writing by the Sellers’ Representative prior to the Closing, subject to Section 2.8(e), the aggregate amount of the Estimated Sellers’ Transaction Expenses, for further distribution by the Sellers’ Representative
to the applicable payees entitled to a portion of the Estimated Seller’ Transaction Expenses; 

  
 19 

 (g) HealthHelp Corp and the Company, as applicable, shall each deliver a certification pursuant
to Section 1445 of the Code and the Treasury Regulations promulgated thereunder stating that (i) interests in HealthHelp Corp are not U.S. real property interests and (ii) the transfer of interests in the Company are not subject to
withholding under Section 1445 of the Code; 
 (h) each HealthHelp Corp Seller shall deliver to Purchaser stock certificates
representing all of the HealthHelp Corp Stock held by such HealthHelp Corp Seller, endorsed in blank or accompanied by duly executed assignment documents, or affidavit(s) of loss in lieu thereof; 

(i) the Company shall deliver written resignations, effective as of the Closing Date, of all of the officers and members of the Company
Board; 
 (j) HealthHelp Corp shall deliver written resignations, effective as of the Closing Date, of the board of directors and all of
the officers of HealthHelp Corp; 
 (k) the Company shall deliver certificates issued by the Secretary of State of the state of Delaware
certifying that each of HealthHelp Corp, the Company and the Operating Company has legal existence and is in good standing as of a date that is no earlier than five (5) Business Days prior to the Closing; 

(l) Purchaser shall deliver to the Sellers’ Representative certified copies of the resolutions duly adopted by (A) the board of
managers (or equivalent governing bodies) of each of the Stock Purchaser, Parent and Merger Sub and (B) Parent in its capacity as the sole member of Merger Sub, in each case authorizing the execution, delivery and performance of this Agreement,
the Transaction Documents and the consummation of all transactions contemplated hereby; 
 (m) the Parties shall deliver the Escrow
Agreement duly executed by Parent, the Sellers’ Representative and the Escrow Agent; 
 (n) the employment agreement duly executed and
delivered by Farnsworth and the Operating Company; 
 (o) the employment agreements duly executed and delivered by each Key Employee and
the Operating Company; 
 (p) the Company shall deliver the Written Consent; 

(q) the Operating Company shall deliver a certificate executed by an officer of the Operating Company as of the Closing Date certifying as
to: (A) the certificate of formation of the Operating Company, as in effect at the time of the Closing; and (B) the Operating Agreement of the Operating Company, as in effect at the time of the Closing; 

  
 20 

 (r) the Company shall deliver a certificate executed by an officer of the Company as of the
Closing Date certifying as to: (i) the certificate of formation of the Company, as in effect immediately prior to the Closing; (ii) the Operating Agreement of the Company, as in effect immediately prior to the Closing and (iii) the
resolutions duly adopted by the Company Board authorizing the execution, delivery and performance of this Agreement and the consummation of all transactions contemplated hereby; 

(s) HealthHelp Corp shall deliver a certificate executed by an officer of HealthHelp Corp as of the Closing Date certifying as to:
(i) the certificate of incorporation of HealthHelp Corp, as in effect at the time of the Closing; and (ii) the Bylaws of HealthHelp Corp in effect at the time of the Closing and (iii) the resolutions duly adopted by the board of
directors of HealthHelp Corp authorizing the execution, delivery and performance of this Agreement and the consummation of all transactions contemplated hereby; 

(t) the Sellers’ Representative shall deliver a validly completed and executed Internal Revenue Service Form W-8 BEN or Form W-9, as applicable, from each HealthHelp Corp Seller establishing such HealthHelp Corp Seller’s exemption from withholding Tax; 

(u) the Company shall deliver a written consent to assignment from XXXX, as required pursuant to the XXXX Contract, in connection with the
transactions contemplated hereby, in the form attached hereto as Exhibit B; and 
 (v) the Operating Company shall deliver an
amendment to the HCCA Agreement, in the form attached hereto as Exhibit C. 
 2.12 Determination of Post-Closing
Adjustment. 
 (a) Promptly, but in any event within ninety (90) days after the Closing Date, Purchaser and its auditors shall
prepare and deliver to the Sellers’ Representative a statement, duly certified by the Stock Purchaser and Parent as accurately setting forth Purchaser’s good faith determination of (i) the Cash of the HealthHelp Entities and
HealthHelp Corp as of immediately prior to the Closing, (ii) the Sellers’ Transaction Expenses, (iii) the Indebtedness of the HealthHelp Entities and HealthHelp Corp as of immediately prior to the Closing, and (iv) the Working
Capital of the HealthHelp Entities as of 11:59 p.m. on the date immediately preceding the Closing Date, in each case as determined on a consolidated basis in accordance with GAAP, applied on a basis consistent with the Accounting Principles,
together with (x) the consolidated balance sheet of the HealthHelp Entities as of the Closing and the balance sheet of HealthHelp Corp as of the Closing (the “Closing Balance Sheet”) from which such determinations were derived,
and (y) such other information on which the calculations reflected thereon are based, in such detail as shall be reasonably acceptable to the Sellers’ Representative (such statement, together with such accompanying balance sheet and other
information, the “Closing Statement”). 

  
 21 

 (b) If the Sellers’ Representative disagrees with Purchaser’s determination of the
Cash, Indebtedness, Working Capital and/or the Sellers’ Transaction Expenses, in each case as reflected on the Closing Statement, the Sellers’ Representative may, within thirty (30) days after receipt of the Closing Statement, deliver
a written notice (the “Dispute Notice”) to Purchaser setting forth the Sellers’ Representative’s calculation of each disputed amount (each an “Item of Dispute”). The Sellers’ Representative shall have
reasonable access to (i) all books and records and work papers (including those of Purchaser’s, HealthHelp Corp’s and the HealthHelp Entities’ accountants and auditors), but only to the extent such information specifically
relates to the Closing Statement, (ii) such historical financial information (to the extent in Purchaser’s possession) and all other items relating to the Closing Statement as is reasonably requested by the Sellers’ Representative and
(iii) employees and accountants of Purchaser, HealthHelp Corp and the HealthHelp Entities to the extent access of such individuals is reasonably necessary to assist the Sellers’ Representative in its review of such work papers and the
Closing Statement; provided, that in each case, such access shall be in a manner that does not interfere with the normal business operations of Purchaser, HealthHelp Corp or the HealthHelp Entities. If Purchaser does not receive a Dispute
Notice within thirty (30) days after receipt by the Sellers’ Representative of the Closing Statement, the Closing Statement shall be conclusive and binding upon each of the Parties. If Purchaser receives a Dispute Notice from the
Sellers’ Representative within thirty (30) days after receipt by the Sellers’ Representative of the Closing Statement, Purchaser and the Sellers’ Representative shall use reasonable efforts to resolve each Item of Dispute, and,
if any Item of Dispute is so resolved, the Closing Statement shall be modified to the extent necessary to reflect such resolution. If any Item of Dispute remains unresolved as of the thirtieth
(30th) day after delivery by the Sellers’ Representative of the Dispute Notice, Purchaser and the Sellers’ Representative shall jointly retain PricewaterhouseCoopers LLP or such other
independent valuation firm of recognized international standing that is reasonably acceptable to Purchaser and the Seller’ Representative (the “Valuation Firm”) to resolve such remaining disagreement, it being understood that
any item not included as an Item of Dispute in the Dispute Notice shall be conclusive and binding upon each of the Parties as set forth in the Closing Statement. If Purchaser and Sellers’ Representative are unable to agree on the choice of the
Valuation Firm, then the Valuation Firm will be selected jointly by a public accounting firm of recognized national standing designated by the Sellers’ Representative and a public accounting firm of a recognized national standing designated by
Purchaser. Purchaser and the Sellers’ Representative shall request that the Valuation Firm render a determination as to each unresolved Item of Dispute within thirty (30) days after its retention, and Purchaser and the Sellers’
Representative shall, and Purchaser shall cause HealthHelp Corp and the HealthHelp Entities and each of their respective agents and representatives to, cooperate fully with the Valuation Firm so as to enable it to make such determination as quickly
and accurately as reasonably practicable, including by the provision by Purchaser, HealthHelp Corp and the HealthHelp Entities of all books and records and work papers (including those of their accountants and auditors), but only to the extent such
information specifically relates to the Closing Statement, and all other items reasonably requested by the Valuation Firm (in each case in such a manner so as not to waive or eliminate any privilege applicable to any such information). The Valuation
Firm shall consider only those items and amounts that were set forth on the Closing Statement and the Dispute Notice that remain unresolved by Purchaser and the Sellers’ Representative. In resolving any Item of Dispute, the Valuation Firm may
not assign a value to any item greater than the greatest value for such item claimed by either Party, or less than the smallest value for such item claimed by either Party, on the Closing Statement or the Dispute Notice, as applicable. The Valuation
Firm’s determination(s) shall be made in accordance with GAAP, applied in a manner consistent with the Accounting Principles, and shall be based upon the definitions of Cash, Sellers’ Transaction Expenses, Indebtedness and Working Capital
(as applicable) included herein, and shall not be an independent review. The Valuation Firm’s determination of each Item of Dispute submitted to it shall be in writing, shall conform with this Section 2.12 and shall be
conclusive and binding upon each of the Parties, and the Closing Statement shall be modified to the extent necessary to reflect such determination(s). The Valuation Firm shall allocate its fees, costs and expenses between Purchaser on the one hand,
and the Sellers’ Representative on the other hand, based upon the percentage which the portion of the contested amount not awarded to each such Party bears to the amount actually contested by such Party. The Cash of the HealthHelp Entities and
HealthHelp Corp, Sellers’ Transaction Expenses, Indebtedness of the HealthHelp Entities and HealthHelp Corp and the Working Capital of the HealthHelp Entities, in each case as finally determined pursuant to this
Section 2.12, are referred to herein as the “Actual Cash,” “Actual Sellers’ Transaction Expenses,” the “Actual Indebtedness” and the “Actual Working
Capital”, respectively. The Aggregate Closing Consideration as calculated using Actual Cash (instead of Estimated Cash), Actual Sellers’ Transaction Expenses (instead of Estimated Sellers’ Transaction Expenses), Actual
Indebtedness (instead of Estimated Indebtedness) and Actual Working Capital (instead of Estimated Working Capital) are referred to herein as the “Actual Aggregate Closing Consideration”. 

  
 22 

 (c) Payment to Purchaser. If the Actual Aggregate Closing Consideration as finally
determined is less than the Aggregate Closing Consideration (such shortfall, the “Shortfall Amount”), the Sellers’ Representative and Purchaser shall jointly instruct the Escrow Agent to pay, within five (5) Business Days
after such determination, (i) in the event that the Shortfall Amount is equal to or less than the amount of funds in the Escrow Fund (A) to Purchaser, by wire transfer of immediately available funds from the Escrow Fund to a bank account
designated in writing by Purchaser, the Shortfall Amount, and (B) to the Sellers’ Representative (for distribution to the Unitholders (other than HealthHelp Corp) and the HealthHelp Corp Sellers in accordance with the Distribution
Waterfall), the then-remaining balance of the Escrow Fund, if any, by wire transfer of immediately available funds to a bank account designated in writing by the Sellers’ Representative; provided, that in the event that the Shortfall
Amount exceeds the funds in the Escrow Fund (the amount of such excess, if any, the “Excess Shortfall Amount”), then the Seller Indemnifying Parties, severally in accordance with their Pro Rata Shares, shall pay or cause to be paid
to Purchaser the Excess Shortfall Amount. 
 (d) Payment to the Sellers’ Representative. If the Actual Aggregate
Closing Consideration as finally determined is more than the Aggregate Closing Consideration (such excess, the “Excess Amount”), Purchaser shall (i) pay, within five (5) Business Days after such determination, to the
Sellers’ Representative (for distribution to the Unitholders (other than HealthHelp Corp) and the HealthHelp Corp Sellers in accordance with the Distribution Waterfall), by wire transfer of immediately available funds to a bank account
designated in writing by the Sellers’ Representative, cash in an amount equal to the Excess Amount and (ii) jointly with the Sellers’ Representative, instruct the Escrow Agent to pay, within five (5) Business Days after such
determination to the Sellers’ Representative (for distribution to the Unitholders (other than HealthHelp Corp) and the HealthHelp Corp Sellers in accordance with the Distribution Waterfall), the amount in the Escrow Fund in its entirety by wire
transfer of immediately available funds to a bank account designated in writing by the Sellers’ Representative. 

  
 23 

 2.13 Deferred Payments. In addition to the payments provided for elsewhere in this
Agreement, the Unitholders (other than HealthHelp Corp) and the HealthHelp Corp Sellers shall have a contingent right to the following payments, in accordance with and subject to the terms and conditions of this
Section 2.13. 
 (a) 2017 General Deferred Payment. No later than March 31, 2018, Purchaser shall
pay, or cause to be paid, to the Sellers’ Representative, for further distribution to the General Holdback Sellers in accordance with the Distribution Waterfall, an amount in cash equal to the 2017 General Deferred Payment Amount;
provided, that the 2017 General Deferred Payment Amount shall only become payable hereunder if the XXXX Condition shall have been satisfied for the Company’s 2017 fiscal year. 

(b) 2018 General Deferred Payment. No later than March 31, 2019, Purchaser shall pay, or cause to be paid, to the Sellers’
Representative, for further distribution to the General Holdback Sellers in accordance with the Distribution Waterfall, an amount in cash equal to the 2018 General Deferred Payment Amount; provided, that the 2018 General Deferred Payment
Amount shall only become payable hereunder if the XXXX Condition shall have been satisfied for the Company’s 2018 fiscal year. 
 (c)
2017 Farnsworth Deferred Payment. No later than March 31, 2018, Purchaser shall pay, or cause to be paid, to an account designated in writing by Farnsworth, an amount in cash equal to the 2017 Farnsworth Deferred Payment Amount;
provided, that the 2017 Farnsworth Deferred Payment Amount shall only become payable hereunder if the XXXX Condition shall have been satisfied for the Company’s 2017 fiscal year. 

(d) 2018 Farnsworth Deferred Payment. No later than March 31, 2019, Purchaser shall pay, or cause to be paid, to an account
designated in writing by Farnsworth, an amount in cash equal to the 2018 Farnsworth Deferred Payment Amount; provided, that the 2018 Farnsworth Deferred Payment Amount shall only become payable hereunder if the XXXX Condition shall have been
satisfied for the Company’s 2018 fiscal year. 
 (e) 2017 Farnsworth Supplemental Deferred Payment. No later than thirty
(30) days following the first (1st) anniversary of the Closing Date, Purchaser shall pay, or cause to be paid, to an account designated in writing by Farnsworth, an amount in cash equal to
XXXX of the Farnsworth Holdback Amount; provided, that such amount shall only become payable hereunder if Farnsworth’s employment with the Operating Company (and/or its Affiliates) shall not have been terminated (y) for
“Cause” (as defined in the Employment Agreement, dated on or about the date hereof, between the Operating Company and Farnsworth (the “Employment Agreement”)) or (z) by Farnsworth without “Good Reason” (as
defined in the Employment Agreement), in either case prior to the first (1st) anniversary of the Closing Date. 

  
 24 

 (f) 2018 Farnsworth Supplemental Deferred Payment. No later than thirty (30) days
following the second (2nd) anniversary of the Closing Date, Purchaser shall pay, or cause to be paid, to an account designated in writing by Farnsworth, an amount in cash equal to XXXX of the
Farnsworth Holdback Amount; provided, that such amount shall only become payable hereunder if Farnsworth’s employment with the Operating Company (and/or its Affiliates) shall not have been terminated (y) for “Cause” (as
defined in the Employment Agreement) or (z) by Farnsworth without “Good Reason” (as defined in the Employment Agreement), in either case prior to the second (2nd) anniversary of the
Closing Date. 
 (g) Calculation; Dispute Resolution. On the applicable date of determination with respect to the payments provided
for in Section 2.13(a) through (d), Purchaser shall deliver to the Sellers’ Representative a statement setting forth (i) Purchaser’s determination of whether a payment is due and payable under the applicable provision of
this Section 2.13, and (ii) the calculations and/or evidence supporting such determination in such detail as shall be reasonably acceptable to the Sellers’ Representative. If the Sellers’ Representative
disagrees with such statement, it may, within thirty (30) days after receipt of such statement, deliver a written notice to Purchaser setting forth its calculations relating to the disputed items. Within thirty (30) days’ after
receipt of such written notice, Purchaser and the Sellers’ Representative shall use reasonable efforts to resolve each such disputed item. If any disputed item remains unresolved as of the thirtieth (30th) day after receipt by Purchaser of such written notice, Purchaser and the Sellers’ Representative shall jointly retain the Valuation Firm (which decision of the Valuation Firm shall be final
and binding on all the Parties) to resolve such remaining disagreements. The other provisions of Section 2.12(b) shall apply to this Section 2.13(g) mutatis mutandis. 

(h) The payments pursuant to Section 2.13 shall be made to Farnsworth and/or the Sellers’ Representative, as
applicable, in cash by wire transfer of immediately available funds to an account designated by the applicable payee within three (3) Business Days of the final determination of the payment amount (if any) pursuant to this
Section 2.13. 
 (i) Purchaser shall have the right to operate the business and activities of Purchaser and the
HealthHelp Entities following the Closing in any way that Purchaser deems appropriate in its sole discretion. The Parties acknowledge and agree that this Section 2.13 shall not create any duty of Purchaser or the HealthHelp
Entities to Farnsworth or the General Holdback Sellers, including any fiduciary duty or any other express or implied duty, other than a duty of good faith and fair dealing. 

(j) The Parties do not intend the right of Farnsworth or the General Holdback Sellers to receive the payments provided for in this
Section 2.13 to be a security. Accordingly, the right of Farnsworth or the General Holdback Sellers to receive the payments provided for in this Section 2.13 (A) shall not be represented by a
certificate, (B) does not represent an ownership interest in the Stock Purchaser, Parent or the HealthHelp Entities, and (C) does not entitle Farnsworth or the General Holdback Sellers to any rights common to equity holders of Purchaser or
the HealthHelp Entities. 

  
 25 

 (k) Definitions.  

(i) “2017 Actual Revenue Percentage” means a fraction, expressed as a percentage, the numerator of which is
the Actual XXXX Revenue for the Company’s 2017 fiscal year, and the denominator of which is the XXXX Revenue Target. 

(ii) “2017 Farnsworth Deferred Payment Amount” means an amount in cash equal to the product obtained by
multiplying (i) XXXX of the Farnsworth Holdback Amount by (ii) a fraction, the numerator of which is the 2017 Actual Revenue Percentage XXXX and the denominator of which is XXXX (it being understood that in no event shall the 2017 Farnsworth
Deferred Payment Amount be less than zero nor more than XXXX of the Farnsworth Holdback Amount). 
 (iii) “2017
General Deferred Payment Amount” means an amount in cash equal to the product obtained by multiplying (i) XXXX of the General Holdback Amount by (ii) a fraction, the numerator of which is the 2017 Actual Revenue Percentage XXXX and the
denominator of which is XXXX (it being understood that in no event shall the 2017 General Deferred Payment Amount be less than zero nor more than XXXX of the General Holdback Amount). 

(iv) “2018 Actual Revenue Percentage” means a fraction, expressed as a percentage, the
numerator of which is the Actual XXXX Revenue for the Company’s 2018 fiscal year, and the denominator of which is the XXXX Revenue Target. 

(v) “2018 Farnsworth Deferred Payment Amount” means an amount in cash equal to the product obtained by
multiplying (i) XXXX of the Farnsworth Holdback Amount by (ii) a fraction, the numerator of which is the 2018 Actual Revenue Percentage XXXX and the denominator of which is XXXX (it being understood that in no event shall the 2018 Farnsworth
Deferred Payment Amount be less than zero nor more than XXXX of the Farnsworth Holdback Amount). 
 (vi) “2018
General Deferred Payment Amount” means an amount in cash equal to the product obtained by multiplying (i) XXXX of the General Holdback Amount by (ii) a fraction, the numerator of which is the 2018 Actual Revenue Percentage XXXX and the
denominator of which is XXXX (it being understood that in no event shall the 2018 General Deferred Payment Amount be less than zero nor more than XXXX of the General Holdback Amount). 

(vii) “Actual XXXX Revenue” means, with respect to any fiscal year of the Company, the actual revenue
associated with XXXX in such fiscal year, in each case determined in accordance with GAAP. 
 (viii) “Farnsworth
Holdback Amount” means XXXX 

  
 26 

 (ix) “General Holdback Amount” means XXXX. 

(x) “General Holdback Sellers” means, collectively, (i) the Unitholders (other than Farnsworth and
HealthHelp Corp) and (ii) the HealthHelp Corp Sellers. 
 (xi) “XXXX” means XXXX, together with its
Affiliates. 
 (xii) “XXXX Condition” means, with respect to any fiscal year of the Company, (A) the
XXXX Contract being in effect on the last Business Day of such fiscal year, (B) XXXX having not, during such fiscal year, provided any notice to the Company that it intends to terminate the XXXX Contract, (C) the Company having no
Knowledge that XXXX intends to terminate the XXXX Contract and (D) the Actual XXXX Revenue for such fiscal year exceeding XXXX of the XXXX Revenue Target. 

(xiii) “XXXX Contract” means the XXXX, by and between the Operating Company and XXXX, including all
amendments, extensions, supplements and modifications thereto from time to time, with the most recent amendment dated XXXX, and all exhibits, statements of work or their equivalent executed in connection therewith describing the services to be
provided by the Operating Company to XXXX and its Affiliates. 
 (xiv) “XXXX Revenue Target” means XXXX.

 (l) For the avoidance of doubt, (i) any portion of the Farnsworth Holdback to which Farnworth is entitled under this Agreement
shall be paid to Farnsworth by Parent (and not Stock Purchaser) as deferred purchase price in consideration for Farnsworth’s Company Units and (ii) any portion of the General Holdback to which the General Holdback Sellers are entitled
under this Agreement shall be paid to the Unitholders (other than HealthHelp Corp) by Parent (and not Stock Purchaser) as deferred purchase price in consideration for their Company Units and to the HealthHelp Corp Sellers by Stock Purchaser (and not
Parent) as deferred purchase price in consideration of their HealthHelp Corp Stock. 
 (m) Purchaser, the Surviving Company and the
Sellers’ Representative agree for all Tax purposes: (i) the rights of (A) Farnsworth to the Farnsworth Holdback Amount (or any portion thereof) and (B) the General Holdback Sellers to the General Holdback Amount (or any portion
thereof), in each case, shall be treated as deferred contingent purchase price for the disposition of their Company Units and the HealthHelp Corp Stock, as applicable, eligible for installment sale treatment under Section 453 of the Code and
any corresponding provision of state, local or non-U.S. applicable Law and (ii) if and to the extent any amount of the Farnsworth Holdback Amount or General Holdback Amount is actually distributed to
Farnsworth or the General Holdback Sellers, as applicable, interest may be imputed on such amount as required by Section 483 or Section 1274 of the Code. All Parties hereto shall file all Tax Returns consistently with the foregoing.  

  
 27 

 2.14 Allocation of Amounts Paid By Purchaser or Merger Sub. The Aggregate Final
Consideration and the portion of the liabilities of the HealthHelp Entities (plus other relevant capitalizable items of Parent) attributable to the transfer of Company Units (other than the HealthHelp Corp Units) pursuant to the Merger and the
resulting inside basis adjustments to the assets of the Company with respect to Parent shall be allocated for all purposes (including Tax) (the “Purchase Price Allocation”) among the assets of the Company as of the Closing Date in a
manner consistent with the Purchase Price Allocation methodology set forth in Schedule 2.14 and all applicable Tax Law requirements (including, without limitation, Sections 743, 751 and 755 of the Code). Parent shall prepare a draft of
such allocation consistent with the methodology set forth in Schedule 2.14 by the earlier of sixty (60) days following the determination of Aggregate Final Consideration or the date such basis adjustments are required to be made under
applicable law, and shall submit such allocation to the Sellers’ Representative for its review and approval. Parent shall make such revisions as are reasonably requested by Sellers’ Representative; provided, that such revisions are
consistent with the methodology set forth on Schedule 2.14. Each of the Parties shall file all Tax Returns (including amended returns and claims for refund) and information reports for Tax purposes in a manner consistent with the
Purchase Price Allocation. In the event there is a dispute with respect to the Purchase Price Allocation, Parent and the Sellers’ Representative shall jointly retain a Valuation Firm (which decision of the Valuation Firm shall be final and
binding on all the Parties) to resolve such dispute; provided, that any decision of the Valuation Firm shall be made in a manner consistent with the Purchase Price Allocation methodology set forth in Schedule 2.14 and all applicable
Tax Law requirements. The other provisions of Section 2.12(b) shall apply to this Section 2.14 mutatis mutandis. Any adjustments to the Aggregate Final Consideration applicable to the transfer of
Company Units (other than HealthHelp Corp Units) pursuant to the Merger shall be allocated in a manner consistent with such methodology. 

2.15 Distribution Waterfall. The Parties hereby agree that, except as otherwise provided herein, the Distribution Waterfall shall
govern the allocation among the Unitholders (other than HealthHelp Corp) and the HealthHelp Corp Sellers of any payments to or from the Unitholders (other than HealthHelp Corp) and/or the HealthHelp Corp Sellers that are contemplated by this
Agreement. The Company, Farnsworth, the Sellers’ Representative and the HealthHelp Corp Sellers hereby agree that the Distribution Waterfall has been prepared in accordance with the priorities set forth in the Company LLC Agreement, as in
effect on the date hereof, as amended by this Section 2.15. The calculations and formulae contained in the Distribution Waterfall shall, among other things, provide for the allocation solely to the HealthHelp Corp Sellers
(and not the Unitholders) of any increase or decrease in the Aggregate Closing Consideration and/or Aggregate Final Consideration which is attributable to (y) any Cash held in accounts in the name or for the benefit of HealthHelp Corp or
(z) the HealthHelp Corp Unpaid Taxes. To the extent that the allocation of the Aggregate Closing Consideration and/or Aggregate Final Consideration in accordance with the Distribution Waterfall and this Agreement would constitute an amendment
to the Company LLC Agreement, each of the Company, Farnsworth and HealthHelp Corp hereby consents to such amendment. 

  
 28 

 ARTICLE 3 

REPRESENTATIONS AND WARRANTIES REGARDING THE HEALTHHELP ENTITIES 

As a material inducement to Purchaser and Merger Sub to enter into this Agreement, the Company hereby represents and warrants to Purchaser and
Merger Sub as follows: 
 3.1 Organization. Each HealthHelp Entity is duly organized as a limited liability company, validly existing
and in good standing under the laws of the State of Delaware. Each HealthHelp Entity is duly qualified, licensed or admitted to do business as a foreign entity and is in good standing in every jurisdiction in which the operation of its business or
the ownership of its assets requires it to be so qualified, licensed, admitted or in good standing, except to the extent the failure to be so qualified, licensed, admitted or in good standing would not have a Material Adverse Effect. Other than as
disclosed on Schedule 3.1, the HealthHelp Entities have not engaged in any trade or business other than the Business or conducted business under any name (including any “trading” or “doing business as” name) other
than their current or former corporate legal names. The organizational documents of each HealthHelp Entity, which have previously been furnished to Purchaser in the Data Room, reflect all amendments thereto, and are true, correct and complete in all
material respects. 
 3.2 Power; Authorization of Transactions. Each HealthHelp Entity has all requisite limited liability
company power and authority to carry on the Business as now conducted. The Company has all requisite limited liability company power and authority to execute and deliver this Agreement and the Transaction Documents to which the Company is a party
and to perform its obligations hereunder and thereunder. The execution, delivery and performance by the Company of this Agreement and the Transaction Documents and each of the transactions contemplated hereby or thereby have been duly and validly
authorized by the Company Board and pursuant to the Written Consent, and no other act or proceeding on the part of the Company, the Company Board or the Unitholders is necessary to authorize the execution, delivery or performance by the Company of
this Agreement or the Transaction Documents or the consummation of any of the transactions contemplated hereby or thereby. This Agreement and the Transaction Documents to which the Company is a party have been or will be duly executed and delivered
by the Company, and, assuming the due execution and delivery of this Agreement, and the Transaction Documents to which the Company is a party by the other parties hereto and thereto, this Agreement and the Transaction Documents, upon execution and
delivery by the Company, will each constitute, a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by (a) applicable insolvency, bankruptcy,
reorganization, moratorium or other similar Laws affecting creditors’ rights generally, and (b) applicable equitable principles (whether considered in a proceeding at Law or in equity). 

  
 29 

 3.3 Capitalization and Subsidiaries. Schedule 3.3 accurately sets forth the
authorized, issued and outstanding equity of each HealthHelp Entity and the name and number of equity interests held by each stockholder or member thereof. There are no membership interests held by the Company in treasury nor are there any
membership interests outstanding but not issued. All of the issued and outstanding equity of each HealthHelp Entity has been validly issued, fully paid and non-assessable, and are owned of record and
beneficially by its respective stockholder or member thereof as set forth on Schedule 3.3, free and clear of all Liens. None of the equity interests of either HealthHelp Entity were issued in violation of any applicable Law or Material
Contract to which the HealthHelp Corp or any of the HealthHelp Entity is a party or by which any of them is bound or is subject to or in violation of any preemptive or similar rights of any Person. Except as set forth in this Agreement and on
Schedule 3.3, there are no outstanding or authorized options, warrants, rights, voting trusts, proxies, contracts, pledges, calls, puts, rights to subscribe, conversion rights or other agreements or commitments to which any HealthHelp Entity
is a party or which is binding upon any HealthHelp Entity providing for the issuance, disposition or acquisition of any of its equity or any rights or interests exercisable therefor, or which could affect the ability of HealthHelp Corp, HealthHelp
Corp Sellers or any HealthHelp Entity to consummate the transactions contemplated hereby. There are no outstanding or authorized equity appreciation, phantom stock or similar rights with respect to any HealthHelp Entity. Except as set forth on
Schedule 3.3, no HealthHelp Entity owns or controls (directly or indirectly) any stock, partnership interest, joint venture interest, equity participation or other security or interest in any other Person. 

3.4 No Breach. Except as set forth on Schedule 3.4, the execution, delivery and performance by the Company of this Agreement and
the Transaction Documents to which the Company is a party and the consummation of each of the transactions contemplated hereby or thereby do not and will not (a) conflict with or result in violation or breach of, or default under, any provision
of the organizational documents of any HealthHelp Entity, (b) assuming compliance by Purchaser with Section 6.5, conflict with or result in violation or breach of any provision of any Law or require any authorization,
consent, approval, exemption or notice to any Governmental Authority under the provisions of any Law (except for the filing and recordation of the Certificate of Merger as required by the DLLCA), to which any HealthHelp Entity is subject, except, in
the case of clause (b), where the violation, conflict, breach, failure to give such notice, to file, or to obtain any such authorization, consent, approval or exemption would not reasonably be expected to be material to the Company,
(c) violate, conflict with, result in a breach of, constitute a default under, result in the acceleration of, or create in any party the right to accelerate, terminate, modify or cancel any Material Contract or any material Permit affecting the
Business, or (d) result in the creation or imposition of any Liens (other than Permitted Liens) on any properties or assets of the HealthHelp Entities. 

  
 30 

 3.5 Financial Statements. 

(a) Schedule 3.5 sets forth a true, correct and complete copy of the following financial statements (the “Financial
Statements”): 
 (i) the unaudited consolidated balance sheet of the HealthHelp Entities as of January 31,
2017 (the “Latest Balance Sheet”) and the related unaudited consolidated statements of operations, owners’ equity and cash flows for the twelve (12)-month period then ended; and 

(ii) the audited consolidated balance sheet of the HealthHelp Entities as of December 31, 2015, and the related audited
consolidated statements of operations, owner’s equity and cash flows for the fiscal year then ended (the “Audited Balance Sheet”). 

Except as set forth on Schedule 3.5, each of the Financial Statements presents fairly in all material respects the consolidated financial condition,
results of operations and cash flows of the HealthHelp Entities throughout the periods covered thereby and such Financial Statements have been prepared in accordance with GAAP consistently applied throughout the periods indicated (except that the
unaudited Financial Statements are subject to normal and recurring year-end adjustments and reclassifications and lack footnote disclosure and other presentation items). 

(b) The HealthHelp Entities maintain and have maintained a system of internal accounting controls and procedures sufficient to reasonably
ensure in all material respects that: (i) all transactions are executed in accordance with the general or specific authorization of the management of the HealthHelp Entities; (ii) all transactions are recorded as necessary in order to
permit the preparation of the Financial Statements in conformity with GAAP, (iii) use of the HealthHelp Entities’ assets is permitted only in accordance with the general or specific authorization of the HealthHelp Entities’
management; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. None of the HealthHelp Entities, HealthHelp Corp or the
HealthHelp Corp Sellers has received or otherwise obtained Knowledge of any Liability regarding the inadequacy of such systems and procedures or the inaccuracy or lack of integrity of the Financial Statements. The HealthHelp Entities do not maintain
and have not maintained any off-the-books accounts. 
 3.6
Indebtedness/Undisclosed Liabilities. 
 (a) None of the HealthHelp Entities has any Indebtedness which constitutes indebtedness for
borrowed money of the HealthHelp Entities and HealthHelp Corp, other than Indebtedness that is being paid pursuant to the Section 2.11(e) of this Agreement or which will otherwise be taken into account in the final determination of the Actual
Aggregate Closing Consideration. 
 (b) None of the HealthHelp Entities has any Liabilities of the type which would be required under GAAP
to be disclosed on the financial statements of the HealthHelp entities and to the Knowledge of the Company, none of the HealthHelp Entities has any other Liabilities of any kind, in each case, except (i) those which are adequately reflected or
reserved against in the Latest Balance Sheet as of the date of the Latest Balance Sheet, (ii) obligations arising under the Contracts of HealthHelp Corp or any HealthHelp Entity in effect on the date hereof (other than any such obligations
arising out of a breach of any such Contract), (iii) those which have been incurred in the ordinary course of business consistent with past practice since the Latest Balance Sheet date and which are not, individually or in the aggregate, material in
amount, and (iv) as otherwise disclosed or described in Schedule 3.6(b). None of the HealthHelp Entities has made, or entered into commitments to make, any capital expenditures since the Latest Balance Sheet date outside the
ordinary course of business consistent with the past practice. 

  
 31 

 3.7 Absence of Certain Developments. Except as set forth on Schedule 3.7, since the
date of the Latest Balance Sheet, (a) there has not been any Material Adverse Effect, (b) the HealthHelp Entities have conducted their business in the ordinary course of business consistent with past practice, and (c) no HealthHelp
Entity has: 
 (i) sold, leased, assigned, licensed or transferred any of its material properties or assets or portion
thereof, other than in the ordinary course of business consistent with past practice and other than sales of obsolete assets or assets with no book value; 

(ii) created, incurred, assumed or guaranteed any Indebtedness outside the ordinary course of business involving more than
$250,000 (other than borrowings under any Indebtedness that shall be fully repaid pursuant to Section 2.11(e)); 

(iii) amended or authorized the amendment of any of its governing and organizational documents or entered into any
indemnification or similar Contracts with directors, managers, officers or employees; 
 (iv) made any material change in
its accounting methods or practices, except in so far as was required by a change in GAAP; 
 (v) made any loan to, or any
acquisition of substantially all of the assets of (including by merger or consolidation), any other Person, in each case involving a payment by such HealthHelp Entity in excess of $250,000; 

(vi) reclassified, split, combined or subdivided, directly or indirectly, any of its equity interest; 

(vii) effected, established or adopted or entered into any plan with respect to any restructuring, reorganization,
recapitalization or complete or partial liquidation; 
 (viii) entered into any joint venture, partnership, limited
liability company agreement or similar arrangement; 
 (ix) granted or paid any material increase in the compensation of any
of its directors, officers or Key Employees, other than in the ordinary course of business, as required by Law, or required pursuant to the terms of an Employee Plan or other written Contract with such director, officer or Key Employee; 

  
 32 

 (x) had any material damage, destruction or loss to its property to the extent
not covered by insurance; 
 (xi) committed to make any single capital expenditure in excess of $250,000 or aggregate
capital expenditures in excess of $250,000 which expenditures have not been satisfied in full prior to the date hereof; 

(xii) entered into a new line of business or abandoned or discontinued any existing lines of business; 

(xiii) disclosed to any Person any trade secret, process, technology, know-how or
other confidential or proprietary information of the HealthHelp Entities, not heretofore a matter of public knowledge, except in the ordinary course of business consistent with past practice and in accordance with any applicable confidentiality or
proprietary agreements restricting the disclosure of such trade secrets, formulas, processes, technologies, know-how or other confidential or proprietary information; 

(xiv) (A) made, changed or revoked any material Tax election, changed any method of Tax accounting, filed any amended Tax
Return, surrendered any right to claim a refund of Taxes or consented to any extension or waiver of the limitation period applicable to any material Tax claim or assessment or (B) entered into any closing, settlement or other agreement with any
Governmental Authority relating to material Taxes of the HealthHelp Entities; 
 (xv) terminated any Key Employee or
received any resignation, notice or indication from any Key Employee that such Key Employee intends to terminate his/her employment with any HealthHelp Entity; or 

(xvi) entered into any Contract to do any of the foregoing. 

3.8 Real Property. 
 (a)
No Owned Real Property. Since January 1, 2014, the HealthHelp Entities have not owned any real property. 
 (b) Leased Real
Property. Schedule 3.8(b) sets forth the address of each Leased Real Property as of the date hereof and all applicable lease, sublease or license agreements (including all amendments) related thereto (each, a “Lease”).
Except as set forth on Schedule 3.8(b), with respect to each Lease: 
 (i) the Leased Real Property set forth on
Schedule 3.8(b) constitutes all of the real property utilized by the HealthHelp Entities and the Company has provided to Purchaser true, correct and complete copies of each such Lease; 

  
 33 

 (ii) to the Knowledge of the Company, such Lease is valid, binding and
enforceable against the applicable HealthHelp Entity, except as such enforceability may be limited by (A) applicable insolvency, bankruptcy, reorganization, moratorium or other similar Laws affecting creditors’ rights generally, and
(B) applicable equitable principles (whether considered in a proceeding at Law or in equity); 
 (iii) the HealthHelp
Entity party thereto has paid all rents and other charges to the extent due and payable as of the date of this Agreement under such Lease and is not in breach or default in any material respect under such Lease, and to the Knowledge of the Company,
no event has occurred or circumstance exists which, with the delivery of notice, the passage of time or both, would constitute such breach or default in any material respect. None of the HealthHelp Entities are parties to any written or oral lease,
assignment or similar arrangement under which any HealthHelp Entity, as a lessor, sublessor, assignor or otherwise, makes available for use by any third party any portion of the Leased Real Property; and 

(iv) no portion of the Leased Real Property, or any of the buildings or improvements located thereon or the use of the Leased
Real Property, is in material violation of any applicable Law. 
 3.9 Title to Tangible Assets. Except for properties and assets that
have been sold or otherwise disposed of by the HealthHelp Entities in the ordinary course of business consistent with past practice since the date of the Latest Balance Sheet, the HealthHelp Entities have good and valid title to, or a valid
leasehold interest in, all of the material tangible personal property used in the operation of the Business, including all the properties and assets reflected on the Latest Balance Sheet, subject to no Liens except Permitted Liens. 

3.10 Contracts and Commitments. 

(a) Schedule 3.10(a) lists all of the following Contracts to which any HealthHelp Entity is a party and which are in effect as of the
date hereof (collectively, the “Material Contracts”): 
 (i) all Contracts, or group of related Contracts,
with the top 5 clients of the HealthHelp Entities collectively (by revenue) during calendar year 2016 (collectively, the “Material Customers”) indicating the aggregate amount of the revenue paid by each such Material Customer to any
HealthHelp Entity during such periods; 
 (ii) all Contracts, or group of related Contracts, with the top 10 vendors of the
HealthHelp Entities collectively (by aggregate expenditure) during calendar year 2016 (collectively, the “Material Suppliers”), indicating the aggregate amount of expense paid by the HealthHelp Entities to each such Material
Supplier during such periods; 
 (iii) any Contract under which any HealthHelp Entity has any Indebtedness, including
guaranteed Indebtedness of others, in each case having an outstanding principal amount in excess of $250,000, but excluding intercompany indebtedness or endorsements for the purpose of collection; 

  
 34 

 (iv) any employment agreement or offer letter to which any HealthHelp Entity is
a party involving aggregate payments to any Person during Calendar year 2016 in excess of $100,000, or any Contract with independent contractors or consultants (or similar arrangements) to which any HealthHelp Entity is a party involving aggregate
payments to any Person during calendar year 2016 in excess of $250,000 or which contain severance or similar obligations on the part of any HealthHelp Entity; 

(v) all broker, distributor, dealer, manufacturer’s representative, franchise, agency, sales promotion, market research,
marketing consulting and advertising Contracts to which any HealthHelp Entity is a party involving aggregate payments to any Person during calendar year 2016 in excess of $100,000; 

(vi) all Contracts that limit or purport to limit the ability of any HealthHelp Entity to compete in any line of business or
with any Person or in any geographic area or during any period of time or to solicit any Person’s actual or prospective customers, suppliers, or vendors; 

(vii) all Contracts that require any HealthHelp Entity to purchase its total requirements of any product or service from a
third party or that contain “take or pay”; 
 (viii) any Contract containing a
so-called “most favored nation”, “meets competition” or “most favored customer” clause; 

(ix) all Contracts that provide for the indemnification by any HealthHelp Entity of any Person or the assumption of any Tax or
environmental Liability of any Person outside of the ordinary course of business that, to the Knowledge of the Company, could result in payments in excess of $250,000; 

(x) any Contract pursuant to which a partnership or joint venture was established by any HealthHelp Entity; 

(xi) all Contracts, entered into after January 1, 2014, that relate to the acquisition or disposition of any business, a
material amount of stock or assets of any other Person or any real property (whether by merger, sale of stock, sale of assets or otherwise); 

(xii) any Contract whereby any HealthHelp Entity is obligated to pay royalties or license fees to another Person (other than
any license of mass-marketed or otherwise generally available software) involving aggregate payments in any calendar year in excess of $250,000; 

  
 35 

 (xiii) all Contracts with any Governmental Authority to which any HealthHelp
Entity is a party; and 
 (xiv) any other Contract, in each case not included in Section 3.10(a)(i)- (xiii) or
otherwise set forth on Schedule 3.10(a), to which any HealthHelp Entity is a party or by or to which any of its assets are bound or subject which has future Liability to such HealthHelp Entity in excess of $250,000 per annum and is not
terminable by it upon notice of sixty (60) calendar days or less for a cost of less than $250,000 (other than (A) warranty obligations in the ordinary course of business and (B) purchase orders). 

(b) Except as disclosed on Schedule 3.10(b), each (i) Material Contract is (A) valid, binding and enforceable against the
applicable HealthHelp Entity except as such enforceability may be limited by (x) applicable insolvency, bankruptcy, reorganization, moratorium or other similar Laws affecting creditors’ rights generally, and (y) applicable equitable
principles (whether considered in a proceeding at Law or in equity) and (B) in full force and effect and (ii) HealthHelp Entity has performed all material obligations required to be performed by it to date under the Material Contracts to
which it is a party and is not (with or without the lapse of time or the giving of notice, or both) in breach or default in any material respect thereunder, or each HealthHelp Entity has obtained all necessary waivers with respect to any such non-performance, breach or default, and there does not exist, to the Knowledge of the Company, any event, condition or omission which would constitute a breach or default in any material respect, whether by lapse of
time or notice or both, by any other Person under any such Material Contract. As of the date of this Agreement, the HealthHelp Entities, HealthHelp Corp, or the HealthHelp Corp Sellers have not received written notice, or to the Knowledge of the
Company, oral notice, of (A) any default in any material respect by the HealthHelp Entities under any Material Contract or (B) any intention or desire of any Material Customer or Material Supplier to cancel or otherwise terminate or
materially and adversely modify its relationship with any HealthHelp Entity. A true, correct and complete copy of each written Material Contract (including all modifications, amendments and supplements thereto and waivers thereunder in writing) has
been made available in the Data Room or otherwise delivered to Purchaser. 
 3.11 Proprietary Rights. 

(a) Schedule 3.11 contains a complete and accurate list, as of the date hereof, of all (i) patented or registered Proprietary
Rights and pending patent applications and other applications for registration of Proprietary Rights owned by any HealthHelp Entity (the “Registered Proprietary Rights”), (ii) licenses granted by any HealthHelp Entity to any
third party with respect to any Proprietary Rights, (iii) licenses and sublicenses granted by any third party to any HealthHelp Entity with respect to any Proprietary Rights (other than any license of
mass-marketed or otherwise generally available software), and (iv) all proprietary software developed by or on behalf of any HealthHelp Entity and used in the operation of the Business. To the Knowledge
of the Company, all of the Registered Proprietary Rights are valid and enforceable, and are subsisting and in full force and effect. 

  
 36 

 (b) The HealthHelp Entities are the sole and exclusive legal and beneficial owners of all right,
title, and interest in and to the Proprietary Rights owned by the HealthHelp Entities, and the HealthHelp Entities have the valid and enforceable right to use all other Proprietary Rights used in or necessary for the conduct of the Business as
currently conducted, in each case, free and clear of all Liens (other than Permitted Liens). 
 (c) To the Knowledge of the Company, the
HealthHelp Entities have entered into binding, valid and enforceable written Contracts with each current and former employee and independent contractor who contributed to the invention, creation or development of any Proprietary Rights during the
course of employment or engagement with the HealthHelp Entities, whereby such employee or independent contractor (i) acknowledges the HealthHelp Entity’s exclusive ownership of all Proprietary Rights invented, created or developed by such
employee or independent contractor within the scope of his or her employment or engagement with the HealthHelp Entity; (ii) grants to the applicable HealthHelp Entity a present, irrevocable assignment of any ownership interest such employee or
independent contractor may have in or to such Proprietary Rights, to the extent such Proprietary Rights do not constitute a “work made for hire” under applicable Law; and (iii) irrevocably waives any right or interest, including any
moral rights, regarding any such Proprietary Rights, to the extent permitted by applicable Law. 
 (d) Neither the execution, delivery or
performance of this Agreement and the Transaction Documents, nor the consummation of the transactions contemplated hereunder and thereunder, will result in the loss or impairment of, or payment of any additional amounts with respect to, the
HealthHelp Entities’ right to own or use any Proprietary Rights used in or necessary for the conduct of the Business as currently conducted. 

(e) The HealthHelp Entities have taken commercially reasonable and necessary steps to maintain and enforce the Proprietary Rights and to
preserve the confidentiality of all trade secrets, know-how and confidential information included therein, including by requiring all Persons having access thereto to execute binding, written non-disclosure agreements. 
 (f) The HealthHelp Entities take commercially reasonable actions which are
consistent with industry standards to back up its computer systems and databases used or held for use in the Business in a manner sufficient to enable resumed or continued functioning in all material respects following a hardware, telecommunications
or related interruption or failure. 
 (g) To the Knowledge of the Company, since January 1, 2014, the operation of the Business as
formerly and presently conducted has not infringed or misappropriated the Proprietary Rights of any third party. To the Knowledge of the Company, no Person has infringed upon or misappropriated any of the Proprietary Rights owned by any HealthHelp
Entity. 

  
 37 

 3.12 Litigation; Proceedings. Except as set forth Schedule 3.12, there are no
Actions pending or, to the Knowledge of the Company, threatened and, since January 1, 2014, there have been no Actions that were resolved or settled for amounts in excess of $250,000, against any HealthHelp Entity or any of their respective
assets or the Business, at law or in equity, or before or by any Governmental Authority or arbitrator, and no event has occurred or circumstances exist that would reasonably be expected to give rise to, or serve as a basis for, any such Action,
except in each case as would not reasonably be expected to be material to the Company. No HealthHelp Entity is subject to any unsatisfied judgment, penalties, injunction, order or decree of any Governmental Authority. 

3.13 Compliance with Laws; Permits. 

(a) Except with respect to Environmental Matters (which are the subject of Section 3.14), Labor and Employment
Matters (which are the subject of Section 3.15), Employee Plans (which is the subject of Section 3.16) and Tax Matters (which are the subject of Section 3.17), to the
Knowledge of the Company, each HealthHelp Entity is and, since January 1, 2014, has been in compliance with all Laws applicable to the ownership and operation of the Business, except where the failure to comply would not reasonably be expected
to be material to the Company. To the Knowledge of the Company, as of the date of this Agreement, none of the HealthHelp Entities, HealthHelp Corp or HealthHelp Corp Sellers has received from any Person any written notice of any violation in any
material respect by any HealthHelp Entity of any Laws. 
 (b) To the Knowledge of the Company, (i) all permits, licenses, franchises,
approvals, authorizations, registrations, certificates, variances and similar rights obtained, or required to be obtained, from Governmental Authorities (“Permits”) required for any HealthHelp Entity to conduct the Business have
been obtained and are valid and in full force and effect, except where the failure to obtain or maintain the validity of such Permits would not reasonably be expected to be material to the Company, and (ii) all fees and charges with respect to
such Permits as of the date of this Agreement have been paid in full. Schedule 3.13(b) lists all current Permits issued to any HealthHelp Entity as of the date of this Agreement, including the names of the Permits and their respective dates
of issuance and expiration. To the Knowledge of the Company, each HealthHelp Entity has complied since January 1, 2014, and is now complying, with all of the Permits disclosed in Schedule 3.13(b) and no event has occurred that, with or
without notice or lapse of time or both, would reasonably be expected to result in the revocation, suspension, lapse or material limitation of any such Permit. As of the date of this Agreement, none of the HealthHelp Entities has, to the Knowledge
of Company, received any written communication regarding any material adverse change in the status or terms and conditions of any such Permit or that, by virtue of the transactions contemplated hereby, any such Permit may not be granted or renewed.

 3.14 Environmental Matters. To the Knowledge of the Company, each HealthHelp Entity is, and since January 1, 2014 was, in
compliance with all Environmental Laws, except where the failure to comply would not reasonably be expected to be material to the Company. To the Knowledge of the Company, no HealthHelp Entity has, since January 1, 2014, received any written
notice or Action regarding any violation of, or any material Liability or material investigatory, corrective or remedial obligation under, any Environmental Law. There are no Actions relating to the environmental matters pending against or involving
any HealthHelp Entities and, to the Knowledge of the Company, there is no reasonable basis for any Action relating to the environmental matters to be made against any HealthHelp Entity or which could, after the Closing, result in any Liability to
Purchaser or any of its Affiliates, except as would not reasonably be expected to be material to the Company. 

  
 38 

 3.15 Labor and Employment Matters. 

(a) None of the HealthHelp Entities is a party to any collective bargaining agreement with respect to employees of the HealthHelp Entities.
To the Knowledge of the Company, as of the date of this Agreement, there are no current union organizing activities among the employees of the HealthHelp Entities. There are no unfair labor practice charges or complaints pending, or to the Knowledge
of the Company, threatened against any HealthHelp Entity before the National Labor Relations Board. There is currently no work stoppage, strike or other material labor dispute by or with employees of the HealthHelp Entities (or their
representatives), nor, to the Knowledge of the Company, is any such dispute threatened. 
 (b) The Company has made available in the Data
Room a true, complete and correct list of all persons who are employees, independent contractors or consultants of the HealthHelp Entities as of December 31, 2016, including any employee who is on layoff, sick time, disability, or other leave
of absence. Except as set forth on Schedule 3.15(b), as of December 31, 2016, no employee or former employee of any HealthHelp Entity (or any spouse or dependent of such employee or former employee) is eligible to elect, has elected, or
is receiving any group health plan coverage that is required to be provided pursuant to Section 4980B of the Code and Part 6 of Subtitle B of Title I of ERISA (sometimes referred to as “COBRA”) or comparable state continuation
coverage rights. 
 (c) Since January 1, 2014, the HealthHelp Entities have complied in all respects with all Laws relating to the
labor and employment practices including all Laws relating to labor relations, collective bargaining, equal employment opportunities, fair employment practices, employment discrimination, harassment, retaliation, reasonable accommodation, disability
rights or benefits, immigration, wages, hours, overtime compensation, child labor, health and safety, workers’ compensation, leaves of absence and unemployment insurance, except where the failure to so comply would not reasonably be expected to
be material to the Company. None of the HealthHelp Entities, HealthHelp Corp or HealthHelp Corp Sellers has received from any Person any written notice of any violation by the HealthHelp Entities of any Laws pertaining to employment or employment
practices, including misclassification of workers or unpaid wages. All reports required to be filed by or on behalf of the HealthHelp Entities with any Governmental Authorities have been filed. 

3.16 Employee Plans. 

(a) Except as set forth on Schedule 3.16, with respect to current or former employees of the HealthHelp Entities, no HealthHelp Entity
maintains, contributes to or has any obligation to contribute to, or, to the Knowledge of the Company, has any material Liability with respect to any (i) qualified defined contribution or defined benefit plans which are employee pension benefit
plans (as defined in Section 3(2) of ERISA) (the “Employee Pension Plans”), (ii) employee welfare benefit plans (as defined in Section 3(1) of ERISA) (“Employee Welfare Plans”), or (iii) material
plan, policy, program or arrangement which provides nonqualified deferred compensation benefits or any other material program, plan, policy or arrangement which provides any health, life, disability, accident, vacation, tuition reimbursement or
other fringe benefits (“Other Plans”). No HealthHelp Entity maintains or has any obligation to contribute to any Employee Welfare Plan or Other Plan which provides employer-paid
post-employment health, accident or life insurance benefits to current or former employees, current or future retirees, their spouses, dependents or beneficiaries, other than health continuation benefits under
Code Section 4980B. All Employee Pension Plans, all Employee Welfare Plans and all Other Plans set forth on Schedule 3.16 shall be referred to herein collectively as the “Employee Plans.” The Data Room contains true and
complete copies of all documents, as amended through the date hereof, embodying the Employee Plans and any employee handbook. 

  
 39 

 (b) There are no pending or, to the Knowledge of the Company, threatened claims (other than
routine claims for benefits and appeals of such claims) by or on behalf of any Employee Plan or any trusts which are associated with such Employee Plans. 

(c) Except as set forth on Schedule 3.16, the Employee Plans have since January 1, 2014 been maintained, funded and administered
in all material respects in compliance with their terms and with the applicable requirements of ERISA and the Code. 
 (d) Neither the
HealthHelp Entities nor any ERISA Affiliate sponsors, maintains, administers or contributes to, or has since January 1, 2011 ever sponsored, maintained, administered or contributed to, or since January 1, 2011 has had or could have had any
Liability to any (i) plan that is a multiemployer plan (as defined in Section 3(37) of ERISA) or (ii) plan that is subject to the minimum funding requirements of Part 3 of Subtitle B of Title I of ERISA or Section 412 of the
Code. 
 (e) Except as set forth on Schedule 3.16(e), the consummation of the transactions contemplated herein will not, either
alone or in combination with another event, (i) entitle any current or former employee, officer, director or consultant of the HealthHelp Entities to severance pay or any other similar payment, (ii) accelerate the time of payment or
vesting of, or increase in any material respect the amount of, compensation or benefits due to any such individual or trigger any other material obligation pursuant to any Employee Plan, or (iii) result in any payment that would be an
“excess parachute payment” to a “disqualified individual” as those terms are defined in Section 280G of the Code. 

(f) Each Employee Plan that is intended to be qualified within the meaning of Section 401(a) of the Code is the subject of a favorable and
current determination letter and/or opinion letter as to its qualification and as of the date of this Agreement, to the Knowledge of the Company, nothing has occurred that would reasonably be expected to cause the loss of such qualification. 

  
 40 

 3.17 Tax Matters. 

(a) Except as set forth on Schedule 3.17, each HealthHelp Entity has timely filed all income and other material Tax Returns required
to be filed by it, which Tax Returns are true, correct and complete in all material respects, and all Taxes due and owing by the HealthHelp Entities have been paid, whether or not shown on any Tax Return. The Company has made available to Purchaser
in the Data Room copies of all income and other material Tax Returns filed with respect to the HealthHelp Entities for taxable periods ending on or after December 31, 2013, and all examination reports, and statements of deficiencies assessed
against or agreed to by any HealthHelp Entity with respect to such taxable periods. No HealthHelp Entity is subject to a Lien for Taxes with respect to its assets except for Permitted Liens. 

(b) Except as set forth on Schedule 3.17: 

(i) no HealthHelp Entity has consented to extend the time in which any Tax may be assessed or collected by any taxing
authority, which extension is in effect as of the date hereof; 
 (ii) no HealthHelp Entity has requested or been granted an
extension of the time for filing any Tax Return to a date later than the Closing Date, other than customary automatic extensions to file any Tax Returns; 

(iii) there is no Action or audit now in progress or pending against or with respect to the HealthHelp Entities with respect
to any Tax, nor has any HealthHelp Entity been, since January 1, 2014, subject to any such Action or audit or received a notice of deficiency, additional assessment or pending notice of deficiency or assessment of any Tax; 

(iv) no HealthHelp Entity has been a member of an Affiliated Group (other than a group of which such entity or another
HealthHelp Entity is or was the parent); 
 (v) no HealthHelp Entity is a party to or bound by any Tax allocation or Tax
sharing agreement (excluding, for this purpose, any agreement entered into in the ordinary course of business that is primarily not related to Taxes, such as leases, licenses or credit agreements); 

(vi) each HealthHelp Entity has withheld and paid to the applicable taxing authority each Tax required to have been withheld
and paid in connection with amounts paid or owing to any employee, independent contractor, creditor, customer, shareholder or other party, and complied with all information reporting and backup withholding provisions of applicable Law; 

(vii) no written claim has been made by any taxing authority in any jurisdiction where a HealthHelp Entity does not file Tax
Returns that it is, or may be, subject to Tax or filing requirement by that jurisdiction; 

  
 41 

 (viii) no HealthHelp Entity is a party to, or bound by, any closing agreement or
offer in compromise with any taxing authority; 
 (ix) no private letter rulings, technical advice memoranda or similar
agreement or rulings have been requested, entered into or issued by any taxing authority with respect to a HealthHelp Entity. 

(x) no HealthHelp Entity has Liability for Taxes of any Person under Treasury Regulations
Section 1.1502-6 (or any corresponding provision of state, local or foreign Law), as transferee or successor, by contract or otherwise; 

(xi) no HealthHelp Entity has agreed to make, nor is it required to make, any adjustment under Sections 481(a) or 263A of
the Code or any comparable provision of state, local or foreign Tax Laws by reason of a change in accounting method or otherwise; 

(xii) no HealthHelp Entity will be required to include any item of income in, or exclude any item of deduction from, taxable
income for any taxable period (or portion thereof) ending after the Closing Date as a result of any (A) “closing agreement” as descried in Section 7121 of the Code (or any corresponding or similar provision of state, local or non-U.S. law) executed on or prior to the Closing date, (B) installment sale or open transaction disposition made on or prior to the Closing Date, (C) prepaid amount or any other income eligible for
deferral under the Code or Treasury Regulations promulgated thereunder received on or prior to the Closing Date or (D) election made under Section 108(i) of the Code prior to the Closing; 

(xiii) no HealthHelp Entity is or has been a party to any “listed transaction” within the meaning of
Section 6707A(c)(2) of the Code and Treasury Regulations Section 1.6011 4(b)(2); and 
 (xiv) a valid election
under Section 754 of the Code was in effect for the Company’s 2008 taxable year. 
 (c) For purposes of U.S. federal income Tax,
the Company is, and has been since its formation, classified as a partnership under Treasury Regulations Section 301.7701-3 and the Operating Company is, and has been since formation, classified as a
partnership or disregarded entity under Treasury Regulations Section 301.7701-3. 
 The representations and
warranties set forth in this Section 3.17, Section 3.7(xiv), Section 3.10(a)(ix) and Section 3.16 (to the extent it relates to Taxes) shall constitute the only representations and
warranties by the HealthHelp Entities with respect to Taxes, and the HealthHelp Entities make no representation or warranty regarding the amount, value or condition of, or any limitations on, any Tax asset or attribute of the HealthHelp Entities,
including but not limited to net operating losses, to the extent that such Tax asset or attribute would affect the Tax liability of the Purchaser, the Surviving Company or any of their respective Affiliates for any Post-Closing Tax Period, including
the ability of the Purchaser or any of its Affiliates to utilize any such tax attributes after the Closing. 

  
 42 

 3.18 Health Care Matters; HIPAA. 

(a) Each HealthHelp Entity is in compliance in all material respects with the applicable privacy, security, transaction standards, breach
notification and other provisions and requirements of the Health Insurance Portability and Accountability Act of 1996, Pub. L. 104-99 (“HIPAA”) and any comparable state laws. No HealthHelp
Entity has received any written (or, to the Knowledge of the Company, oral) communication from any Governmental Authority that alleges that any HealthHelp Entity is not in compliance in any material respect with the applicable privacy, security,
transaction standards, breach notification and other provisions and requirements of HIPAA or any comparable state laws. Each HealthHelp Entity functions as a “business associate” as that term is defined under HIPAA. As a business
associate, each HealthHelp Entity has the requisite privacy and security policies, procedures and systems to comply in all material respects with the terms of its business associate agreements. As of the date of this Agreement, no HealthHelp Entity
is in breach in any material respect of any business associate agreement. 
 (b) Except as set forth on Schedule 3.18, as of
January 1, 2014, no HealthHelp Entity has received any written (or, to the Knowledge of the Company, oral) complaints, or notices of inquiry or investigation, from any Person, patient, client or customer regarding its or any of its agents,
employees or contractors’ uses or disclosures of, or security practices regarding, individually identifiable health information or other medical or personal information. 

(c) Each HealthHelp Entity has policies, procedures and systems in place to ensure the privacy and security of all business, proprietary,
individually identifiable, personal, medical and any other private information, in compliance in all material respects with federal and state law. In addition, each HealthHelp Entity has adequate policies, procedures and systems in place to prevent
improper use or disclosure of, or access to, all business, proprietary, individually identifiable, personal, medical and any other private information, in each case that are customary for the companies in the industry in which the HealthHelp
Entities operate. Since January 1, 2011, no breach has occurred with respect to any unsecured protected health information maintained by or for any HealthHelp Entity that is subject to the notification requirements of 45 C.F.R. §§
164.406 or 164.408(b), and no information security or privacy breach event has occurred that would require notification under any comparable state laws. 

3.19 Related Party Transactions. Except as otherwise disclosed on Schedule 3.19, none of the HealthHelp Entities is now, and has
not since January 1, 2015 been, a party to or bound by any Contract to which a Related Party is a party, and no property or asset of the HealthHelp Entities has been purchased or otherwise acquired from any Related Party in anticipation of the
transactions contemplated hereby. 

  
 43 

 3.20 Bank Accounts. Schedule 3.20 sets forth a complete and accurate list of all
bank accounts, trust accounts, suspense or similar accounts and safe deposit boxes of the HealthHelp Entities, the name and address of each bank or financial institution in which any HealthHelp Entity has any such account or safe deposit box, the
number of any such account or safe deposit box and the names of the Persons authorized to draw on or have access to each such account or safe deposit box. 

3.21 Information Security and Data Privacy. 

(a) Each HealthHelp Entity has taken commercially reasonable steps to safeguard the information technology systems utilized in its operation,
including the implementation of procedures to ensure that such information technology systems are free from any disabling codes or instructions, timer, copy protection device, clock, counter or other limiting design or routing and any “back
door,” “time bomb,” “trojan horse,” “worm,” “drop dead devices,” “virus,” or other software routines or hardware components that in each case permit unauthorized access or the unauthorized
disablement or unauthorized erasure of data or other software by a third party, and to date, to the Knowledge of the Company, there have been no successful unauthorized intrusions or breaches of the security of the information technology systems.
Each HealthHelp Entity has dedicated the technical, administrative, budgetary and human resources reasonably necessary for maintenance of safe information security practices and to ensure compliance with all Laws related to data security. The
HealthHelp Entities have appropriate safeguards in place to oversee any vendors helping to safeguard the information technology systems utilized in the operation of the Business. 

(b) The HealthHelp Entities previously complied with, and are presently in compliance with, in all material respects, all applicable Laws and
its internal policies applicable to data privacy, data security or personal information. To the Knowledge of the Company, none of the HealthHelp Entities has experienced any incident in which personal information or other sensitive data was or may
have been stolen or improperly accessed, and none of the HealthHelp Entities is aware of any facts suggesting the likelihood of the foregoing, including without limitation, any breach of security or receipt of any notices or complaints from any
Person regarding personal information or other data. Since January 1, 2014, no notice, Action or assertion has been received by any HealthHelp Entity, HealthHelp Corp or HealthHelp Corp Sellers or has been filed, commenced or, to the Knowledge
of the Company, threatened any HealthHelp Entity alleging any violation of any Laws relating to data security. 
 3.22 Accounts
Receivable. The accounts receivable reflected on the Latest Balance Sheet and the accounts receivable arising after the date thereof (a) have arisen from bona fide transactions entered into by any HealthHelp Entity involving the rendering
of services in the ordinary course of business consistent with past practice; and (b) constitute only valid claims of the HealthHelp Entities not subject to claims of set-off or other defenses or
counterclaims other than normal cash discounts accrued in the ordinary course of business consistent with past practice. The reserve for bad debts shown on the Latest Balance Sheet or, with respect to accounts receivable arising after the Latest
Balance Sheet date, on the accounting records of any HealthHelp Entity have been determined in accordance with GAAP, subject to normal year-end adjustments and the absence of disclosures normally made in
footnotes. 

  
 44 

 3.23 Insurance. Schedule 3.23 sets forth a true and complete list of all current
policies or binders of fire, liability, product liability, umbrella liability, real and personal property, workers’ compensation, vehicular, directors’ and officers’ liability, fiduciary liability and other casualty and property
insurance maintained by the HealthHelp Corp or their Affiliates (including the HealthHelp Entities) and relating to the assets, the Business, operations, employees, officers, members and managers of the HealthHelp Entities (collectively, the
“Insurance Policies”) and true, correct and complete copies of such Insurance Policies have been made available to Purchaser in the Data Room. Such Insurance Policies are in full force and effect. As of the date of this Agreement,
neither the HealthHelp Corp Sellers, HealthHelp Corp nor the HealthHelp Entities have received any notice of cancellation of, premium increase with respect to, or alteration of coverage under, any of such Insurance Policies. All premiums due on such
Insurance Policies have been paid in accordance with the payment terms of each Insurance Policy. The Insurance Policies do not provide for any retroactive premium adjustment or other experience-based liability on the part of the HealthHelp Entities.
All such Insurance Policies (a) are valid and binding in accordance with their terms and (b) have not been subject to any lapse in coverage. There are no claims related to the Business pending under any such Insurance Policies as to which
coverage has been denied or disputed or in respect of which there is an outstanding reservation of rights. 
 3.24 Brokerage. Except
as set forth on Schedule 3.24, none of the HealthHelp Entities has any Liability or obligation to pay any fees or commissions to any broker, finder or agent with respect to the transactions contemplated by this Agreement. 

ARTICLE 4 
 REPRESENTATIONS AND
WARRANTIES OF THE HEALTHHELP CORP SELLERS 
 As a material inducement to Purchaser and Merger Sub to enter into this Agreement and
purchase the HealthHelp Corp Stock, each HealthHelp Corp Seller represents and warrants to Purchaser and Merger Sub, severally and not jointly, as follows: 

4.1 Organization. Such HealthHelp Corp Seller is duly organized, validly existing and in good standing under the laws of the
jurisdiction of its organization. 
 4.2 Authorization of Transactions. Such HealthHelp Corp Seller has full legal capacity,
corporate power and authority to execute and deliver this Agreement and the Transaction Documents to which such HealthHelp Corp Seller is a party, and to perform its obligations hereunder and thereunder. The execution, delivery and performance by
such HealthHelp Corp Seller of this Agreement and the Transaction Documents and each of the transactions contemplated hereby or thereby have been duly and validly authorized by the applicable board of such HealthHelp Corp Seller, and no other act or
proceeding on the part of such HealthHelp Corp Seller, the applicable board of such HealthHelp Corp Seller is necessary to authorize the execution, delivery or performance by such HealthHelp Corp Seller of this Agreement or the Transaction Documents
or the consummation of any of the transactions contemplated hereby or thereby. This Agreement and the Transaction Documents to which such HealthHelp Corp Seller is a party have been or will be duly executed and delivered by such HealthHelp Corp
Seller, and, assuming the due execution and delivery of this Agreement and the Transaction Documents to which such HealthHelp Corp Seller is a party by the other parties hereto and thereto, this Agreement and the Transaction Documents, upon
execution and delivery by such HealthHelp Corp Seller, will each constitute a valid and binding obligation of such HealthHelp Corp Seller, enforceable against such HealthHelp Corp Seller in accordance with its terms, except as such enforceability
may be limited by (a) applicable insolvency, bankruptcy, reorganization, moratorium or other similar Laws affecting creditors’ rights generally, and (b) applicable equitable principles (whether considered in a proceeding at Law or in
equity). 

  
 45 

 4.3 No Breach. Except as set forth on Schedule 4.3, the execution, delivery and
performance by such HealthHelp Corp Seller of this Agreement and the Transaction Documents to which such HealthHelp Corp Seller is a party and the consummation of each of the transactions contemplated hereby or thereby will not (a) conflict
with or result in violation or breach of, or default under, any provision of the organizational documents of such HealthHelp Corp Seller, (b) assuming compliance by Purchaser with Section 6.5, conflict with or result
in violation or breach of any provision of any Law or require any authorization, consent, approval, exemption or notice to any Governmental Authority under the provisions of any Law (except for the filing and recordation of the Certificate of Merger
as required by the DLLCA), to which such HealthHelp Corp Seller is subject, except, in the case of clause (b), where the violation, conflict, breach, failure to give such notice, to file, or to obtain any such authorization, consent, approval or
exemption would not reasonably be expected to materially and adversely affect such HealthHelp Corp Seller’s ability to consummate the transaction contemplated hereby, or (c) violate, conflict with, result in a breach of, constitute a
default under, result in the acceleration of, or create in any party the right to accelerate, terminate, modify or cancel any material Contract to which such HealthHelp Corp Seller is a party or by which its assets are bound. 

4.4 Litigation. There are no Actions pending, or to such HealthHelp Corp Seller’s Knowledge, threatened, and since January 1,
2014, there have been no Actions against or affecting such HealthHelp Corp Seller, at law or in equity, or before or by any Governmental Authority, which would have a material adverse effect on such HealthHelp Corp Seller’s ability to
consummate the transactions contemplated hereby. 
 4.5 Brokerage. Such HealthHelp Corp Seller does not have any Liability or
obligation to pay any fees or commissions to any broker, finder or agent with respect to the transactions contemplated by this Agreement. 

4.6 Ownership. Such HealthHelp Corp Seller holds of record and owns beneficially all of the HealthHelp Corp Stock set forth next to
such HealthHelp Corp Seller’s name on Schedule 5.6, free and clear of any Liens and any other restrictions on transfer (other than such Liens and/or restrictions that shall be released, waived or otherwise terminated in connection with
the Closing and other than any restrictions under the Securities Act and state securities Laws). Such HealthHelp Corp Seller is not a party to any purchase option, call option, put option, subscription right, preemptive right or similar right
providing for the disposition or acquisition of the HealthHelp Corp Stock held by such HealthHelp Corp Seller. Such HealthHelp Corp Seller is not a party to any voting trust, proxy or other agreement or understanding with respect to the voting of
any of the HealthHelp Corp Stock held by such HealthHelp Corp Seller. 

  
 46 

 ARTICLE 5 

REPRESENTATIONS AND WARRANTIES OF HEALTHHELP CORP 

As a material inducement to Purchaser and Merger Sub to enter into this Agreement and purchase the HealthHelp Corp Stock, HealthHelp Corp
represents and warrants to Purchaser and Merger Sub as follows: 
 5.1 Organization. HealthHelp Corp is a corporation, duly
organized, validly existing and in good standing under the laws of the State of Delaware. 
 5.2 Authorization of Transactions.
HealthHelp Corp has all requisite corporate power and authority to execute and deliver this Agreement and the Transaction Documents to which HealthHelp Corp is a party and to perform its obligations hereunder and thereunder. The execution, delivery
and performance by HealthHelp Corp of this Agreement and the Transaction Documents and each of the transactions contemplated hereby or thereby have been duly and validly authorized by the board of directors of HealthHelp Corp, and no other act or
proceeding on the part of HealthHelp Corp or the board of directors of HealthHelp Corp is necessary to authorize the execution, delivery or performance by HealthHelp Corp of this Agreement and the Transaction Documents or the consummation of any of
the transactions contemplated hereby or thereby. This Agreement and the Transaction Documents to which HealthHelp Corp is a party have been or will be duly executed and delivered by HealthHelp Corp and, assuming the due execution and delivery of
this Agreement and the Transaction Documents to which HealthHelp Corp is a party by the other parties hereto and thereto, this Agreement and the Transaction Documents, upon execution and delivery by HealthHelp Corp, will each constitute, a valid and
binding obligation of HealthHelp Corp, enforceable against HealthHelp Corp in accordance with its terms, except as such enforceability may be limited by (a) applicable insolvency, bankruptcy, reorganization, moratorium or other similar Laws
affecting creditors’ rights generally, and (b) applicable equitable principles (whether considered in a proceeding at Law or in equity). 

5.3 No Breach. Except as set forth on Schedule 5.3, the execution, delivery and performance by HealthHelp Corp of this Agreement
and the Transaction Documents to which HealthHelp Corp is a party and the consummation of each of the transactions contemplated hereby or thereby will not (a) conflict with or result in violation or breach of, or default under, any provision of
the organizational documents of HealthHelp Corp, (b) assuming compliance by Purchaser with Section 6.5, conflict with or result in violation or breach of any provision of any Law or require any authorization, consent,
approval, exemption or notice to any Governmental Authority under the provisions of any Law (except for the filing and recordation of the Certificate of Merger as required by the DLLCA) to which HealthHelp Corp is subject, except, in the case of
clause (b), where the violation, conflict, breach, failure to give such notice, to file, or to obtain any such authorization, consent, approval or exemption would not reasonably be expected to be material to HealthHelp Corp, or (c) violate,
conflict with, result in a breach of, constitute a default under or result in the acceleration of any material Contract to which HealthHelp Corp is a party or by which its assets are bound. 

  
 47 

 5.4 Litigation. There are no Actions pending, or to the Knowledge of HealthHelp Corp,
threatened, and, since January 1, 2014, there have been no Actions that were resolved or settled for amounts in excess of $250,000, against HealthHelp Corp, at law or in equity, or before or by any Governmental Authority, which would reasonably
be expected to be material to HealthHelp Corp. 
 5.5 Brokerage. HealthHelp Corp does not have any Liability or obligation to pay any
fees or commissions to any broker, finder or agent with respect to the transactions contemplated by this Agreement. 
 5.6
Capitalization; Prior Activities. 
 (a) Schedule 5.6 accurately sets forth the authorized, issued and outstanding capital
stock of HealthHelp Corp and the name and number of shares of HealthHelp Corp Stock held by each HealthHelp Corp Seller. All of the issued and outstanding shares of HealthHelp Corp Stock have been validly issued and are fully paid and are
nonassessable. Except as set forth in this Agreement and on Schedule 5.6, there are no outstanding or authorized options, warrants, rights, contracts, pledges, calls, puts, rights to subscribe, conversion rights or other agreements or
commitments to which HealthHelp Corp is a party or which is binding upon HealthHelp Corp providing for the issuance, disposition or acquisition of any of its equity or any rights or interests exercisable therefor. There are no outstanding or
authorized equity appreciation, phantom stock or similar rights with respect to HealthHelp Corp. 
 (b) Except for the HealthHelp Corp
Units, HealthHelp Corp (i) does not have any equity interest, direct or indirect, in any Person and (ii) does not have any other assets or Liabilities. HealthHelp Corp was formed for the sole purpose of, and HealthHelp Corp has conducted
no material activity other than, holding Company Units and activities ancillary thereto. 
 5.7 Tax Matters. 

(a) Except as set forth on Schedule 5.7, HealthHelp Corp has timely filed all income and other material Tax Returns required to be
filed by it, and all material Taxes due and owing have been paid, whether or not shown on any Tax Return. HealthHelp Corp has made available to Purchaser in the Data Room copies of all income and other material Tax Returns filed with respect to
HealthHelp Corp for taxable periods ending on or after December 31, 2013, and all examination reports, and statements of deficiencies assessed against or agreed to by HealthHelp Corp with respect to such taxable periods. 

  
 48 

 (b) Except as set forth on Schedule 5.7: 

(i) HealthHelp Corp has not consented to extend the time in which any Tax may be assessed or collected by any taxing
authority, which extension is in effect as of the date hereof; 
 (ii) HealthHelp Corp has not requested or been granted an
extension of the time for filing any Tax Return to a date later than the Closing Date, other than customary automatic extensions to file any Tax Returns; 

(iii) there is no Action or audit now in progress or pending against or with respect to HealthHelp Corp with respect to any
Tax; 
 (iv) HealthHelp Corp has not been a member of an Affiliated Group (other than a group of which such entity is or was
the parent); 
 (v) HealthHelp Corp is not a party to or bound by any Tax allocation or Tax sharing agreement (excluding,
for this purpose, any agreement entered into in the ordinary course of business that is primarily not related to Taxes, such as leases, licenses or credit agreements); 

(vi) HealthHelp Corp has withheld and paid to the applicable taxing authority each Tax required to have been withheld and paid
in connection with amounts paid or owing to any employee, independent contractor, creditor, customer, shareholder or other party, and complied with all information reporting and backup withholding provisions of applicable Law; 

(vii) no written claim has been made by any taxing authority in any jurisdiction where HealthHelp Corp does not file Tax
Returns that it is, or may be, subject to Tax by that jurisdiction; 
 (viii) HealthHelp Corp is not a party to, or bound
by, any closing agreement or offer in compromise with any taxing authority; 
 (ix) no private letter rulings, technical
advice memoranda or similar agreement or rulings have been requested, entered into or issued by any taxing authority with respect to HealthHelp Corp. 

(x) HealthHelp Corp has no Liability for Taxes of any Person under Treasury Regulations
Section 1.1502-6 (or any corresponding provision of state, local or foreign Law), as transferee or successor, by contract or otherwise; 

(xi) HealthHelp Corp has not agreed to make, nor is it required to make, any adjustment under Sections 481(a) or 263A of the
Code or any comparable provision of state, local or foreign Tax Laws by reason of a change in accounting method or otherwise; 

  
 49 

 (xii) HealthHelp Corp will not be required to include any item of income in, or
exclude any item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any (A) “closing agreement) as described in Section 7121 of the Code (or any corresponding or
similar provision of state, local or non-U.S. Law) executed on or prior to the Closing Date, (B) installment sale or open transaction disposition made on or prior to the Closing Date, (C) prepaid
amount or any other income eligible for deferral under the Code or Treasury Regulations promulgated thereunder received on or prior to the Closing Date or (D) election mated under Section 108(i) of the Code prior to the Closing; and 

(xiii) HealthHelp Corp has not been a party to any “listed transaction” within the meaning of
Section 6707A(c)(2) of the Code and Treasury Regulations Section 1.6011-4(b)(2). 
 The representations and
warranties set forth in this Section 5.7 shall constitute the only representations and warranties by HealthHelp Corp with respect to Taxes, and HealthHelp Corp makes no representation or warranty regarding the amount, value
or condition of, or any limitations on, any Tax asset or attribute of HealthHelp Corp, including but not limited to net operating losses, to the extent that such Tax asset or attribute would affect the Tax liability of Purchaser, HealthHelp Corp or
any of their respective Affiliates for any Post-Closing Tax Period, including the ability of the Purchaser or any of its Affiliates to utilize any such tax attributes after the Closing. 

ARTICLE 6 

REPRESENTATIONS AND WARRANTIES OF THE STOCK PURCHASER, PARENT AND MERGER SUB 

As an inducement to HealthHelp Corp, the HealthHelp Corp Sellers and the Company to enter into this Agreement, the Stock Purchaser, Parent and
Merger Sub represent and warrant to each such Person as follows: 
 6.1 Organization; Ownership of Merger Sub; No Prior Activities.
Each of the Stock Purchaser, Parent and Merger Sub is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization. Parent owns 100% of the issued and outstanding limited liability company interests of
Merger Sub. Merger Sub was formed for the sole purpose of, and Merger Sub has conducted no activity other than, engaging in the transactions contemplated by this Agreement. Except for obligations or liabilities incurred in connection with its
formation and the transactions contemplated by this Agreement, Merger Sub has not and will not have incurred, directly or indirectly, through any Subsidiary or Affiliate, any obligations or liabilities or engaged in any business activities of any
type or kind whatsoever or entered into any agreements or arrangements with any Person. 

  
 50 

 6.2 Authorization of Transactions. The Stock Purchaser, Parent and Merger Sub have
all requisite organizational power and authority to execute and deliver this Agreement and the Transaction Documents and to perform their respective obligations hereunder and thereunder. The execution, delivery and performance by the Stock
Purchaser, Parent and Merger Sub of this Agreement and the Transaction Documents and the transactions contemplated hereby and thereby have been duly and validly authorized by such Person’s governing body and no other act or proceeding on the
part of the Stock Purchaser, Parent or Merger Sub, or their respective governing bodies, stockholders or members, as applicable, is necessary to authorize the execution, delivery or performance of this Agreement or the Transaction Documents or the
consummation of the transactions contemplated hereby or thereby. This Agreement and the Transaction Documents have been or will be duly executed and delivered by the Stock Purchaser, Parent and Merger Sub and, assuming the due execution and delivery
of this Agreement and the Transaction Documents by the other parties hereto and thereto, this Agreement and the Transaction Documents, upon execution and delivery by the Stock Purchaser, Parent and Merger Sub, will each constitute, a valid and
binding obligation of the Stock Purchaser, Parent and Merger Sub, enforceable in accordance with its terms, except as such enforceability may be limited by (a) applicable insolvency, bankruptcy, reorganization, moratorium or other similar Laws
affecting creditors’ rights generally, and (b) applicable equitable principles (whether considered in a proceeding at Law or in equity). 

6.3 No Breach. Except as set forth on Schedule 6.3, the execution, delivery and performance by the Stock Purchaser,
Parent and Merger Sub of this Agreement and the Transaction Documents and the consummation of each of the transactions contemplated hereby or thereby will not (a) violate any provision of the organizational documents of the Stock Purchaser,
Parent or Merger Sub, (b) violate any Law or require any authorization, consent, approval, exemption or notice to any Governmental Authority under the provisions of any Law (except for the filing and recordation of the Certificate of Merger as
required by the DLLCA) to which the Stock Purchaser, Parent or Merger Sub is subject, or (c) violate, conflict with, result in a breach of, constitute a default under or result in the acceleration of any contract to which the Stock Purchaser,
Parent or Merger Sub is a party or by which such Person’s assets are bound, except in each case, where the violation, conflict, breach, default, failure to give notice, to file or to obtain any such authorization, consent, approval or exemption
would not reasonably be expected to materially and adversely affect the Stock Purchaser’s, Parent’s or Merger Sub’s ability to consummate the transactions contemplated hereby. 

6.4 Litigation. There are no Actions pending or, to the knowledge of each Purchaser, threatened against the Stock Purchaser, Parent or
Merger Sub, at law or in equity, or before or by any Governmental Authority, which would have a material adverse effect on such Stock Purchaser’s, Parent’s or Merger Sub’s ability to consummate the transactions contemplated hereby.

  
 51 

 6.5 Investment Intent; Restricted Securities. Purchaser is acquiring the HealthHelp Corp
Stock and the Company Units solely for Purchaser’s own account, for investment purposes only, and not with a view of distribution thereof. The Stock Purchaser and Parent understand and acknowledge that (i) neither the HealthHelp Corp Stock
nor the Company Units have not been registered or qualified under the Securities Act, or under any securities Laws of any state of the United States or any other jurisdiction, and have been issued in reliance upon specific exemptions thereunder,
(ii) the HealthHelp Corp Stock and the Company Units constitute “restricted securities” as defined in Rule 144 under the Securities Act, (iii) none of the Company Units or the HealthHelp Corp Stock is traded or tradable on any
securities exchange or over-the-counter and (iv) none of the Company Units or HealthHelp Corp Stock may be sold, transferred or otherwise disposed of unless a
registration statement under the Securities Act with respect to such HealthHelp Corp Stock or Company Units, as applicable, and qualification in accordance with any applicable state securities Laws becomes effective or unless such registration and
qualification is inapplicable, or an exemption therefrom is available. Each of the Stock Purchaser and Parent is an “accredited investor” as defined in Rule 501(a) of the Securities Act. 

6.6 Brokerage. Except as set forth on Schedule 6.6, none of the Stock Purchaser, Parent or Merger Sub has any liability or
obligation to pay any fees or commissions to any broker, finder or agent with respect to the transactions contemplated by this Agreement. 

6.7 Financing. Purchaser has sufficient unrestricted cash on hand and available credit facilities to pay all amounts required to be
paid by the Stock Purchaser or Parent at the Closing pursuant to the terms of this Agreement, and to pay all of the related fees and expenses of the Stock Purchaser, Parent and Merger Sub. 

6.8 No Other Representations. Each of the Stock Purchaser, Parent and Merger Sub acknowledges that except for the specific
representations and warranties made by the Company, the HealthHelp Corp Sellers and HealthHelp Corp in Article 3, Article 4, and Article 5 of the Agreement, and the representations and warranties contained in the other
Transaction Documents, they are not relying upon and will not rely upon any representation or warranty of any HealthHelp Entity, HealthHelp Corp or any HealthHelp Corp Seller or any Affiliate thereof or any managers, directors, partners, officers,
employees, direct or indirect equityholders, agents or other representatives, or any of them, nor upon the accuracy of any records, estimates, budgets, projects or other predictions, any data, any financial information or any memoranda or offering
materials or presentations, including any offering memorandum or similar materials, made available or given to Parent, the Stock Purchaser or Merger Sub in the performance of such investigation. 

ARTICLE 7 
 INTENTIONALLY
OMITTED 
 ARTICLE 8 

ADDITIONAL AGREEMENTS 

8.1 Further Assurances. In case at any time after the Closing any further action is necessary to carry out the purposes of this
Agreement, each of the Parties shall take such further action (including the execution and delivery of such further instruments and documents) as any other Party reasonably may request, in each case to the extent the taking of any such action is
commercially reasonable in the circumstance. 

  
 52 

 8.2 Press Releases; Confidentiality. The Parties agree that no press release or other
public announcement (including in any trade journal or other publication) of the transactions contemplated hereby shall be made without the prior written consent of the Stock Purchaser, Parent and the Sellers’ Representative; provided,
that foregoing shall not prohibit (a) disclosure required by any applicable Law, (b) any disclosure made in connection with the enforcement of any right or remedy relating to this Agreement or the transactions contemplated hereby, or
(c) any disclosure by any HealthHelp Corp Seller or their Affiliates of the terms of the transactions contemplated hereby on a confidential basis as part of such Person’s ordinary course reporting or review procedure or in connection with
such Persons’ ordinary course fundraising, marketing, information or reporting activities. 
 8.3 Transaction Expenses. Except
as expressly provided herein, each Party shall be solely responsible for payment of any fees and expenses incurred by or on behalf of it or its Affiliates in connection with the transactions contemplated hereby or otherwise required by applicable
Law; provided, that all fees, costs and expenses of the Escrow Agent shall be borne in equal amounts by the Stock Purchaser or Parent, on the one hand, and Seller Indemnifying Parties, on the other hand. For the avoidance of doubt, the costs
of procuring R&W Insurance Policy (including, but not limited to, costs incurred in respect of premium payments, diligence and other fees, expenses and Taxes related thereto) will be at the sole cost and expense of either the Stock Purchaser or
Parent and none of the Company, the Unitholders or the HealthHelp Corp Sellers will have any liability with respect to such costs.  

8.4 Directors’ and Officers’ Indemnification. 

(a) From and after the Closing, Purchaser shall not, and shall cause each of its Subsidiaries and Affiliates (including HealthHelp Corp and
the HealthHelp Entities) not to, amend, repeal or otherwise modify the indemnification provisions of any such Person’s certificate of incorporation, bylaws or other similar governing documents as in effect immediately prior to the Closing in
any manner that would adversely affect the rights thereunder of individuals who, on or prior to the Closing, were directors, officers, managers, employees or holders of equity interests of such Person. 

(b) At the Closing, the Company and the Sellers’ Representative shall obtain, maintain and fully pay for irrevocable “tail”
insurance policies (the “D&O Tail Policies”) naming all Persons who were directors, managers or officers of HealthHelp Corp and/or the HealthHelp Entities (each, a “D&O Indemnified Person”) on or prior to
the Closing as direct beneficiaries with a claims period of at least six (6) years, and such D&O Tail Policies have been provided to Purchaser prior to the date hereof. Purchaser has not, and HealthHelp Corp and the HealthHelp Entities have
not, cancelled or changed such insurance policies in any respect. 
 (c) In the event the Stock Purchaser, Parent, HealthHelp Corp, any
HealthHelp Entity or any of their respective successors or assigns (i) consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity in such consolidation or merger, or (ii) transfers
all or substantially all of its properties and assets to any Person, then and in either such case, the Stock Purchaser or Parent shall make proper provision so that the successors and assigns of the Stock Purchaser, Parent, HealthHelp Corp or the
applicable HealthHelp Entities, as the case may be, shall assume the obligations set forth in this Section 8.4. 

  
 53 

 (d) The provisions of this Section 8.4 shall survive for a period of
six (6) years from the Closing Date; provided, that in the event any claim or claims are asserted or made within such survival period, all such rights to indemnification in respect of any claim or claims shall continue until final
disposition of such claim or claims. 
 (e) The provisions of this Section 8.4 are intended to be for the benefit
of, and shall be enforceable by, each D&O Indemnified Person, his or her heirs, executors or administrators. The Parties agree that each D&O Indemnified Person (including his or her heirs, executors or administrators or other similar
representatives) is intended to be, and shall be, a third party beneficiary of this Agreement for the purpose of this Section 8.4. 

8.5 Post-Closing Record Retention and Access. From and for a period of six (6) years following the Closing Date, Purchaser shall
provide, at the Sellers’ Representative’s expense, the Sellers’ Representative and its authorized representatives with reasonable access, during normal business hours, to any books and records and other materials in the
possession of HealthHelp Corp, the HealthHelp Entities or any of their Affiliates relating to periods prior to the Closing Date solely in connection with and to the extent necessary for purposes of (a) the preparation of Tax Returns, amended
Tax Returns or claims for refund, (b) the preparation of financial statements including for periods ending on or prior to the Closing Date, (c) the management and handling of any Action, whether or not such Action is a matter with respect
to which indemnification may be sought hereunder, and (d) compliance with the rules and regulations of the Internal Revenue Service, the Securities and Exchange Commission or any other Governmental Authority or applicable Law; provided,
that in each case, such access shall be in a manner that does not interfere with the normal business operations of Purchaser, HealthHelp Corp or the HealthHelp Entities. Unless otherwise consented to in writing by the Sellers’ Representative,
Purchaser shall not, and shall cause each of HealthHelp Corp and the HealthHelp Entities not to, for a period of six (6) years following the Closing Date, destroy, alter or otherwise dispose of any books and records and other materials of
HealthHelp Corp or the HealthHelp Entities, or any portions thereof, relating to periods prior to the Closing Date without first offering to surrender to the Sellers’ Representative such books and records and materials or such portions thereof.

  
 54 

 8.6 Release. The HealthHelp Corp Sellers, for themselves and on behalf of their Related
Parties, hereby unconditionally remise, release and forever discharge HealthHelp Corp, the HealthHelp Entities and each of their respective individual, joint or mutual, past, present and future officers, directors, managers, employees, agents,
attorneys, Affiliates, partners, members, stockholders, controlling persons, parent corporations, subsidiaries, successors and assigns (individually, a “Releasee” and collectively, “Releasees”) from any and all
manner of Actions, causes of action, suits, claims, counterclaims, demands, proceedings, orders, obligations, Contracts, promises, covenants, defenses and Liabilities whatsoever arising in their capacity as an owner, member, manager or officer of
HealthHelp Corp or either of the HealthHelp Entities (including those arising out of the HealthHelp Corp’s investment in, or the operations of, the HealthHelp Entities), whether known or unknown, suspected or unsuspected, both at law and in
equity, which the HealthHelp Corp Sellers or any of their Related Parties now has, have ever had or may hereafter have against the respective Releasees arising contemporaneously with or prior to the Closing Date or on account of or arising out of
any matter, cause or event occurring contemporaneously with or prior to the Closing Date, including any claims for contribution against the Company with respect to indemnifiable breaches of this Agreement by the HealthHelp Corp Sellers pursuant to
Article 11, but not including claims arising with respect to any breaches of this Agreement or any other agreement entered into in connection herewith by the Stock Purchaser or Parent; provided, that nothing contained herein shall
operate to release any rights of any Releasee arising under or in connection with (a) this Agreement or the other Transaction Documents, (b) any rights to indemnification and/or advancement of expenses under (1) the organizational
documents of HealthHelp Corp or any HealthHelp Entity, (2) the indemnification Contracts listed on Schedule 3.10(a)(ix), or (3) the D&O Tail Policies or (c) in the case of any Releasee who is an employee or other
service provider of HealthHelp Corp or any HealthHelp Entity: (i) any rights with respect to current pay period salaries, accrued vacation and accrued bonuses earned prior to the Closing Date in the ordinary course of business and the
reimbursement of reasonable business related expenses incurred prior to the Closing Date, in accordance with the expense reimbursement policy of the HealthHelp Entities; or (ii) any rights under any retirement or health and welfare benefit plan
of the HealthHelp Entities. The HealthHelp Corp Sellers hereby expressly waive any provision of Law that provides an exception to a general release for claims that the creditor does not know or suspect to exist in their or its favor at the time of
executing the release, which if known by them might have materially affected their settlement with the debtor. 
 8.7 HealthHelp
Name. No HealthHelp Corp Seller nor their Affiliates shall adopt or assume the names “HealthHelp Inc.”, “HealthHelp” or any other name, variation, combination or derivative reasonably likely to cause confusion therewith. 

8.8 Sellers Non-Competition and Non-Solicitation. 

(a) In consideration of payments received by each HealthHelp Corp Seller in connection with the transactions contemplated by this Agreement,
during the Restricted Period, except pursuant to a written agreement with either Purchaser, no HealthHelp Corp Seller shall (and each such HealthHelp Corp Seller shall cause its controlled Affiliates in whom such HealthHelp Corp Seller has an equity
interest, but specifically excluding the limited partners of any such HealthHelp Corp Seller, not to), directly or indirectly, (i) employ, engage, recruit, (ii) solicit for employment or engagement or (iii) take any other action that
is intended to induce or knowingly encourage, or has the direct and intended effect of inducing or encouraging, Farnsworth, any Key Employee, or any Person employed as a Vice President or director of the HealthHelp Entities as of the Effective Time
(which, for the avoidance of doubt, shall exclude any individuals who are employed by Affiliates of the Sellers’ Representative), to terminate his or her employment with the Stock Purchaser, Parent or the HealthHelp Entities; provided,
that this Section 8.8(a) shall not restrict or prevent general solicitations of employment not targeted at such individuals. 

  
 55 

 (b) In consideration of payments received by Farnsworth in connection with the transactions
contemplated by this Agreement and Farnsworth’s continued employment with the Operating Company, during the Farnsworth Restricted Period, except pursuant to a written agreement with either Purchaser, Farnsworth shall not (and shall cause her
Affiliates not to), directly or indirectly: 
 (i) (A) engage in, manage, operate, join, control or participate in, whether
as an employee, agent, consultant, advisor, independent contractor, sole proprietor, principal, partner, member, stockholder, officer, director or otherwise, a Restricted Business, (B) beneficially own any equity or profits interest in any
Restricted Business, (C) aid or knowingly assist anyone else in the conduct of any business or organization that, directly or indirectly, engages in a Restricted Business, or (D) request or advise any past or present customer or
distributor of or supplier or vendor to the HealthHelp Entities to withdraw, curtail, cancel or not undertake a contractual or business relationship with the HealthHelp Entities, the Stock Purchaser, Parent or its Affiliates; provided, that
nothing herein shall preclude Farnsworth from (y) investing in and holding a passive equity interest of less than five percent (5%) of a publicly-traded entity that is engaged in a trade or business substantially similar to or competitive with
the Restricted Business or (z) serving on the board of directors (or similar governing body) of, or in an advisory capacity to, any of Cianna Health and/or Vital Decisions; 

(ii) solicit the business of any customer of the HealthHelp Entities in a manner that would interfere with the relationship
between Purchaser and the HealthHelp Entities, on the one hand, and any such Person, on the other hand (including making any negative or disparaging statements or communications about Purchaser, HealthHelp Corp or the HealthHelp Entities); or 

(iii) (A) employ, engage, recruit, (B) solicit for employment or engagement, or (C) take any other action that is
intended to induce or knowingly encourage, or has the direct and intended effect of inducing or encouraging, any Person to terminate his or her employment with Purchaser or the HealthHelp Entities; provided, that this Section
8.8(b)(iii) shall not restrict or prevent general solicitations of employment not targeted at such individuals. 
 (c) The Parties
acknowledge the necessity of the protections against competition and solicitation by each of the HealthHelp Corp Sellers and Farnsworth, as applicable, that are contained in this Section 8.8 to protect the legitimate
business interests of Purchaser, HealthHelp Corp and the HealthHelp Entities and acknowledge that the nature and scope of such protection has been carefully considered by the Parties. The HealthHelp Corp Sellers and Farnsworth further acknowledge
and agree that the provisions and restrictions of the covenants set forth in this Section 8.8 form part of the consideration under this Agreement and are among the inducements for Purchaser entering into and consummating
the transactions contemplated hereby for the benefit of the HealthHelp Corp Sellers and Farnsworth. Each of the HealthHelp Corp Sellers and Farnsworth further acknowledges that the restrictions contained in this Agreement are fair, reasonable and
necessary to protect the legitimate interests of Purchaser and the HealthHelp Entities and that Purchaser would not have entered into this Agreement in the absence of such restrictions. 

  
 56 

 (d) In the event of a breach of the covenants contained in this
Section 8.8, each of the HealthHelp Corp Sellers and Farnsworth recognize that monetary damages would be inadequate to compensate Purchaser and Purchaser shall be entitled to an injunction restraining such breach, without
the requirement to post any bond or surety with respect thereto, with the costs (including reasonable attorneys’ fees) of obtaining such injunction to be borne by the HealthHelp Corp Sellers or Farnsworth, as applicable. Nothing contained
herein shall be construed as prohibiting Purchaser from pursuing any other remedy available to it for such breach or threatened breach, including making any claim for damages, specific performance or equitable relief. 

(e) If any court determines that any provision or covenant contained in this Section 8.8 is an unreasonable
restriction upon any of the HealthHelp Corp Sellers or Farnsworth, such restrictions shall be modified, rewritten or interpreted to include as much of their nature and scope as will render them enforceable. 

8.9 Other Tax Provisions. 

(a) Additional Cooperation on Tax Matters. Purchaser and Sellers’ Representative shall cooperate fully, as and to the extent
reasonably requested by the other Party, in connection with the preparation and filing of any Tax Return and any audit, litigation or other proceeding with respect to Taxes. Such cooperation shall include the retention and (upon the other
Party’s request) the provision of records and information which are reasonably relevant to any such Tax Return, audit, litigation or other proceeding or any tax planning and making employees available on a mutually convenient basis to provide
additional information and explanation of any material provided hereunder. Purchaser and Sellers’ Representative further agree, upon request, to use their commercially reasonable efforts to obtain any certificate or other document from any
Governmental Authority or any other Person as may be necessary to mitigate, reduce or eliminate any Tax that could be imposed (including, but not limited to, any Transfer Taxes). 

  
 57 

 (b) Preparation of Tax Returns. Sellers’ Representative shall prepare and file, or
cause to be prepared and filed at the Unitholders’ (excluding HealthHelp Corp) and HealthHelp Corp Sellers’ cost and expense, all income Tax Returns (including IRS Form 1065 and Schedule K-1) of the
HealthHelp Entities for all taxable periods ending on or prior to the Closing Date (the “Seller Prepared Returns”). Except as specifically provided herein, including the correction of the item identified on Schedule 3.17(a)
within the 2016 Tax Returns of the appropriate HealthHelp Entities, and as otherwise required by applicable Tax Law, Seller Prepared Returns shall be prepared in a manner that is consistent with prior Tax Returns filed by the HealthHelp Entities.
For the avoidance of doubt, Purchaser and its Affiliates will cooperate in good faith with Sellers’ Representative in preparing and filing any Seller Prepared Returns, including, without limitation, causing an appropriate officer or
representative of a HealthHelp Entity to sign and/or file a Seller Prepared Return. Purchaser shall prepare and file, or cause to be prepared and filed, at the sole cost and expense of Purchaser, all other Tax Returns of HealthHelp Corp and the
HealthHelp Entities for Pre-Closing Tax Periods (including any income Tax Returns for a Straddle Period) that are required to be filed after the Closing Date. In addition, Purchaser shall prepare pro
forma United States Federal income Tax Return (IRS Form 1120) for HealthHelp Corp for the taxable year that includes the Closing Date as if such taxable year ended on the Closing Date, with such Tax Returns calculating the Taxes of HealthHelp
Corp and other items in accordance with the provisions of Section 8.9(g) and this Section 8.9(b) (including, for this purpose, preparing such Pro Forma Returns based on a pro forma Schedule K-1 prepared by the Company with respect to HealthHelp Corp assuming HealthHelp Corp only held the HealthHelp Corp Units through the Closing Date and received allocations of income, expense, profit, loss and credit
from the Company through the Closing Date based on an interim closing of the books of the Company in the manner set forth in this Section 8.9(b) and Section 8.9(g) (the “Pro Forma Returns,” and, together with
the Tax Returns prepared by Purchaser pursuant to the preceding sentence, the “Purchaser Prepared Returns”). The cost of preparing the Pro Forma Returns shall be paid fifty percent (50%) by Purchaser, on the one hand, and fifty
percent (50%) by the HealthHelp Corp Sellers, on the other hand. Except as otherwise required by this Agreement or applicable Tax Law, all Purchaser Prepared Returns shall be prepared in a manner that is consistent with prior Tax Returns of filed by
the HealthHelp Entities and HealthHelp Corp. To the extent the taxable year of a HealthHelp Entity that is treated as a partnership for U.S. federal and applicable state and local tax purposes does not end on the Closing Date as a matter of law, the
Parties hereto agree that the applicable HealthHelp Entity shall use the interim closing of the books method under Code Section 706 and Treasury Regulations Section 1.706-4, using the “calendar
day” convention, effective as of the end of the day of the Closing Date for purposes of determining how such HealthHelp Entity’s income, profit, loss, deduction or any other items allocable to any tax periods that include the Closing Date
shall be allocated to the Unitholders, on the one hand, and the Purchaser (or such other Person(s) holding Company Units following the Closing), on the other hand. The Parties agree (i) that the Sellers’ Transaction Expenses and any other
expenses incurred by HealthHelp Corp or the HealthHelp Entities, as applicable, with respect to the transactions contemplated by this Agreement will be treated as deductible in a Pre-Closing Tax Period, and
all Tax Returns (including Pro Forma Returns) will be prepared pursuant to this Section 8.9(b) consistent with such treatment, (ii) Purchaser shall not, and shall cause HealthHelp Corp not to, elect to waive any carryback of net
operating losses under Section 172(b)(3) of the Code on any Tax Return of HealthHelp Corp filed in respect of a taxable period beginning before the Closing Date, (iii) to the maximum extent permitted by Law, any Tax deductions arising from the
Sellers’ Transaction Expenses and any other expenses incurred by the HealthHelp Entities with respect to the transactions contemplated by this Agreement allocated by the Company to HealthHelp Corp that are deducted in Pre-Closing Tax Periods pursuant to this Section 8.9(b) shall reduce the HealthHelp Corp Unpaid Taxes (but never to be less than $0) and (iv) for the avoidance of doubt, notwithstanding Company’s
representation in Section 3.17(b)(xiv), Purchaser may make a protective Code Section 754 election for the Company for the taxable year that includes the Closing Date. No later than thirty (30) days prior to filing any Purchaser
Prepared Return (or, in the case of the Pro Forma Returns, no later than thirty (30) days prior to the filing of the income Tax Returns for HealthHelp Corp for the taxable year that includes the Closing Date), which shall be no later than
ninety (90) days following the end of a taxable year with respect to any income Tax Return of a HealthHelp Entity or HealthHelp Corp for a taxable year that includes the Closing Date, Purchaser shall provide to the Sellers’ Representative
drafts of each such Purchaser Prepared Return and shall, prior to filing thereof, make any changes reasonably requested by the Sellers’ Representative and otherwise obtain the approval of the Sellers’ Representative to the filing thereof
which approval shall not be unreasonably withheld, conditioned or delayed. Without limiting the general provisions of this Section 8.9(b), Purchaser shall cause the HealthHelp Entities and HealthHelp Corp to prepare and file all income Tax
Returns for each taxable year that includes Closing Date (including, for the avoidance of doubt, the IRS Form 1065 for the Company) no later than one hundred fifty (150) days following the end of such applicable taxable year. If the
Sellers’ Representative and Purchaser cannot agree on a Purchaser Prepared Return, all disputed items shall be referred to, and decided by, a “Big Four” accounting firm expert in such Tax matters that is mutually agreed upon by the
Parties in a manner consistent with this Agreement. 

  
 58 

 (c) Audits of Tax Returns. Purchaser shall notify Sellers’ Representative within
thirty (30) days upon the receipt of any notice, or becoming aware, of any audit or other similar examination with respect to Taxes of HealthHelp Corp or the HealthHelp Entities for any Pre-Closing Tax
Period (a “Tax Contest”); provided, that no failure or delay of Purchaser in providing such notice shall reduce or otherwise affect the obligations of the Unitholders pursuant to this Agreement, except to the extent that the
Unitholders or the HealthHelp Corp Sellers are materially and adversely prejudiced as a result of such failure or delay. Purchaser shall control, or cause HealthHelp Corp or the HealthHelp Entities, as applicable, to control the conduct of any
Tax Contest; provided, that if a Tax Contest relates to a Seller Prepared Return or any other Tax Return for a Pre-Closing Tax Period for which items of income, deductions, credits, gains or losses are
passed through to the Unitholders under applicable Law or a Tax of HealthHelp Corp or a HealthHelp Entity for which the Purchaser Indemnitees may be indemnified under Article 11, Sellers’ Representative shall have the right to assume
control of such Tax Contest at the Unitholders’ (excluding HealthHelp Corp) and HealthHelp Corp Sellers’ cost and expense; provided, further, that (i) Parent or Stock Purchaser, as applicable, at its cost and expense,
shall have the right to participate in any such Tax Contest and (ii) if such settlement could materially and adversely affect Parent or Stock Purchaser, as applicable, Sellers’ Representative shall not settle any Tax Contest without
Parent’s or Stock Purchaser’s written consent, as applicable, not to be unreasonably withheld, conditioned or delayed. If Sellers’ Representative does not elect to control such Tax Contest, or for any other Tax Contest that
relates to a Pre-Closing Tax Period for which the Unitholders may be liable for the Taxes thereunder (including pursuant to Article 11) or any Tax Contest the settlement of which could otherwise
adversely affect the Unitholders or the HealthHelp Corp Sellers, in each case that Sellers’ Representative does not otherwise control pursuant to this Agreement, Parent or Stock Purchaser shall control such Tax Contest; provided, that
(A) Sellers’ Representative, at the Unitholders’ (excluding HealthHelp Corp) and HealthHelp Corp Sellers’ cost and expense, shall have the right to participate in any such Tax Contest and (B) Parent or Stock Purchaser, as
applicable, shall not settle any such Tax Contest without Sellers’ Representative’s written consent, not to be unreasonably withheld, conditioned or delayed. To the extent that this Section 8.9(c) is inconsistent with
Section 11.6 as to any Tax matters, this Section 8.9(c) shall control. 

  
 59 

 (d) Tax Refunds. (i) The HealthHelp Corp Sellers shall be entitled to (A) any
refunds received for federal, state, local or foreign Taxes paid for any Pre-Closing Tax Period (including the portion of any Straddle Period included in the Pre-Closing
Tax Period) of HealthHelp Corp and (B) without duplication for amounts described in clause (A), any net overpayment or net loss of Taxes shown on any Pro Forma Return that is used to otherwise reduce or offset any Taxes on the actual income Tax
Returns of HealthHelp Corp for the taxable year that includes (but does not end on) the Closing Date (each, a “HealthHelp Corp Tax Refund”) and (ii) the HealthHelp Corp Sellers and the Unitholders (other than HealthHelp Corp)
shall be entitled to any refunds received for federal, state, local or foreign Taxes paid for any Pre-Closing Tax Period (including the portion of any Straddle Period included in the Pre-Closing Tax Period) of the HealthHelp Entities ending on or prior to the Closing Date (each, a “HealthHelp Tax Refund”), in each case along with any interest paid by the relevant taxing
authority with respect thereto, except to the extent that any such HealthHelp Corp Tax Refund or HealthHelp Tax Refund results from the carryback of Tax attributes from a Post-Closing Tax Period of any Affiliate of Parent or Stock Purchaser,
including HealthHelp Corp and the HealthHelp Entities. Any such refunds to which such Persons are entitled that are received by any HealthHelp Entity, HealthHelp Corp or any Affiliate of the foregoing after the Closing Date, whether by offset,
credit, receipt of payment or otherwise, shall be caused by Parent or Stock Purchaser, as applicable, to be paid to Sellers’ Representative within fifteen (15) Business Days after receipt thereof (or, in the case of amounts described in
clause (i)(B) above, within fifteen (15) Business Days after filing the applicable income Tax Return of HealthHelp Corp for the taxable year that includes (but does not end on) the Closing Date). The Sellers’ Representative shall disburse
any such refund (1) in the case of a HealthHelp Corp Tax Refund, to the HealthHelp Corp Sellers pro rata based upon the percentage set forth next to each such HealthHelp Corp Seller’s name on Schedule 2.1 and (2) in the case of
a HealthHelp Tax Refund, to the HealthHelp Corp Sellers and the Unitholders (other than HealthHelp Corp) in accordance with the Distribution Waterfall. Purchaser shall cooperate with the Sellers’ Representative in obtaining such refunds,
including through the filing of amended Tax Returns or refund claims, it being understood that (x) Purchaser and HealthHelp Corp will carryback any net operating losses for taxable periods ending on or prior to or including the Closing Date to
prior taxable periods as allowable by applicable Tax Law and shall claim Tax refunds as a result of such carryback (including through the filing of amended Tax Returns) and (y) upon the request of the Sellers’ Representative, Purchaser and
HealthHelp Corp shall cooperate with the Sellers’ Representative in preparing and filing Tax Returns (including amendments of prior Tax Returns and claims for refunds) for any taxable period ending on or prior to or including the Closing Date
to claim such refunds. 
 (e) Post-Closing Tax Actions. None of Parent, Stock Purchaser or any of their respective Affiliates
(including on or after the Closing Date, HealthHelp Corp and the HealthHelp Entities) shall (i) file, or cause to be filed, any restatement or amendment of, modification to, or claim for refund relating to, any Tax Return of HealthHelp Corp or
the HealthHelp Entities for Pre-Closing Tax Period, (ii) make or change any Tax election with respect to HealthHelp Corp or the HealthHelp Entities for any
Pre-Closing Tax Period, (iii) extend or waive any statute of limitations with respect to Taxes or Tax Returns of HealthHelp Corp or the HealthHelp Entities for a
Pre-Closing Tax Period, (iv) make any election under Section 336 or 338 of the Code with respect to the transactions contemplated by this Agreement, (v) file Tax Returns for any HealthHelp
Entity or HealthHelp Corp for a Pre-Closing Tax Period in a jurisdiction in which such HealthHelp Entity or HealthHelp Corp has not historically filed Tax Returns, (vi) initiate discussions or
examinations with a taxing authority or make any voluntary disclosures with respect to Taxes or Tax Returns of a HealthHelp Entity or HealthHelp Corp for Pre-Closing Tax periods, (vii) change any
accounting method or adopt any convention for a HealthHelp Entity or HealthHelp Corp that shifts taxable income form a period (or portion thereof) ending on or before the Closing Date or shifts deductions or losses from a Pre-Closing Tax Period to a period beginning (or deemed to being) after the Closing Date or (viii) take any action after the Closing on the Closing Date outside the ordinary course of business, in each case,
without the prior written consent of the Sellers’ Representative, not to be unreasonably withheld, conditioned or delayed. 

  
 60 

 (f) No Intermediary Tax Shelter. The Stock Purchaser, Parent and its Affiliates shall not
engage in any intermediary transaction tax shelter with respect to HealthHelp Corp. 
 (g) Apportionment of Taxes. For purposes of
this Agreement, in the case of any Straddle Period, the amount of any Taxes or refund for Taxes of HealthHelp Corp or the HealthHelp Entities (i) based on or measured by income or receipts, sales or use, employment, or withholding for the Pre-Closing Tax Period shall be determined based on an interim closing of the books as of the close of business on the Closing Date (and for such purpose, the taxable period of any partnership or other pass-through
entity in which HealthHelp Corp or the HealthHelp Entities hold a beneficial interest shall be deemed to terminate at such time) and (ii) the amount of other Taxes of HealthHelp Corp or the HealthHelp Entities for a Straddle Period for the Pre-Closing Tax Period shall be deemed to be the amount of such Tax for the entire taxable period multiplied by a fraction, the numerator of which is the number of days in the Straddle Period prior to and including
the Closing Date and the denominator of which is the number of days in such Straddle Period. In the case of clause (i) of the preceding sentence, exemptions, allowances or deductions that are calculated on an annual basis (including
depreciation and amortization deductions) shall be allocated between the portion of the Straddle Period ending on the Closing Date and the portion of the Straddle Period thereafter in proportion to the number of days in each such portion. 

(h) Tax Treatment of Escrow Fund. The Parties agree that for federal and applicable state and local income Tax purposes: (i)
Parent shall be treated as the owner of the portion of the Escrow Fund allocable to the purchase of Company Units (other than the HealthHelp Corp Units) and Stock Purchaser shall be treated as the owner of the portion of the Escrow Fund allocable to
the purchase of the HealthHelp Corp Stock, and all interest and earnings earned from the investment and reinvestment of the Escrow Fund, or any portion thereof, shall be allocable to Parent and Stock Purchaser, as applicable based on their
respective allocable portion of the Escrow Fund, pursuant to Section 468B(g) of the Code and Proposed Treasury Regulation Section 1.468B-8, (ii) the right of the Unitholders (excluding HealthHelp Corp) and the
HealthHelp Corp Sellers to the Escrow Fund shall be treated as deferred contingent purchase price eligible for installment sale treatment under Section 453 of the Code and any corresponding provision of state, local or non-U.S. Law, as appropriate, (iii) if and to the extent any amount of the Escrow Fund is actually distributed to the Unitholders (excluding HealthHelp Corp) or the HealthHelp Corp Sellers, interest may be
imputed on such amount as required by Section 483 or 1274 of the Code and (iv) in the event any interest and earnings earned thereon paid to the Unitholders (excluding HealthHelp Corp) or the HealthHelp Corp Sellers under this Agreement
exceeds the imputed interest, such interest shall be treated as interest or other income and not as purchase price. Clause (iv) of the preceding sentence is intended to ensure that the right of the Unitholders (excluding HealthHelp Corp)
and the HealthHelp Corp Sellers to the Escrow Fund and any interest and earnings earned thereon is not treated as a contingent payment without a stated maximum selling price under Section 453 of the Code and the Treasury Regulations promulgated
thereunder. All Parties hereto shall file all Tax Returns consistently with the foregoing provisions of this Section 8.9(h). 

  
 61 

 (i) Tax Treatment. For all Tax purposes, the transactions contemplated by this Agreement
will be reported in a manner that is consistent with the treatment described in this Section 8.9(i), and no Party hereto (and none of their respective Affiliates) will take any Tax position inconsistent therewith on any Tax Return or
otherwise, except as otherwise required by Law or a “determination,” within the meaning of Section 1313(a)(1) of the Code or any similar provision of any state, local or non-U.S. Law. In
particular: 
 (A) The purchase of the HealthHelp Corp Stock by Stock Purchaser from the HealthHelp Corp Sellers shall be
treated as a taxable sale of stock governed by Section 1001 of the Code, and shall not result in the taxable year of HealthHelp Corp ending on the Closing Date for U.S. federal (and applicable state, local and
non-U.S.) income Tax purposes. 
 (B) The acquisition of the Company Units (other
than HealthHelp Corp Units) by Parent by virtue of the Merger shall be treated as a sale by the Unitholders (other than HealthHelp Corp) and a purchase by Parent of interests in a partnership governed by Sections 741 and 1001 of the Code, and shall
not be treated as a termination of the Company for U.S. federal income Tax purposes pursuant to Section 708(b) of the Code. 
 8.10
Transfer Taxes. All sales and transfer taxes, recording charges and similar taxes, fees or charges imposed as a result of the transactions contemplated by this Agreement (collectively, the “Transfer Taxes”), together with any
interest, penalties or additions to such Transfer Taxes, shall be borne in equal amounts by either the Stock Purchaser or Parent, on the one hand, and the HealthHelp Corp Sellers and the Unitholders (other than HealthHelp Corp), on the other hand.
The Sellers’ Representative and Purchaser shall cooperate in timely making all filings, returns, reports and forms as necessary or appropriate to comply with the provisions of all applicable Laws in connection with the payment of such Transfer
Taxes, and shall cooperate in good faith to minimize, to the fullest extent possible under such Laws, the amount of any such Transfer Taxes payable in connection therewith. 

8.11 R&W Insurance Policy. Parent shall not agree or consent to any amendment to the second sentence of Section IX (or any
successor provision) of the R&W Insurance Policy, or any other amendment to the R&W Insurance Policy that has the effect of amending or overriding such sentence, in each case without the prior written consent of the Sellers’
Representative. 

  
 62 

 ARTICLE 9 

INTENTIONALLY OMITTED 

ARTICLE 10 
 INTENTIONALLY
OMITTED 
 ARTICLE 11 

INDEMNIFICATION 
 11.1
Survival. Subject to the limitations and other provisions of this Agreement, the representations and warranties contained herein shall survive the Closing and shall remain in full force and effect for a period of eighteen (18) months
after the Closing Date; provided, that (y) the representations and warranties in Section 3.1 (Organization), Section 3.2 (Power; Authorization of Transactions),
Section 3.3 (Capitalization and Subsidiaries), Section 3.24 (Brokerage), Section 4.1 (Organization), Section 4.2 (Authorization of Transactions),
Section 4.5 (Brokerage), Section 4.6 (Ownership), Section 5.1 (Organization), Section 5.2 (Authorization of Transactions),
Section 5.5 (Brokerage) and Section 5.6 (Capitalization; Prior Activities) (collectively, the “Seller Fundamental Representations”) shall survive indefinitely, and the
representations and warranties in Sections Section 3.17 (Tax Matters) and Section 5.7 (Tax Matters) shall survive for the full period of all applicable statutes of limitations (giving effect to any
waiver, mitigation or extension thereof) governing the subject matter of such provisions, plus sixty (60) days, and (z) the representations and warranties in Section 3.11 (Proprietary Rights),
Section 3.16 (Employee Plans) and Section 3.18 (Health Care Matters; HIPAA) shall survive for a period of three (3) years following the Closing Date. All covenants and agreements of the
Parties contained herein which require performance following the Closing shall survive the Closing in accordance with their terms. Notwithstanding the foregoing, any claims asserted in good faith with reasonable specificity (to the extent known at
such time) and in writing by notice from the non-breaching Party to the breaching Party prior to the expiration date of the applicable survival period shall not thereafter be barred by the expiration of the
relevant representation or warranty and such claims shall survive until finally resolved. 
 11.2 Indemnification By the Seller
Indemnifying Parties or the HealthHelp Corp Sellers. 
 (a) Subject to the other terms and conditions of this Article 11,
including the Cap and other limitations, conditions and procedures set forth herein, the Seller Indemnifying Parties shall, severally (and not jointly) in accordance with their Pro Rata Shares, indemnify and defend each of the Stock Purchaser,
Parent and its Affiliates (including the Company) and their respective Representatives (collectively, the “Purchaser Indemnitees”) against, and shall hold each of them harmless from and against and in respect of, and shall pay and
reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the Purchaser Indemnitees based upon, arising out of, with respect to or by reason of: 

(i) any inaccuracy in or breach of any of the representations or warranties of the HealthHelp Entities contained in Article
3 of this Agreement (as qualified by the Disclosure Schedules); 

  
 63 

 (ii) any breach or non-fulfilment of any
covenant, agreement or obligation to be performed by the HealthHelp Entities prior to the Closing pursuant to this Agreement; 

(iii) the failure of the HealthHelp Entities or HealthHelp Corp to comply with Laws prior to the Closing relating to the
unlawful access or use of protected health information by Persons from outside the United States; 
 (iv) any Taxes of any
HealthHelp Entity, as properly determined under relevant Tax Law, for any taxable period (or portion thereof) ending on or before the Closing Date including, for the avoidance of doubt, the portion of any Straddle Period ending on the Closing Date
(determined in accordance with the provisions of Section 8.9(b) and Section 8.9(g)), including, for the avoidance of doubt, any Taxes of the HealthHelp Entities for Pre-Closing Tax
Periods arising out of the matters described in Schedule 3.17; provided, that the foregoing shall exclude any Taxes (A) included in the computation of Indebtedness, as finally determined or (B) that arise solely as result of
a material breach of Section 8.9 by Purchaser or any of their Affiliates; or 
 (v) any Action by
any Unitholders (other than HealthHelp Corp) or alleged Unitholder regarding the sufficiency of the Aggregate Closing Consideration or the allocation of the Aggregate Closing Consideration in accordance with the terms of this Agreement is incorrect
in any manner. 
 (b) Subject to the other terms and conditions of this Article 11, including the Cap and other limitations,
conditions and procedures set forth herein, the HealthHelp Corp Sellers shall, severally (and not jointly) in accordance with their pro rata ownership of HealthHelp Corp, indemnify and defend each of the Purchaser Indemnitees against, and shall hold
each of them harmless from and against and in respect of, and shall pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the Purchaser Indemnitees based upon, arising out of, with respect to or by reason
of: 
 (i) any inaccuracy in or breach of any of the representations or warranties of the HealthHelp Corp Sellers or
HealthHelp Corp contained in Article 4 or Article 5 of this Agreement (as qualified by the Disclosure Schedules); 

(ii) any breach or non-fulfilment of any covenant, agreement or obligation to be
performed by the HealthHelp Corp Sellers pursuant to this Agreement; 

  
 64 

 (iii) any breach or non-fulfilment of
any covenant, agreement or obligation to be performed by HealthHelp Corp prior to the Closing pursuant to this Agreement; or 

(iv) any Taxes of HealthHelp Corp, as properly determined under relevant Tax Law, for any taxable period (or portion thereof)
ending on or before the Closing Date including, for the avoidance of doubt, the portion of any Straddle Period ending on the Closing Date (determined in accordance with the provisions of Section 8.9(b) and Section 8.9(g) and
consistent with the Pro Forma Returns as finally determined pursuant to Section 8.9(b)), including, for the avoidance of doubt, any Taxes of HealthHelp Corp for Pre-Closing Tax Periods arising out
of the matters described on Schedule 5.7; provided, that the foregoing shall exclude any Taxes (A) included in the computation of Indebtedness, as finally determined or (B) that arise solely as result of a material
breach of Section 8.9 by Purchaser or any of their Affiliates. 
 11.3 Indemnification By Purchaser.
Subject to the other terms and conditions of this Article 11, Purchaser shall indemnify and defend each of the HealthHelp Corp Sellers, the Unitholders and their Representatives, heirs, executors and administrators (collectively, the
“Seller Indemnitees”) against, and shall hold each of them harmless from and against and in respect of, and shall pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the Seller
Indemnitees based upon, arising out of, with respect to or by reason of: 
 (a) any inaccuracy in or breach of any of the representations
or warranties of Purchaser or Merger Sub contained in this Agreement; or 
 (b) any breach or
non-fulfilment of any covenant, agreement or obligation to be performed by Purchaser or Merger Sub pursuant to this Agreement. 

11.4 Certain Limitations. The indemnification provided for in Section 11.2 and
Section 11.3 shall be subject to the following limitations: 
 (a) The Purchaser Indemnitees shall not claim, nor
shall the Seller Indemnified Parties or the HealthHelp Corp Sellers have any obligations to indemnify pursuant to Section 11.2(a)(i) or 11.2(b)(i) in respect of, any Losses resulting from a single event or claim or series of
events or claims based on the same or similar facts, in each case which do not exceed $25,000 (the “Per-Claim Threshold”); provided, that once the
Per-Claim Threshold has been met with respect to any event or claim or series of events or claims based on the same or similar facts, the full amount of such Losses may be claimed by the Purchaser Indemnitees
pursuant to Section 11.2(a)(i) or 11.2(b)(i), as applicable (but subject to all other applicable limitations under this Article 11); provided, further, that the
Per-Claim Threshold shall not apply to Losses pursuant to Section 11.2(a)(i) or 11.2(b)(i) with respect to claims arising out of breaches of any Seller Fundamental Representations or any
representation or warranty made in or pursuant to Section 3.17 (Tax Matters) and Section 5.7 (Tax Matters); provided, further, that once the aggregate amount of Losses resulting from
claims that do not exceed the Per-Claim Threshold equals or exceeds One Hundred Fifty Thousand Dollars ($150,000), the Per-Claim Threshold will not apply to any Losses
thereafter. 

  
 65 

 (b) Neither the Seller Indemnifying Parties nor the HealthHelp Corp Sellers, as applicable,
shall have any obligation to indemnify the Purchaser Indemnitees against Losses pursuant to Section 11.2(a)(i) or 11.2(b)(i), respectively, arising out of or based upon any inaccuracy in or breach of any representation or warranty
made in or pursuant to this Agreement unless and until the aggregate of all such Losses exceeds Six Hundred Seventy-Five Thousand Dollars ($675,000) (the “Threshold”) at which time only Losses in excess of the Threshold may be
asserted; provided, that that on the first anniversary of the Closing Date, the Threshold shall be reduced to Three Hundred Thirty-Seven Thousand Five Hundred Dollars ($337,500) (the “Reduced Threshold”), it being understood
that in the event that, prior to the first anniversary of the Closing Date, the Purchaser Indemnitees suffer Losses in excess of the Reduced Threshold which, but for the application of the Threshold, would have been indemnifiable pursuant to
Section 11.2(a)(i) or 11.2(b)(i), the Reduced Threshold shall not be applied retroactively to such Losses to require indemnification in respect thereof; and provided, further, that neither the Threshold nor the
Reduced Threshold shall be applicable to any claim for Losses based upon any inaccuracy in or breach of any Seller Fundamental Representation or any representation or warranty made in or pursuant to Section 3.17 (Tax
Matters) and Section 5.7 (Tax Matters); and provided, further, that all Losses for which indemnification is limited by application of the Per-Claim Threshold shall be
disregarded when determining whether the Threshold or the Reduced Threshold, as applicable, shall have been met. 
 (c) Neither the Seller
Indemnifying Parties nor the HealthHelp Corp Sellers, as applicable, shall be obligated to indemnify the Purchaser Indemnitees against Losses pursuant to Section 11.2(a)(i) or 11.2(b)(i), respectively, in an aggregate amount that
exceeds Six Hundred Seventy-Five Thousand Dollars ($675,000) (the “Cap”), which will represent the sole and exclusive remedy of the Purchaser Indemnitees for any such claims (subject, however, to recourse to the R&W Insurance
Policy); provided, that on the first anniversary of the Closing Date, the Cap shall be reduced to Three Hundred Thirty-Seven Thousand Five Hundred Dollars ($337,500) (the “Reduced Cap”), it being understood that in the event
that Losses in excess of the Reduced Cap shall have been paid pursuant to Section 11.2(a)(i) or 11.2(b)(i) prior to the first anniversary of the Closing Date, in no event shall the Reduced Cap be applied retroactively to such
Losses to require the Purchaser Indemnitees to refund any such amounts in excess of the Reduced Cap; and provided, further, that neither the Cap nor the Reduced Cap shall be applicable to any claim for Losses based upon any inaccuracy
in or breach of any Seller Fundamental Representation or any representation or warranty made in or pursuant to Section 3.17 (Tax Matters) and Section 5.7 (Tax Matters). 

(d) In no event shall: 

(i) the Seller Indemnifying Parties, collectively, be obligated to indemnify the Purchaser Indemnitees against Losses in an
aggregate amount that exceeds the Aggregate Final Consideration; 

  
 66 

 (ii) any individual Seller Indemnifying Party be obligated to indemnify the
Purchaser Indemnitees for any individual Loss which is indemnifiable under Section 11.2(a) in an amount which exceeds such Seller Indemnifying Party’s Pro Rata Share of such Loss; 

(iii) any HealthHelp Corp Seller be obligated to indemnify the Purchaser Indemnitees for any individual Loss which is
indemnifiable under Section 11.2(b) in an amount which exceeds such HealthHelp Corp Seller’s pro rata portion of such Loss, as determined based on such HealthHelp Corp Seller’s percentage ownership in HealthHelp Corp as of
immediately prior to the Closing; or 
 (iv) any individual Seller Indemnifying Party be obligated to indemnify the
Purchaser Indemnitees for any amounts which exceed, in the aggregate, the portion of the Aggregate Final Consideration received by such Seller Indemnified Party hereunder. 

(e) For purposes of this Article 11, any inaccuracy in or breach of any representation or warranty and the amount of any Losses
that are the subject matter of a claim for indemnification hereunder shall be determined without regard to any materiality or Material Adverse Effect qualification contained in such representation or warranty; provided, that this
Section 11.4(e) shall not apply to (a) the representations and warranties set forth in Section 3.5(a) and Section 3.7 or (b) any reference to a “Material Contract.” 

(f) (d) No Seller Indemnifying Party shall be liable for Taxes of the HealthHelp Entities or HealthHelp Corp, as applicable, with respect to
the Post-Closing Tax Period; provided, that the foregoing limitation shall not apply with respect to breaches under Sections 3.17(b)(v), 3.17(b)(viii), 3.17(b)(xi), 3.17(b)(xii), 5.7(b)(v),
5.7(b)(viii), 5.7(b)(xi) or 5.7(b)(xii). 
 (g) No Indemnified Party shall be entitled to recover (i) for the
same Loss relating to any matter more than once to prevent duplicative recovery or (ii) for any Loss that was or will be taken into account in the calculation of the Aggregate Final Consideration. 

(h) The amount of any Losses subject to indemnification under Section 11.2 shall be calculated net of any Loss Tax
Benefit realized by a Purchaser Indemnitee in the year of the Losses giving rise to such indemnification claim or the immediately succeeding one (1) taxable year. For purposes hereof, “Loss Tax Benefit” shall mean the net Tax
savings or benefits realized by a Purchaser Indemnitee that is attributable to any deduction, loss, credit, refund or other reduction in Tax resulting from or arising out of such Losses, in each case computed at the highest marginal Tax rates
applicable to the Purchaser Indemnitee. 
 (i) Each Indemnified Party shall take all commercially reasonable steps to mitigate any loss
upon becoming aware of any event, state of facts, circumstances or developments which would reasonably be expected to, or does, give rise thereto and the Indemnified Party shall provide the Indemnifying Party a reasonable opportunity to cure any
breach. 

  
 67 

 (j) Subject to Section 11.4(k) below, to the extent that any Losses which are
indemnifiable by the Seller Indemnifying Parties hereunder may also be recoverable against the R&W Insurance Policy, the Purchaser Indemnitees shall first seek recourse against the R&W Insurance Policy, and shall only seek recourse against
the Seller Indemnifying Parties if recovery against the R&W Insurance Policy is denied (it being understood that the indemnification obligations of the Seller Indemnifying Parties shall in any case be subject to the other limitations on
indemnification contained herein); provided, that the foregoing shall not be applicable to Losses arising out of any breaches of the Seller Fundamental Representations. 

(k) To the extent that any Losses which are indemnifiable by (i) the Seller Indemnifying Parties pursuant to
Section 11.2(a)(iv) (collectively, the “Seller Indemnifiable Tax Losses”) or (ii) the HealthHelp Corp Sellers pursuant to Section 11.2(b)(iv) (collectively, the “HealthHelp Corp Indemnifiable Tax
Losses”) may also be recoverable against the R&W Insurance Policy (after giving effect to the application of any retention or similar amounts) the Purchaser Indemnitees shall first seek recourse against the R&W Insurance Policy in
accordance with Section 11.4(j) in an aggregate amount up to Two Million Four Hundred Thousand Dollars ($2,400,000). In the event that (1) the Purchaser Indemnitees shall have recovered against the R&W Insurance Policy any amounts in
respect of Seller Indemnifiable Tax Losses and/or HealthHelp Corp Indemnifiable Tax Losses pursuant to the immediately preceding sentence and (2) at any time thereafter the aggregate amount of all Losses recovered against the R&W Insurance
Policy equals Twelve Million Dollars ($12,000,000) (the “Policy Limit”), then the Purchaser Indemnitees shall be entitled to seek recourse against (i) the Seller Indemnifying Parties for Losses in excess of the Policy Limit
which, but for the application of the Cap, would be indemnifiable by the Seller Indemnifying Parties pursuant to this Article 11, in an amount not to exceed the actual amount recovered under the R&W Insurance Policy for all Seller
Indemnifiable Tax Claims and (ii) the HealthHelp Corp Sellers for Losses in excess of the Policy Limit which, but for the application of the Cap, would be indemnifiable by the Seller Indemnifying Parties pursuant to this Article 11, in
an amount not to exceed the actual amount recovered under the R&W Insurance Policy for all HealthHelp Corp Indemnifiable Tax Losses. For the avoidance of doubt, in no event shall the foregoing provisions of this
Section 11.4(k) be deemed to modify, in any respect, any of the limitations on indemnification contained in this Article 11, other than the application of the Cap as provided in Section 11.4(c). 

11.5 Inter-Party Claims. 

(a) Any Person seeking indemnification pursuant to this Article 11 (the “Indemnified Party”) shall promptly
notify in writing the other Person(s) from whom such indemnification is sought (the “Indemnifying Party”) of the Indemnified Party’s assertion of such claim for indemnification, describing the basis of such claim, but failure
to give such notice promptly shall not adversely affect the Indemnified Party’s rights to indemnification except to the extent that the Indemnifying Party can show that the failure to give such notice on a timely basis materially and adversely
affected the Indemnifying Party’s ability to defend the claim or that such notice was not given within the time periods specified in Section 11.1. 

  
 68 

 11.6 Third Party Claims. 

(a) Each Indemnified Party shall promptly notify in writing the Indemnifying Party of the assertion by any third party (i.e., any Person who
is not a Purchaser Indemnitee or a Seller Indemnitee) of any claim to which the indemnification set forth in this Article 11 relates (which shall also constitute the notice required by Section 11.5), but failure to
give such notice promptly shall not adversely affect the Indemnified Party’s rights to indemnification except to the extent that the Indemnifying Party can show that the failure to give such notice on a timely basis materially and adversely
affected the Indemnifying Party’s ability to defend the claim or that such notice was not given within the time periods specified in Section 11.1. 

(b) Except as set forth below in this Section 11.6(b), the Indemnifying Party shall have the right, upon written notice to the
Indemnified Party, to undertake the defense of such third-party claim. The failure of the Indemnifying Party to give such notice and to undertake the defense of such a claim shall constitute a waiver of the Indemnifying Party’s rights to defend
such third-party claim under this Section 11.6(b) and, in the absence of gross negligence or willful misconduct on the part of the Indemnified Party, shall preclude the Indemnifying Party from disputing the manner in which the
Indemnified Party may conduct the defense of such claim or the reasonableness of any amount paid by the Indemnified Party in satisfaction of such claim. The election of the Indemnifying Party to undertake the defense of any third-party claim
pursuant to this Section 11.6(b) will, without admitting Liability to any third party with respect to such claim, conclusively establish for the purposes of this Agreement that the claims made in such third-party claim are within the
scope of, and subject to, indemnification by the Indemnifying Party pursuant to this Article 11. Notwithstanding the foregoing, under no circumstances shall an Indemnifying Party be entitled to undertake the defense of a third-party claim if (i) such claim alleges criminal liability for any Purchaser Indemnitee or involves a Governmental Authority or any claim in respect of Taxes, (ii) such claim involves requests for
injunctive or other equitable relief in respect of a Purchaser Indemnitee or its business, or (iii) such claim is one in which the Indemnifying Party is also a party and there exists a conflict of interest between the Indemnifying Party and the
Indemnified Party in the conduct of such defense. 
 (c) The Indemnified Party shall not settle such claim without the Indemnifying
Party’s consent, which will not be unreasonably withheld, conditioned or delayed. The Indemnified Party shall, subject to obligations of confidentiality rights of privilege, or other restrictions under Contract or Law, make available to the
Indemnifying Party or its representatives all records and other materials reasonably required by them and in the possession or under the control of the Indemnified Party for the use of the Indemnifying Party and its representatives in defending any
such claim, and shall in other respects give reasonable cooperation in such defense, and any costs or expenses associated with taking such actions shall be included as Losses hereunder. 

  
 69 

 (d) The Indemnifying Party must obtain the prior written consent of the Indemnified Party (which
the Indemnified Party will not unreasonably withhold, condition or delay) before entering into any settlement or compromise of such claim or proceeding or ceasing to defend such claim or proceeding. Notwithstanding the foregoing, the Indemnifying
Party may, without the prior written consent of the Indemnified Party, settle or compromise any third-party claim, or consent to the entry of judgment with respect to a third-party claim; provided, that such settlement, compromise, or
judgment involves solely the payment of monetary damages by the Indemnifying Party, without admission of any Liability on the part of any Indemnified Party, and includes, as an unconditional term thereof, a full and complete release of the
Indemnified Party by the claimant or the plaintiff of all Liability with respect to such claim. 
 (e) The election by the Indemnifying
Party, pursuant to Section 11.6(b), to undertake the defense of a third-party claim shall not preclude the Person against whom such claim has been made also from participating or continuing to participate in such defense. 

11.7 Tax Treatment of Indemnification Payments. All indemnification payments made under this Agreement shall be treated by the
Parties as an adjustment to the Gross Purchase Price payable by Parent and/or Stock Purchaser, as applicable, for Tax purposes, unless otherwise required by Law. 

11.8 R&W Insurance Policy. Purchaser and its Affiliates will not amend, waive or otherwise modify the R&W Insurance Policy in
any manner that would allow the insurer thereunder or any other Person to subrogate or otherwise make or bring any Action against any of the HealthHelp Corp Sellers, Unitholders or the HealthHelp Entities, or any of their Affiliates, or any past,
present or future managers, directors, partners, officers, employees, direct or indirect equityholders, agents or other representatives of any of the foregoing, except to the extent such Party committed fraud. 

11.9 Right of Set-Off. In Purchaser’s sole and absolute discretion, Purchaser, on behalf
of itself and any other Purchaser Indemnitee, may at any time set-off any amounts that have been Finally Determined to be owed to any of them by the Seller Indemnifying Parties pursuant to this
Article 11 (but subject in all cases to the limitations contained herein), against any amounts owed by Purchaser or any of its Affiliates to the Seller Indemnified Parties pursuant to Section 2.13. For the
avoidance of doubt, in no event shall this Section 11.9 be construed as to allow Purchaser to so offset (with respect to any Loss) any amount in excess of the amount of Losses for which any Seller Indemnified Party would be
obligated to indemnify the Purchaser Indemnitees pursuant to this Article 11 (including the limitations contained herein). The exercise of such right of set-off by Purchaser shall not constitute an
event of default under any obligation owed by Purchaser or any of its Affiliates to the HealthHelp Corp Sellers. Neither the exercise nor the failure to exercise such right of set-off will constitute an
election of remedies or limit Purchaser in any manner in the enforcement of any other remedies that may be available to it. For purposes of this Section 11.9, “Finally Determined” shall mean the parties
have reached a binding agreement in writing or a court of competent jurisdiction shall have entered a final and non-appealable order resolving any dispute. 

11.10 Denial of Claims. The HealthHelp Corp Sellers acknowledge and agree that the denial of any claim by any Purchaser Indemnitee
under the R&W Insurance Policy shall not be construed as, or used as evidence that, such Purchaser Indemnitee is not entitled to indemnification under this Article 11. 

  
 70 

 11.11 Other Indemnification and Insurance. Subject to the terms of
Section 11.4(j) and Section 11.4(k), amounts in respect of which the Indemnified Party would otherwise be entitled to indemnification shall be offset by any amounts or benefits received (whether in the form of cash, credit or
some other beneficial arrangement) from any third party in respect of such Loss and the aggregate amount of any insurance proceeds actually received (whether in the form of cash or credit) in respect of such Loss, net of any related costs and
expenses, including the aggregate cost of pursuing any related insurance claims, including any deductible amount paid by an Indemnifying Party, retroactive premiums and premium increases. In furtherance of the foregoing, in respect of any Losses
covered by insurance or for which an indemnity, contribution or other similar right against a third party is available, the Indemnified Party shall use commercially reasonable efforts to seek recovery under such insurance or indemnity, contribution
or similar right; provided, that no Indemnified party shall be obligated to litigate or bring any Action to obtain recovery from any insurance policy. 

11.12 Exclusive Remedy. The Parties agree that after the Closing, the exclusive remedies of the Purchaser Indemnitees and the Seller
Indemnitees for any Losses based upon, arising out of or otherwise in respect of the transactions contemplated by this Agreement are (y) the indemnification obligations of the Parties set forth in this Article 11 (subject to the
limitations contained herein) and (z) in the case of the Purchaser Indemnitees, recovery from the R&W Policy, if applicable. To the maximum extent permitted by applicable Law, each of the Stock Purchaser, Parent and Merger Sub, on behalf of
themselves and each Purchaser Indemnitee, hereby waives all other rights and remedies with respect to the transactions contemplated by this Agreement, whether under Law or otherwise; provided, however, that nothing contained in this
Article 11 shall preclude a party from seeking or obtaining injunctive relief to prevent breaches of the covenants and agreements contained herein which require performance following the Closing. Notwithstanding anything to the contrary
herein, the existence of this Article 11 and of the rights and restrictions set forth herein and therein do not limit any legal remedy against any Party hereto to the extent such Party committed actual fraud in connection with the
negotiation or consummation of the transactions contemplated by this Agreement or the negotiation, preparation or execution of this Agreement. 

  
 71 

 ARTICLE 12 

MISCELLANEOUS 
 12.1
Sellers’ Representative; Waiver of Conflicts; Retention of Privilege. 
 (a) At the Closing, MTS Health
Investors, LLC (and each successor appointed in accordance with Section 12.1(e)) shall be constituted and appointed as the Sellers’ Representative. For purposes of this Agreement and the Transaction Documents, the term
“Sellers’ Representative” shall mean the representative, true and lawful agent, proxy and attorney-in-fact of the HealthHelp Corp Sellers and the
Unitholders (other than HealthHelp Corp) for all purposes of this Agreement and the other Transaction Documents, with full power and authority on such Person’s behalf to: (i) consummate the transactions contemplated by this Agreement and the
other Transaction Documents, (ii) pay such Person’s expenses (whether incurred on or after the date hereof) incurred in connection with the negotiation and performance of this Agreement and the other Transaction Documents, (iii) receive, give
receipt and disburse any funds received hereunder on behalf of such Person and to hold back from disbursement any such funds to the extent it reasonably determines may be necessary, (iv) execute and deliver any certificates representing the
HealthHelp Corp Stock and/or Company Units, if any, and execute such further instruments as Purchaser shall reasonably request, (v) execute and deliver on behalf of such Person all documents contemplated herein and therein and any amendment or
waiver hereto and thereto, (vi) take all other actions to be taken by or on behalf of such Person in connection herewith or therewith, (vii) negotiate, settle, compromise and otherwise handle all disputes under this Agreement or any other
Transaction Document, including without limitation, disputes pursuant to Section 2.12 (Determination of Post-Closing Adjustment), (viii) waive or terminate any condition to the obligation of such Person to consummate the
transactions contemplated by this Agreement or the other Transaction Documents, (ix) to prepare, review and comment on Tax Returns and participate and/or control any applicable Tax Contests, (x) act with respect to all indemnification matters
referred to in this Agreement and any other Transaction Documents, including the right to compromise on behalf of such HealthHelp Corp Seller or the Unitholder any indemnification claim made by or against such HealthHelp Corp Seller or the
Unitholder, (xi) give and receive notices on behalf of such Person, and (xii) do or refrain from doing each and every act and exercise any and all rights which such Person is, or the HealthHelp Corp Sellers and/or Unitholders (other than HealthHelp
Corp) collectively are, permitted or required to do or exercise under this Agreement or the other Transaction Documents. The HealthHelp Corp Sellers and the Unitholders (other than HealthHelp Corp), by approving the principal terms of the Merger
and/or accepting the consideration payable to them hereunder, irrevocably grant unto said attorney-in-fact and agent full power and authority to do and perform each and
every act and thing necessary or desirable to be done in connection with the transactions contemplated by this Agreement and the other Transaction Documents, as fully to all intents and purposes as such HealthHelp Corp Sellers or Unitholders (other
than HealthHelp Corp) might or could do in person. Each of the HealthHelp Corp Sellers and Unitholders (other than HealthHelp Corp) agrees that such agency and proxy are coupled with an interest, are therefore irrevocable without the consent of the
Sellers’ Representative and shall survive the death, incapacity or bankruptcy of any such HealthHelp Corp Seller or Unitholder (other than HealthHelp Corp). 

  
 72 

 (b) All decisions, actions, consents and instructions of the Sellers’ Representative shall
be final and binding upon all the HealthHelp Corp Sellers and the Unitholders (other than HealthHelp Corp) and no such HealthHelp Corp Seller or Unitholder shall have any right to object, dissent, protest or otherwise contest the same, except in the
case of fraud or bad faith by the Sellers’ Representative. The Sellers’ Representative is authorized to act on behalf of the HealthHelp Corp Sellers and Unitholders (other than HealthHelp Corp) notwithstanding any dispute or disagreement
among HealthHelp Corp Sellers and Unitholders, and any Person shall be entitled to conclusively and absolutely rely on any and all action taken by the Sellers’ Representative as the acts of the HealthHelp Corp Sellers and Unitholders under this
Agreement without liability to, or obligation to inquire of, the HealthHelp Corp Sellers or Unitholders. 
 (c) Neither the Sellers’
Representative nor any agent employed by Sellers’ Representative shall incur any liability to any HealthHelp Corp Seller or Unitholder relating to the performance of its duties hereunder except for actions or omissions by the Sellers’
Representative or such agent constituting fraud or bad faith as determined in a final and non-appealable judgment of a court of competent jurisdiction. The Sellers’ Representative shall not have by reason
of this Agreement a fiduciary relationship in respect of any HealthHelp Corp Seller or Unitholder, except in respect of amounts actually received on behalf of such HealthHelp Corp Seller or Unitholder. 

(d) The HealthHelp Corp Sellers and the Unitholders shall cooperate with the Sellers’ Representative and any accountants, attorneys or
other agents whom the Sellers’ Representative may retain to assist in carrying out Sellers’ Representative’s duties hereunder. The HealthHelp Corp Sellers and the Unitholders (other than HealthHelp Corp) shall reimburse the
Sellers’ Representative for all costs and expenses incurred, including professional fees, on a pro rata basis, based on the amount each such HealthHelp Corp Seller’s or Unitholder’s (other than HealthHelp Corp) would have borne of
such costs and expenses had such costs and expenses been deducted from the Aggregate Final Consideration prior to such Aggregate Final Consideration being distributed pursuant to the Distribution Waterfall. 

(e) In the event that the Sellers’ Representative becomes unable to perform the Sellers’ Representative’s responsibilities or
resigns from such position, the Sellers’ Representative, upon written notice to the Stock Purchaser and Parent, shall select another representative to fill such vacancy and such substituted representative shall (i) be deemed to be the
Sellers’ Representative for all purposes of this Agreement and the other Transaction Documents and (ii) exercise the rights and powers of, and be entitled to the indemnity, reimbursement and other benefits of, the Sellers’ Representative
hereunder. 

  
 73 

 (f) At the Effective Time, Parent shall deliver cash to the Sellers’ Representative in an
amount equal to One Million Two Hundred Fifty Thousand Dollars ($1,250,000) (the “Sellers’ Representative Expense Fund”) to be held in trust to cover and reimburse the fees and expenses incurred by the
Sellers’ Representative for its obligations and the obligations of the Seller Indemnifying Parties in connection with this Agreement and the transactions contemplated hereby. The Sellers’ Representative shall disperse to the Unitholders
(other than HealthHelp Corp) and the HealthHelp Corp Sellers the remaining balance of the Sellers’ Representative Expense Fund in accordance with the Distribution Waterfall, as and when determined by the Sellers’ Representative in its sole
discretion. Without limiting the foregoing, each Unitholder (other than HealthHelp Corp) and each HealthHelp Corp Seller shall, on a several basis, only to the extent of such Person’s pro rata portion in accordance with the Distribution
Waterfall, indemnify and defend the Sellers’ Representative and hold the Sellers’ Representative harmless against any loss, damage, cost, liability or expense actually incurred without fraud, gross negligence or willful misconduct by the
Sellers’ Representative (as determined in a final and non-appealable judgment of a court of competent jurisdiction) and arising out of or in connection with the acceptance, performance or administration
of the Sellers’ Representative duties under this Agreement. Any expenses or taxable income incurred by the Sellers’ Representative in connection with the performance of its duties under this Agreement shall not be the personal obligation
of the Sellers’ Representative but shall be payable by and attributable to the Unitholders (other than HealthHelp Corp) and the HealthHelp Corp Sellers based on each such Person’s pro rata portion determined in accordance with the
Distribution Waterfall. Notwithstanding anything to the contrary in this Agreement, the Sellers’ Representative shall be entitled and is hereby granted the right to set off and deduct any unpaid or
non-reimbursed expenses and unsatisfied liabilities incurred by the Sellers’ Representative in connection with the performance of its duties hereunder from amounts actually delivered to the Sellers’
Representative pursuant to this Agreement. Additionally, in connection with any unpaid or non-reimbursed expenses and unsatisfied liabilities incurred by the Sellers’ Representative in connection with the
performance of its duties hereunder, the Sellers’ Representative shall be entitled and is hereby granted the right to direct any funds that would otherwise be actually payable to Unitholders (other than HealthHelp Corp) and the HealthHelp Corp
Sellers from the Sellers’ Representative Expense Fund to itself no earlier than the date such payments are actually made. The Sellers’ Representative may also from time to time submit invoices to the Unitholders (other than HealthHelp
Corp) and the HealthHelp Corp Sellers covering such expenses and liabilities, which shall be paid by such Persons promptly following the receipt thereof on a pro rata basis based on the Distribution Waterfall. Upon the request of any Unitholder
(other than HealthHelp Corp) or HealthHelp Corp Seller, the Sellers’ Representative shall provide such Person with an accounting of all expenses and liabilities paid by the Sellers’ Representative in its capacity as such. All amounts
deposited to the Sellers’ Representative Expense Fund shall be treated for federal and applicable state and local income Tax purposes as having been paid to the Unitholders or the HealthHelp Corp Sellers, as applicable, at the Closing. 

(g) The Sellers’ Representative represents and warrants that it has full corporate power and authority to enter into, execute, deliver
and perform its obligations under this Agreement and each of the Transaction Documents applicable to the Sellers’ Representative and to consummate the contemplated transactions. Each of the Transaction Documents to which the Sellers’
Representative is a party constitutes, or will constitute as of the Closing Date, a legal, valid and binding agreement of the Sellers’ Representative enforceable against it in accordance with the terms of each such Transaction Document, except
as enforceability may be limited by (i) applicable bankruptcy, insolvency, reorganization, moratorium, or other similar laws now or hereafter in effect relating to affecting creditors’ rights generally and (ii) applicable equitable principles
(whether considered in a proceeding at Law or in equity). 
 (h) Waiver of Conflicts; Retention of Privilege. 

(i) Purchaser, Merger Sub, each HealthHelp Corp Seller and each Unitholder (other than HealthHelp Corp), by its execution and
delivery of a Letter of Transmittal, acknowledges that the Company, the Unitholders, the HealthHelp Corp Sellers and the Sellers’ Representative have retained Goodwin Procter LLP (“Goodwin”) to act as their counsel in
connection with the transactions contemplated hereby and that Goodwin has not acted as counsel for any other Person in connection with the transactions contemplated hereby and that no other Party or Person has the status of a client of Goodwin for
conflict of interest or any other purposes as a result thereof. 

  
 74 

 (ii) Purchaser, Merger Sub, each HealthHelp Corp Seller and each Unitholder
(other than HealthHelp Corp), by its execution and delivery of a Letter of Transmittal, hereby: (x) waives, on behalf of themselves and each of their Affiliates any claim they have or may have that Goodwin has a conflict of interest in connection
with or is otherwise prohibited from engaging in such representation; and (y) agrees that, in the event that a dispute arises after the Closing between Purchaser or any of its Affiliates (including the Company) and any Unitholder, HealthHelp Corp
Seller or the Sellers’ Representative or any of their respective Affiliates, Goodwin may represent any such Person in such dispute even though the interest of any such parties may be directly adverse to Purchaser or any of its Affiliates
(including the Company) and even though Goodwin may have represented the Company in a matter substantially related to such dispute. 

(iii) Purchaser, Merger Sub, each HealthHelp Corp Seller and each Unitholder (other than HealthHelp Corp), by its execution
and delivery of a Letter of Transmittal, for themselves and their respective Affiliates (including, as applicable, the Company), further agree that, as to all pre-Closing communications between or among
Goodwin, the Company, any Unitholder, any HealthHelp Corp Seller and/or the Sellers’ Representative that relate in any way to the transactions contemplated herein, the attorney-client privilege and all other rights to any evidentiary privilege
belong to the Sellers’ Representative and may be controlled by the Sellers’ Representative and shall not pass to or be claimed by Purchaser or the Company. Notwithstanding the foregoing, in the event that a dispute arises between
Purchaser, the Company or any of their respective Affiliates, on the one hand, and a third Person other than a Party or any third-party beneficiary to this Agreement after the Closing, on the other hand, the
Company may assert the attorney-client privilege to prevent disclosure of confidential communications by Goodwin to such third party. 

(iv) The Parties agree that Goodwin is intended to be, and shall be, a third party beneficiary of this Agreement for the
purpose of this Section 12.1. 
 12.2 Amendment and Waiver. This Agreement may not be amended, altered or
modified except by a written instrument executed by Purchaser and the Sellers’ Representative. No course of dealing between or among any Persons having any interest in this Agreement will be deemed effective to modify, amend or discharge any
part of this Agreement or any rights or obligations of any Person under or by reason of this Agreement. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute, a waiver of any other provisions, whether or not
similar, nor shall any waiver constitute a continuing waiver. 

  
 75 

 12.3 Notices. All notices, requests and other communications hereunder must be in writing
and will be deemed to have been duly given only if delivered personally against written receipt or by email or facsimile transmission with confirmation of receipt requested or mailed by prepaid first class certified mail, return receipt requested,
or mailed by overnight courier prepaid, to the Parties at the following addresses, email addresses or facsimile numbers: 
 If to any
HealthHelp Corp Seller or the Sellers’ Representative (on behalf of itself or the Unitholders), then to: 
 c/o MTS Health
Investors, LLC 
 623 Fifth Avenue 

New York, New York 10022 

Facsimile: (212) 887-2100 

Email: Moses@mtspartners.com and Buzik@mtspartners.com 

Attention: Oliver Moses and Alexander Buzik 

with a copy (which shall not constitute notice) to: 

Goodwin Procter LLP 
 The New York
Times Building 
 620 Eighth Avenue 

New York, New York 10018 

Facsimile: (212) 355-3333 

Email: cnugent@goodwinlaw.com and cdwyer@goodwinlaw.com 

Attention: Christian C. Nugent and Christopher A. Dwyer 

If to the Stock Purchaser, then to:  

WNS Global Services (P) Ltd 
 Gate
No 4, Plant 10 / 11 Godrej & Boyce Complex 
 Pirojshanagar, L.B.S. Marg, Vikhroli (West) 

Mumbai, Maharashtra, 400079, India 

Email: Arijit.Sen@wns.com 

Attention: Arijit Sen 

  
 76 

 If to Parent, Merger Sub, HealthHelp Corp or the Surviving Company, then to: 

WNS North America Inc. 
 15
Exchange Place, 
 Jersey City, New Jersey 07302 

Email: Yogendra.Goyal@wns.com 

Attention: Mr. Yogendra Goyal 

with a copy (which shall not constitute notice) to: 

Reed Smith LLP 
 599 Lexington
Avenue 
 22nd Floor 
 New York,
New York 10022 
 Facsimile: (212) 521-5450 

Email: nrele@reedsmith.com 

Attention: Niket Rele 
 All such
notices, requests and other communications will (i) if delivered personally to the address as provided in this Section 12.3 or by facsimile transmission to the facsimile number as provided in this
Section 12.3 or by email transmission to the email address as provided in this Section 12.3, be deemed given on the day so delivered if delivered before 5:00 p.m. local time of the recipient on a
Business Day, and otherwise on the next following Business Day, (ii) if delivered by mail in the manner described above to the address as provided in this Section 12.3, be deemed given on the earlier of the third
Business Day following mailing or upon actual receipt, and (iii) if delivered by overnight courier to the address as provided in this Section 12.3, be deemed given on the earlier of the first Business Day following the
date sent by such overnight courier or upon actual receipt, in each case regardless of whether such notice, request or other communication is received by any other Person to whom a copy of such notice is to be delivered pursuant to this
Section 12.3. Any Party from time to time may change its address, facsimile number or other information for the purpose of notices to that Party by giving notice specifying such change to the other Parties. 

12.4 Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit of each of the Parties
and their respective successors and permitted assigns. Neither this Agreement nor any rights, benefits or obligations set forth herein may be assigned by any of the Parties without the prior written consent of Purchaser and the Sellers’
Representative, any attempted assignment without such prior written consent shall be void; provided, that no consent shall be required in connection with an assignment pursuant to Sections 8.4(c) or 12.1(e). 

12.5 Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid
under applicable Law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable Law, such provision will be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of
such provision or the remaining provisions of this Agreement. 

  
 77 

 12.6 Construction and Interpretation. Where specific language is used to clarify by
example a general statement contained herein, such specific language shall not be deemed to modify, limit or restrict in any manner the construction of the general statement to which it relates. The language used in this Agreement shall be deemed to
be the language chosen by the Parties to express their mutual intent, and no rule of strict construction shall be applied against any Party. Unless the context of this Agreement otherwise requires, (i) words of any gender include each other
gender, (ii) words using the singular or plural number also include the plural or singular number, respectively, (iii) the terms “hereof,” “herein,” “hereby” and derivative or similar words refer to this
entire Agreement, (iv) the terms “Article” or “Section” refer to the specified Article or Section of this Agreement and (v) the word “including” means “including without limitation.” 

12.7 Captions. The captions used in this Agreement are for convenience of reference only and do not constitute a part of this Agreement
and shall not be deemed to limit, characterize or in any way affect any provision of this Agreement, and all provisions of this Agreement shall be enforced and construed as if no caption had been used in this Agreement. 

12.8 No Third-Party Beneficiaries. Except as otherwise expressly set forth in this Agreement, nothing herein expressed or implied is
intended or shall be construed to confer upon or give to any third party, other than the Parties and their respective permitted successors and assigns, any rights or remedies under or by reason of this Agreement. 

12.9 Specific Performance. Each of the Parties acknowledges that the rights of each Party to consummate the transactions contemplated
hereby are unique and recognize and affirm that in the event of a breach of this Agreement by any Party, money damages would be inadequate and the non-breaching Party would have no adequate remedy at law.
Accordingly, the Parties agree that such non-breaching Party shall have the right, in addition to any other rights and remedies existing in their favor at law or in equity, to enforce their rights and the
other Party’s obligations hereunder not only by an action or actions for damages but also by an action or actions for specific performance, injunctive and/or other equitable relief (without posting of bond or other security). 

12.10 Complete Agreement. This Agreement, together with the schedules and exhibits referred to herein and the other Transaction
Documents contain the complete agreement among the Parties and supersede any prior understandings, agreements or representations by or among the Parties, written or oral, which may have related to the subject matter hereof in any way. 

12.11 Counterparts. This Agreement may be executed in one or more counterparts, any one of which may be by facsimile or electronic
delivery (i.e., by email of a PDF signature page), and each of which shall be deemed an original and all of which taken together shall constitute one and the same instrument. 

12.12 Governing Law. This Agreement shall be governed by and construed in accordance with the domestic Laws of the State of Delaware
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. 

  
 78 

 12.13 Waiver of Jury Trial. EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY. EACH PARTY (A) CERTIFIES THAT NO
REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES
HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 12.13. 

12.14 Exclusive Jurisdiction and Venue; Service of Process. 

(a) Each Party (i) submits to the exclusive jurisdiction and venue of the United States District Court for the District of Delaware or
the Court of Chancery of the State of Delaware, as applicable, for any Action arising from or in connection with the interpretation or enforcement of this Agreement, (ii) waives to the extent not prohibited by applicable Law, and agrees not to
assert, by way of motion, as a defense or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that any such
Action brought in one of the above-named courts should be dismissed on grounds of forum non conveniens, should be transferred or removed to any court other than one of the above-named courts, or should be stayed by reason of the pendency of
some other Action in any other court other than one of the above-named courts or that this Agreement or any other agreement contemplated hereby or the subject matter hereof or thereof may not be enforced in or by such court and (iii) agrees not
to commence any such Action other than before one of the above-named courts. Notwithstanding the previous sentence, a Party may commence any Action in a court other than the above-named courts solely for the purpose of enforcing an order or judgment
issued by one of the above-named courts. 
 (b) Each of the Parties hereby (i) consents to service of process in any Action among any
of the Parties relating to or arising in whole or in part under or in connection with this Agreement or any other agreement contemplated hereby or the transactions contemplated herein in any manner permitted by Delaware Law, (ii) agrees that
service of process made in accordance with clause (i) or made by registered or certified mail, return receipt requested, at its address specified pursuant to Section 12.3, will constitute good and valid service of
process in any such Action and (iii) waives and agrees not to assert (by way of motion, as a defense, or otherwise) in any such Action any claim that service of process made in accordance with clause (i) or (ii) does not constitute good
and valid service of process. 

  
 79 

 12.15 Disclosure Schedules. The information set forth in each section or subsection of the
Schedules to this Agreement (the “Disclosure Schedules”) shall be deemed to provide the information contemplated by, or otherwise qualify, the provisions of this Agreement set forth in the corresponding section or subsection of this
Agreement and any other section or subsection of this Agreement to the extent that such disclosure is reasonably apparent from a reading of such disclosure item to be applicable to such other section or subsection, regardless of whether such section
or subsection is qualified by reference to the Disclosure Schedules. Matters reflected in the Disclosure Schedules are not necessarily limited to matters required by the Agreement to be reflected in the Disclosure Schedules, are included for
informational purposes and do not necessarily include other matters of a similar nature. The inclusion, in and of itself, of any information in the Disclosure Schedules shall not be deemed to be an admission or an acknowledgement or otherwise to
imply that such information is material for purposes of the Agreement or outside the ordinary course of business. 

*    *    *    *    * 

  
 80 

 IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above-written.

  

			
	COMPANY:
	
	HEALTHHELP HOLDINGS, LLC
	
	  

	Name:	 	Cherrill Farnsworth
	Title:	 	Chief Executive Officer

 [Signature Pages - Stock Purchase Agreement and Plan of Merger] 

 
			
	HEALTHHELP CORP:
	
	MTS HEALTHHELP INC.
	
	  

	Name:	 	Oliver T. Moses
	Title:	 	President
	
	SELLERS’ REPRESENTATIVE:
	
	MTS HEALTH INVESTORS, LLC
	
	  

	Name:	 	Oliver T. Moses
	Title:	 	Senior Managing Director

 [Signature Pages - Stock Purchase Agreement and Plan of Merger] 

 
			
	HEALTHHELP CORP SELLERS:
	
	MTS HEALTH INVESTORS II, L.P.
	
	By: MTS Health Investors II GP, LLC, its general partner
	
	  

	Name:	 	Oliver T. Moses
	Title:	 	Senior Managing Director
	
	BROOKE PRIVATE EQUITY ADVISORS FUND II, L.P.
		
	By:	 	
	
	  

	Name:	 	
	Title:	 	
	
	BROOKE PRIVATE EQUITY ADVISORS FUND II (D), L.P.
		
	By:	 	
	
	  

	Name:	 	
	Title:	 	
	
	BPEA LIFE SCIENCES FUND I LIMITED PARTNERSHIP
		
	By:	 	
	
	  

	Name:	 	
	Title:	 	

 [Signature Pages - Stock Purchase Agreement and Plan of Merger] 

 
	
	CHERRILL FARNSWORTH:
	
	  

 [Signature Pages - Stock Purchase Agreement and Plan of Merger] 

 
			
	STOCK PURCHASER:
	
	WNS GLOBAL SERVICES PRIVATE LIMITED
	
	  

	Name:	 	
	Title:	 	
	
	PARENT:
	
	WNS NORTH AMERICA INC.
	
	  

	Name:	 	
	Title:	 	
	
	MERGER SUB:
	
	WNS HEALTHCARE NORTH AMERICA LLC
	
	  

	Name:	 	
	Title:	 	

 [Signature Pages - Stock Purchase Agreement and Plan of Merger]EX-4.14

 Exhibit 4.14 

EXECUTION VERSION 
 Dated
                     
 WNS NORTH
AMERICA INC. 
 arranged by 

BNP PARIBAS 
 with 

BNP PARIBAS 
 acting through
its Hong Kong branch 
 (acting as Agent) 

and 
 BNP PARIBAS 

acting through its Hong Kong branch 

(acting as Security Agent) 
  

 
 US$34,000,000

 FACILITY AGREEMENT 
  

 
  

 
 9 Raffles Place 

#42-02 Republic Plaza 

Singapore 048619 
 Tel:
+65.6536.1161 
 UEN No. T09LL1649F 

www.lw.com 

 CONTENTS 
  

							
	Clause	  	Page	 
			
	 1.
	  	DEFINITIONS AND INTERPRETATION	  	 	1	 
			
	 2.
	  	THE FACILITY	  	 	18	 
			
	 3.
	  	PURPOSE	  	 	19	 
			
	 4.
	  	CONDITIONS OF UTILISATION	  	 	19	 
			
	 5.
	  	UTILISATION	  	 	20	 
			
	 6.
	  	REPAYMENT	  	 	21	 
			
	 7.
	  	PREPAYMENT AND CANCELLATION	  	 	21	 
			
	 8.
	  	INTEREST	  	 	24	 
			
	 9.
	  	INTEREST PERIODS	  	 	24	 
			
	 10.
	  	CHANGES TO THE CALCULATION OF INTEREST	  	 	25	 
			
	 11.
	  	FEES	  	 	27	 
			
	 12.
	  	TAX GROSS-UP AND INDEMNITIES	  	 	27	 
			
	 13.
	  	INCREASED COSTS	  	 	32	 
			
	 14.
	  	MITIGATION BY THE LENDERS	  	 	33	 
			
	 15.
	  	OTHER INDEMNITIES	  	 	33	 
			
	 16.
	  	COSTS AND EXPENSES	  	 	35	 
			
	 17.
	  	REPRESENTATIONS	  	 	36	 
			
	 18.
	  	INFORMATION UNDERTAKINGS	  	 	40	 
			
	 19.
	  	FINANCIAL COVENANTS	  	 	43	 
			
	 20.
	  	GENERAL UNDERTAKINGS	  	 	45	 
			
	 21.
	  	EVENTS OF DEFAULT	  	 	54	 
			
	 22.
	  	CHANGES TO THE LENDERS	  	 	58	 
			
	 23.
	  	CHANGES TO THE OBLIGORS	  	 	64	 
			
	 24.
	  	ROLE OF THE ADMINISTRATIVE PARTIES	  	 	65	 
			
	 25.
	  	THE SECURITY AGENT	  	 	74	 
			
	 26.
	  	CHANGE OF SECURITY AGENT AND DELEGATION	  	 	81	 
			
	 27.
	  	APPLICATION OF PROCEEDS	  	 	83	 
			
	 28.
	  	SHARING AMONG THE FINANCE PARTIES	  	 	84	 
			
	 29.
	  	BAIL-IN	  	 	85	 
			
	 30.
	  	PAYMENT MECHANICS	  	 	87	 
			
	 31.
	  	SET-OFF	  	 	89	 
			
	 32.
	  	TURNOVER OF RECEIPTS	  	 	89	 
			
	 33.
	  	NOTICES	  	 	91	 
			
	 34.
	  	CALCULATIONS AND CERTIFICATES	  	 	93	 
			
	 35.
	  	PARTIAL INVALIDITY	  	 	93	 

  
 i 

							
			
	 36.
	  	REMEDIES AND WAIVERS	  	 	93	 
			
	 37.
	  	AMENDMENTS AND WAIVERS	  	 	94	 
			
	 38.
	  	DISCLOSURE OF INFORMATION	  	 	95	 
			
	 39.
	  	CONFIDENTIALITY OF FUNDING RATES AND REFERENCE BANK QUOTATIONS	  	 	98	 
			
	 40.
	  	COUNTERPARTS	  	 	100	 
			
	 41.
	  	GOVERNING LAW	  	 	100	 
			
	 42.
	  	ENFORCEMENT	  	 	100	 
		
	SCHEDULE 1	  	 	102	 
			
		  	THE ORIGINAL LENDERS	  			
		
	SCHEDULE 2	  	 	103	 
			
		  	CONDITIONS	  			
		
	SCHEDULE 3	  	 	107	 
			
		  	UTILISATION REQUEST	  			
		
	SCHEDULE 4	  	 	108	 
			
		  	FORM OF TRANSFER CERTIFICATE	  			
		
	SCHEDULE 5	  	 	110	 
			
		  	FORM OF COMPLIANCE CERTIFICATE	  			
		
	SCHEDULE 6	  	 	111	 
			
		  	FORM OF RESIGNATION LETTER	  			
		
	SCHEDULE 7	  	 	112	 
			
		  	EXISTING SECURITY	  			
		
	SCHEDULE 8	  	 	113	 
			
		  	TIMETABLES	  			
		
	SIGNATORIES	  	 	115	 

  
 ii 

 THIS AGREEMENT is dated
                                         2017 and
made 
 BETWEEN: 
  

	(1)	WNS NORTH AMERICA INC., a corporation established under the laws of the State of Delaware, United States with its registered address at The Corporation Trust Centre, 1209 Orange Street, County of New Castle,
Wilmington, Delaware 19801, United States (the Borrower); 

  

	(2)	BNP PARIBAS (the Arranger), a société anonyme incorporated in France and acting through its Hong Kong branch at 63/F, Two IFC, 8 Finance Street, Central, Hong Kong; 

 

	(3)	THE FINANCIAL INSTITUTIONS listed in Schedule 1 (The Original Lenders) as lenders (the Original Lenders); and 

  

	(4)	BNP PARIBAS as agent of the Finance Parties (the Agent), a société anonyme incorporated in France and acting through its Hong Kong branch at 63/F, Two IFC, 8 Finance Street, Central, Hong
Kong; and 

  

	(5)	BNP PARIBAS as security trustee for the Secured Parties (the Security Agent), a société anonyme incorporated in France and acting through its Hong Kong branch at 63/F, Two IFC, 8 Finance
Street, Central, Hong Kong. 

 IT IS AGREED as follows: 
  

	1.	DEFINITIONS AND INTERPRETATION 

  

	1.1	Definitions 

 In this Agreement: 

“Acceptable Bank” means: 
  

	 	(a)	a bank or financial institution which has a rating for its long-term unsecured and non credit enhanced debt obligations of BBB or higher by Standard & Poor’s Rating Services or Fitch Ratings Ltd or Baa2 or
higher by Moody’s Investors Service Limited or a comparable rating from an internationally recognised credit rating agency; 

  

	 	(b)	a bank or financial institution incorporated in India which has the highest possible investment grade rating for its long-term unsecured and non credit-enhanced debt obligations from Credit Analysis & Research
Ltd, CRISIL, ICRA and/or India Ratings and Research (a wholly owned subsidiary of Fitch Group); or 

  

	 	(c)	any other bank or financial institution approved by the Agent. 

 “Accountants’ and
Tax Due Diligence Reports” means the following reports: 
  

	 	(a)	a financial due diligence report dated 19 October 2016 prepared by Grant Thornton India LLP; and 

  

	 	(b)	a tax due diligence report dated 19 October 2016 prepared by Grant Thornton India LLP, 

each relating to the assets being acquired pursuant to the Acquisition. 

Signature Page to Facility Agreement 

 “Acquisition” means the acquisition by the Borrower of the Target Shares
on the terms of the SPA. 
 “Acquisition Costs” means all fees, costs and expenses, stamp, registration and other Taxes
incurred by the Borrower or any other member of the Group in connection with the Acquisition or the Transaction Documents, including without limitation, all Deal Fees (as defined in the SPA). 

“Administrative Party” means each of the Agent, the Arranger and the Security Agent. 

“Affiliate” means, in relation to any person, a Subsidiary of that person or a Holding Company of that person or any other
Subsidiary of that Holding Company. 
 “APLMA” means the Asia Pacific Loan Market Association Limited. 

“Asset Agreement” means the agreement to be entered into between Denali Sourcing and Software Services (I) Pvt. Ltd and
WNS Global Services Private Limited (India) on or about the date hereof, substantially in the form distributed to the Lenders prior to the signing of this Agreement. 

“Assignment Agreement” means an agreement substantially in a recommended form of the APLMA or any other form agreed between
the relevant assignor, assignee and the Agent. 
 “Authorisation” means: 

 

	 	(a)	an authorisation, consent, approval, resolution, licence, exemption, filing, notarisation, lodgement or registration; or 

  

	 	(b)	in relation to anything which will be fully or partly prohibited or restricted by law if a Governmental Agency intervenes or acts in any way within a specified period after lodgement, filing, registration or
notification, the expiry of that period without intervention or action. 

 “Availability Period” means the
period from and including the date of this Agreement to and including the date falling three Months after the date of this Agreement. 

“Available Commitment” means at any time a Lender’s Commitment minus: 

 

	 	(a)	the aggregate amount of its participations in any outstanding Loan; and 

  

	 	(b)	in relation to any proposed Utilisation, the aggregate amount of its participations in any Loan that is due to be made on or before the proposed Utilisation Date. 

“Available Facility” means at any time the aggregate of the Lenders’ Available Commitments. 

“Base Case Model” means the financial model including profit and loss, balance sheet and cashflow projections in agreed form
relating to the Group (for these purposes assuming completion of the Acquisition). 
 “Break Costs” means the amount (if
any) by which: 
  

	 	(a)	the interest which a Lender should have received pursuant to the terms of this Agreement for the period from the date of receipt of all or any part of the principal amount of the Loan or Unpaid Sum to the last day of
the current Interest Period in respect of that Loan or Unpaid Sum, had the principal amount or Unpaid Sum received been paid on the last day of that Interest Period; 

  
 2 

 exceeds: 
  

	 	(b)	the amount of interest which that Lender would be able to obtain by placing an amount equal to the principal amount or Unpaid Sum received by it on deposit with a leading bank in the Relevant Interbank Market for a
period starting on the Business Day following receipt or recovery and ending on the last day of the current Interest Period. 

“Business Day” means: 
  

	 	(a)	for the purposes of determining LIBOR, a day (other than a Saturday or Sunday) on which banks are open for the transaction of domestic and foreign exchange business in London; and 

 

	 	(b)	for all other purposes, a day (other than a Saturday or Sunday) on which banks are open for general business in London, Hong Kong and New York. 

“Cash” means, at any time, cash denominated in U.S. dollars or the currency of any jurisdiction in which the Group does
business from time to time, in hand or at bank and (in the latter case) credited to an account in the name of an Obligor or any other member of the Group with an Acceptable Bank and to which an Obligor is alone (or together with other Obligors or
member of the Group) beneficially entitled and for so long as: 
  

	 	(a)	that cash is repayable on demand; 

  

	 	(b)	repayment of that cash is not contingent on the prior discharge of any other indebtedness of any member of the Group or of any other person whatsoever or on the satisfaction of any other condition; 

 

	 	(c)	there is no Security or Quasi-Security (excluding paragraph (b)(i), (ii) or (iii) of Clause 20.6 (Negative pledge)) over that cash except for Transaction Security or any Security constituted by a netting or set-off arrangement entered into by members of the Group in the ordinary course of their banking arrangements which is permitted under paragraph (c)(ii) of Clause 20.6 (Negative pledge); and

  

	 	(d)	the cash is freely and immediately available to be applied in repayment or prepayment of the Facility. 

“Cash Balance” means, as of any date of measurement, the sum of the Cash balances and Cash Equivalent Investments which would
appear as such on a balance sheet of the Borrower or any member of the Group which was prepared as at such date. 
 “Cash Equivalent
Investments” means at any time: 
  

	 	(a)	certificates of deposit maturing within one year after the relevant date of calculation and issued by an Acceptable Bank; 

  

	 	(b)	any investment in marketable debt obligations issued or guaranteed by the government of jurisdiction (other than those in Sanctioned Countries) in which the Group does business from time to time or by an instrumentality
or agency of any of them having an equivalent credit rating, maturing within one year after the relevant date of calculation and not convertible or exchangeable to any other security; 

 

	 	(c)	commercial paper not convertible or exchangeable to any other security: 

  

	 	(i)	for which a recognised trading market exists; 

  
 3 

	 	(ii)	issued by an issuer incorporated in jurisdiction (other than those in Sanctioned Countries) in which the Group does business from time to time ; 

 

	 	(iii)	which matures within one year after the relevant date of calculation; and 

  

	 	(iv)	which has a credit rating of either A-1 or higher by Standard & Poor’s Rating Services or F1 or higher by Fitch Ratings Ltd or
P-1 or higher by Moody’s Investors Service Limited, or, if no rating is available in respect of the commercial paper, the issuer of which has, in respect of its long-term unsecured and non-credit enhanced debt obligations, an equivalent rating; 

  

	 	(d)	sterling bills of exchange eligible for rediscount at the Bank of England and accepted by an Acceptable Bank (or their dematerialised equivalent); 

 

	 	(e)	any investment in money market funds which (i) have a credit rating of either A-1 or higher by Standard & Poor’s Rating Services or F1 or higher by Fitch
Ratings Ltd or P-1 or higher by Moody’s Investors Service Limited, (ii) which invest substantially all their assets in securities of the types described in paragraphs (a) to (d) above and
(iii) can be turned into cash on demand; 

  

	 	(f)	in relation to any member of the Group incorporated in India only, any investment in money market funds or liquid mutual funds in India which (i) have the highest possible investment grade credit rating from Credit
Analysis & Research Ltd, CRISIL and/or ICRA, (ii) which invest substantially all their assets in securities of the types described paragraphs (a) to (d) above and (iii) can be turned into cash on demand; 

 

	 	(g)	any other debt security approved by the Majority Lenders, 

 in each case, in a currency in which
the Group does business from time to time to which any Obligor is alone (or together with other Obligors and members of the Group are beneficially entitled at that time) and which is not issued or guaranteed by any member of the Group or subject to
any Security (other than Security arising under the Transaction Security Documents). 
 “Change of Control” means the Parent
Guarantor ceases directly or indirectly to: 
  

	 	(a)	have the power (whether by way of ownership of shares, proxy, contract, agency or otherwise) to: 

  

	 	(i)	cast, or control the casting of, more than 51% of the maximum number of votes that might be cast at a general meeting of the Borrower; 

 

	 	(ii)	appoint or remove all, or the majority, of the directors or other equivalent officers of the Borrower; or 

  

	 	(iii)	give directions with respect to the operating and financial policies of the Borrower with which the directors or other equivalent officers of the Borrower are obliged to comply; or 

 

	 	(b)	hold beneficially more than 51% of the issued share capital of the Borrower (excluding any part of that issued share capital that carries no right to participate beyond a specified amount in a distribution of either
profits or capital). 

 “Charged Property” means all of the assets which from time to time are, or are
expressed to be, the subject of Transaction Security. 
 “Closing Date” means the date on which Completion occurs. 

  
 4 

 “Code” means the U.S. Internal Revenue Code of 1986. 

“Commitment” means: 
  

	 	(a)	in relation to an Original Lender, the amount set opposite its name under the heading Commitment in Schedule 1 (The Original Lenders) and the amount of any other Commitment transferred to it under this
Agreement; and 

  

	 	(b)	in relation to any other Lender, the amount of any Commitment transferred to it under this Agreement, 

to the extent not cancelled, reduced or transferred by it under this Agreement. 

“Completion” means the date on which completion of the Acquisition occurs under the SPA. 

“Compliance Certificate” means a certificate delivered pursuant to Clause 18.2 (Compliance Certificate) and signed
either by a director of the Parent Guarantor, or an authorised signatory of the Parent Guarantor who is a senior executive (i.e. senior vice-president or above) with responsibility for the financial matters of the Parent Guarantor, substantially in
the form set out in Schedule 5 (Form of Compliance Certificate). 
 “Confidential Information” means all information
relating to the Borrower, any Obligor, the Group, the Target Group, the Finance Documents or a Facility of which a Finance Party becomes aware in its capacity as, or for the purpose of becoming, a Finance Party or which is received by a Finance
Party in relation to, or for the purpose of becoming a Finance Party under, the Finance Documents or a Facility from either: 
  

	 	(a)	any member of the Group or any of its advisers; or 

  

	 	(b)	another Finance Party, if the information was obtained by that Finance Party directly or indirectly from any member of the Group or the Target Group or any of their respective advisers, 

in whatever form, and includes information given orally and any document, electronic file or any other way of representing or recording
information which contains or is derived or copied from such information but excludes information that: 
  

	 	(i)	is or becomes public information other than as a direct or indirect result of any breach by that Finance Party of Clause 38 (Disclosure of Information); or 

 

	 	(ii)	is identified in writing at the time of delivery as non-confidential by any member of the Group or the Target Group or any of their respective advisers; or 

 

	 	(iii)	is known by that Finance Party before the date the information is disclosed to it in accordance with paragraphs (a) or (b) above or is lawfully obtained by that Finance Party after that date, from a source which
is, as far as that Finance Party is aware, unconnected with the Group or the Target Group and which, in either case, as far as that Finance Party is aware, has not been obtained in breach of, and is not otherwise subject to, any obligation of
confidentiality. 

 “Confidentiality Undertaking” means a confidentiality undertaking substantially in a
recommended form of the APLMA or in any other form agreed between the Borrower and the Agent. 

  
 5 

 “Default” means an Event of Default or any event or circumstance specified in
Clause 21 (Events of Default) which would (with the expiry of a grace period, the giving of notice, the making of any determination under the Finance Documents or any combination of any of the foregoing) be an Event of Default. 

“Delegate” means any delegate, agent, attorney or co-trustee appointed by the Security
Agent. 
 “Disclosure Schedules” has the meaning given to that term in the SPA. 

“Disruption Event” means either or both of: 
  

	 	(a)	a material disruption to those payment or communications systems or to those financial markets which are, in each case, required to operate in order for payments to be made in connection with the Facility (or otherwise
in order for the transactions contemplated by the Finance Documents to be carried out) which disruption is not caused by, and is beyond the control of, any of the Parties; and 

 

	 	(b)	the occurrence of any other event which results in a disruption (of a technical or systems-related nature) to the treasury or payments operations of a Party preventing that, or
any other Party: 

  

	 	(i)	from performing its payment obligations under the Finance Documents; or 

  

	 	(ii)	from communicating with other Parties in accordance with the terms of the Finance Documents, 

  

	 	    	and which (in either such case) is not caused by, and is beyond the control of, the Party whose operations are disrupted. 

“Distress Event” means the enforcement of any Transaction Security. 

“Environmental Claim” means any claim, action, proceeding or investigation by any person in respect of any Environmental Law.

 “Environmental Law” means any applicable law (including common law), regulation, rule, statute, ordinance, enforcement
policy, judgment, order, decree or judicial or administrative determination in any jurisdiction in which any member of the Group conducts business which relates to the pollution or protection of the environment or harm to or the protection of human
health or the health of animals or plants. 
 “Environmental Permits” means any Authorisation and the filing of any
notification, report or assessment required under any Environmental Law for the operation of the business of any member of the Group conducted on or from the properties owned or used by the relevant member of the Group. 

“Event of Default” means any event or circumstance specified as such in Clause 21 (Events of Default). 

“Facility” means the term loan facility made available under this Agreement as described in Clause 2 (The
Facility). 
 “Facility Office” means the office or offices notified by a Lender to the Agent in writing on or before
the date it becomes a Lender (or, following that date, by not less than five Business Days’ written notice) as the office or offices through which it will perform its obligations under this Agreement.  

“FATCA” means: 
  

	 	(a)	sections 1471 to 1474 of the Code and any associated regulations; 

  
 6 

	 	(b)	any treaty, law or regulation of any other jurisdiction, or relating to an intergovernmental agreement between the U.S. and any other jurisdiction, which (in either case) facilitates the implementation of any law or
regulation referred to in paragraph (a) above; or 

  

	 	(c)	any agreement pursuant to the implementation of any treaty, law or regulation referred to in paragraph (a) or (b) above with the U.S. Internal Revenue Service, the U.S. government or any governmental or taxation
authority in any other jurisdiction. 

 “FATCA Application Date” means: 

 

	 	(a)	in relation to a “withholdable payment” described in section 1473(1)(A)(i) of the Code (which relates to payments of interest and certain other payments from sources within the U.S.), 1 July 2014;

  

	 	(b)	in relation to a “withholdable payment” described in section 1473(1)(A)(ii) of the Code (which relates to “gross proceeds” from the disposition of property of a type that can produce interest from
sources within the U.S.), 1 January 2019; or 

  

	 	(c)	in relation to a “passthru payment” described in section 1471(d)(7) of the Code not falling within paragraph (a) or (b) above, 1 January 2019, 

or, in each case, such other date from which such payment may become subject to a deduction or withholding required by FATCA as a result of any
change in FATCA after the date of this Agreement. 
 “FATCA Deduction” means a deduction or withholding from a payment under
a Finance Document required by FATCA. 
 “FATCA Exempt Party” means a Party that is entitled to receive payments free from
any FATCA Deduction. 
 “Fee Letter” means any letter or letters referring to this Agreement or the Facility between one or
more Administrative Parties and the Borrower setting out any of the fees referred to in Clause 11 (Fees). 
 “Final Repayment
Date” means the date falling 36 Months after the first Utilisation Date. 
 “Finance Document” means this
Agreement, any Fee Letter, any Resignation Letter, any Transaction Security Document, any Utilisation Request, and any other document designated as such by the Agent and the Borrower. 

“Finance Party” means an Administrative Party or a Lender. 

“Financial Indebtedness” means any indebtedness for or in respect of: 

 

	 	(a)	moneys borrowed; 

  

	 	(b)	any amount raised by acceptance under any acceptance credit facility or dematerialised equivalent; 

  

	 	(c)	any amount raised pursuant to any note purchase facility or the issue of bonds, notes, debentures, loan stock or any similar instrument; 

  
 7 

	 	(d)	the amount of any liability in respect of any lease or hire purchase contract which would, in accordance with GAAP, be treated as a finance or capital lease; 

 

	 	(e)	receivables sold or discounted (other than any receivables to the extent they are sold on a non-recourse basis); 

 

	 	(f)	any amount raised under any other transaction (including any forward sale or purchase agreement) having the commercial effect of a borrowing; 

 

	 	(g)	any derivative transaction entered into in connection with any financial indebtedness which is incurred with the objective of protecting against fluctuation in any rate or price (and, when calculating the value of any
derivative transaction, only the marked to market value (or, if any actual amount is due as a result of the termination or close out of that derivative transaction, that amount) shall be taken into account); 

 

	 	(h)	any counter-indemnity obligation in respect of a guarantee, indemnity, bond, standby or documentary letter of credit or any other instrument issued by a bank or financial institution in respect of an underlying
liability which would fall within paragraphs (a) to (g) above; and 

  

	 	(i)	without double-counting, the amount of any liability in respect of any guarantee or indemnity for any of the items referred to in paragraphs (a) to (h) above which appears as a contingent liability in the
consolidated financial statements of the Parent Guarantor, and which for the avoidance of doubt shall exclude performance guarantees, guarantees in relation to hedging in the ordinary course of business and customary tax indemnities.

 “Financial Quarter” means the period commencing on the day after one Quarter Date and ending on the next
Quarter Date. 
 “Financial Year” means the annual accounting period of the Group ending on or about 31 March in each
year or, any other date agreed between the Borrower and the Agent. 
 “Funding Rate” means any individual rate notified by a
Lender to the Agent pursuant to paragraph (a)(ii) of Clause 10.4 (Cost of funds). 
 “Funds Flow Statement” means a
funds flow statement in agreed form between the Borrower and the Agent; 
 “GAAP” means generally accepted accounting
principles in the jurisdiction of incorporation of the relevant Obligor, including IFRS. 
 “Governmental Agency” means any
government or any governmental agency, semi-governmental or judicial entity or authority (including, without limitation, any stock exchange or any self-regulatory
organisation established under statute). 
 “Group” means the Parent Guarantor and its Subsidiaries from time to time. 

“Group Structure Chart” means the group structure chart delivered to the Agent under this Agreement from time to time. 

“Holding Company” means, in relation to a person, any other person in respect of which it is a Subsidiary. 

“IFRS” means international accounting standards within the meaning of the IAS Regulation 1606/2002 to the extent applicable to
the relevant financial statements. 

  
 8 

 “Inbound Intercompany Loan” means a loan from the Parent Guarantor, or a
member of the Group to the Borrower pursuant to which the Borrower incurs any Financial Indebtedness. 
 “Indirect Tax”
means any goods and services tax, consumption tax, value added tax or any tax of a similar nature. 
 “Information
Package” means the Reports and the Base Case Model. 
 “Insolvency Event” in relation to an entity means
that the entity: 
  

	 	(a)	is dissolved (other than pursuant to a consolidation, amalgamation or merger); 

  

	 	(b)	becomes insolvent or is unable to pay its debts or fails or admits in writing its inability generally to pay its debts as they become due; 

 

	 	(c)	makes a general assignment, arrangement or composition with or for the benefit of its creditors; 

  

	 	(d)	institutes or has instituted against it, by a regulator, supervisor or any similar official with primary insolvency, rehabilitative or regulatory jurisdiction over it in the jurisdiction of its incorporation or
organisation or the jurisdiction of its head or home office, a proceeding seeking a judgment of insolvency or bankruptcy or any other relief under any bankruptcy or insolvency law or other similar law affecting creditors’ rights, or a petition
is presented for its winding-up or liquidation by it or such regulator, supervisor or similar official; 

  

	 	(e)	has instituted against it a proceeding seeking a judgment of insolvency or bankruptcy or any other relief under any bankruptcy or insolvency law or other similar law affecting creditors’ rights, or a petition is
presented for its winding-up or liquidation, and, in the case of any such proceeding or petition instituted or presented against it, such proceeding or petition is instituted or presented by a person or entity
not described in paragraph (d) above and: 

  

	 	(i)	results in a judgment of insolvency or bankruptcy or the entry of an order for relief or the making of an order for its winding-up or liquidation; or 

 

	 	(ii)	is not dismissed, discharged, stayed or restrained in each case within 30 days of the institution or presentation thereof; 

  

	 	(f)	has exercised in respect of it one or more of the stabilisation powers pursuant to Part 1 of the Banking Act 2009 and/or has instituted against it a bank insolvency proceeding pursuant to Part 2 of the Banking Act 2009
or a bank administration proceeding pursuant to Part 3 of the Banking Act 2009; 

  

	 	(g)	has a resolution passed for its winding-up, official management or liquidation (other than pursuant to a consolidation, amalgamation or merger); 

 

	 	(h)	seeks or becomes subject to the appointment of an administrator, provisional liquidator, conservator, receiver, trustee, custodian or other similar official for it or for all or substantially all its assets (other than,
for so long as it is required by law or regulation not to be publicly disclosed, any such appointment which is to be made, or is made, by a person or entity described in paragraph (d) above); 

 

	 	(i)	has a secured party take possession of all or substantially all its assets or has a distress, execution, attachment, sequestration or other legal process levied, enforced or sued on or against all or substantially all
its assets and such secured party maintains possession, or any such process is not dismissed, discharged, stayed or restrained, in each case within 30 days thereafter; 

  
 9 

	 	(j)	causes or is subject to any event with respect to it which, under the applicable laws of any jurisdiction, has an analogous effect to any of the events specified in paragraphs (a) to (i) above; or

  

	 	(k)	takes any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the foregoing acts. 

“Intellectual Property” means: 
  

	 	(a)	any patents, trademarks, service marks, designs, business names, copyrights, database rights, design rights, domain names, moral rights, inventions, confidential information, knowhow and other intellectual property
rights and interests (which may now or in the future subsist), whether registered or unregistered; and 

  

	 	(b)	the benefit of all applications and rights to use such assets of each member of the Group (which may now or in the future subsist). 

“Intercompany Loan” means an Inbound Intercompany Loan or an Outbound Intercompany Loan. 

“Interest Period” means, in relation to the Loan, each period determined in accordance with Clause 9 (Interest Periods)
and, in relation to an Unpaid Sum, each period determined in accordance with Clause 8.2 (Default interest). 
 “Interpolated
Screen Rate” means the percentage rate (rounded upwards to four decimal places per annum determined by the Agent equal to: 
  

	 	    	S + ((D * (L -S)) / (LD -SD)) 

where: 
  

	 	    	“L” = the Screen Rate for a period longer than, but as close as possible to, the duration of the Relevant Interest Period; 

 

	 	    	“S” = the Screen Rate for a period shorter than, but as close as possible to, the duration of the Relevant Interest Period; 

 

	 	    	“LD” = the number of days in the period for which L is quoted; 

  

	 	    	“SD” = the number of days in the period for which the S is quoted; 

  

	 	    	“D” = the number of days in the Relevant Interest Period minus SD; and 

  

	 	    	“Relevant Interest Period” means the Interest Period of the Loan in respect of which the Interpolated Screen Rate is being determined. 

“Joint Venture” means any joint venture entity, whether a company, unincorporated firm, undertaking, association, joint
venture or partnership or any other entity. 
 “Last Financial Quarter” means the period commencing on January 1 of
each year and ending on 31 March of that year. 
 “Legal Due Diligence Report” means the legal due diligence reports
dated 3 October 2016 prepared by Kelly Drye & Warren LLP relating to the Acquisition. 

  
 10 

 “Legal Opinion” means any legal opinion delivered to the Agent under Clause 4
(Conditions of Utilisation) or Clause 23 (Changes to the Obligors). 
 “Legal Reservations” means: 

 

	 	(a)	the principle that equitable remedies may be granted or refused at the discretion of a court and the limitation of enforcement by laws relating to insolvency, reorganisation and other laws generally affecting the rights
of creditors; 

  

	 	(b)	the time barring of claims under the Limitation Acts, the possibility that an undertaking to assume liability for or indemnify a person against non-payment of UK stamp duty may be
void and defences of set-off or counterclaim; 

  

	 	(c)	similar principles, rights and defences under the laws of any Relevant Jurisdiction; and 

  

	 	(d)	any other matters which are set out as qualifications or reservations as to matters of law of general application in the Legal Opinions. 

“Lender” means: 
  

	 	(a)	any Original Lender; and 

  

	 	(b)	any bank, financial institution, trust, fund or other entity which has become a Party in accordance with Clause 22 (Changes to the Lenders), 

which in each case has not ceased to be a Party in accordance with the terms of this Agreement. 

“LIBOR” means, in relation to the Loan:  
  

	 	(a)	the applicable Screen Rate as of the Specified Time for the currency of the Loan and for a period equal in length to the Interest Period of the Loan; or 

 

	 	(b)	as otherwise determined pursuant to Clause 10.1 (Unavailability of Screen Rate), 

 and
if, in either case, that rate is less than zero, LIBOR will be deemed to be zero. 
 “Limitation Acts” means the Limitation
Act 1980 and the Foreign Limitation Periods Act 1984. 
 “Loan” means, as the context requires, the loan made or to be made
under the Facility or the principal amount outstanding at any time of that loan. 
 “Loan Debt” means all liabilities
payable or owing by the Borrower and Obligors to the Finance Parties under or in connection with the Finance Documents. 
 “London
Business Day” means a day (other than a Saturday or Sunday) on which commercial banks are open for general business including dealings in interbank deposits in London. 

“Majority Lenders” means a Lender or Lenders whose Commitments aggregate more than 66 2/3% of the Total Commitments (or, if
the Total Commitments have been reduced to zero, aggregated more than 66 2/3% of the Total Commitments immediately prior to the reduction). 

“Margin” means 1.27% per annum. 

  
 11 

 “Material Adverse Effect” means a material adverse effect on (a) the
business, operations, property, condition (financial or otherwise) or prospects of the Group taken as a whole; (b) the ability of any of the Obligors to perform its obligations under the Finance Documents; or (c) the validity or
enforceability of, or the rights or remedies of any Finance Party under, the Finance Documents. 
 “Month” means a period
starting on one day in a calendar month and ending on the numerically corresponding day in the next calendar month, except that: 
  

	 	(a)	subject to paragraph (c) below, if the numerically corresponding day is not a Business Day, that period shall end on the next Business Day in that calendar month in which that period is to end if there is one, or
if there is not, on the immediately preceding Business Day; 

  

	 	(b)	if there is no numerically corresponding day in the calendar month in which that period is to end, that period shall end on the last Business Day in that calendar month; and 

 

	 	(c)	if an Interest Period begins on the last Business Day of a calendar month, that Interest Period shall end on the last Business Day in the calendar month in which that Interest Period is to end. 

The above rules will apply only to the last Month of any period. 

“New Lender” has the meaning given to that term in Clause 22 (Changes to the Lenders). 

“Obligors” means the Borrower and the Parent Guarantor, and “Obligor” means each one of them. 

“Obligors’ Agent” means the Borrower, appointed to act on behalf of each Obligor in relation to the Finance Documents
pursuant to Clause 2.3 (Obligors’ Agent). 
 “OFAC” means the Office of Foreign Assets Control of the U.S.
Department of the Treasury. 
 “Original Financial Statements” means: 

 

	 	(a)	in relation to the Group, the audited consolidated financial statements of the Group for the financial year ended 31 March 2016; and 

 

	 	(b)	in relation to the Target, the unaudited consolidated financial statements for the financial year ended 31 December 2015. 

“Outbound Intercompany Loan” means a loan from Borrower to the Parent Guarantor or a member of the Group pursuant to
which the Borrower is the creditor of any Financial Indebtedness. 
 “Parent Guarantee” means the guarantee entered into on
or about the date hereof by the Parent Guarantor for the benefit of the Finance Parties. 
 “Parent Guarantor” means
WNS (Holdings) Limited, a company incorporated under the laws of Jersey with registration number 82262 whose registered office is at 22 Grenville Street, St Helier, Jersey JE4 8PX, Channel Islands. 

“Party” means a party to this Agreement. 

“Quarter Date” means 31 March, 30 June, 30 September and 31 December in any year. 

  
 12 

 “Quasi-Security” has the meaning given to that term in Clause 20.6 (Negative
pledge). 
 “Quotation Day” means: 
  

	 	(a)	in relation to any period for which an interest rate is to be determined, two London Business Days before the first day of that period unless market practice differs in the Relevant Interbank Market in which case the
Quotation Day will be determined by the Agent in accordance with market practice in the Relevant Interbank Market (and if quotations would normally be given by leading banks in the Relevant Interbank Market on more than one day, the Quotation Day
will be the last of those days); and 

  

	 	(b)	in relation to any Interest Period the duration of which is selected by the Agent pursuant to Clause 8.2 (Default interest), such date as may be determined by the Agent (acting reasonably). 

“Receiver” means a receiver or receiver and manager or administrative receiver of the whole or any part of the Charged
Property. 
 “Reference Bank Rate” means the arithmetic mean of the rates (rounded upwards to four decimal places) as
supplied to the Agent at its request by the Reference Banks, as the rate at which the relevant Reference Bank could borrow funds in the London interbank market in U.S. dollars and for the relevant period, were it to do so by asking for and then
accepting interbank offers for deposits in reasonable market size in U.S. dollars and for that period. 
 “Reference Bank
Quotation” means any quotation supplied to the Agent by a Reference Bank. 
 “Reference Bank” means the principal
London offices of BNP Paribas or such other bank or banks as may be appointed by the Agent in consultation with the Borrower. 

“Related Fund” in relation to a fund (the “first fund”), means a fund which is managed or advised by the same
investment manager or investment adviser as the first fund or, if it is managed by a different investment manager or investment adviser, a fund whose investment manager or investment adviser is an Affiliate of the investment manager or investment
adviser of the first fund. 
 “Relevant Interbank Market” means the London interbank market.  

“Relevant Jurisdiction” means, in relation to an Obligor: 

 

	 	(a)	its jurisdiction of incorporation; 

  

	 	(b)	any jurisdiction where any asset subject to or intended to be subject to the Transaction Security to be created by it is situated; 

  

	 	(c)	any jurisdiction where it conducts its business; and 

  

	 	(d)	the jurisdiction whose laws govern the perfection of any of the Transaction Security Documents entered into by it. 

“Repayment Date” means each date set out in Clause 6.1 (Repayment of Loan). 

“Repayment Instalment” means each scheduled instalment specified under Clause 6.1 (Repayment of Loan) for repayment of
the Loan. 
 “Repeating Representations” means each of the representations and warranties set out in Clauses 17.1
(Status) to 17.6 (Governing law and enforcement), 17.10(b) (No Default), 17.11 (No misleading information), 17.12(a) and (b) (Financial statements), 17.15 (Authorised Signatures), 17.17 (Anti-corruption
law and Anti-money laundering law), 17.18 (Sanctions), 17.20 (U.S. Laws) and 17.21 (Solvency). 

  
 13 

 “Reports” means: 

 

	 	(a)	each Legal Due Diligence Report; and 

  

	 	(b)	each Accountants’ and Tax Due Diligence Report. 

 “Representative” means
any delegate, agent, manager, administrator, nominee, attorney, trustee or custodian. 
 “Resignation Letter” means a letter
substantially in the form set out in Schedule 6 (Form of Resignation Letter). 
 “Retiring Security Agent” has the
meaning given to that term in Clause 26.1(d) (Resignation of the Security Agent). 
 “Sanctions” means any economic
or trade sanctions or restrictive measures enacted, administered, imposed or enforced by the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC), the U.S. Department of State, the United Nations Security Council, the
French Republic, and/or the European Union, the Governmental Agencies of or associated with any of the foregoing, including OFAC, the U.S. Department of State, and Her Majesty’s Treasury. 

“Screen Rate” means, in relation to LIBOR, the London interbank offered rate administered by ICE Benchmark
Administration Limited (or any other person which takes over the administration of that rate) for U.S. dollars and period displayed (before any correction, recalculation or republication by the administrator) on LIBOR01 of the Thomson Reuters screen
(or any replacement Thomson Reuters page which displays that rate) or the appropriate page of such other information or service which publishes that rate from time to time in place of Thomson Reuters. If the rate which is shown on such screen is
less than zero, it shall be deemed to be zero. If such page or service ceases to be available, the Agent may specify another page or service displaying the relevant rate after consultation with the Borrower.  

“Secured Liabilities” means all present and future obligations and liabilities (whether actual or contingent and whether owed
jointly or severally or in any other capacity whatsoever) of each Obligor to any Secured Party under each Finance Document. 

“Secured Party” means a Finance Party, a Receiver or any Delegate. 

“Security” means a mortgage, charge, pledge, lien or other security interest securing any obligation of any person or any
other agreement or arrangement having a similar effect.  
 “Security Agent’s Spot Rate of Exchange” means the
Security Agent’s spot rate of exchange for the purchase of the relevant currency with U.S. dollars in the Hong Kong foreign exchange market at or about 11.00 a.m. London time on a particular day. 

“Security Agreement” means the security agreement governed by New York law to be executed by (among others) the
Borrower in respect of all or substantially all of its assets. 
 “Security Property” means 

 

	 	(a)	the Transaction Security expressed to be granted in favour of the Security Agent as trustee for the Secured Parties and all proceeds of that Transaction Security; 

  
 14 

	 	(b)	all obligations expressed to be undertaken by an Obligor to pay amounts in respect of the Secured Liabilities to the Security Agent as trustee for the Secured Parties and secured by the Transaction Security together
with all representations and warranties expressed to be given by an Obligor in favour of the Security Agent as trustee for the Secured Parties; and 

  

	 	(c)	any other amounts or property, whether rights, entitlements, choses in action or otherwise, actual or contingent, which the Security Agent is required by the terms of the Finance Documents to hold as trustee on trust
for the Secured Parties. 

 “SPA” means the stock purchase agreement to be entered into on or about the date
hereof between the Borrower as purchaser and the Vendors as sellers in respect of, among other things, the acquisition of the Target Shares. 

“Specified Time” means a time determined in accordance with Schedule 8 (Timetables). 

Stock Pledge Agreement means the stock pledge agreement governed by New York law to be executed by (among others) the Borrower in
respect of all the shares in the Target. 
 “Subsidiary” means, in relation to any company or corporation, a company or
corporation: 
  

	 	(a)	which is controlled, directly or indirectly, by the first mentioned company or corporation; 

  

	 	(b)	more than half the issued equity share capital of which is beneficially owned, directly or indirectly, by the first mentioned company or corporation; or 

 

	 	(c)	which is a Subsidiary of another Subsidiary of the first mentioned company or corporation, 

 and
for this purpose, a company or corporation shall be treated as being controlled by another if that other company or corporation is able to direct its affairs and/or to control the composition of its board of directors or equivalent body. 

“Target Group” means Target and its respective Subsidiaries. 

“Target” means Denali Sourcing Services, Inc., a company incorporated in the State of Delaware, United States whose registered
office is at 1209 Orange Street, in the City of Wilmington, County of New Castle, 19801, Delaware, United States. 
 “Target
Shares” means all of the shares in the Target. 
 “Tax” means any tax, levy, impost, duty or other charge or
withholding of a similar nature (including any penalty or interest payable in connection with any failure to pay or any delay in paying any of the same). 

“Tax Deduction” has the meaning given to such term in Clause 12.1 (Tax definitions). 

“Total Commitments” means at any time the aggregate of the Commitments (being US$34,000,000 at the date of this Agreement).

 “Transaction Documents” means the Finance Documents and the SPA. 

“Transaction Security” means the Security created or evidenced or expressed to be created or evidenced under the Transaction
Security Documents. 
 “Transaction Security Document” means: 

 

	 	(a)	the Parent Guarantee; 

  
 15 

	 	(b)	the Stock Pledge Agreement; 

  

	 	(c)	the Security Agreement; 

  

	 	(d)	any other document evidencing or creating or expressed to evidence or create Security over any asset to secure any obligation of any Obligor to a Secured Party under the Finance Documents; or 

 

	 	(e)	any other document designated as such by the Security Agent and the Borrower. 

“Transfer Certificate” means a certificate substantially in the form set out in Schedule 4 (Form of Transfer
Certificate) or any other form agreed between the Agent and the Borrower. 
 “Transfer Date” means, in relation to an
assignment or a transfer, the later of: 
  

	 	(a)	the proposed Transfer Date specified in the relevant Assignment Agreement or Transfer Certificate; and 

  

	 	(b)	the date on which the Agent executes the relevant Assignment Agreement or Transfer Certificate. 

“Treasury Transactions” means any derivative transaction entered into in connection with protection against or benefit from
fluctuation in any rate or price. 
 “Unpaid Sum” means any sum due and payable but unpaid by an Obligor under the Finance
Documents. 
 “U.S.” means the United States of America. 

“Utilisation” means a utilisation of the Facility. 

“Utilisation Date” means the date of a Utilisation, being the date on which the Loan is to be made. 

“Utilisation Request” means a notice substantially in the form set out in Schedule 3 (Utilisation Request). 

“Vendors” means Alpar Kamber, Donald Dougherty and John R. Evans as selling shareholders and Priyadarshan Deshmukh, Peter E.
Nero and Alan C. Veeck as selling optionholders of the Target, and Alpar Kamber in his capacity as representative of the selling shareholders and selling optionholders of the Target (each, a “Vendor”). 

 

	1.2	Construction 

  

	 	(a)	Unless a contrary indication appears, any reference in this Agreement to: 

  

	 	(i)	any Administrative Party, the Agent, the Arranger, any Finance Party, any Lender, any Obligor, any Party, any Secured Party, the Security Agent or any other
person shall be construed so as to include its successors in title, permitted assigns and permitted transferees and, in the case of the Security Agent, any person for the time being appointed as Security Agent or Security Agents in accordance with
the Finance Documents; 

  

	 	(ii)	assets includes present and future properties, revenues and rights of every description; 

  
 16 

	 	(iii)	a Finance Document or a Transaction Document or any other agreement or instrument is a reference to that Finance Document or Transaction Document or other agreement or instrument as amended, novated,
supplemented, extended or restated; 

  

	 	(iv)	including shall be construed as “including without limitation” (and cognate expressions shall be construed similarly); 

 

	 	(v)	indebtedness includes any obligation (whether incurred as principal or as surety) for the payment or repayment of money, whether present or future, actual or contingent; 

 

	 	(vi)	a Lender’s participation in a Loan or Unpaid Sum includes an amount (in the currency of such Loan or Unpaid Sum) representing the fraction or portion (attributable to such Lender by virtue of the provisions
of this Agreement) of the total amount of such Loan or Unpaid Sum and the Lender’s rights under this Agreement in respect thereof; 

  

	 	(vii)	a person includes any individual, firm, company, corporation, government, state or agency of a state or any association, trust, joint venture, consortium or partnership (whether or not having separate legal
personality); 

  

	 	(viii)	a regulation includes any regulation, rule, official directive, request or guideline (whether or not having the force of law) of any governmental, intergovernmental or supranational body, agency, department or
regulatory, self-regulatory or other authority or organisation; 

  

	 	(ix)	a provision of law is a reference to that provision as amended or re-enacted; and 

  

	 	(x)	a time of day is a reference to Hong Kong time. 

  

	 	(b)	Section, Clause and Schedule headings are for ease of reference only. 

  

	 	(c)	Unless a contrary indication appears, a term used in any other Finance Document or in any notice given under or in connection with any Finance Document has the same meaning in that Finance Document or notice as in this
Agreement. 

  

	 	(d)	A Default (other than an Event of Default) is continuing if it has not been remedied or waived and an Event of Default is continuing if it has not been waived. 

 

	 	(e)	Where this Agreement specifies an amount in a given currency (the “specified currency”) or its equivalent, the equivalent is a reference to the amount of any other currency which, when
converted into the specified currency utilising the Agent’s spot rate of exchange for the purchase of the specified currency with that other currency at or about 11.00 a.m. on the relevant date, is equal to the relevant amount in the specified
currency. 

  

	1.3	Third party rights 

  

	 	(a)	Unless expressly provided to the contrary in a Finance Document a person who is not a Party has no right under the Contracts (Rights of Third Parties) Act 1999 (the “Third Parties Act”) to enforce or to
enjoy the benefit of any term of this Agreement. 

  
 17 

	 	(b)	Subject to Clause 37.3 (Other Exceptions) but otherwise notwithstanding any term of any Finance Document, the consent of any third person who is not a Party is not required to rescind or vary this
Agreement at any time. 

  

	 	(c)	Any Receiver, Delegate or any person described in Clause 25.8 (Exclusion of liability) may, subject to this Clause 1.3 and the Third Parties Act, rely on any Clause of this Agreement which expressly confers
rights on it. 

  

	2.	THE FACILITY 

  

	2.1	The Facility 

 Subject to the terms of this Agreement, the Lenders make available to the
Borrower a U.S. dollar term loan facility in an aggregate amount equal to the Total Commitments. 
  

	2.2	Finance Parties’ rights and obligations 

  

	 	(a)	The obligations of the Finance Parties under the Finance Documents are several. Failure by a Finance Party to perform its obligations under the Finance Documents does not affect the obligations of any other Party under
the Finance Documents. No Finance Party is responsible for the obligations of any other Finance Party under the Finance Documents. 

  

	 	(b)	The rights of the Finance Parties under or in connection with the Finance Documents are separate and independent rights and any debt arising under the Finance Documents to a Finance Party from an Obligor is a separate
and independent debt. The rights of each Finance Party include any debt owing to that Finance Party under the Finance Documents and any part of the Loan or any other amount owed by an Obligor which relates to a Finance Party’s participation in
the Facility or its role under a Finance Document is a debt owing to that Finance Party by that Obligor. 

  

	 	(c)	A Finance Party may, except as specifically provided in the Finance Documents, separately enforce its rights under or in connection with the Finance Documents. 

 

	2.3	Obligors’ Agent 

  

	 	(a)	Each Obligor (other than the Borrower) by its execution of this Agreement irrevocably appoints the Borrower to act on its behalf as its agent in relation to the Finance Documents and irrevocably authorises:

  

	 	(i)	the Borrower on its behalf to supply all information concerning itself contemplated by this Agreement to the Finance Parties and to give all notices and instructions, to make such agreements and to effect the relevant
amendments, supplements and variations capable of being given, made or effected by any Obligor notwithstanding that they may affect the Obligor, without further reference to or the consent of that Obligor; and 

 

	 	(ii)	each Finance Party to give any notice, demand or other communication to that Obligor pursuant to the Finance Documents to the Borrower, 

 

	 	    	and in each case the Obligor shall be bound as though the Obligor itself had given the notices and instructions (including, without limitation, any Utilisation Requests) or executed or made the agreements or effected
the amendments, supplements or variations, or received the relevant notice, demand or other communication. 

  

	 	(b)	Every act, omission, agreement, undertaking, settlement, waiver, amendment, supplement, variation, notice or other communication given or made by the Obligors’ Agent or given to the Obligors’ Agent under any
Finance Document on behalf of another Obligor or in connection with any Finance Document (whether or not known to any other Obligor and whether occurring before or after such other Obligor became an Obligor under any Finance Document) shall be
binding for all purposes on that Obligor as if that Obligor had expressly made, given or concurred with it. In the event of any conflict between any notices or other communications of the Obligors’ Agent and any other Obligor, those of the
Obligors’ Agent shall prevail. 

  
 18 

	3.	PURPOSE 

  

	3.1	Purpose 

 The Borrower shall apply all amounts borrowed by it under the Facility towards:

  

	 	(a)	payment to the Vendors of the purchase price for the Target Shares; and 

  

	 	(b)	payment of the Acquisition Costs (other than periodic fees); 

 in each case, as described in the
Funds Flow Statement. 
  

	3.2	Monitoring 

 No Finance Party is bound to monitor or verify the application of any amount
borrowed pursuant to this Agreement. 
  

	4.	CONDITIONS OF UTILISATION 

  

	4.1	Initial conditions precedent 

  

	 	(a)	The Borrower may not deliver a Utilisation Request unless the Agent has received all of the documents and other evidence listed in Part 1 of Schedule 2 (Conditions) in form and substance satisfactory to the
Agent. The Agent shall notify the Borrower and the Lenders promptly upon being so satisfied. 

  

	 	(b)	Other than to the extent that the Majority Lenders notify the Agent in writing to the contrary before the Agent gives the notification described in paragraph (a) above, the Lenders authorise (but do not require)
the Agent to give that notification. The Agent shall not be liable for any damages, costs or losses whatsoever as a result of giving any such notification. 

  

	4.2	Further conditions precedent 

 The Lenders will be obliged to comply with Clause 5.4
(Lenders’ participations) only if on the date of the Utilisation Request and on the proposed Utilisation Date: 
  

	 	(a)	no Default is continuing or would result from the proposed Loan and none of the circumstances described in Clause 7.2 (Change of Control) has occurred; and 

 

	 	(b)	the Repeating Representations to be made by each Obligor are true in all material respects. 

  

	4.3	Maximum number of Loans 

 No more than one Loan shall be outstanding at any given time.
The Facility shall be drawn in full in a single drawdown. 

  
 19 

	5.	UTILISATION 

  

	5.1	Delivery of a Utilisation Request 

 The Borrower may utilise the Facility by delivery to
the Agent of a duly completed Utilisation Request not later than the Specified Time. 
  

	5.2	Completion of a Utilisation Request 

  

	 	(a)	Each Utilisation Request is irrevocable and will not be regarded as having been duly completed unless: 

  

	 	(i)	the proposed Utilisation Date is a Business Day within the Availability Period; 

  

	 	(ii)	the currency and amount of the Utilisation comply with Clause 5.3 (Currency and amount); and 

  

	 	(iii)	the proposed first Interest Period complies with Clause 9 (Interest Periods). 

  

	 	(b)	Only one Loan may be requested in each Utilisation Request. 

  

	5.3	Currency and amount 

 The currency specified in a Utilisation Request must be U.S.
dollars. 
  

	5.4	Lenders’ participations 

  

	 	(a)	If the conditions set out in Clause 4 (Conditions of Utilisation) and 5.1 (Delivery of a Utilisation Request) to 5.3 (Currency and amount) above have been met, each Lender shall make its
participation in the Loan available by the Utilisation Date through its Facility Office. 

  

	 	(b)	The amount of each Lender’s participation in the Loan will be equal to the proportion borne by its Available Commitment to the Available Facility immediately prior to making the Loan. 

 

	 	(c)	The Agent shall notify each Lender of the amount of the Loan and the amount of its participation in the Loan by the Specified Time. 

 

	5.5	Cancellation of Available Facility 

 The Commitments which, at that time, are unutilised
shall be immediately cancelled at 5.00 p.m. on the last day of the Availability Period. 

  
 20 

	6.	REPAYMENT 

  

	6.1	Repayment of Loan 

  

	 	(a)	The Borrower must repay the Loan in instalments by repaying on each Repayment Date an amount which reduces the outstanding aggregate Loan by the amount set forth opposite each of the Repayment Dates listed in the table
below (in each case as such amount may be reduced by any earlier prepayments pursuant to Clause 7 (Prepayment and Cancellation)): 

  

					
	Repayment Date	  	Repayment Instalment	 
		
	 Date falling 6 months after the first Utilisation Date
	  	US$	5,650,000	 
		
	 Date falling 12 months after the first Utilisation Date
	  	US$	5,650,000	 
		
	 Date falling 18 months after the first Utilisation Date
	  	US$	5,650,000	 
		
	 Date falling 24 months after the first Utilisation Date
	  	US$	5,650,000	 
		
	 Date falling 30 months after the first Utilisation Date
	  	US$	5,650,000	 
		
	 Final Repayment Date
	  	US$	5,750,000	 

  

	 	(b)	The Loan must be repaid in full on the Final Repayment Date. 

  

	6.2	Reborrowing 

 The Borrower may not reborrow any part of the Facility which is repaid.

  

	7.	PREPAYMENT AND CANCELLATION 

  

	7.1	Illegality 

 If, at any time, it is or will become unlawful in any applicable
jurisdiction for a Lender to perform any of its obligations as contemplated by this Agreement or to fund or maintain its participation in the Loan or it is or will become unlawful for any Affiliate of a Lender for that Lender to do so: 

 

	 	(a)	that Lender shall promptly notify the Agent upon becoming aware of that event; 

  

	 	(b)	upon the Agent notifying the Borrower, the Commitment of that Lender will be immediately cancelled; and 

  

	 	(c)	to the extent that the Lenders’ participation has not been transferred pursuant to paragraph (d) of Clause 7.6 (Right of prepayment and cancellation in relation to a single Lender), the Borrower shall
repay that Lender’s participation in the Loan on the last day of the Interest Period for the Loan occurring after the Agent has notified the Borrower or, if earlier, the date specified by the Lender in the notice delivered to the Agent (being
no earlier than the last day of any applicable grace period permitted by law). 

  

	7.2	Change of Control 

 Upon the occurrence of: 

 

	 	(a)	any Change of Control; or 

  

	 	(b)	the sale of any of the shares in the Target by the Borrower to a person who is not a member of the Group whether in a single transaction or a series of related transactions, the Facility will be cancelled and all
outstanding Utilisations, together with accrued interest, and all other amounts accrued under the Finance Documents, shall become immediately due and payable. 

  
 21 

	7.3	Non-completion of the Acquisition 

 If the
Closing Date does not occur by the date falling 1 month from the signing of the SPA (provided that such date may be extended with the consent of the Agent acting on the instructions of the Lenders), the Facility will be cancelled and all outstanding
Utilisations, together with accrued interest, and all other amounts accrued under the Finance Documents, shall become immediately due and payable. 
  

	7.4	Voluntary cancellation 

 The Borrower may, if it gives the Agent not less than seven
Business Days’ (or such shorter period as the Majority Lenders may agree) prior notice, reduce the Available Facility to zero or by such amount (being a minimum amount of US$5,000,000 and minimum integral multiples of US$1,000,000)) as the
Borrower may specify in such notice. Any such reduction under this Clause 7.4 shall reduce the Commitments of the Lenders rateably. 
  

	7.5	Voluntary prepayment of the Loan 

  

	 	(a)	The Borrower may, if it gives the Agent not less than seven Business Days’ (or such shorter period as the Majority Lenders may agree) prior notice, prepay the whole or any part of the Loan (but, if in part, being
an amount that reduces the amount of the Loan by a minimum amount of US$5,000,000 and minimum integral multiples of US$50,000). 

  

	 	(b)	The Loan may be prepaid only after the last day of the Availability Period (or, if earlier, the day on which the Available Facility is zero). 

 

	7.6	Right of prepayment and cancellation in relation to a single Lender 

  

	 	(a)	If: 

  

	 	(i)	any sum payable to any Lender by an Obligor is required to be increased under paragraph (a) of Clause 12.2 (Tax gross-up); or 

 

	 	(ii)	any Lender claims indemnification from the Borrower under Clause 12.3 (Tax indemnity) or Clause 13.1 (Increased costs), 

 

	 	    	the Borrower may, whilst the circumstance giving rise to the requirement for that increase or indemnification continues, give the Agent notice of cancellation of the Commitment of that Lender and its intention to
procure the repayment of that Lender’s participation in the Loan or give the Agent notice of its intention to replace that Lender in accordance with paragraph (d) below. 

 

	 	(b)	On receipt of a notice of cancellation referred to in paragraph (a) above, the Commitment of that Lender shall immediately be reduced to zero. 

 

	 	(c)	On the last day of each Interest Period which ends after the Borrower has given notice of cancellation under paragraph (a) above (or, if earlier, the date specified by the Borrower in that notice), the Borrower
shall prepay that Lender’s participation in the Loan. 

  

	 	(d)	The Borrower may, in the circumstances set out in paragraph (a) above, on 15 Business Days’ prior notice to the Agent and that Lender, replace that Lender by requiring that Lender to (and, to the extent
permitted by law, that Lender shall) transfer pursuant to Clause 22 (Changes to the Lenders)) all (and not part only) of its rights and obligations under this Agreement to a Lender or other bank, financial institution, trust, fund or other
entity selected by the Borrower which confirms its willingness to assume and does assume all the obligations of the transferring Lender in accordance with Clause 22 (Changes to the Lenders) for a purchase price in cash equal to the
outstanding principal amount of such Lender’s participation in the outstanding Loan and all accrued interest (to the extent that the Agent has not given a notification under Clause 22.13 (Pro rata interest settlement), Break Costs and
other amounts payable in relation thereto under the Finance Documents. 

  
 22 

	 	(e)	The replacement of a Lender pursuant to paragraph (d) above shall be subject to the following conditions: 

  

	 	(i)	the Borrower shall have no right to replace the Agent; 

  

	 	(ii)	neither the Agent nor any Lender shall have any obligation to find a replacement Lender; 

  

	 	(iii)	in no event shall the Lender replaced under paragraph (d) above be required to pay or surrender any of the fees received by such Lender pursuant to the Finance Documents; and 

 

	 	(iv)	no Lender shall be obliged to execute a Transfer Certificate unless it is satisfied that it has completed all “know your customer” and other similar procedures that it is required (or deems desirable) to
conduct in relation to the transfer to such replacement Lender. 

  

	 	(f)	A Lender shall perform the procedures described in paragraph (e)(iv) above as soon as reasonably practicable following delivery of a notice referred to in paragraph (d) above and shall notify the Agent and the
Borrower when it is satisfied that it has completed those checks. 

  

	7.7	Restrictions 

  

	 	(a)	Any notice of cancellation or prepayment given by any Party under this Clause 7 shall be irrevocable and, unless a contrary indication appears in this Agreement, shall specify the date or dates upon which the relevant
cancellation or prepayment is to be made and the amount of that cancellation or prepayment. 

  

	 	(b)	Any prepayment under this Agreement shall be made together with accrued interest on the amount prepaid and, subject to any Break Costs, without premium or penalty. 

 

	 	(c)	Any prepayments or cancellations under this Agreement shall reduce the outstanding amount under this Agreement in inverse order of maturity. 

 

	 	(d)	The Borrower may not reborrow any part of the Facility which is prepaid. 

  

	 	(e)	The Borrower shall not repay or prepay all or any part of the Loan or reduce any Commitment except at the times and in the manner expressly provided for in this Agreement. 

 

	 	(f)	If any Commitment is reduced in accordance with this Agreement, the amount of such reduction may not be subsequently reinstated. 

  

	 	(g)	If the Agent receives a notice under this Clause 7 it shall promptly forward a copy of that notice to either the Borrower or the affected Lender, as appropriate. 

 

	 	(h)	If all or part of the Loan is repaid or prepaid and is not available for redrawing, an amount of the Commitments (equal to the amount of the Loan which is repaid or prepaid) will be deemed to be cancelled on the date of
repayment or prepayment. Any cancellation under this paragraph (h) (save in connection with any repayment or, as the case may be, prepayment under paragraph (c) of Clause 7.1 (Illegality) or paragraph (c) of Clause 7.6 (Right of
prepayment and cancellation in relation to a single Lender)) shall reduce the Commitments of the Lenders rateably. 

  
 23 

	8.	INTEREST 

  

	8.1	Calculation of interest 

 The rate of interest on the Loan for each Interest Period is
the percentage rate per annum which is the aggregate of the applicable: 
  

	 	(a)	Margin; and 

  

	 	(b)	LIBOR. 

  

	8.2	Default interest 

  

	 	(a)	If an Obligor fails to pay any amount payable by it under a Finance Document on its due date, interest shall accrue on the Unpaid Sum from the due date to the date of actual payment (both before and after judgment) at a
rate which is, subject to paragraph (b) below, 2% higher than the rate which would have been payable if the Unpaid Sum had, during the period of non-payment, constituted a Loan in the currency of the
Unpaid Sum for successive Interest Periods, each of a duration selected by the Agent (acting reasonably). Any interest accruing under this Clause 8.2 shall be immediately payable by the Obligor on demand by the Agent. 

 

	 	(b)	If any Unpaid Sum consists of all or part of the Loan which became due on a day which was not the last day of an Interest Period: 

  

	 	(i)	the first Interest Period for that Unpaid Sum shall have a duration equal to the unexpired portion of the current Interest Period; and 

 

	 	(ii)	the rate of interest applying to the Unpaid Sum during that first Interest Period shall be 2% higher than the rate which would have applied if the Unpaid Sum had not become due. 

 

	 	(c)	Default interest (if unpaid) arising on an Unpaid Sum will be compounded with the Unpaid Sum at the end of each Interest Period applicable to that Unpaid Sum but will remain immediately due and payable.

  

	8.3	Notification of rates of interest 

 The Agent shall promptly notify the Lenders and the
Borrower of the determination of a rate of interest under this Agreement. 
  

	9.	INTEREST PERIODS 

  

	9.1	Selection of Interest Periods 

  

	 	(a)	Each Interest Period for the Loan shall be three Months, or any other period agreed between the Borrower and the Agent (acting on the written instructions of all the Lenders). 

  
 24 

	 	(b)	An Interest Period for the Loan shall not extend beyond the Final Repayment Date. 

  

	 	(c)	Each Interest Period for the Loan shall start on the Utilisation Date or (if the Loan has already been made) on the last day of the preceding Interest Period. 

 

	9.2	Non-Business Days 

 If an Interest Period would
otherwise end on a day which is not a Business Day, that Interest Period will instead end on the next Business Day in that calendar month (if there is one) or the preceding Business Day (if there is not). 

 

	10.	CHANGES TO THE CALCULATION OF INTEREST 

  

	10.1	Unavailability of Screen Rate 

  

	 	(a)	If no Screen Rate is available for LIBOR for the Interest Period of a Loan, the applicable LIBOR shall be the Interpolated Screen Rate for a period equal in length to the Interest Period of that Loan. 

 

	 	(b)	If no Screen Rate is available for LIBOR for: 

  

	 	(i)	the currency of a Loan; or 

  

	 	(ii)	the Interest Period of the Loan and it is not possible to calculate the Interpolated Screen Rate, 

  

	 	    	the applicable LIBOR shall be the Reference Bank Rate as of the Specified Time for the currency of that Loan and for a period equal in length to the Interest Period of that Loan. 

 

	 	(c)	If paragraph (b) above applies but no Reference Bank Rate is available for the relevant currency or Interest Period there shall be no LIBOR for that Loan and Clause 10.4 (Cost of funds) shall apply to that
Loan for that Interest Period. 

  

	10.2	Calculation of a Reference Bank Rate 

  

	 	(a)	Subject to paragraph (b) below, if LIBOR is to be determined on the basis of a Reference Bank Rate but a Reference Bank does not supply a quotation by the Specified Time, the Reference Bank Rate shall be calculated
on the basis of the quotations of the remaining Reference Banks. 

  

	 	(b)	If at or about noon (Hong Kong time) on the Quotation Day none or only one of the Reference Banks supplies a quotation, there shall be no Reference Bank Rate for the relevant Interest Period. 

 

	10.3	Market disruption 

 If before close of business in London on the Quotation Day for the
relevant Interest Period the Agent receives notifications from a Lender or Lenders (whose participations in the Loan exceed 50%) that the cost to it of funding its participation in the Loan from whatever source it may reasonably select would be in
excess of LIBOR then Clause 10.4 (Cost of funds) shall apply to the Loan for the relevant Interest Period. 

  
 25 

	10.4	Cost of funds 

  

	 	(a)	If this Clause 10.4 applies, the rate of interest on each Lender’s share of the Loan for the relevant Interest Period shall be the percentage rate per annum which is the sum of: 

 

	 	(i)	the Margin; and 

  

	 	(ii)	the rate notified to the Agent by that Lender as soon as practicable and in any event by close of business on the date falling five Business Days after the Quotation Day (or, if earlier, on the date falling three
Business Days before the date on which interest is due to be paid in respect of that Interest Period), to be that which expresses as a percentage rate per annum the cost to the relevant Lender of funding its participation in the Loan from whatever
source it may reasonably select. 

  

	 	(b)	If this Clause 10.4 applies and the Agent or the Borrower so requires, the Agent and the Borrower shall enter into negotiations (for a period of not more than 30 days) with a view to agreeing a substitute basis for
determining the rate of interest. 

  

	 	(c)	Any alternative basis agreed pursuant to paragraph (b) above shall, with the prior consent of all the Lenders and the Borrower, be binding on all Parties. 

 

	 	(d)	If this Clause 10.4 applies pursuant to Clause 10.3 (Market disruption) and: 

  

	 	(i)	a Lender’s Funding Rate is less than LIBOR; or 

  

	 	(ii)	a Lender does not supply a quotation by the time specified in paragraph (a)(ii) above, 

  

	 	    	the cost to that Lender of funding its participation in that Loan for that Interest Period shall be deemed, for the purposes of paragraph (a) above, to be LIBOR. 

 

	 	(e)	If this Clause 10.4 applies pursuant to Clause 10.1 (Unavailability of Screen Rate) but any Lender does not supply a quotation by the time specified in paragraph (a)(ii) above the rate of interest shall be
calculated on the basis of the quotations of the remaining Lenders. 

  

	10.5	Notification to the Borrower 

 If Clause 10.4 (Cost of funds) applies the Agent
shall, as soon as is practicable, notify the Borrower. 
  

	10.6	Break Costs 

  

	 	(a)	The Borrower shall, within three Business Days of demand by a Finance Party, pay to that Finance Party its Break Costs attributable to all or any part of the Loan or any Unpaid Sum being paid by the Borrower on a day
other than the last day of an Interest Period for the Loan or any Unpaid Sum. 

  

	 	(b)	Each Lender shall, as soon as reasonably practicable after a demand by the Agent, provide a certificate confirming the amount of its Break Costs for any Interest Period in which they accrue. 

  
 26 

	11.	FEES 

  

	11.1	Commitment fee 

  

	 	(a)	The Borrower must pay to the Agent (for the account of each Lender) a commitment fee computed at the rate of 0.45% per annum of each Lender’s Available Commitment at close of business (in the principal financial
centre of the country of the relevant currency) on each day of the period from and including the date falling 15 days after the date of this Agreement to and including the end of the Availability Period (or, if any such day shall not be a Business
Day, at such close of business on the immediately preceding Business Day). 

  

	 	(b)	The accrued commitment fee is payable in arrears: 

  

	 	(i)	on the last day of each quarter date during the Availability Period; 

  

	 	(ii)	on the last day of the Availability Period; and 

  

	 	(iii)	if a Lender’s Commitment is reduced to zero before the last day of the Availability Period, on the day on which such reduction to zero becomes effective. 

 

	11.2	Arrangement fee 

 The Borrower shall pay to the Arranger an arrangement fee in the amount
and at the times agreed in a Fee Letter. 
  

	11.3	Agency fee 

 The Borrower shall pay to the Agent (for its own account) an agency fee in
the amount and at the times agreed in a Fee Letter. 
  

	11.4	Security Agency fee 

 The Borrower shall pay to the Security Agent (for its own account)
a security agency fee in the amount and at the times agreed in a Fee Letter. 
  

	12.	TAX GROSS-UP AND INDEMNITIES 

  

	12.1	Tax definitions 

  

	 	(a)	In this Clause 12: 

  

	 	    	“IRS” means the U.S. Internal Revenue Service. 

  

	 	    	“Protected Party” means a Finance Party which is or will be subject to any liability or required to make any payment for or on account of Tax in relation to any sum received or receivable (or any sum
deemed for the purposes of Tax to be received or receivable) under a Finance Document. 

  

	 	    	“Tax Credit” means a credit against, relief or remission for, or repayment of, any Tax. 

  

	 	    	“Tax Deduction” means a deduction or withholding for or on account of Tax from a payment under a Finance Document, other than a FATCA Deduction. 

  
 27 

	 	    	“Tax Payment” means an increased payment made by an Obligor to a Finance Party under Clause 12.2 (Tax gross-up) or a payment under Clause 12.3 (Tax
indemnity). 

  

	 	    	“United States person” has the meaning given to it in Section 7701(a)(30) of the Code. 

  

	 	(b)	Unless a contrary indication appears, in this Clause 12 a reference to “determines” or “determined” means a determination made in the absolute discretion of the person making the
determination acting in good faith. 

  

	12.2	Tax gross-up 

  

	 	(a)	All payments to be made by or on behalf of an Obligor to any Finance Party under the Finance Documents shall be made free and clear of and without any Tax Deduction unless a Tax Deduction is required by law, in which
case the sum payable by the relevant Obligor (in respect of which such Tax Deduction is required to be made) shall be increased to the extent necessary to ensure that such Finance Party receives a sum net of any deduction or withholding equal to the
sum which it would have received had no such Tax Deduction been made or required to be made. 

  

	 	(b)	The Borrower shall promptly upon becoming aware that an Obligor must make a Tax Deduction (or that there is any change in the rate or the basis of a Tax Deduction) notify the Agent accordingly. Similarly, a Lender shall
notify the Agent on becoming so aware in respect of a payment payable to that Lender. If the Agent receives such notification from a Lender it shall notify the Borrower and that Obligor. 

 

	 	(c)	If an Obligor is required to make a Tax Deduction, that Obligor shall make that Tax Deduction and any payment required in connection with that Tax Deduction within the time allowed and in the minimum amount required by
law. 

  

	 	(d)	Within 30 days of making either a Tax Deduction or any payment required in connection with that Tax Deduction, the Obligor making that Tax Deduction shall deliver to the Agent for the Finance Party entitled to the
payment evidence reasonably satisfactory to that Finance Party that the Tax Deduction has been made or (as applicable) any appropriate payment paid to the relevant taxing authority. 

 

	12.3	Tax indemnity 

  

	 	(a)	The Borrower shall (within five Business Days of demand by the Agent) pay to a Protected Party an amount equal to the loss, liability or cost which that Protected Party determines will be or has been (directly or
indirectly) suffered for or on account of Tax by that Protected Party in respect of a Finance Document. 

  

	 	(b)	Paragraph (a) above shall not apply: 

  

	 	(i)	with respect to any Tax assessed on a Finance Party; 

  

	 	(A)	under the law of the jurisdiction in which that Finance Party is incorporated or, if different, the jurisdiction (or jurisdictions) in which that Finance Party is treated as resident for tax purposes; or

  

	 	(B)	under the law of the jurisdiction in which that Finance Party’s Facility Office is located in respect of amounts received or receivable in that jurisdiction, if that Tax is imposed on or calculated by reference to
the net income received or receivable (but not any sum deemed to be received or receivable) by that Finance Party; or 

  
 28 

	 	(ii)	to the extent a loss, liability or cost: 

  

	 	(A)	is compensated for by an increased payment under Clause 12.2 (Tax gross-up); or 

  

	 	(B)	relates to a FATCA Deduction required to be made by a Party. 

  

	 	(c)	A Protected Party intending to make a claim under paragraph (a) above shall promptly notify the Agent of the event which will give, or has given rise to the claim, whereupon the Agent shall notify the Borrower
thereof. 

  

	 	(d)	A Protected Party shall, on receiving a payment from an Obligor under this Clause 12.3, notify the Agent.  

  

	12.4	Tax credit 

 If an Obligor makes a Tax Payment and the relevant Finance Party determines
that: 
  

	 	(a)	a Tax Credit is attributable to an increased payment of which that Tax Payment forms part, to that Tax Payment or to a Tax Deduction in consequence of which that Tax Payment was required; and 

 

	 	(b)	that Finance Party has obtained and utilised that Tax Credit, 

 the Finance Party shall pay an
amount to the Obligor which that Finance Party determines will leave it (after that payment) in the same after-Tax position as it would have been in had the Tax Payment not been required to be made by the
Obligor. 
  

	12.5	Stamp taxes 

  

	 	(a)	The Borrower shall: 

  

	 	(i)	pay all stamp duty, registration and other similar Taxes payable in respect of any Finance Document; and 

  

	 	(ii)	within five Business Days of demand, indemnify each Finance Party against any cost, loss or liability that Finance Party incurs in relation to any stamp duty, registration or other similar Tax paid or payable in respect
of any Finance Document. 

  

	 	(b)	The Borrower shall pay and within five Business Days of demand, indemnify each Secured Party against any cost, loss or liability that Secured Party incurs in relation to any stamp duty, registration or other similar Tax
paid or payable in respect of any Finance Document (save for any such assignment, transfer or sub-participation entered into pursuant to, or in connection with, Clause 14 (Mitigation by the Lenders)).

  

	12.6	Indirect tax 

  

	 	(a)	All amounts set out or expressed in a Finance Document to be payable by any Party to a Finance Party shall be deemed to be exclusive of any Indirect Tax. If any Indirect Tax is chargeable on any supply made by any
Finance Party to any Party in connection with a Finance Document, that Party shall pay to the Finance Party (in addition to and at the same time as paying the consideration) an amount equal to the amount of the Indirect Tax (and such Finance Party
must promptly provide an appropriate Indirect Tax invoice to that Party). 

  

	 	(b)	Where a Finance Document requires any Party to reimburse a Finance Party for any costs or expenses, that Party shall also at the same time reimburse or indemnify the Finance Party against all Indirect Tax incurred by
that Finance Party in respect of the costs or expenses to the extent the Finance Party reasonably determines that it is not entitled to credit or repayment in respect of the Indirect Tax. 

  
 29 

	12.7	FATCA Deduction 

  

	 	(a)	Each Party may make any FATCA Deduction it is required to make by FATCA, and any payment required in connection with that FATCA Deduction, and no Party shall be required to increase any payment in respect of which it
makes such a FATCA Deduction or otherwise compensate the recipient of the payment for that FATCA Deduction. 

  

	 	(b)	Each Party shall promptly, upon becoming aware that it must make a FATCA Deduction (or that there is any change in the rate or the basis of such FATCA Deduction), notify the Party to whom it is making the payment and,
in addition, shall notify the Borrower and the Agent and the Agent shall notify the other Finance Parties. 

  

	12.8	FATCA Information 

  

	 	(a)	Subject to paragraph (c) below, each Party shall, within ten Business Days of a reasonable request by another Party: 

  

	 	(i)	confirm to that other Party whether it is: 

  

	 	(A)	a FATCA Exempt Party; or 

  

	 	(B)	not a FATCA Exempt Party; and 

  

	 	(ii)	supply to that other Party such forms, documentation and other information relating to its status under FATCA as that other Party reasonably requests for the purposes of that other Party’s compliance with FATCA;

  

	 	(iii)	supply to that other Party such forms, documentation and other information relating to its status as that other Party reasonably requests for the purposes of that other Party’s compliance with any other law,
regulation, or exchange of information regime. 

  

	 	(b)	If a Party confirms to another Party pursuant to paragraph (a)(i) above that it is a FATCA Exempt Party and it subsequently becomes aware that it is not or has ceased to be a FATCA Exempt Party, that Party shall notify
that other Party reasonably promptly. 

  

	 	(c)	Paragraph (a) above shall not oblige any Finance Party to do anything, and paragraph (a)(iii) above shall not oblige any other Party to do anything, which would or might in its reasonable opinion constitute a
breach of: 

  

	 	(i)	any law or regulation; 

  

	 	(ii)	any fiduciary duty; or 

  

	 	(iii)	any duty of confidentiality. 

  
 30 

	 	(d)	If a Party fails to confirm whether or not it is a FATCA Exempt Party or to supply forms, documentation or other information requested in accordance with paragraph (a)(i) or (ii) above (including, for the avoidance
of doubt, where paragraph (c) above applies), then such Party shall be treated for the purposes of the Finance Documents (and payments under them) as if it is not a FATCA Exempt Party until such time as the Party in question provides the
requested confirmation, forms, documentation or other information. 

  

	 	(e)	Each Lender shall, within ten Business Days of: 

  

	 	(i)	where the relevant Lender is a Lender at the date of this Agreement, the date of this Agreement; 

  

	 	(ii)	where the relevant Lender is a New Lender, the relevant Transfer Date; or 

  

	 	(iii)	the date of a request from the Agent, 

  

	 	    	supply to the Agent: 

  

	 	(A)	a withholding certificate on Form W-8, Form W-9 or any other relevant form; or 

 

	 	(B)	any withholding statement or other document, authorisation or waiver as the Agent may require to certify or establish the status of such Lender under FATCA or that other law or regulation. 

 

	 	(f)	The Agent shall provide any withholding certificate, withholding statement, document, authorisation or waiver it receives from a Lender pursuant to paragraph (e) above to the Borrower. 

 

	 	(g)	If any withholding certificate, withholding statement, document, authorisation or waiver provided to the Agent by a Lender pursuant to paragraph (e) above is or becomes materially inaccurate or incomplete, that
Lender shall promptly update it and provide such updated withholding certificate, withholding statement, document, authorisation or waiver to the Agent unless it is unlawful for the Lender to do so (in which case the Lender shall promptly notify the
Agent). The Agent shall provide any such updated withholding certificate, withholding statement, document, authorisation or waiver to the Borrower. 

  

	 	(h)	The Agent may rely on any withholding certificate, withholding statement, document, authorisation or waiver it receives from a Lender pursuant to paragraph (e) or (g) above without further verification. The Agent
shall not be liable for any action taken by it under or in connection with paragraphs (e), (f) or (g) above. 

  

	 	(i)	If a Lender fails to supply any withholding certificate, withholding statement, document, authorisation, waiver or information in accordance with paragraph (e) above, or any withholding certificate, withholding
statement, document, authorisation, waiver or information provided by a Lender to the Agent is or becomes materially inaccurate or incomplete, then such Lender shall indemnify the Agent, within five Business Days of demand, against any cost, loss,
Tax or liability (including, without limitation, for negligence or any other category of liability whatsoever) incurred by the Agent (including any related interest and penalties) in acting as Agent under the Finance Documents as a result of such
failure. 

  

	 	(j)	If, in accordance with paragraph (f) above, the Agent provides the Borrower with sufficient information to determine its withholding obligations under FATCA, but the Borrower fails to withhold as required by FATCA,
the Borrower shall indemnify the Agent, within five Business Days of demand, against any cost, loss, Tax or liability (including, without limitation, for negligence or any other category of liability whatsoever) incurred by the Agent (including any
related interest and penalties) in acting as Agent under the Finance Documents as a result of such failure. 

  
 31 

	13.	INCREASED COSTS 

  

	13.1	Increased costs 

  

	 	(a)	Subject to Clause 13.3 (Exceptions) the Borrower shall, within three Business Days of a demand by the Agent, pay for the account of a Finance Party the amount of any Increased Costs incurred by that Finance Party
or any of its Affiliates as a result of (i) the introduction of or any change in (or in the interpretation, administration or application of) any law or regulation or (ii) compliance with any law or regulation made after the date of this
Agreement(whether such implementation, application or compliance is by a government, regulator, Finance Party or any of its Affiliates). The terms “law” and “regulation” in this paragraph (a) shall include any law or
regulation concerning capital adequacy, prudential limits, liquidity, reserve assets or Tax. 

  

	 	(b)	In this Agreement: 

 Increased Costs means: 

 

	 	(a)	a reduction in the rate of return from the Facility or on a Finance Party’s (or its Affiliate’s) overall capital (including as a result of any reduction in the rate of return on capital brought about by more
capital being required to be allocated by such Finance Party); 

  

	 	(b)	an additional or increased cost; or 

  

	 	(c)	a reduction of any amount due and payable under any Finance Document, 

 which is incurred or
suffered by a Finance Party or any of its Affiliates to the extent that it is attributable to the undertaking, funding or performance by such Finance Party of any of its obligations under any Finance Document or any participation of such Finance
Party in the Loan or any Unpaid Sum. 
  

	13.2	Increased cost claims 

  

	 	(a)	A Finance Party (other than the Agent) intending to make a claim pursuant to Clause 13.1 (Increased costs) shall notify the Agent of the event giving rise to the claim, following which the Agent shall promptly
notify the Borrower. 

  

	 	(b)	Each Finance Party (other than the Agent) shall, as soon as practicable after a demand by the Agent, provide a certificate confirming the amount of its Increased Costs. 

 

	13.3	Exceptions 

  

	 	(a)	Clause 13.1 (Increased costs) does not apply to the extent any Increased Cost is: 

  

	 	(i)	attributable to a Tax Deduction required by law to be made by an Obligor; 

  

	 	(ii)	attributable to a FATCA Deduction required to be made by a Party; 

  
 32 

	 	(iii)	compensated for by Clause 12.3 (Tax indemnity) (or would have been compensated for under Clause 12.3 (Tax indemnity) but was not so compensated solely because the exclusions in paragraph (b) of Clause
12.3 (Tax indemnity) applied); or 

  

	 	(iv)	attributable to the wilful breach by the relevant Finance Party or its Affiliates of any law or regulation. 

  

	 	(b)	In this Clause 13.3, a reference to a “Tax Deduction” has the same meaning given to the term in Clause 12.1 (Tax definitions). 

 

	14.	MITIGATION BY THE LENDERS 

  

	14.1	Mitigation 

  

	 	(a)	Each Finance Party shall, in consultation with the Borrower, take all reasonable steps to mitigate any circumstances which arise and which would result in any amount becoming payable under or pursuant to, or cancelled
pursuant to, any of Clause 7.1 (Illegality), Clause 12 (Tax Gross-Up and Indemnities) or Clause 13 (Increased Costs), including (but not limited to) transferring its rights and obligations
under the Finance Documents to another Affiliate or Facility Office. 

  

	 	(b)	Paragraph (a) above does not in any way limit the obligations of any Obligor under the Finance Documents. 

  

	14.2	Limitation of liability 

  

	 	(a)	The Borrower shall promptly indemnify each Finance Party for all costs and expenses reasonably incurred by that Finance Party as a result of steps taken by it under Clause 14.1 (Mitigation). 

 

	 	(b)	A Finance Party is not obliged to take any steps under Clause 14.1 (Mitigation) if, in the opinion of that Finance Party (acting reasonably), to do so might be prejudicial to it. 

 

	14.3	Conduct of business by the Finance Parties 

 No provision of this Agreement will: 

 

	 	(a)	interfere with the right of any Finance Party to arrange its affairs (tax or otherwise) in whatever manner it thinks fit; 

  

	 	(b)	oblige any Finance Party to investigate or claim any credit, relief, remission or repayment available to it or the extent, order and manner of any claim; or 

 

	 	(c)	oblige any Finance Party to disclose any information relating to its affairs (tax or otherwise) or any computations in respect of Tax. 

 

	15.	OTHER INDEMNITIES 

  

	15.1	Currency indemnity 

  

	 	(a)	If any sum due from an Obligor under the Finance Documents (a “Sum”), or any order, judgment or award given or made in relation to a Sum, has to be converted from the currency (the “First
Currency”) in which that Sum is payable into another currency (the “Second Currency”) for the purpose of: 

  

	 	(i)	making or filing a claim or proof against that Obligor; or 

  

	 	(ii)	obtaining or enforcing an order, judgment or award in relation to any litigation or arbitration proceedings, 

  
 33 

	 	    	that Obligor shall as an independent obligation, within three Business Days of demand, indemnify each Secured Party to whom that Sum is due against any cost, loss or liability arising out of or as a result of the
conversion including any discrepancy between (A) the rate of exchange used to convert that Sum from the First Currency into the Second Currency and (B) the rate or rates of exchange available to that person at the time of its receipt of
that Sum. 

  

	 	(b)	Each Obligor waives any right it may have in any jurisdiction to pay any amount under the Finance Documents in a currency or currency unit other than that in which it is expressed to be payable. 

 

	15.2	Other indemnities 

  

	 	(a)	The Borrower shall (or shall procure that an Obligor will), within five Business Days of demand, indemnify each Secured Party against any cost, loss or liability incurred by that Secured Party as a result of:

  

	 	(i)	the occurrence of any Event of Default; 

  

	 	(ii)	the information produced or approved by any Obligor being or being alleged to be misleading and/or deceptive in any respect; 

  

	 	(iii)	a failure by an Obligor to pay any amount due under a Finance Document on its due date or in the relevant currency, including without limitation, any cost, loss or liability arising as a result of Clause 28 (Sharing
among the Finance Parties); 

  

	 	(iv)	any enquiry, investigation, subpoena (or similar order) or litigation with respect to any Obligor or with respect to the transactions contemplated or financed under this Agreement; 

 

	 	(v)	funding, or making arrangements to fund, its participation in the Loan requested by the Borrower in a Utilisation Request but not made by reason of the operation of any one or more of the provisions of this Agreement
(other than by reason of default or negligence by that Finance Party alone); or 

  

	 	(vi)	the Loan (or part of the Loan) not being prepaid in accordance with a notice of prepayment given by the Borrower. 

  

	 	(b)	The Borrower shall (or shall procure that an Obligor will), within three Business Days of demand, promptly indemnify each Finance Party, each Affiliate of a Finance Party and each officer or employee of a Finance Party
or its Affiliate, against any cost, loss or liability incurred by that Finance Party or its Affiliate (or officer or employee of that Finance Party or Affiliate) in connection with or arising out of the Acquisition or the funding of the Acquisition
(including but not limited to those incurred in connection with any litigation, arbitration or administrative proceedings or regulatory enquiry concerning the Acquisition), unless such loss or liability is caused by the gross negligence or wilful
misconduct of that Finance Party or its Affiliate (or employee or officer of that Finance Party or Affiliate). Any Affiliate or any officer or employee of a Finance Party or its Affiliate may rely on this Clause 15.2 subject to Clause 1.3 (Third
party rights) and the provisions of the Third Parties Act. 

  
 34 

	15.3	Indemnity to the Agent 

 The Borrower shall (or shall procure that an Obligor will),
within three Business Days of demand, promptly indemnify the Agent against any cost, loss or liability incurred by the Agent (acting reasonably) as a result of: 
  

	 	(a)	investigating any event which it reasonably believes is a Default; 

  

	 	(b)	acting or relying on any notice, request or instruction which it reasonably believes to be genuine, correct and appropriately authorised; or 

 

	 	(c)	instructing lawyers, accountants, tax advisers, surveyors or other professional advisers or experts as permitted under this Agreement. 

 

	15.4	Obligors’ indemnity to the Security Agent 

 Each Obligor shall promptly indemnify
the Security Agent and every Receiver and Delegate against any cost, loss or liability incurred by any of them: 
  

	 	(a)	as a result of: 

  

	 	(i)	any failure by the Borrower to comply with obligations under Clause 16 (Costs and Expenses); 

  

	 	(ii)	the taking, holding, protection or enforcement of the Transaction Security; 

  

	 	(iii)	the exercise of any of the rights, powers, discretions and remedies vested in the Security Agent and each Receiver and Delegate by the Finance Documents or by law; or 

 

	 	(iv)	any default by any Obligor in the performance of any of the obligations expressed to be assumed by it in the Finance Documents; or 

  

	 	(b)	which otherwise relates to any of the Charged Property or the performance of the terms of the Finance Documents (otherwise than as a result of its gross negligence or wilful misconduct). 

 

	15.5	Priority of indemnity 

 The Security Agent and every Receiver and Delegate may, in
priority to any payment to the Secured Parties, indemnify itself out of the Charged Property in respect of, and pay and retain, all sums necessary to give effect to the indemnity in Clause 15.4 (Obligors’ indemnity to the Security Agent)
and shall have a lien on the Transaction Security and the proceeds of enforcement of the Transaction Security for all moneys payable to it. 
  

	16.	COSTS AND EXPENSES 

  

	16.1	Transaction expenses 

 The Borrower shall, within seven Business Days of demand, pay the
Administrative Parties the amount of all costs and expenses (including legal fees) reasonably incurred by any of them (and, in the case of the Security Agent, any Receiver or Delegate) in connection with the negotiation, preparation, printing,
execution, syndication and perfection of: 
  

	 	(a)	this Agreement and any other documents referred to in this Agreement or in a Transaction Security Document; and 

  

	 	(b)	any other Finance Documents executed after the date of this Agreement. 

  
 35 

	16.2	Amendment costs 

 If (a) an Obligor requests an amendment, waiver or consent or
(b) an amendment is required pursuant to Clause 30.9 (Change of currency), the Borrower shall, within seven Business Days of demand, reimburse each of the Agent and the Security Agent for the amount of all costs and expenses (including
legal fees) reasonably incurred by the Agent or the Security Agent (and, in the case of the Security Agent, any Receiver or Delegate) in responding to, evaluating, negotiating or complying with that request or requirement. 

 

	16.3	Security Agent’s ongoing costs 

  

	 	(a)	In the event of (i) a Default or (ii) the Security Agent considering it necessary or expedient or (iii) the Security Agent being requested by an Obligor or the Agent (acting on the written instructions of
the Majority Lenders) to undertake duties which the Security Agent and the Borrower agree to be of an exceptional nature and/or outside the scope of the normal duties of the Security Agent under the Finance Documents, the Borrower shall pay to the
Security Agent any additional remuneration (together with any applicable Indirect Tax) that may be agreed between them. 

  

	 	(b)	If the Security Agent and the Borrower fail to agree upon the nature of the duties or upon any additional remuneration, that dispute shall be determined by an investment bank (acting as an expert and not as an
arbitrator) selected by the Security Agent and approved by the Borrower or, failing approval, nominated (on the application of the Security Agent) by the President for the time being of the Law Society of England and Wales (the costs of the
nomination and of the investment bank being payable by the Borrower ) and the determination of any investment bank shall be final and binding upon the parties to this Agreement. 

 

	16.4	Enforcement and preservation costs 

 The Borrower shall, within three Business Days of
demand, pay to each Secured Party the amount of all costs and expenses (including legal fees) incurred by that Secured Party in connection with the enforcement of, or the preservation of any rights under, any Finance Document and the Transaction
Security and any proceedings instituted by or against that Secured Party as a consequence of it entering into a Finance Document, taking or holding the Transaction Security, or enforcing those rights. 

 

	17.	REPRESENTATIONS 

 The Borrower makes the representations and warranties set out in this Clause 17 on
behalf of itself and each other Obligor to each Finance Party on the date of this Agreement. 
  

	17.1	Status 

  

	 	(a)	It is a corporation, duly incorporated and validly existing under the laws of the jurisdiction of incorporation. 

  

	 	(b)	It and each of its Subsidiaries has the power to own its assets and carry on its business as it is being conducted. 

  

	17.2	Binding obligations 

 Subject to the Legal Reservations, the obligations expressed to be
assumed by it in each Finance Document are legal, valid, binding and enforceable obligations. 

  
 36 

	17.3	Non-conflict with other obligations 

 The entry
into and performance by it of, and the transactions contemplated by, the Finance Documents do not and will not conflict with: 
  

	 	(a)	any law or regulation applicable to it; 

  

	 	(b)	its and each of its Subsidiaries’ constitutional documents; or 

  

	 	(c)	any agreement or instrument binding upon it or any of its Subsidiaries or any of its or any of its Subsidiaries’ assets. 

  

	17.4	Power and authority 

 It has the power to enter into, perform and deliver, and has taken
all necessary action to authorise its entry into, performance and delivery of, the Finance Documents to which it is a party and the transactions contemplated by those Finance Documents. 

 

	17.5	Validity and admissibility in evidence 

 All Authorisations required or desirable: 

 

	 	(a)	to enable it lawfully to enter into, exercise its rights and comply with its obligations in the Finance Documents to which it is a party; and 

 

	 	(b)	to make the Finance Documents to which it is a party admissible in evidence in its Relevant Jurisdiction, 

have been obtained or effected and are in full force and effect. 
  

	 	(c)	All Authorisations necessary for it and its Subsidiaries to carry on their business have been obtained or effected and are in full force and effect. 

 

	17.6	Governing law and enforcement 

 Subject to Legal Reservations: 

 

	 	(a)	the choice of governing law of the Finance Documents will be recognised and enforced in its Relevant Jurisdictions; and 

  

	 	(b)	any judgment obtained in relation to a Finance Document in the jurisdiction of the governing law of that Finance Document will be recognised and enforced in its Relevant Jurisdictions. 

 

	17.7	Deduction of Tax 

 It is not required under the law applicable where it is incorporated
or resident or at the address specified in this Agreement to make any Tax Deduction from any payment it may make under any Finance Document. 
  

	17.8	No filing or stamp taxes 

 Except for payment of any stamp fees in respect of any Finance
Documents brought into India, it is not necessary under the laws of its Relevant Jurisdictions that the Finance Documents be filed, recorded or enrolled with any court or other authority in that jurisdiction or that any stamp, registration or
similar tax be paid on or in relation to the Finance Documents or the transactions contemplated by the Finance Documents. 

  
 37 

	17.9	Taxation 

 It is not materially overdue in the filing of any tax returns and it is not
overdue in the payment of any amount in respect of Tax (save where such payment is in dispute and has been adequately provided for by the Group) which has had or could reasonably be expected to have a Material Adverse Effect. 

 

	17.10	No default 

  

	 	(a)	No Event of Default is continuing or is reasonably likely to result from the making of any Utilisation. 

  

	 	(b)	No other event or circumstance is outstanding which constitutes a default under any other agreement or instrument which is binding on it or any of its Subsidiaries or to which its (or any of its Subsidiaries’)
assets are subject which has or is reasonably likely to have a Material Adverse Effect. 

  

	17.11	No misleading information 

 Save as disclosed in writing to the Agent and the Arranger
prior to the date of this Agreement (or, in relation to the Information Package, prior to the date of the Information Package): 
  

	 	(a)	all factual written information (supplied by any member of the Group was true, complete and accurate in all material respects as at the date it was given and was not misleading in any respect as at the date it was
provided or as at the date (if any) at which it is stated. 

  

	 	(b)	any financial projections provided by or on behalf of any member of the Group (whether or not contained in the Information Memorandum) have been prepared on the basis of recent historical information and on the basis of
reasonable assumptions. 

  

	 	(c)	nothing has occurred and no information has been given or withheld that results in the information supplied by any member of the Group as being untrue or misleading in any material respect. 

 

	 	(d)	all written information (other than the Information Package) supplied by any member of the Group was true, complete and accurate in all material respects as at the date it was given and was not misleading in any
respect. 

  

	17.12	Financial statements 

  

	 	(a)	Its financial statements most recently supplied to the Agent (which, at the date of this Agreement, are the Original Financial Statements) were prepared in accordance with GAAP consistently applied save to the extent
expressly disclosed in such financial statements or to the Agent in writing to the contrary, prior to the date of this Agreement. 

  

	 	(b)	Its financial statements most recently supplied to the Agent (which, at the date of this Agreement, are the Original Financial Statements) give a true and fair view and represent its financial condition and operations
(consolidated in the case of the Borrower) during the relevant financial year save to the extent expressly disclosed to the Agent in writing to the contrary, prior to the date of this Agreement. 

 

	 	(c)	There has been no material adverse change in the business activities, financial condition, credit standing and/or prospects of the Parent Guarantor or the Borrower and/or their Subsidiaries since the date to which the
Original Financial Statements were drawn up. 

  
 38 

	17.13	Pari passu ranking 

 Its payment obligations under the Finance Documents rank at least
pari passu with the claims of all of its other unsecured and unsubordinated creditors, except for obligations mandatorily preferred by law applying to companies generally. 

 

	17.14	No proceedings pending or threatened 

 No litigation, arbitration or administrative
proceedings of or before any court, arbitral body or agency which, if adversely determined, might reasonably be expected to have a Material Adverse Effect has or have (to the best of its knowledge and belief) been started or threatened against it or
any of its Subsidiaries. 
  

	17.15	Authorised Signatures 

 Any person specified as its authorised signatory under Schedule 2
(Conditions) or paragraph (f) of Clause 18.4 (Information: miscellaneous) is authorised to sign Utilisation Requests (in the case of the Borrower only) and other notices on its behalf. 

 

	17.16	Acquisition 

  

	 	(a)	The SPA contains all the terms of the Acquisition. 

  

	 	(b)	There is no disclosure made in the Disclosure Schedules or any other disclosure to the SPA which has or may have a material adverse effect on any of the information, opinions, intentions, forecasts and projections
contained or referred to in the Information Package. 

  

	 	(c)	To the best of its knowledge no representation or warranty (as qualified by the Disclosure Schedules) given by any party to the SPA is untrue or misleading in any material respect. 

 

	17.17	Anti-corruption law and Anti-money laundering law 

 Neither it nor any of its
Subsidiaries, directors or officers, or, to the best knowledge of the Borrower, any affiliate, agent or employee of it, has engaged in any activity or conduct which would violate any applicable anti-bribery, anti-corruption or anti-money laundering
laws, regulations or rules in any applicable jurisdiction and the Borrower has instituted and maintains policies and procedures designed to prevent violation of such laws, regulations and rules. 

 

	17.18	Sanctions 

 Neither it nor any of its Subsidiaries, nor any directors, officers or (to
the best knowledge of the Borrower), agents, employees of it or any of its Subsidiaries is an individual or entity (a “Person”) that is, or is owned or controlled by Persons that are: (i) the target of any Sanctions (a
“Sanctioned Person”) or (ii) located, organized or resident in a country or territory that is, or whose government is, the subject of Sanctions broadly prohibiting dealings with such government, country, or territory (a
“Sanctioned Country”). 
  

	17.19	Group Structure Chart 

  

	 	(a)	Assuming Completion has occurred, the Group Structure Chart delivered to the Agent pursuant to Part 1 of Schedule 2 (Conditions) is true, complete and accurate in all material respects and shows the following
information: 

  

	 	(i)	each member of the Group, including current name and company registration number, its jurisdiction of incorporation and/or its jurisdiction of establishment, a list of shareholders and indicating whether a company is
not a company with limited liability; and 

  

	 	(ii)	all minority interests in any member of the Group and any person in which any member of the Group holds shares in its issued share capital or equivalent ownership interest of such person. 

  
 39 

	17.20	U.S. Laws 

 No member of the Group is: 

 

	 	(a)	required to be registered as an investment company or subject to regulation under the United States Investment Company Act of 1940; or 

 

	 	(b)	subject to regulation under any United States Federal or State law or regulation that limits its ability to incur or guarantee indebtedness. 

As used herein, “investment company” has the meaning given to it in the United States Investment Company Act of 1940. 

 

	17.21	Solvency 

 No: 
  

	 	(a)	corporate action, legal proceeding or other procedure, or step described in paragraph (a) of Clause 21.6 (Insolvency); or 

 

	 	(b)	creditor’s process described in Clause 21.8 (Creditors’ process), 

 has been
taken or, to the knowledge of the Borrower, threatened in relation to a member of the Group and none of the circumstances in Clause 21.6 (Insolvency) applies to a member of the Group. 

 

	17.22	Repetition 

 The Repeating Representations are deemed to be made by each Obligor by
reference to the facts and circumstances then existing on the date of each Utilisation Request, each Utilisation Date and the first day of each Interest Period. 
  

	18.	INFORMATION UNDERTAKINGS 

 The undertakings in this Clause 18 remain in force from the
date of this Agreement for so long as any amount is outstanding under the Finance Documents or any Commitment is in force. 
  

	18.1	Financial statements 

  

	 	(a)	The Borrower shall supply to the Agent in sufficient copies for all the Lenders: 

  

	 	(i)	as soon as the same become available, but in any event within 180 days after the end of each of its Financial Years, the Borrower’s audited consolidated financial statements for that Financial Year;

  

	 	(ii)	as soon as the same become available, but in any event within 60 days after the end of each Financial Quarter other than the Last Financial Quarter of each of its Financial Years, the Borrower’s unaudited
consolidated financial statements for that Financial Quarter; and 

  
 40 

	 	(iii)	as soon as the same become available, but in any event within 120 days after the end of the Last Financial Quarter of each of its Financial Years, the Borrower’s unaudited consolidated financial statements for that
Financial Quarter. 

  

	 	(b)	The Borrower shall (or shall procure that the Parent Guarantor shall) supply to the Agent in sufficient copies for all the Lenders: 

  

	 	(i)	as soon as the same become available, but in any event within 120 days after the end of each of the Financial Years of the Parent Guarantor, the Parent Guarantor’s audited consolidated financial statements for that
Financial Year; and 

  

	 	(ii)	as soon as the same become available, but in any event within 60 days after the end of each Financial Quarter other than the Last Financial Quarter of each of the Financial Years of the Parent Guarantor, the Parent
Guarantor’s unaudited consolidated financial statements for that Financial Quarter. 

  

	18.2	Compliance Certificate 

 The Borrower shall supply to the Agent, with each set of
financial statements delivered pursuant to paragraph (i) and (ii) of Clause 18.1 (Financial statements), a Compliance Certificate setting out (in reasonable detail) computations as to compliance with Clause 19 (Financial
Covenants) as at the date as at which those financial statements were drawn up. 
  

	18.3	Requirements as to financial statements 

  

	 	(a)	Each set of financial statements delivered by the Borrower or the Parent Guarantor pursuant to Clause 18.1 (Financial statements) shall be certified by a director and/or an authorised signatory of the relevant
company who is a senior executive (i.e. senior vice-president or above) with responsibility for the financial matters of the Borrower or the Parent Guarantor, as the case may be, as fairly representing its financial condition as at the date as at
which those financial statements were drawn up. 

  

	 	(b)	Each set of financial statements delivered by the Borrower or the Parent Guarantor pursuant to Clause 18.1 (Financial statements) shall give a true and fair view of (if audited) or fairly represent (if unaudited)
the financial condition and operations of the relevant company. 

  

	 	(c)	The Borrower shall procure that each set of financial statements delivered pursuant to Clause 18.1 (Financial statements) is prepared using GAAP. 

 

	 	(d)	The Borrower shall procure that each set of financial statements of an Obligor delivered pursuant to Clause 18.1 (Financial statements) is prepared using GAAP, accounting practices and financial reference periods
consistent with those applied in the preparation of the Original Financial Statements for that Obligor unless, in relation to any set of financial statements, it notifies the Agent that there has been a change in GAAP, the accounting practices or
reference periods and its auditors (or, if appropriate, the auditors of the Obligor) deliver to the Agent: 

  

	 	(i)	a description of any change necessary for those financial statements to reflect the GAAP, accounting practices and reference periods upon which that Obligor’s Original Financial Statements were prepared; and

  
 41 

	 	(ii)	sufficient information, in form and substance as may be reasonably required by the Agent, to enable the Lenders to determine whether Clause 19 (Financial Covenants) has been complied with and make an accurate
comparison between the financial position indicated in those financial statements and that Obligor’s Original Financial Statements. 

Any reference in this Agreement to those financial statements shall be construed as a reference to those financial statements as adjusted to
reflect the basis upon which the Original Financial Statements were prepared. 
  

	18.4	Information: miscellaneous 

 The Borrower shall supply to the Agent (in sufficient copies
for all the Finance Parties, if the Agent so requests): 
  

	 	(a)	all documents dispatched by the Borrower to its creditors generally at the same time as they are despatched; 

  

	 	(b)	promptly upon becoming aware of the relevant claim the details of any material claim which is current, threatened or pending against any Vendor or any other person in respect of the SPA; 

 

	 	(c)	promptly upon becoming aware of them, the details of any litigation, arbitration or administrative proceedings which are current, threatened or pending against any member of the Group, and which might, if adversely
determined, have a Material Adverse Effect; 

  

	 	(d)	promptly, such information as the Security Agent may reasonably require about the Charged Property and compliance of the Obligors with the terms of any Transaction Security Documents; 

 

	 	(e)	promptly, such further information regarding the financial condition, business and operations of any member of the Group as any Finance Party (through the Agent) may reasonably request; and 

 

	 	(f)	promptly, notice of any change in authorised signatories of any Obligor who are authorised to sign any notices or statements signed by a director, company secretary or authorised signatory of such Obligor accompanied by
specimen signatures of any new authorised signatories. 

  

	18.5	Notification of default 

  

	 	(a)	Each Obligor shall notify the Agent of any Default (and the steps, if any, being taken to remedy it) promptly upon becoming aware of its occurrence (unless that Obligor is aware that a notification has already been
provided by another Obligor). 

  

	 	(b)	Promptly upon a request by the Agent, the Borrower shall supply to the Agent a certificate signed by a director or authorised signatory on its behalf certifying that no Default is continuing (or if a Default is
continuing, specifying the Default and the steps, if any, being taken to remedy it). 

  

	18.6	Know your customer checks 

  

	 	(a)	Each Obligor shall promptly upon the request of the Agent supply, or procure the supply of, such documentation and other evidence as is reasonably requested by the Agent (for itself or on behalf of any Lender (including
for any Lender on behalf of any prospective new Lender)) in order for the Agent, such Lender or any prospective new Lender to conduct any know your customer or other similar procedures under applicable laws and regulations and internal
policies. 

  

	 	(b)	Each Lender shall promptly upon the request of the Agent supply, or procure the supply of, such documentation and other evidence as is reasonably requested by the Agent (for itself) in order for the Agent to conduct any
know your customer or other similar procedures under applicable laws and regulations and internal policies. 

  
 42 

	19.	FINANCIAL COVENANTS 

  

	19.1	Financial definitions 

 In this Agreement: 

“Borrowings” means, as at any particular time, the aggregate outstanding principal, capital or nominal amount (and any fixed
or minimum premium payable on prepayment or redemption) of the Financial Indebtedness of members of the Group but: 
  

	 	(a)	excluding any indebtedness referred to in paragraph (g) of the definition of Financial Indebtedness and any guarantee or indemnity in respect of that indebtedness; 

 

	 	(b)	excluding any Financial Indebtedness owed by one member of the Group to another member of the Group; and 

  

	 	(c)	including, in the case of finance or capital leases only, the capital element value thereto, 

and so that no amount shall be included or excluded more than once. 

“Debt Service Cover” means the ratio of Debt Service to EBITDA in respect of any Relevant Period. 

“Debt Service” means, in respect of any Relevant Period, the sum of: 

 

	 	(a)	Interest Expense for that Relevant Period; and 

  

	 	(b)	that part of all Borrowings outstanding at the commencement of that Relevant Period originally scheduled for repayment in that Relevant Period (whether or not paid or repaid when due). 

“EBITDA” means, in relation to any Relevant Period, the total consolidated operating profit of the Group for that Relevant
Period: 
  

	 	(a)	before taking into account: 

  

	 	(i)	Interest Expense; 

  

	 	(ii)	Tax; 

  

	 	(iii)	any share of the profit of any associated company or undertaking, except for dividends received in cash by any member of the Group; 

  

	 	(iv)	extraordinary and exceptional items; 

  

	 	(v)	any realised or unrealised exchange losses (including those arising on translation of currency debt) that are not related to the operations of the Group (it being understood that exchange losses related to hedging in
the ordinary course of business are to be included in the calculation of EBITDA); 

  
 43 

	 	(vi)	any loss against book value arising on a disposal or revaluation of any asset in the ordinary course of trading; 

  

	 	(vii)	to the extent included, any fair value adjustments and amounts written off the value of investments; 

  

	 	(viii)	any restructuring costs in respect of restructurings approved by the Majority Lenders; 

  

	 	(ix)	any amount charged to the profit and loss account for transaction costs and expenses relating to the Acquisition; 

  

	 	(x)	any amortisation of stock based compensation expenses and any fringe benefits and taxes associated therewith to the extent recoverable from employees; and 

 

	 	(b)	after adding back all amounts provided for depreciation and amortisation for that Relevant Period, 

as determined (except as needed to reflect the terms of this Clause 19) from the consolidated financial statements of the Parent Guarantor and
Compliance Certificates delivered under Clause 18.1 (Financial statements) and Clause 18.2 (Compliance Certificate). 

“Finance Lease” means any lease or hire purchase contract which would, in accordance with GAAP, be treated as a finance or
capital lease. 
 “Interest Expense” means in relation to any Relevant Period, the aggregate amount of interest and any
other finance charges (whether or not paid, payable or capitalised) accrued by the Group in that Relevant Period in respect of Borrowings: 
  

	 	(a)	including the interest element of leasing and hire purchase payments; 

  

	 	(b)	including commitment fees, commissions, arrangement fees and guarantee fees; 

  

	 	(c)	including amounts in the nature of interest payable in respect of any shares other than equity share capital; 

  

	 	(d)	excluding any such obligations to any member of the Group; 

  

	 	(e)	excluding any amount charged to the profit and loss account in respect of the Relevant Period for transaction costs and expenses relating to the Acquisition (other than interest payable in respect of the Facility); and

  

	 	(f)	excluding any amount in the nature of accrued interest, fees or periodic payments or premia owing to any member of the Group on any deposit or bank account, 

adjusted (but without double counting) by adding back the net amount payable (or deducting the net amount receivable) by members of the Group
in respect of that Relevant Period under any interest or (so far as they relate to interest) currency hedging arrangements, all as determined (except as needed to reflect the terms of this Clause 19) from the consolidated financial statements of the
Borrower and Compliance Certificates delivered under Clause 18.1 (Financial statements) and Clause 18.2 (Compliance Certificate). 

  
 44 

 “Net Leverage” means, in respect of any Relevant Period, the ratio of Total Net
Debt on the last day of that Relevant Period to EBITDA in respect of that Relevant Period. 
 “New Shareholder Injections”
means the aggregate amount subscribed for by any person (other than a member of the Group) for ordinary shares in the Borrower or for subordinated loan notes or other subordinated debt instruments in the Borrower on terms acceptable to the Majority
Lenders. 
 “Relevant Period” means each period of 12 months ending on a Quarter Date. 

“Total Net Debt” means, at any time, the aggregate amount of all obligations of members of the Group for or in respect of
Borrowings at that time but: 
  

	 	(a)	excluding any such obligations to any other member of the Group; 

  

	 	(b)	excluding any such obligations in respect of, to the extent they constitute Borrowings, any New Shareholder Injections; 

  

	 	(c)	including, in the case of Finance Leases only, their capitalised value; 

  

	 	(d)	deducting the aggregate amount of Cash held by the Group at that time; and 

  

	 	(e)	deducting Cash Equivalent investments held by the Group, 

 and so that no amount shall be
included or excluded more than once. 
  

	19.2	Financial condition 

 The Borrower shall (and the Borrower will procure that the Parent
Guarantor will) ensure that: 
  

	 	(a)	Debt Service Cover: Debt Service Cover in respect of any Relevant Period shall not be less than 1.1:1. 

  

	 	(b)	Net Leverage: Net Leverage in respect of any Relevant Period shall not exceed 3:1. 

  

	19.3	Financial testing 

  

	 	(a)	The financial covenants set out in Clause 19.2 (Financial condition) shall be calculated and interpreted on a consolidated basis in accordance with GAAP applicable to the Original Financial Statements of the
Parent Guarantor and (to the extent not expressed in US$) shall be converted into US$ on the basis of the exchange rates used in the latest consolidated quarterly financial statements of the Parent Guarantor and tested by reference to each of the
financial statements delivered pursuant to paragraph (i) or (ii) of Clause 18.1 (Financial statements) and/or each Compliance Certificate delivered pursuant to Clause 18.2 (Compliance Certificate). 

 

	 	(b)	The first testing date shall be 31 March 2017. 

  

	20.	GENERAL UNDERTAKINGS 

 The undertakings in this Clause 20 remain in force from the date
of this Agreement for so long as any amount is outstanding under the Finance Documents or any Commitment is in force. 
  

	20.1	Authorisations 

  

	 	(a)	The Borrower shall (and the Borrower will procure that each Obligor will) promptly: 

  

	 	(i)	obtain, comply with and do all that is necessary to maintain in full force and effect; and 

  

	 	(ii)	supply certified copies to the Agent of, 

  
 45 

	 	    	any Authorisation required to: 

  

	 	(A)	enable it to perform its obligations under the Finance Documents and the SPA; 

  

	 	(B)	to ensure the legality, validity, enforceability or admissibility in evidence in its jurisdiction of incorporation of any Finance Document or the SPA; and 

 

	 	(C)	carry on its business where failure to do so has or is reasonably likely to have a Material Adverse Effect. 

  

	20.2	Compliance with laws 

 The Borrower shall (and the Borrower will procure that each
Obligor will) comply in all respects with all laws to which it may be subject, if failure so to comply would materially impair its ability to perform its obligations under the Finance Documents. 

 

	20.3	Pari passu ranking 

 The Borrower shall (and the Borrower will procure that each Obligor
will) ensure that its payment obligations under the Finance Documents rank and continue to rank at least pari passu with the claims of all of its other unsecured and unsubordinated creditors, except for obligations mandatorily preferred by
law applying to companies generally. 
  

	20.4	The SPA 

  

	 	(a)	The Borrower shall promptly pay all amounts payable to the Vendors under the SPA as and when they become due (except to the extent that any such amounts are being contested in good faith by a member of the Group and
where adequate reserves are set aside for any such payment). 

  

	 	(b)	The Borrower shall, (and the Borrower will procure that each other member of the Group will), take all reasonable and practical steps to preserve and enforce its rights (or the rights of any other member of the Group)
and pursue any claims and remedies arising under the SPA. 

  

	20.5	Other Agreements 

 The Borrower shall complete the sale and purchase of the assets which
are the subject of the Asset Agreement no later than 30 Business Days after the date of this Agreement. 
  

	20.6	Negative pledge 

 In this Clause 20.6, “Quasi-Security” means an
arrangement or transaction described in paragraph (b) below. 
  

	 	(a)	The Borrower shall not (and the Borrower will ensure that no Obligor or member of the Group will) create or permit to subsist any Security over any of its assets. 

  
 46 

	 	(b)	The Borrower shall not (and the Borrower will ensure that no Obligor or member of the Group will): 

  

	 	(i)	sell, transfer or otherwise dispose of any of its assets, unless such disposals are in the normal course of business, and on terms whereby they are leased to or re-acquired by an
Obligor or any other member of the Group; 

  

	 	(ii)	sell, transfer or otherwise dispose of any of its receivables on recourse terms, except for the discounting of bills or notes in the ordinary course of trade; 

 

	 	(iii)	enter into or permit to subsist any title retention arrangement; 

  

	 	(iv)	enter into or permit to subsist any arrangement under which money or the benefit of a bank or other account may be applied, set-off or made subject to a combination of accounts;
or 

  

	 	(v)	enter into or permit to subsist any other preferential arrangement having a similar effect, 

  

	 	    	in circumstances where the arrangement or transaction is entered into primarily as a method of raising Financial Indebtedness or of financing the acquisition of an asset. 

 

	 	(c)	Paragraphs (a) and (b) above do not apply to: 

  

	 	(i)	any Security or Quasi-Security listed in Schedule 7 (Existing Security) except to the extent the principal amount secured by that Security or Quasi-Security exceeds the amount stated in that Schedule;

  

	 	(ii)	any netting or set-off arrangement entered into by any member of the Group in the ordinary course of its banking arrangements for the purpose of netting debit and credit balances;

  

	 	(iii)	any payment or close out netting or set-off arrangement pursuant to any hedging transaction entered into by a member of the Group for the purpose of: 

 

	 	(A)	hedging any risk to which any member of the Group is exposed in its ordinary course of trading; or 

  

	 	(B)	its interest rate or currency management operations which are carried out in the ordinary course of business and for non-speculative purposes only, 

 

	 	    	excluding, in each case, any Security or Quasi-Security under a credit support arrangement in relation to a hedging transaction; 

  

	 	(iv)	any lien arising by operation of law and in the ordinary course of trading provided that the debt which is secured thereby is paid when due or contested in good faith by appropriate proceedings and properly
provisioned; 

  

	 	(v)	any Security or Quasi-Security created pursuant to any Finance Document; 

  

	 	(vi)	any Security or Quasi-Security arising under any retention of title, hire purchase or conditional sale arrangement or arrangements having similar effect in respect of goods supplied to a member of the Group in the
ordinary course of trading and on the supplier’s standard or usual terms and not arising as a result of any default or omission by any member of the Group; 

  
 47 

	 	(vii)	any Security or Quasi-Security granted in connection with bank guarantees, performance bonds or other similar financial accommodations which are posted by or on behalf of any member of the Group in the ordinary course
of its business for the purpose of securing its performance obligations to its customers and/or for the purposes of securing any customs or excise payment obligation; or 

 

	 	(viii)	any Security or Quasi-Security securing indebtedness the principal amount of which (when aggregated with the principal amount of any other indebtedness which has the benefit of Security or Quasi-Security given by any
member of the Group other than any permitted under paragraphs (i) to (vii) above) does not exceed US$50,000,000 (or its equivalent in another currency or currencies). 

 

	20.7	Disposals 

  

	 	(a)	The Borrower shall not (and the Borrower will ensure that no Obligor or member of the Group will) enter into a single transaction or a series of transactions (whether related or not) and whether voluntary or involuntary
to sell, lease, transfer or otherwise dispose of any asset. 

  

	 	(b)	Paragraph (a) above does not apply to any sale, lease, transfer or other disposal: 

  

	 	(i)	of trading stock or cash made by any member of the Group in the ordinary course of trading of the disposing entity; 

  

	 	(ii)	of any asset by a member of the Group (the “Disposing Company”) to another member of the Group (the “Acquiring Company”) in the ordinary course of business, provided that if the
Disposing Company had given Security over the asset, the prior written consent of the Agent shall be required for such disposal; 

  

	 	(iii)	of assets (other than shares, businesses or intellectual property) in exchange for other assets comparable or superior as to type, value and quality and provided that the asset received is subject to at least the same
level of Transaction Security as the asset replaced (if applicable); 

  

	 	(iv)	of Cash Equivalent Investments for cash or in exchange for other Cash Equivalent Investments; 

  

	 	(v)	of obsolete or redundant vehicles, plant and equipment for cash; 

  

	 	(vi)	arising as a result of any Security which is permitted under paragraph (c) of Clause 20.6 (Negative pledge); or 

  

	 	(vii)	where the higher of the market value or consideration receivable (when aggregated with the higher of the market value or consideration receivable for any other sale, lease, transfer or other disposal by members of the
Group, other than any permitted under paragraphs (i) to (vi) above) does not exceed US$10,000,000 (or its equivalent in another currency or currencies) in any Financial Year, 

 

	 	    	provided that none of the above exceptions shall permit any member of the Group to cease to hold a majority shareholding interest in any of its Subsidiaries (without the consent of all the Lenders). 

  
 48 

	20.8	Arm’s length basis 

 The Borrower shall not (and the Borrower will ensure that no
Obligor or member of the Group will) enter into any transaction with any person except on arm’s length terms and for full market value save for any Intercompany Loan which is permitted under paragraph (b)(ii) of Clause 20.12 (Financial
Indebtedness). 
  

	20.9	Merger 

 The Borrower shall not (and the Borrower will ensure that no Obligor or member
of the Group will) without the prior written consent of the Agent enter into any amalgamation, demerger, merger or corporate reconstruction, other than any amalgamation, demerger, merger or corporate reconstruction between wholly-owned Subsidiaries
of the Parent Guarantor that are not Obligors. 
  

	20.10	Change of business 

 The Borrower shall procure that no substantial change is made to the
general nature of the business of the Borrower or the Group (taken as a whole) from that carried on at the date of this Agreement. 
  

	20.11	Loans and guarantees 

  

	 	(a)	The Borrower shall not (and the Borrower will ensure that no Obligor or member of the Group will) make or allow to subsist any loans, grant any credit or give or allow to remain outstanding any guarantee or indemnity
(except as required under any of the Finance Documents) to or for the benefit of any person or otherwise voluntarily assume any liability, whether actual or contingent, in respect of any obligation of any person. 

 

	 	(b)	Paragraph (a) above does not apply to: 

  

	 	(i)	any trade credit extended by any member of the Group to its customers on normal commercial terms and in the ordinary course of its trading activities; 

 

	 	(ii)	any loans extended by 

  

	 	(A)	an Obligor to an Obligor; 

  

	 	(B)	a non-Obligor to a non-Obligor; 

  

	 	(C)	a non-Obligor to an Obligor, 

  

	 	    	provided that, in each case, the Borrower would, as at the Quarter Date for which Financial Statements have been most recently delivered to the Agent under Clause 19.2 (Financial Condition), have been in pro
forma compliance with the financial covenants set out in Clause 19 (Financial Covenants) after giving effect to the incurrence of such Financial Indebtedness, assuming for such purposes that such Financial Indebtedness was incurred at the
beginning of the Relevant Period to which such Financial Statements related; 

  

	 	(iii)	any guarantee granted by the Borrower or any member of the Group entered into to hedge currency or interest rate exposure of, or otherwise in respect of Financial Indebtedness of a member of the Group, which in each
case is permitted to be incurred under the terms of the Finance Documents; 

  
 49 

	 	(iv)	any performance or payment guarantees given by the pursuant to outsourcing agreements with its customers entered into, in each case, in the ordinary course of its business; 

 

	 	(v)	any loan where all the proceeds of such loan are used to satisfy a payment obligation of an Obligor under the Finance Documents; or 

  

	 	(vi)	any Financial Indebtedness arising under an Inbound Intercompany Loan or an Outbound Intercompany Loan. 

  

	20.12	Financial Indebtedness 

  

	 	(a)	The Borrower shall not (and the Borrower will ensure that no Obligor or member of the Group will) incur or permit to remain outstanding any Financial Indebtedness. 

 

	 	(b)	Paragraph (a) above does not apply to: 

  

	 	(i)	any Financial Indebtedness incurred pursuant to any Finance Documents; 

  

	 	(ii)	any Financial Indebtedness arising under any loan or guarantee permitted pursuant to Clause 20.11 (Loans and guarantees); 

  

	 	(iii)	any Financial Indebtedness under finance or capital leases of vehicles, plant, equipment or computers, provided that the aggregate capital value of all such items so leased under outstanding leases by members of the
Group does not exceed US$20,000,000 (or its equivalent in other currencies) at any time; or 

  

	 	(iv)	any Financial Indebtedness incurred provided that, the Borrower would, as at the Quarter Date for which Financial Statements have been most recently delivered to the Agent under Clause 19.2 (Financial Condition),
be in pro forma compliance with the financial covenants set out in Clause 19 (Financial Covenants) after giving effect to the incurrence of such Financial Indebtedness, assuming for such purposes that such Financial Indebtedness was incurred
at the beginning of the Relevant Period to which such Financial Statements related. 

  

	20.13	Dividends and share redemption 

  

	 	(a)	Except as permitted under paragraph (b) below, the Borrower shall not (and will ensure that no member of the Group will): 

  

	 	(i)	declare, make or pay any dividend, charge, fee or other distribution (or interest on any unpaid dividend, charge, fee or other distribution) (whether in cash or in kind) on or in respect of its share capital (or any
class of its share capital); 

  

	 	(ii)	repay or distribute any dividend or share premium reserve; 

  

	 	(iii)	pay or allow any member of the Group to pay any management, advisory or other fee to or to the order of any of the shareholders of the Borrower; or 

 

	 	(iv)	redeem, repurchase, defease, retire or repay any of its share capital or resolve to do so. 

  

	 	(b)	Paragraph (a) above does not apply to: 

  

	 	(i)	the payment of a dividend to the Borrower or any member of the Group, or the making of any payments to a member of the Group to facilitate a share buyback by another member of the Group; 

 

	 	(ii)	any share buyback by the Parent Guarantor pursuant to the share buyback program, provided that the Group would, as at the Quarter Date for which Financial Statements have been most recently delivered to the Agent under
Clause 19.2 (Financial Condition), be in pro forma compliance with the financial covenants set out in Clause 19 (Financial Covenants) after giving effect to such buyback, assuming for such purposes that such buyback was incurred at the
beginning of the Relevant Period to which such Financial Statements related. 

  
 50 

	20.14	Share capital 

  

	 	(a)	The Borrower shall not (and the Borrower will ensure that no Obligor or member of the Group will) issue any shares except pursuant to: 

 

	 	(i)	an issue of ordinary shares by the Borrower to the Parent Guarantor paid for in full in cash upon issue and which by their terms are not redeemable and where (A) such shares are of the same class and on the same
terms as those initially issued by the Borrower (B) such issue does not lead to a Change of Control and (C) where the newly-issued shares also become subject to the Transaction Security on the same terms; and 

 

	 	(ii)	an issuance of shares from a member of the Group to another member of the Group or to employees or directors of any member of the Group. 

 

	20.15	Treasury Transactions 

 The Borrower shall not (and the Borrower will ensure that no
Obligor or member of the Group will) enter into any Treasury Transaction, other than: 
  

	 	(a)	foreign exchange contracts entered into in the ordinary course of business and not for speculative purposes; 

  

	 	(b)	any Treasury Transaction entered into for the hedging of actual or projected real exposures to interest rate and currency fluctuations which arise in the ordinary course of trading activities of a member of the Group
and is not for speculative purposes. 

  

	20.16	Insurance 

  

	 	(a)	The Borrower shall (and the Borrower will ensure that each Obligor and each member of the Group will) maintain insurances on and in relation to its business and assets against those risks and to the extent as is usual
for companies carrying on the same or substantially similar business. 

  

	 	(b)	All insurances must be with reputable independent insurance companies or underwriters. 

  

	20.17	Intellectual Property 

 The Borrower shall (and the Borrower will ensure that each
Obligor and each member of the Group will): 
  

	 	(a)	preserve and maintain the subsistence and validity of the Intellectual Property necessary for the business of the relevant Group member; 

  
 51 

	 	(b)	use reasonable endeavours to prevent any infringement in any material respect of the Intellectual Property; 

  

	 	(c)	make registrations and pay all registration fees and taxes necessary to maintain the Intellectual Property in full force and effect and record its interest in that Intellectual Property; and 

 

	 	(d)	not use or permit the Intellectual Property to be used in a way or take any step or omit to take any step in respect of that Intellectual Property which may materially and adversely affect the existence or value of the
Intellectual Property or imperil the right of any member of the Group to use such property. 

  

	20.18	Environmental compliance 

 The Borrower shall (and the Borrower will ensure that each
Obligor and each member of the Group will) comply in all material respects with all Environmental Law, obtain and maintain any Environmental Permits and take all reasonable steps in anticipation of known or expected future changes to or obligations
under Environmental Law or any Environmental Permits which, failure to do so, might reasonably be expected to have a Material Adverse Effect. 
  

	20.19	Environmental Claims 

 The Borrower shall (and the Borrower will ensure that each Obligor
will) inform the Agent in writing as soon as reasonably practicable upon becoming aware of: 
  

	 	(a)	any Environmental Claim which has been commenced or (to the best of such Obligor’s knowledge and belief) is threatened against any member of the Group; or 

 

	 	(b)	any facts or circumstances which will or might reasonably be expected to result in any Environmental Claim being commenced or threatened against any member of the Group, 

in each case where such Environmental Claim might reasonably be expected, if determined against that member of the Group, to have a Material
Adverse Effect. 
  

	20.20	Anti-corruption law 

  

	 	(a)	The Borrower shall not (and the Borrower will ensure that no Obligor or member of the Group will) directly or indirectly engage in any activity or conduct which would violate any applicable anti-bribery, anti-corruption
or anti-money laundering laws, regulations or rules in any applicable jurisdiction . 

  

	 	(b)	The Borrower shall (and the Borrower will ensure that each Obligor and each member of the Group will): 

  

	 	(i)	conduct its businesses in compliance with applicable anti-corruption laws; and 

  

	 	(ii)	maintain policies and procedures designed to promote and achieve compliance with such laws. 

  

	20.21	Sanctions 

 The Borrower shall not (and the Borrower will ensure that no member of the
Group will), directly or indirectly, use the proceeds of the loan hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or any other Person (as defined in Clause 17.18 (Sanctions)),
(i) to fund any activities or business of or with any Person, or in any country or territory, that, at the time of such funding, is, a Sanctioned Person (as defined in Clause 17.18 (Sanctions)) or Sanctioned Country (as defined in Clause
17.18 (Sanctions)), or (ii) in any other manner that would result in a violation of Sanctions by any Person (including any Person participating in the loan hereunder, whether as underwriter, advisor, investor, lender, hedge provider,
facility or security agent or otherwise). 

  
 52 

	20.22	Taxation 

  

	 	(a)	The Borrower shall (and the Borrower will ensure that each Obligor and each member of the Group will) pay and discharge all Taxes imposed upon it or its assets within the time period allowed without incurring penalties
unless and only to the extent that: 

  

	 	(i)	such payment is being contested in good faith; 

  

	 	(ii)	adequate reserves are being maintained for those Taxes and the costs required to contest them which have been disclosed in its latest financial statements delivered to the Agent under Clause 18.1 (Financial
statements); and 

  

	 	(iii)	such payment can be lawfully withheld and failure to pay those Taxes does not have or is not reasonably likely to have a Material Adverse Effect. 

 

	 	(b)	The Borrower shall not (and the Borrower will ensure that no member of the Group will), change its residence for Tax purposes other than with the prior written consent of the Lenders (such consent not to be unreasonably
withheld). 

  

	20.23	Further assurance 

  

	 	(a)	The Borrower shall (and the Borrower will ensure that each Obligor and each member of the Group will) promptly do all such acts or execute all such documents (including assignments, transfers, mortgages, charges,
notices and instructions) as the Security Agent may reasonably specify (and in such form as the Security Agent may reasonably require in favour of the Security Agent or its nominee(s)): 

 

	 	(i)	to perfect the Security created or intended to be created under or evidenced by the Transaction Security Documents (which may include the execution of a mortgage, charge, assignment or other Security over all or any of
the assets which are, or are intended to be, the subject of the Transaction Security) or for the exercise of any rights, powers and remedies of the Security Agent or the Finance Parties provided by or pursuant to the Finance Documents or by law;

  

	 	(ii)	to confer on the Security Agent or confer on the Finance Parties Security over any property and assets of that Obligor located in any jurisdiction equivalent or similar to the Security intended to be conferred by or
pursuant to the Transaction Security Documents; and/or 

  

	 	(iii)	to facilitate the realisation of the assets which are, or are intended to be, the subject of the Transaction Security. 

  

	 	(b)	The Borrower shall (and the Borrower will ensure that each Obligor and each member of the Group will) take all such action as is available to it (including making all filings and registrations) as may be necessary for
the purpose of the creation, perfection, protection or maintenance of any Security conferred or intended to be conferred on the Security Agent or the Finance Parties by or pursuant to the Finance Documents. 

  
 53 

	20.24	The SPA 

 The Borrower shall, in respect of the SPA: 

 

	 	(a)	comply with and satisfy (or obtain all requisite waivers from the Vendors in respect of) all the conditions to closing set out in Article VI (Conditions to Closing) of the SPA within the deadlines specified in
the SPA; and 

  

	 	(b)	not grant a waiver, consent, approval or amend any provision of the SPA without the prior written consent of the Lenders, other than (A) any waiver, consent, approval or amendment that is minor or technical or not
materially prejudicial to the interests of the Lenders or (B) any waiver, consent, approval or amendment granted or executed or agreed to be granted or executed prior to the date of this Agreement. 

 

	20.25	Conditions subsequent 

 The Borrower must ensure that: 

 

	 	(a)	each of the documents and evidences listed in Part 2 of Schedule 2 (Conditions) are delivered to the Agent in form and substance satisfactory to the Agent by no later than the dates specified in Part 2 of
Schedule 2 (Conditions) for delivery of that document or evidence; and 

  

	 	(b)	By no later than the timelines specified in Part 2 of Schedule 2 (Conditions), evidence of the Transaction Security Documents is delivered to the Security Agent. 

 

	21.	EVENTS OF DEFAULT 

 Each of the events or circumstances set out in the following
subclauses of this Clause 21 (other than Clause 21.17 (Acceleration)) is an Event of Default. 
  

	21.1	Non-payment 

 An Obligor does not pay on the due
date any amount payable pursuant to a Finance Document at the place at and in the currency in which it is expressed to be payable unless: 
  

	 	(a)	its failure to pay is caused by: 

  

	 	(i)	administrative or technical error; or 

  

	 	(ii)	a Disruption Event; and 

  

	 	(b)	payment is made within three Business Days of its due date. 

  

	21.2	Financial covenants and other obligations 

 Any requirement of Clause 19 (Financial
Covenants) is not satisfied. 
  

	21.3	Other obligations 

  

	 	(a)	An Obligor does not comply with any provision of the Finance Documents (other than those referred to in Clause 21.1 (Non-payment) and Clause 21.2 (Financial
covenants and other obligations)). 

  

	 	(b)	No Event of Default under paragraph (a) above will occur if the failure to comply is capable of remedy and is remedied within 15 Business Days of the earlier of (i) the Agent giving notice to the Borrower and
(ii) any Obligor becoming aware of the failure to comply. 

  
 54 

	21.4	Misrepresentation 

 Any representation or statement made or deemed to be made by an
Obligor in the Finance Documents or any other document delivered by or on behalf of any Obligor under or in connection with any Finance Document is or proves to have been incorrect or misleading in any material respect when made or deemed to be
made. 
  

	21.5	Cross default 

  

	 	(a)	Any Financial Indebtedness of any member of the Group is not paid when due nor within any originally applicable grace period. 

  

	 	(b)	Any Financial Indebtedness of any member of the Group is declared to be or otherwise becomes due and payable prior to its specified maturity as a result of an event of default (however described), whether or not such
Financial Indebtedness is accelerated by the creditor(s) in respect of such Financial Indebtedness. 

  

	 	(c)	Any commitment for any Financial Indebtedness of any member of the Group is cancelled or suspended by a creditor of any member of the Group (as applicable) as a result of an event of default (however described).

  

	 	(d)	Any creditor of any member of the Group becomes entitled to declare any Financial Indebtedness of any member of the Group due and payable prior to its specified maturity as a result of an event of default (however
described). 

  

	 	(e)	No Event of Default will occur under this Clause 21.5 if the aggregate amount of Financial Indebtedness or commitment for Financial Indebtedness falling within paragraphs (a) to (d) above is less than US$10,000,000
(or its equivalent in any other currency or currencies). 

  

	21.6	Insolvency 

  

	 	(a)	A member of the Group is, or is presumed or deemed to be, unable or admits inability to pay its debts as they fall due, suspends making payments on any of its debts or, by reason of actual or anticipated financial
difficulties, commences negotiations with one or more of its creditors (excluding any Finance Party in its capacity as such) with a view to rescheduling any of its indebtedness. 

 

	 	(b)	The value of the assets of any member of the Group is less than its liabilities (taking into account contingent and prospective liabilities). 

 

	 	(c)	A moratorium is declared in respect of any indebtedness of any member of the Group. 

  

	21.7	Insolvency proceedings 

  

	 	(a)	Any corporate action, legal proceedings or other procedure or step is taken in relation to: 

  

	 	(i)	the suspension of payments, a moratorium of any indebtedness, winding-up, dissolution, administration, judicial management, provisional supervision or reorganisation (by way of
voluntary arrangement, scheme of arrangement or otherwise) of any member of the Group, other than a solvent liquidation or reorganisation of any member of the Group which is not an Obligor; 

  
 55 

	 	(ii)	a composition or arrangement with any creditor of any member of the Group, or an assignment for the benefit of creditors generally of any member of the Group, or a class of such creditors; 

 

	 	(iii)	the appointment of a liquidator (other than in respect of a solvent liquidation of a member of the Group which is not an Obligor), receiver, administrator, judicial manager, administrative receiver, compulsory manager,
provisional supervisor or other similar officer in respect of any member of the Group or any of its assets; or 

  

	 	(iv)	enforcement of any Security over any assets of any member of the Group, 

  

	 	    	or any analogous procedure or step is taken in any jurisdiction. 

  

	 	(b)	Paragraph (a)(i) above shall not apply to any winding-up petition which is frivolous or vexatious and is discharged, stayed or dismissed within 45 days of commencement.

  

	21.8	Creditors’ process 

 Any expropriation, attachment, sequestration, distress or
execution affects any asset or assets of a member of the Group having an aggregate value of US$10,000,000 and is not discharged within 45 days. 
  

	21.9	Unlawfulness 

  

	 	(a)	It is or becomes unlawful for an Obligor to perform any of its obligations under the Finance Documents or any Transaction Security created or expressed to be created or evidenced by the Transaction Security Documents
ceases to be effective. 

  

	 	(b)	Any obligation or obligations of any Obligor under any Finance Documents are not or cease to be legal, valid, binding or enforceable and the cessation individually or cumulatively materially and adversely affects the
interests of the Lenders under the Finance Documents. 

  

	 	(c)	Any Finance Document ceases to be in full force and effect or any Transaction Security ceases to be legal, valid, binding, enforceable or effective or is alleged by a party to it (other than a Finance Party) to be
ineffective. 

  

	21.10	Repudiation and rescission of agreements 

  

	 	(a)	An Obligor, or any other relevant party, rescinds or purports to rescind or repudiates or purports to repudiate a Finance Document or any of the Transaction Security or evidences an intention to rescind or repudiate a
Finance Document or any Transaction Security. 

  

	 	(b)	Any party to the SPA rescinds or purports to rescind or repudiates or purports to repudiate the SPA in whole or in part where to do so has or is, in the reasonable opinion of the Majority Lenders, likely to have a
material adverse effect on the interests of the Lenders under the Finance Documents. 

  

	21.11	Audit qualification 

 The Borrower’s auditors qualify the audited annual
consolidated financial statements of the Borrower. 

  
 56 

	21.12	Expropriation 

 Any seizure, expropriation, nationalisation, intervention, restriction or
other action by or on behalf of any governmental, regulatory or other authority or other person in relation to any member of the Group or any of its assets, which would have or be reasonably likely to have a Material Adverse Effect. 

 

	21.13	Litigation 

 Any litigation, arbitration, administrative, governmental, regulatory or
other investigations, proceedings or disputes are commenced or threatened in relation to the Transaction Documents or the transactions contemplated in the Transaction Documents or against any member of the Group or its assets or its assets which
have or are reasonably likely to be adversely determined and if so adversely determined, would have or be reasonably likely to have a Material Adverse Effect. 
  

	21.14	Cessation of business 

 The Borrower suspends or ceases to carry on all or a material
part of its business or of the business of the Group taken as a whole. 
  

	21.15	Material adverse change 

 Any event or circumstance occurs which the Majority Lenders
reasonably believe has or is reasonably likely to have a Material Adverse Effect. 
  

	21.16	United States Bankruptcy Laws 

  

	 	(a)	In this Clause 21.16: 

  

	 	    	“U.S. Bankruptcy Law” means the United States Bankruptcy Code or any other United States Federal or State bankruptcy, insolvency or similar law. 

 

	 	    	“U.S. Debtor” means an Obligor that is (i) incorporated or organized under the laws of the United States of America or any State of the United States of America (including the District of Columbia)
or that has a place of business or property in the United States of America or (ii) an individual. 

  

	 	(b)	Any of the following occurs in respect of a U.S. Debtor: 

  

	 	(i)	it makes a general assignment for the benefit of creditors; 

  

	 	(ii)	it commences a voluntary case or proceeding under any U.S. Bankruptcy Law; or 

  

	 	(iii)	an involuntary case under any U.S. Bankruptcy Law is commenced against it and is not controverted within 20 days or is not dismissed or stayed within 60 days after commencement of the case; or 

 

	 	(iv)	an order for relief or other order approving any case or proceeding is entered under any U.S. Bankruptcy Law. 

  
 57 

	21.17	Acceleration 

 On and at any time after the occurrence of an Event of Default which is
continuing the Agent may, and shall if so directed by the Majority Lenders, by notice to the Borrower: 
  

	 	(a)	without prejudice to the participations of any Lenders in any portion of the Loan which is then outstanding: 

  

	 	(i)	cancel the Commitments (and reduce them to zero), whereupon they shall immediately be cancelled (and reduced to zero); or 

  

	 	(ii)	cancel any part of any Commitment (and reduce such Commitment accordingly), whereupon the relevant part shall immediately be cancelled (and the relevant Commitment shall be immediately reduced accordingly); and/or

  

	 	(b)	declare that all or part of the Loan, together with accrued interest, and all other amounts accrued or outstanding under the Finance Documents be immediately due and payable, whereupon they shall become immediately due
and payable; and/or 

  

	 	(c)	declare that all or part of the Loan be payable on demand, whereupon they shall immediately become payable on demand by the Agent on the written instructions of the Majority Lenders; and/or 

 

	 	(d)	exercise or direct the Security Agent to exercise any or all of its rights, remedies, powers or discretions under the Finance Documents, 

provided that, if an Event of Default described in Clause 21.16 (United States Bankruptcy Laws) occurs, the Total Commitments will, if
not already cancelled under this Agreement, be immediately and automatically cancelled and all amounts outstanding under the Finance Documents will be immediately and automatically due and payable, without the requirement of notice or any other
formality. 
  

	22.	CHANGES TO THE LENDERS 

  

	22.1	Assignments and transfers by the Lenders 

  

	 	Subject	to this Clause 22, a Lender (the “Existing Lender”) may, without the consent of the Borrower: 

  

	 	(a)	assign any of its rights; or 

  

	 	(b)	transfer by novation any of its rights and obligations, 

 under the Finance Documents to another
bank or financial institution or to a trust, fund or other entity which is regularly engaged in or established for the purpose of making, purchasing or investing in loans, securities or other financial assets (the “New Lender”),
provided that the Borrower receives not less than three Business Days prior notice of such assignment or transfer and the identity of the New Lender. 
  

	22.2	Conditions of assignment or transfer 

  

	 	(a)	A transfer will be effective only if the procedure set out in Clause 22.5 (Procedure for transfer) is complied with. 

  

	 	(b)	An assignment will be effective only if the procedure and conditions set out in Clause 22.6 (Procedure for assignment) are complied with. 

 

	 	(c)	If: 

  

	 	(i)	a Lender assigns or transfers any of its rights or obligations under the Finance Documents or changes its Facility Office; and 

  

	 	(ii)	as a result of circumstances existing at the date the assignment, transfer or change occurs, an Obligor would be obliged to make a payment to the New Lender or Lender acting through its new Facility Office under
Clause 12 (Tax Gross-Up and Indemnities) or Clause 13 (Increased Costs), 

  
 58 

	 	    	then the New Lender or Lender acting through its new Facility Office is only entitled to receive payment under those Clauses to the same extent as the Existing Lender or Lender acting through its previous Facility
Office would have been if the assignment, transfer or change had not occurred. 

  

	22.3	Assignment or transfer fee 

 The New Lender shall, on the date upon which an assignment
or transfer takes effect, pay to the Agent (for its own account) a fee of US$3,500. 
  

	22.4	Limitation of responsibility of Existing Lenders 

  

	 	(a)	Unless expressly agreed to the contrary, an Existing Lender makes no representation or warranty and assumes no responsibility to a New Lender for: 

 

	 	(i)	the legality, validity, effectiveness, adequacy or enforceability of the Finance Documents or any other documents; 

  

	 	(ii)	the financial condition of any Obligor; 

  

	 	(iii)	the performance and observance by any Obligor of its obligations under the Finance Documents or any other documents; or 

  

	 	(iv)	the accuracy of any statements (whether written or oral) made in or in connection with any Finance Document or any other document, 

  

	 	    	and any representations or warranties implied by law are excluded. 

  

	 	(b)	Each New Lender confirms to the Existing Lender, the other Finance Parties and the Secured Parties that it: 

  

	 	(i)	has made (and shall continue to make) its own independent investigation and assessment of the financial condition and affairs of each Obligor and its related entities in connection with its participation in this
Agreement and has not relied exclusively on any information provided to it by the Existing Lender in connection with any Finance Document; and 

  

	 	(ii)	will continue to make its own independent appraisal of the creditworthiness of each Obligor and its related entities whilst any amount is or may be outstanding under the Finance Documents or any Commitment is in force.

  

	 	(c)	Nothing in any Finance Document obliges an Existing Lender to: 

  

	 	(i)	accept a re-transfer or re-assignment from a New Lender of any of the rights and obligations assigned or transferred under this Clause 22;
or 

  

	 	(ii)	support any losses directly or indirectly incurred by the New Lender by reason of the non-performance by any Obligor of its obligations under the Finance Documents or otherwise.

  
 59 

	22.5	Procedure for transfer 

  

	 	(a)	Subject to the conditions set out in Clause 22.2 (Conditions of assignment or transfer) a transfer is effected in accordance with paragraph (c) below when the Agent executes an otherwise duly completed
Transfer Certificate delivered to it by the Existing Lender and the New Lender and the Agent has received the assignment or transfer fee (as applicable) pursuant to Clause 22.3 (Assignment or transfer fee) in full. The Agent shall, subject to
paragraph (b) below, as soon as reasonably practicable after receipt by it of a duly completed Transfer Certificate appearing on its face to comply with the terms of this Agreement and delivered in accordance with the terms of this Agreement,
execute that Transfer Certificate. 

  

	 	(b)	The Agent shall not be obliged to execute a Transfer Certificate delivered to it by the Existing Lender and the New Lender unless it is satisfied that it has completed all know your customer and other similar
checks or procedures that it is required (or deems desirable) to conduct in relation to the transfer to such New Lender. The Agent shall not be liable to any party for any damages, costs or losses whatsoever for any delay or failure to execute a
Transfer Certificate as a result of such know your customer or other similar procedures. 

  

	 	(c)	Subject to Clause 22.13 (Pro rata interest settlement), on the Transfer Date: 

  

	 	(i)	to the extent that in the Transfer Certificate the Existing Lender seeks to transfer by novation its rights and obligations under the Finance Documents and in respect of the Transaction Security each of the Obligors and
the Existing Lender shall be released from further obligations towards one another under the Finance Documents and in respect of the Transaction Security and their respective rights against one another shall be cancelled (being the
“Discharged Rights and Obligations”); 

  

	 	(ii)	each of the Obligors and the New Lender shall assume obligations towards one another and/or acquire rights against one another which differ from the Discharged Rights and Obligations only insofar as that Obligor and the
New Lender have assumed and/or acquired the same in place of that Obligor and the Existing Lender; 

  

	 	(iii)	the Agent, the Arranger, the Security Agent, the New Lender and other Lenders shall acquire the same rights and assume the same obligations between themselves and in respect of the Transaction Security as they would
have acquired and assumed had the New Lender been an Original Lender with the rights and/or obligations acquired or assumed by it as a result of the transfer and to that extent the Agent, the Arranger, the Security Agent and the Existing Lender
shall each be released from further obligations to each other under the Finance Documents; and 

  

	 	(iv)	the New Lender shall become a Party as a “Lender”. 

  

	 	(d)	The procedure set out in this Clause 22.5 shall not apply to any right or obligation under any Finance Document (other than this Agreement) if and to the extent its terms, or any laws or regulations applicable
thereto, provide for or require a different means of transfer of such right or obligation or prohibit or restrict any transfer of such right or obligation, unless such prohibition or restriction shall not be applicable to the relevant transfer or
each condition of any applicable restriction shall have been satisfied. 

  
 60 

	22.6	Procedure for assignment 

  

	 	(a)	Subject to the conditions set out in paragraph (d) below and in Clause 22.2 (Conditions of assignment or transfer), an assignment may be effected in accordance with paragraph (b) below when the Agent
executes an otherwise duly completed Assignment Agreement delivered to it by the Existing Lender and the New Lender. The Agent shall, subject to paragraph (d)(ii) below, as soon as reasonably practicable after receipt by it of a duly completed
Assignment Agreement appearing on its face to comply with the terms of this Agreement and delivered in accordance with the terms of this Agreement, execute that Assignment Agreement. 

 

	 	(b)	Subject to Clause 22.13 (Pro rata interest settlement), on the Transfer Date: 

  

	 	(i)	the Existing Lender will assign absolutely to the New Lender the rights under the Finance Documents and in respect of the Transaction Security expressed to be the subject of the assignment in the Assignment Agreement;

  

	 	(ii)	the Existing Lender will be released by each Obligor and the other Finance Parties from the obligations owed by it (the “Relevant Obligations”) and expressed to be the subject of the release in the
Assignment Agreement (and any corresponding obligations by which it is bound in respect of the Transaction Security); and 

  

	 	(iii)	the New Lender shall become a Party as a “Lender” and will be bound by obligations equivalent to the Relevant Obligations. 

 

	 	(c)	Lenders may utilise procedures other than those set out in this Clause 22.6 to assign their rights under the Finance Documents (but not, without the consent of the relevant Obligor or unless in accordance with Clause
22.5 (Procedure for transfer), to obtain a release by that Obligor from the obligations owed to that Obligor by the Lenders nor the assumption of equivalent obligations by a New Lender) provided that they comply with the conditions set
out in paragraph (d) below. 

  

	 	(d)	An assignment (whether pursuant to an Assignment Agreement or paragraph (c) above) will only be effective on: 

  

	 	(i)	receipt by the Agent (whether in an Assignment Agreement or otherwise) of written confirmation from the New Lender (in form and substance satisfactory to the Agent) that the New Lender will assume the same obligations
to the other Finance Parties and the Secured Parties as it would have been under if it was an Original Lender; and 

  

	 	(ii)	performance by the Agent of all necessary know your customer or other similar checks or procedures under all applicable laws and regulations and internal policies in relation to such assignment to a New Lender,
the completion of which the Agent shall promptly notify to the Existing Lender and the New Lender. The Agent shall not be obliged to execute an Assignment Agreement delivered to it by an Existing Lender and the New Lender or any document delivered
to it pursuant to paragraph (c) above unless it is satisfied that it has completed all know your customer and other similar procedures that it is required (or deems desirable) to conduct in relation to the assignment to such New Lender.
The Agent shall not be liable to any party for any damages, costs or losses whatsoever for any delay or failure to execute an Assignment Agreement as a result of such know your customer or other similar procedures. 

 

	 	(e)	The procedure set out in this Clause 22.6 shall not apply to any right or obligation under any Finance Document (other than this Agreement) if and to the extent its terms, or any laws or regulations applicable thereto,
provide for or require a different means of assignment of such right or release or assumption of such obligation or prohibit or restrict any assignment of such right or release or assumption of such obligation, unless such prohibition or restriction
shall not be applicable to the relevant assignment, release or assumption or each condition of any applicable restriction shall have been satisfied. 

  
 61 

	22.7	Copy of Transfer Certificate or Assignment Agreement to Borrower 

 The Agent shall, as
soon as reasonably practicable after it has executed a Transfer Certificate or an Assignment Agreement, send to the Borrower a copy of that Transfer Certificate or Assignment Agreement. 

 

	22.8	Maintenance of Register 

 The Agent, acting for these purposes solely as an agent of the
Borrower, will maintain (and make available upon reasonable prior notice at reasonable times for inspection by the Borrower and each Lender) a register for the recordation of, and will record, the names and addresses of the Lenders and the
respective amounts of the Commitments and participations in the Loan of each Lender from time to time (the “Register”). Absent manifest error, the Register shall be conclusive and binding for all purposes, and the Borrower, the
Agent and the Lenders shall treat each person whose name is recorded in the Register as a Lender hereunder for all purposes of this Agreement. 
  

	22.9	Existing consents and waivers 

 A New Lender shall be bound by any consent, waiver,
election or decision given or made by the relevant Existing Lender under or pursuant to any Finance Document prior to the coming into effect of the relevant assignment or transfer to such New Lender. 

 

	22.10	Exclusion of Agent’s liability 

 In relation to any assignment or transfer pursuant
to this Clause 22, each Party acknowledges and agrees that the Agent shall not be obliged to enquire as to the accuracy of any representation or warranty made by a New Lender in respect of its eligibility as a Lender. 

 

	22.11	Assignments and transfers to Obligor group 

 A Lender may not assign or transfer to any
Obligor or any Affiliate of any Obligor any of such Lender’s rights or obligations under any Finance Document, except with the prior written consent of all the Lenders. 
  

	22.12	Security over Lenders’ rights 

  

	 	(a)	In addition to the other rights provided to Lenders under this Clause 22, each Lender may without consulting with or obtaining consent from any Obligor, at any time charge, assign or otherwise create Security in or over
(whether by way of collateral or otherwise) all or any of its rights under any Finance Document to secure obligations of that Lender including, without limitation: 

 

	 	(i)	any charge, assignment or other Security to secure obligations to a federal reserve or central bank (including, for the avoidance of doubt, the European Central Bank) including, without limitation, any assignment of
rights to a special purpose vehicle where Security over securities issued by such special purpose vehicle is to be created in favour of a federal reserve or central bank (including, for the avoidance of doubt, the European Central Bank);; and

  
 62 

	 	(ii)	in the case of any Lender which is a fund, any charge, pledge, assignment or other Security granted to any holders (or trustee or representatives of holders) of obligations owed, or securities issued, by that Lender as
security for those obligations or securities, 

  

	 	    	except that no such charge, assignment, pledge or Security shall: 

  

	 	(A)	release a Lender from any of its obligations under the Finance Documents or substitute the beneficiary of the relevant charge, assignment or Security for the Lender as a party to any of the Finance Documents; or

  

	 	(B)	require any payments to be made by an Obligor other than or in excess of, or grant to any person any more extensive rights than, those required to be made or granted to the relevant Lender under the Finance Documents.

  

	 	(b)	The limitations on assignments or transfers by a Lender set out in any Finance Document shall not apply to the creation of Security pursuant to paragraph (a) above. 

 

	 	(c)	The limitations and provisions referred to in paragraph (b) above shall further not apply to any assignment or transfer of rights under the Finance Documents or of the securities issued by the special purpose
vehicle, made by a federal reserve or central bank (including, for the avoidance of doubt, the European Central Bank) to a third party in connection with the enforcement of Security created pursuant to paragraph (a) above. 

 

	 	(d)	Any Lender may disclose such Confidential Information as that Lender shall consider appropriate to a federal reserve or central bank (including, for the avoidance of doubt, the European Central Bank) to (or through)
whom it creates Security pursuant to paragraph (a) above, and any federal reserve or central bank (including, for the avoidance of doubt, the European Central Bank) may disclose such Confidential Information to a third party to whom it assigns
or transfers (or may potentially assign or transfer) rights under the Finance Documents or the securities issued by the special purpose vehicle in connection with the enforcement of such Security 

 

	22.13	Pro rata interest settlement 

 If the Agent has notified the Lenders that it is able to
distribute interest payments on a “pro rata basis” to Existing Lenders and New Lenders then (in respect of any transfer pursuant to Clause 22.5 (Procedure for transfer) or any assignment pursuant to Clause 22.6
(Procedure for assignment) the Transfer Date of which, in each case, is after the date of such notification and is not on the last day of an Interest Period): 
  

	 	(a)	any interest or fees in respect of the relevant participation which are expressed to accrue by reference to the lapse of time shall continue to accrue in favour of the Existing Lender up to but excluding the Transfer
Date (“Accrued Amounts”) and shall become due and payable to the Existing Lender (without further interest accruing on them) on the last day of the current Interest Period (or, if the Interest Period is longer than six Months, on
the next of the dates which falls at six monthly intervals after the first day of that Interest Period); and 

  
 63 

	 	(b)	the rights assigned or transferred by the Existing Lender will not include the right to the Accrued Amounts, so that, for the avoidance of doubt: 

 

	 	(i)	when the Accrued Amounts become payable, those Accrued Amounts will be payable to the Existing Lender; and 

  

	 	(ii)	the amount payable to the New Lender on that date will be the amount which would, but for the application of this Clause 22.13, have been payable to it on that date, but after deduction of the Accrued Amounts.

  

	23.	CHANGES TO THE OBLIGORS 

  

	23.1	Assignments and transfers by Obligors 

 An Obligor may not assign or transfer any of its
rights or obligations under any Finance Document, except with the prior written consent of all the Lenders. 
  

	23.2	Resignation of the Parent Guarantor 

  

	 	(a)	The Borrower may request that the Parent Guarantor ceases to be a Guarantor by delivering to the Agent a Resignation Letter. 

  

	 	(b)	The Agent shall accept a Resignation Letter and notify the Borrower and the Lenders of its acceptance if: 

  

	 	(i)	no Default is continuing or would result from the acceptance of the Resignation Letter (and the Borrower has confirmed this is the case); and 

 

	 	(ii)	all the Lenders have consented to the Borrower’s request. 

  

	23.3	Resignation and release of security on disposal 

  

	 	(a)	In this Clause: 

  

	 	(i)	“Relevant Obligor” means an Obligor which is the subject of a Third Party Disposal and any Subsidiary of that Obligor; and 

 

	 	(ii)	“Third Party Disposal” means the disposal of an Obligor to a person who is not a member of the Group where that disposal is permitted under Clause 20.7 (Disposals) or made with the approval of
all of the Lenders (and the Borrower has confirmed this is the case). 

  

	 	(b)	If the Parent Guarantor is or is proposed to be the subject of a Third Party Disposal then: 

  

	 	(i)	where the Parent Guarantor created Transaction Security over any of its assets or business in favour of the Security Agent, or Transaction Security in favour of the Security Agent was created over the shares (or
equivalent) of the Parent Guarantor, the Security Agent may, at the cost and request of the Borrower, release those assets, business or shares (or equivalent) and issue certificates of non-crystallisation;

  

	 	(ii)	if the asset which is disposed of consists of shares in the capital of an Obligor, the Security Agent may, at the cost and request of the Borrower, release: 

 

	 	(A)	any Relevant Obligor from all or any part of its Secured Liabilities; and 

  

	 	(B)	any Security granted by a Relevant Obligor over any of its assets pursuant to the Transaction Security Documents; 

  
 64 

	 	(iii)	the resignation of the Parent Guarantor and related release of Transaction Security referred to in paragraphs (i) and (ii) above shall not become effective until the date of that disposal; and 

 

	 	(iv)	if the disposal of the Parent Guarantor is not made the related release of Transaction Security referred to in paragraphs (i) and (ii) above shall have no effect and the obligations of the Parent Guarantor and the
Transaction Security created or intended to be created by or over the Parent Guarantor shall continue in such force and effect as if that release had not been effected. 

 

	24.	ROLE OF THE ADMINISTRATIVE PARTIES 

  

	24.1	Appointment of the Agent 

  

	 	(a)	Each of the other Finance Parties appoints the Agent to act as its agent under and in connection with the Finance Documents. 

  

	 	(b)	Each of the other Finance Parties authorises the Agent to perform the duties, obligations and responsibilities and to exercise the rights, powers, authorities and discretions specifically given to the Agent under or in
connection with the Finance Documents together with any other incidental rights, powers, authorities and discretions. 

  

	24.2	Duties of the Agent 

  

	 	(a)	Subject to paragraph (b) below, the Agent shall promptly forward to a Party the original or a copy of any document which is delivered to the Agent for that Party by any other Party. 

 

	 	(b)	Without prejudice to Clause 22.7 (Copy of Transfer Certificate or Assignment Agreement to Borrower), paragraph (a) above shall not apply to any Transfer Certificate or to any Assignment Agreement.

  

	 	(c)	Except where a Finance Document specifically provides otherwise, the Agent is not obliged to review or check the adequacy, accuracy or completeness of any document it forwards to another Party. 

 

	 	(d)	If the Agent receives notice from a Party referring to this Agreement, describing a Default and stating that the circumstance described is a Default, it shall promptly notify the other Finance Parties.

  

	 	(e)	If the Agent is aware of the non-payment of any principal, interest, commitment fee or other fee payable to a Finance Party (other than to any Administrative Party) under this
Agreement it shall promptly notify the other Finance Parties. 

  

	 	(f)	The Agent shall have only those duties, obligations and responsibilities expressly specified under the Finance Documents. 

  

	 	(g)	The Agent’s duties under the Finance Documents are solely mechanical and administrative in nature. 

  
 65 

	24.3	Role of the Arranger 

 Except as specifically provided in the Finance Documents, the
Arranger has no obligations of any kind to any other Party under or in connection with any Finance Document. 
  

	24.4	No fiduciary duties 

  

	 	(a)	Nothing in any Finance Document constitutes any Administrative Party as a trustee or fiduciary of any other person. 

  

	 	(b)	No Administrative Party shall be bound to account to any Lender for any sum or the profit element of any sum received by it for its own account. 

 

	24.5	Business with the Group 

 Any Administrative Party may accept deposits from, lend money
to and generally engage in any kind of banking or other business with any member of the Group. 
  

	24.6	Rights and discretions of the Agent 

  

	 	(a)	The Agent may rely on: 

  

	 	(i)	any representation, notice or document believed by it to be genuine, correct and appropriately authorised and shall have no duty to verify any signature on any document; 

 

	 	(ii)	any statement purportedly made by a director, authorised signatory or employee of any person regarding any matters which may reasonably be assumed to be within his knowledge or within his power to verify; and

  

	 	(iii)	a certificate from any person 

  

	 	(A)	as to any matter of fact or circumstance which might reasonably be expected to be within the knowledge of that person; or 

  

	 	(B)	to the effect that such person approves of any particular dealing, transaction, step, action or thing, 

  

	 	    	as sufficient evidence that that is the case and, in the case of paragraph (A) above, may assume the truth and accuracy of that certificate. 

 

	 	(b)	The Agent may assume (unless it has received notice to the contrary in its capacity as agent for the Lenders) that: 

  

	 	(i)	any instructions received by it from the Majority Lenders, any Lender or any group of Lenders are duly given in accordance with the terms of the Finance Documents; 

 

	 	(ii)	unless it has received notice of revocation, those instructions have not been revoked; 

  

	 	(iii)	no Default has occurred (unless it has actual knowledge of a Default arising under Clause 21.1 (Non-payment)); 

 

	 	(iv)	any right, power, authority or discretion vested in any Party or the Majority Lenders has not been exercised; and 

  

	 	(v)	any notice or request made by the Borrower is made on behalf of and with the consent and knowledge of all the Obligors. 

  
 66 

	 	(c)	The Agent may engage, pay for and rely on the advice or services of any lawyers, accountants, surveyors or other experts. 

  

	 	(d)	Without prejudice to the generality of paragraph (c) above or paragraph (e) below, the Agent may at any time engage and pay for the services of any lawyers to act as independent counsel to the Agent (and so
separate from any lawyers instructed by the Lenders) if the Agent in its reasonable opinion deems this to be necessary. 

  

	 	(e)	The Agent may rely on the advice or services of any lawyers, accountants, tax advisers, surveyors or other professional advisers or experts (whether obtained by the Agent or by any other Party) and shall not be liable
for any damages, costs or losses to any person, any diminution in value or any liability whatsoever arising as a result of its so relying. 

  

	 	(f)	The Agent may act in relation to the Finance Documents through its personnel and agents. 

  

	 	(g)	The Agent may disclose to any other Party any information it reasonably believes it has received as agent under this Agreement. 

  

	 	(h)	The Agent shall not be bound to enquire: 

  

	 	(i)	whether or not any Default has occurred; 

  

	 	(ii)	as to the performance, default or any breach by any Party of its obligations under any Finance Document; or 

  

	 	(iii)	whether any other event specified in any Finance Document has occurred. 

  

	 	(i)	Notwithstanding any other provision of any Finance Document to the contrary, no Administrative Party is obliged to do or omit to do anything if it would or might in its reasonable opinion constitute a breach of any law
or regulation or a breach of a fiduciary duty or duty of confidentiality. 

  

	 	(j)	Notwithstanding any provision of any Finance Document to the contrary, the Agent is not obliged to expend or risk its own funds or otherwise incur any financial liability in the performance of its duties, obligations or
responsibilities or the exercise of any right, power, authority or discretion if it has grounds for believing the repayment of such funds or adequate indemnity against, or security for, such risk or liability is not reasonably assured to it.

  

	24.7	Majority Lenders’ instructions 

  

	 	(a)	Unless a contrary indication appears in a Finance Document, the Agent shall (i) exercise any right, power, authority or discretion and perform any duties, obligations authorities vested in it as Agent in accordance
with any written instructions given to it by the Majority Lenders (or, if so instructed by the Majority Lenders, refrain from exercising any right, power, authority or discretion or performing any duties, obligations and authorities vested in it as
Agent) and (ii) not be liable for any act (or omission) if it acts (or refrains from taking any action) in accordance with an instruction of the Majority Lenders. 

  
 67 

	 	(b)	Unless a contrary indication appears in a Finance Document, any instructions given by the Majority Lenders will be binding on all the Finance Parties other than the Security Agent. 

 

	 	(c)	The Agent may refrain from acting in accordance with the written instructions of the Majority Lenders (or, if appropriate, the Lenders) or under paragraph (d) below until it has received such security as it may
require for any cost, loss or liability (together with any associated Indirect Tax) which it may incur in complying with the instructions. 

  

	 	(d)	In the absence of written instructions from the Majority Lenders, (or, if appropriate, the Lenders) the Agent may act (or refrain from taking action) as it considers to be in the best interest of the Lenders.

  

	 	(e)	The Agent shall be entitled to request instructions, or clarification of any instruction, from the Majority Lenders (or, if the relevant Finance Document stipulates the matter is a decision for any other Lender or group
of Lenders, from that Lender or group of Lenders) as to whether, and in what manner, it should exercise or refrain from exercising any right, power, authority or discretion. The Agent may refrain from acting unless and until it receives any such
instructions or clarification that it has requested. 

  

	 	(f)	Save in the case of decisions stipulated to be a matter for any other Lender or group of Lenders under the relevant Finance Document and unless a contrary indication appears in a Finance Document, any instructions given
to the Agent by the Majority Lenders shall override any conflicting instructions given by any other Parties and will be binding on all Finance Parties. 

  

	 	(g)	The Agent is not authorised to act on behalf of a Lender (without first obtaining that Lender’s consent) in any legal or arbitration proceedings relating to any Finance Document. This paragraph (g) shall not
apply to any legal or arbitration proceedings relating to the perfection, preservation or protection of rights under the Transaction Security Documents or enforcement of any Transaction Security or Transaction Security Documents. 

 

	24.8	Responsibility for documentation 

 No Administrative Party: 

 

	 	(a)	is responsible for the adequacy, accuracy and/or completeness of any information (whether oral or written) supplied by any Administrative Party, an Obligor or any other person given in or in connection with any Finance
Document or the Information Package; or 

  

	 	(b)	is responsible for the legality, validity, effectiveness, adequacy or enforceability of any Finance Document, the Transaction Security or any other agreement, arrangement or document entered into, made or executed in
anticipation of or in connection with any Finance Document or the Transaction Security; or 

  

	 	(c)	is responsible for any determination as to whether any information provided or to be provided to any Finance Party is non-public information the use of which may be regulated or
prohibited by applicable law or regulation relating to insider dealing or otherwise. 

  
 68 

	24.9	Exclusion of liability 

  

	 	(a)	Without limiting paragraph (b) below (and without prejudice to any other provision of any Finance Document excluding or limiting the liability of the Agent), the Agent shall not be liable for any cost, loss or
liability incurred by any Party as a consequence of: 

  

	 	(i)	any damages, costs or losses to any person, any diminution in value, or any liability whatsoever arising as a result of taking or not taking any action under or in connection with any Finance Document, unless directly
caused by its gross negligence or wilful misconduct; 

  

	 	(ii)	exercising, or not exercising, any right, power, authority or discretion given to it by, or in connection with, any Finance Document or any other agreement, arrangement or document entered into, made or executed in
anticipation of, under or in connection with, any Finance Document, other than by reason of its gross negligence or wilful misconduct; or 

  

	 	(iii)	without prejudice to the generality of paragraphs (i) and (ii) above, any damages, costs or losses to any person, any diminution in value or any liability whatsoever but not including any claim based on the fraud
of the Agent arising as a result of: 

  

	 	(A)	any act, event or circumstance not reasonably within its control; or 

  

	 	(B)	the general risks of investment in, or the holding of assets in, any jurisdiction, 

  

	 	    	including (in each case) such damages, costs, losses, diminution in value or liability arising as a result of: nationalisation, expropriation or other governmental actions; any regulation, currency restriction,
devaluation or fluctuation; market conditions affecting the execution or settlement of transactions or the value of assets (including any Disruption Event); breakdown, failure or malfunction of any third party transport, telecommunications, computer
services or systems; natural disasters or acts of God; war, terrorism, insurrection or revolution; or strikes or industrial action. 

  

	 	(b)	No Party (other than the Agent) may take any proceedings against any officer, employee or agent of the Agent in respect of any claim it might have against the Agent or in respect of any act or omission of any kind by
that officer, employee or agent in relation to any Finance Document and any officer, employee or agent of the Agent may rely on this Clause 24 subject to Clause 1.3 (Third party rights) and the provisions of the Third Parties Act.

  

	 	(c)	The Agent will not be liable for any delay (or any related consequences) in crediting an account with an amount required under the Finance Documents to be paid by the Agent if the Agent has taken all necessary steps as
soon as reasonably practicable to comply with the regulations or operating procedures of any recognised clearing or settlement system used by the Agent for that purpose. 

 

	 	(d)	Nothing in this Agreement shall oblige any Administrative Party to conduct: 

  

	 	(i)	any “know your customer” or other procedures in relation to any person; or 

  

	 	(ii)	any check on the extent to which any transaction contemplated by this Agreement might be unlawful for any Lender, 

  
 69 

	 	    	on behalf of any Lender and each Lender confirms to each Administrative Party that it is solely responsible for any such procedures or check it is required to conduct and that it shall not rely on any statement in
relation to such procedures or check made by any Administrative Party. 

  

	 	(e)	Without prejudice to any provision of any Finance Document excluding or limiting the Agent’s liability, any liability of the Agent arising under or in connection with any Finance Document shall be limited to the
amount of actual loss which has been suffered (as determined by reference to the date of default of the Agent or, if later, the date on which the loss arises as a result of such default) but without reference to any special conditions or
circumstances known to the Agent at any time which increase the amount of that loss. In no event shall the Agent be liable for any loss of profits, goodwill, reputation, business opportunity or anticipated saving, or for special, punitive, indirect
or consequential damages, whether or not the Agent has been advised of the possibility of such loss or damages. 

  

	 	(f)	Without prejudice to any provision of any Finance Document excluding or limiting the Agent’s or the Security Agent’s liability, amounts received by the Agent or the Security Agent pursuant to the terms of the
Finance Documents shall not be held as client money and shall not be interest-bearing. 

  

	24.10	Lenders’ indemnity to the Agent 

  

	 	(a)	Each Lender shall, in accordance with paragraph (b) below, indemnify the Agent, within three Business Days of demand, against any cost, loss or liability incurred by the Agent (otherwise than by reason of the
Agent’s gross negligence or wilful misconduct) in acting as Agent under the Finance Documents (unless the Agent has been reimbursed by an Obligor pursuant to a Finance Document). 

 

	 	(b)	The proportion of such cost, loss or liability to be borne by each Lender shall be: 

  

	 	(i)	if the Loan is outstanding, the proportion borne by (A) the sum of its participation in the Loan then outstanding to (B) the aggregate amount of the Loan; 

 

	 	(ii)	if there is no Loan then outstanding and the Available Facility is then greater than zero, the proportion borne by (A) its Available Commitment to (B) the Available Facility; or 

 

	 	(iii)	if there is no Loan then outstanding and the Available Facility is then zero: 

  

	 	(A)	if the Available Facility became zero after the Loan ceased to be outstanding, the proportion borne by (I) its Available Commitment to (II) the Available Facility immediately before the Available Facility
became zero; or 

  

	 	(B)	if the Loan ceased to be outstanding after the Available Facility became zero, the proportion borne by (I) the sum of its participation in the Loan outstanding immediately before the Loan ceased to be outstanding
to (II) the aggregate amount of the Loan. 

  

	24.11	Resignation of the Agent 

  

	 	(a)	The Agent may resign and appoint one of its Affiliates as successor by giving notice to the other Finance Parties and the Borrower. 

  
 70 

	 	(b)	Alternatively the Agent may resign by giving notice to the other Finance Parties and the Borrower, in which case the Majority Lenders (after consultation with the Borrower) may appoint a successor Agent.

  

	 	(c)	If the Majority Lenders have not appointed a successor Agent in accordance with paragraph (b) above within 30 days after notice of resignation was given, the retiring Agent (after consultation with the Borrower)
may appoint a successor Agent (acting through an office in Hong Kong). 

  

	 	(d)	The retiring Agent shall make available to the successor Agent such documents and records and provide such assistance as the successor Agent may reasonably request for the purposes of performing its functions as Agent
under the Finance Documents. The Borrower shall, within three Business Days of demand, reimburse the retiring Agent for the amount of all costs and expenses (including legal fees) properly incurred by it in making availing such documents and records
and providing such assistance. 

  

	 	(e)	The Agent’s resignation notice shall take effect only upon the appointment of a successor. 

  

	 	(f)	Upon the appointment of a successor, the retiring Agent shall be discharged from any further obligation in respect of the Finance Documents but shall remain entitled to the benefit of this Clause 24. Its successor and
each of the other Parties shall have the same rights and obligations amongst themselves as they would have had if such successor had been an original Party. 

  

	 	(g)	After consultation with the Borrower, the Majority Lenders may, by notice to the Agent, require it to resign in accordance with paragraph (b) above. In this event, the Agent shall resign in accordance with
paragraph (b) above. 

  

	 	(h)	The Agent shall resign in accordance with paragraph (b) above and, to the extent applicable, shall use reasonable endeavours to appoint a successor Agent pursuant to paragraph (c) above if on or after the date
which is three months before the earliest FATCA Application Date relating to any payment to the Agent under the Finance Documents, either: 

  

	 	(i)	the Agent fails to respond to a request under Clause 12.8 (FATCA Information) and the Borrower or a Lender reasonably believes that the Agent will not be (or will have ceased to be) a FATCA Exempt Party on or
after that FATCA Application Date; 

  

	 	(ii)	the information supplied by the Agent pursuant to Clause 12.8 (FATCA Information) indicates that the Agent will not be (or will have ceased to be) a FATCA Exempt Party on or after that FATCA Application Date; or

  

	 	(iii)	the Agent notifies the Borrower and the Lenders that the Agent will not be (or will have ceased to be) a FATCA Exempt Party on or after that FATCA Application Date, 

 

	 	    	and (in each case) the Borrower or a Lender reasonably believes that a Party will be required to make a FATCA Deduction that would not be required if the Agent were a FATCA Exempt Party, and the Borrower or that Lender,
by notice to the Agent, requires it to resign. 

  
 71 

	24.12	Replacement of the Agent 

  

	 	(a)	After consultation with the Borrower, the Majority Lenders may, by giving 30 days’ notice to the Agent replace the Agent by appointing a successor Agent. 

 

	 	(b)	The retiring Agent shall, at the expense of the Lenders, make available to the successor Agent such documents and records and provide such assistance as the successor Agent may reasonably request for the purposes of
performing its functions as Agent under the Finance Documents. 

  

	 	(c)	The appointment of the successor Agent shall take effect on the date specified in the notice from the Majority Lenders to the retiring Agent. As from this date, the retiring Agent shall be discharged from any further
obligation in respect of the Finance Documents (other than its obligations under paragraph (b) above) but shall remain entitled to the benefit of Clause 15.3 (Indemnity to the Agent) and this Clause 24 (and any agency fees for
the account of the retiring Agent shall cease to accrue from (and shall be payable on) that date). 

  

	 	(d)	Any successor Agent and each of the other Parties shall have the same rights and obligations amongst themselves as they would have had if such successor had been an original Party. 

 

	24.13	Confidentiality 

  

	 	(a)	In acting as agent for the Finance Parties, the Agent shall be regarded as acting through its agency division which shall be treated as a separate legal person from any other of its branches, divisions or departments.

  

	 	(b)	If information is received by another branch, division or department of the legal person which is the Agent, it may be treated as confidential to that branch, division or department and the Agent shall not be deemed to
have notice of it. 

  

	 	(c)	The Agent shall not be obliged to disclose to any Finance Party any information supplied to it by the Borrower or any Affiliates of the Borrower on a confidential basis and for the purpose of evaluating whether any
waiver or amendment is or may be required or desirable in relation to any Finance Document. 

  

	24.14	Relationship with the other Finance Parties 

  

	 	(a)	Subject to Clause 22.13 (Pro rata interest settlement) and Clause 30.2 (Distributions by the Agent), the Agent may treat each Lender as a Lender entitled to payments under this Agreement and acting
through its Facility Office unless it has received not less than five Business Days’ prior notice from that Lender to the contrary in accordance with the terms of this Agreement. 

 

	 	(b)	Each Lender shall supply the Agent with any information that the Security Agent may reasonably specify (through the Agent) as being necessary or desirable to enable the Security Agent to perform its functions as
Security Agent. Each Lender shall deal with the Security Agent exclusively through the Agent. 

  

	 	(c)	Any Lender may by notice to the Agent appoint a person to receive on its behalf all notices, communications, information and documents to be made or despatched to that Lender under the Finance Documents. Such notice
shall contain the address, fax number and (where communication by electronic mail or other electronic means is permitted under Clause 33 (Notices)) corporate electronic mail address and/or any other information required to enable the
sending and receipt of information by that means (and, in each case, the department or officer, if any, for whose attention communication is to be made) and be treated as a notification of a substitute corporate email address, address, fax number,
electronic mail address, department and officer by that Lender for the purposes of Clause 33.2 (Addresses) and the Agent shall be entitled to treat such person as the person entitled to receive all such notices, communications, information
and documents as though that person were that Lender. 

  
 72 

	24.15	Credit appraisal by the Lenders 

 Without affecting the responsibility of any Obligor for
information supplied by it or on its behalf in connection with any Finance Document, each Lender confirms to each Administrative Party that it has been, and will continue to be, solely responsible for making its own independent appraisal and
investigation of all risks arising under or in connection with any Finance Document including but not limited to: 
  

	 	(a)	the financial condition, status and nature of each member of the Group; 

  

	 	(b)	the legality, validity, effectiveness, adequacy or enforceability of any Finance Document, the Transaction Security and any other agreement, arrangement or document entered into, made or executed in anticipation of,
under or in connection with any Finance Document or the Transaction Security; 

  

	 	(c)	whether that Finance Party has recourse, and the nature and extent of that recourse, against any Party or any of its respective assets under or in connection with any Finance Document, the Transaction Security, the
transactions contemplated by the Finance Documents or any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with any Finance Document or the Transaction Security; 

 

	 	(d)	the adequacy, accuracy and/or completeness of the Information Package, the Reports and any other information provided by the Agent, any Party or by any other person under or in connection with any Finance Document, the
transactions contemplated by the Finance Documents or any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with any Finance Document; 

 

	 	(e)	the right or title of any person in or to, or the value or sufficiency of any part of the Charged Property, the priority of any of the Transaction Security or the existence of any Security affecting the Charged
Property. 

  

	24.16	Deduction from amounts payable by the Agent 

 If any Party owes an amount to the Agent
under the Finance Documents the Agent may, after giving notice to that Party, deduct an amount not exceeding that amount from any payment to that Party which the Agent would otherwise be obliged to make under the Finance Documents and apply the
amount deducted in or towards satisfaction of the amount owed. For the purposes of the Finance Documents that Party shall be regarded as having received any amount so deducted. 

 

	24.17	Reliance and engagement letters 

 Each Finance Party and Secured Party confirms that each
of the Arranger and the Agent has authority to accept on its behalf (and ratifies the acceptance on its behalf of any letters or reports already accepted by the Arranger or Agent) the terms of any reliance letter or engagement letters relating to
the Reports or any reports or letters provided by accountants in connection with the Finance Documents or the transactions contemplated in the Finance Documents and to bind it in respect of those Reports, reports or letters and to sign such letters
on its behalf and further confirms that it accepts the terms and qualifications set out in such letters. 

  
 73 

	24.18	Agent’s management time 

 Any amount payable to the Agent under Clause 15.3
(Indemnity to the Agent), Clause 16 (Costs and Expenses) and Clause 24.10 (Lenders’ indemnity to the Agent) shall include the cost of utilising the Agent’s management time or other resources and will be calculated
on the basis of such reasonable daily or hourly rates as the Agent may notify to the Borrower and the Lenders, and is in addition to any fee paid or payable to the Agent under Clause 11 (Fees). 

 

	24.19	Role of Reference Banks 

  

	 	(a)	No Reference Bank is under any obligation to provide a quotation or any other information to the Agent. 

  

	 	(b)	No Reference Bank will be liable for any action taken by it under or in connection with any Finance Document, or for any Reference Bank Quotation, unless directly caused by its gross negligence or wilful misconduct.

  

	 	(c)	No Party (other than the relevant Reference Bank) may take any proceedings against any officer, employee or agent of any Reference Bank in respect of any claim it might have against that Reference Bank or in respect of
any act or omission of any kind by that officer, employee or agent in relation to any Finance Document, or to any Reference Bank Quotation, and any officer, employee or agent of each Reference Bank may rely on this Clause 24.19 subject to
Clause 1.3 (Third party rights) and the provisions of the Third Parties Act. 

  

	24.20	Third party Reference Banks 

 A Reference Bank which is not a Party may rely on
Clause 24.19 (Role of Reference Banks), Clause 37.3 (Other exceptions) subject to Clause 1.3 (Third party rights) and the provisions of the Third Parties Act. 

 

	25.	THE SECURITY AGENT 

  

	25.1	Trust 

  

	 	(a)	The Security Agent declares that it shall hold the Security Property on trust or as agent for the Secured Parties on the terms contained in this Agreement. 

 

	 	(b)	Each of the parties to this Agreement agrees that the Security Agent shall have only those duties, obligations and responsibilities expressly specified in this Agreement or in the Transaction Security Documents to which
the Security Agent is expressed to be a party (and no others shall be implied). 

  

	25.2	No independent power 

 The Secured Parties shall not have any independent power to
enforce, or have recourse to, any of the Transaction Security or to exercise any rights or powers arising under the Transaction Security Documents except through the Security Agent. 

 

	25.3	Instructions to Security Agent and exercise of discretion 

  

	 	(a)	Subject to paragraphs (d) and (e) below, the Security Agent shall act in accordance with any instructions given to it by Agent (acting on the written instructions of the Majority Lenders) or, if so instructed by
the Agent (acting on the written instructions of the Majority Lenders), refrain from exercising any right, power, authority or discretion vested in it as Security Agent and shall be entitled to assume that (i) any instructions received by it
from the Agent, the Lenders or the Majority Lenders are duly given in accordance with the terms of the Finance Documents and (ii) unless it has received actual notice of revocation, that those instructions or directions have not been revoked.

  
 74 

	 	(b)	The Security Agent shall be entitled to request instructions, or clarification of any direction, from the Agent (acting on the written instructions of the Majority Lenders) or the Majority Lenders as to whether, and in
what manner, it should exercise or refrain from exercising any rights, powers, authorities and discretions and the Security Agent may refrain from acting unless and until those instructions or clarification are received by it. 

 

	 	(c)	Any instructions given to the Security Agent by Agent (acting on the written instructions of the Majority Lenders) shall override any conflicting instructions given by any other Parties. 

 

	 	(d)	Paragraph (a) above shall not apply: 

  

	 	(i)	where a contrary indication appears in this Agreement; 

  

	 	(ii)	where this Agreement requires the Security Agent to act in a specified manner or to take a specified action; 

  

	 	(iii)	in respect of any provision which protects the Security Agent’s own position in its personal capacity as opposed to its role of Security Agent for the Secured Parties including, without limitation, the provisions
set out in Clause 25.5 (Security Agent’s discretions) to Clause 25.19 (Trustee division separate); 

  

	 	(iv)	in respect of the exercise of the Security Agent’s discretion to exercise a right, power or authority under any of: 

  

	 	(A)	Clause 23.3 (Resignation and release of security on disposal); 

  

	 	(B)	Clause 27.1 (Order of application); 

  

	 	(C)	Clause 27.2 (Prospective liabilities); and 

  

	 	(D)	Clause 27.5 (Permitted Deductions). 

  

	 	(e)	If giving effect to instructions given by the Agent (acting on the written instructions of the Majority Lenders) would (in the Security Agent’s opinion) have an effect equivalent to an amendment or waiver referred
to in Clause 37.2 (All lender matters) or Clause 28.5 (Exceptions)), the Security Agent shall not act in accordance with those instructions unless consent to it so acting is obtained from each Party (other than the Security
Agent) whose consent would have been required in respect of that amendment or waiver. 

  

	 	(f)	In exercising any discretion to exercise a right, power or authority under this Agreement where either: 

  

	 	(i)	it has not received any instructions from the Agent (acting on the written instructions of the Majority Lenders) as to the exercise of that discretion; or 

 

	 	(ii)	the exercise of that discretion is subject to paragraph (d)(iv) above, 

  
 75 

	 	    	the Security Agent shall do so having regard to the interests of all the Secured Parties. 

  

	25.4	Security Agent’s Actions 

 Without prejudice to the provisions of Clause 25.3
(Instructions to Security Agent and exercise of discretion), the Security Agent may (but shall not be obliged to), in the absence of any instructions to the contrary, take such action in the exercise of any of its powers and duties under the
Finance Documents as it considers in its discretion to be appropriate. 
  

	25.5	Security Agent’s discretions 

 The Security Agent may: 

 

	 	(a)	assume (unless it has received actual notice to the contrary from the Agent) that (i) no Default has occurred and no Obligor is in breach of or default under its obligations under any of the Finance Documents and
(ii) any right, power, authority or discretion vested by any Finance Document in any person has not been exercised; 

  

	 	(b)	if it receives any instructions or directions to take any action in relation to the Transaction Security, assume that all applicable conditions under the Finance Documents for taking that action have been satisfied;

  

	 	(c)	engage, pay for and rely on the advice or services of any legal advisers, accountants, tax advisers, surveyors or other experts (whether obtained by the Security Agent or by any other Secured Party) whose advice or
services may at any time seem necessary, expedient or desirable; 

  

	 	(d)	rely upon any communication or document believed by it to be genuine and, as to any matters of fact which might reasonably be expected to be within the knowledge of a Secured Party, or an Obligor, upon a certificate
signed by or on behalf of that person; and 

  

	 	(e)	refrain from acting in accordance with the instructions of any Party (including bringing any legal action or proceeding arising out of or in connection with the Finance Documents) until it has received any
indemnification and/or security that it may in its discretion require (whether by way of payment in advance or otherwise) for all costs, losses and liabilities which it may incur in so acting. 

 

	25.6	Security Agent’s obligations 

 The Security Agent shall promptly: 

 

	 	(a)	copy to the Agent the contents of any notice or document received by it from any Obligor under any Finance Document; 

  

	 	(b)	forward to a Party the original or a copy of any document which is delivered to the Security Agent for that Party by any other Party provided that, except where a Finance Document expressly provides otherwise,
the Security Agent is not obliged to review or check the adequacy, accuracy or completeness of any document it forwards to another Party; and 

  

	 	(c)	inform the Agent of the occurrence of any Default or any default by an Obligor in the due performance of or compliance with its obligations under any Finance Document of which the Security Agent has received notice from
any other Party. 

  
 76 

	25.7	Excluded obligations 

 Notwithstanding anything to the contrary expressed or implied in
the Finance Documents, the Security Agent shall not: 
  

	 	(a)	be bound to enquire as to (i) whether or not any Default has occurred or (ii) the performance, default or any breach by an Obligor of its obligations under any of the Finance Documents; 

 

	 	(b)	be bound to account to any other Party for any sum or the profit element of any sum received by it for its own account; 

  

	 	(c)	be bound to disclose to any other person (including but not limited to any Secured Party) (i) any confidential information or (ii) any other information if disclosure would, or might in its reasonable opinion,
constitute a breach of any law or be a breach of fiduciary duty; or 

  

	 	(d)	have or be deemed to have any relationship of trust or agency with, any Obligor. 

  

	25.8	Exclusion of liability 

 None of the Security Agent, any Receiver or any Delegate shall
accept responsibility or be liable for: 
  

	 	(a)	the adequacy, accuracy or completeness of any information (whether oral or written) supplied by the Security Agent or any other person in or in connection with any Finance Document or the transactions contemplated in
the Finance Documents, or any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with any Finance Document; 

 

	 	(b)	the legality, validity, effectiveness, adequacy or enforceability of any Finance Document, the Security Property or any other agreement, arrangement or document entered into, made or executed in anticipation of, under
or in connection with any Finance Document or the Security Property; 

  

	 	(c)	any losses to any person or any liability arising as a result of taking or refraining from taking any action in relation to any of the Finance Documents, the Security Property or otherwise, whether in accordance with an
instruction from the Agent or otherwise unless directly caused by its gross negligence or wilful misconduct; 

  

	 	(d)	the exercise of, or the failure to exercise, any judgment, discretion or power given to it by or in connection with any of the Finance Documents, the Security Property or any other agreement, arrangement or document
entered into, made or executed in anticipation of, under or in connection with, the Finance Documents or the Security Property; or 

  

	 	(e)	any shortfall which arises on the enforcement or realisation of the Security Property. 

  

	25.9	No proceedings 

 No Party (other than the Security Agent, that Receiver or that Delegate)
may take any proceedings against any officer, employee or agent of the Security Agent, a Receiver or a Delegate in respect of any claim it might have against the Security Agent, a Receiver or a Delegate or in respect of any act or omission of any
kind by that officer, employee or agent in relation to any Finance Document or any Security Property and any officer, employee or agent of the Security Agent, a Receiver or a Delegate may rely on this Clause subject to Clause 1.3 (Third party
rights) and the provisions of the Third Parties Act. 

  
 77 

	25.10	Own responsibility 

 Without affecting the responsibility of any Obligor for information
supplied by it or on its behalf in connection with any Finance Document, each Secured Party confirms to the Security Agent that it has been, and will continue to be, solely responsible for making its own independent appraisal and investigation of
all risks arising under or in connection with any Finance Document including but not limited to: 
  

	 	(a)	the financial condition, status and nature of each member of the Group; 

  

	 	(b)	the legality, validity, effectiveness, adequacy and enforceability of any Finance Document, the Security Property and any other agreement, arrangement or document entered into, made or executed in anticipation of, under
or in connection with any Finance Document or the Security Property; 

  

	 	(c)	whether that Secured Party has recourse, and the nature and extent of that recourse, against any Party or any of its respective assets under or in connection with any Finance Document, the Security Property, the
transactions contemplated by the Finance Documents or any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with any Finance Document or the Security Property; 

 

	 	(d)	the adequacy, accuracy and/or completeness of any information provided by the Security Agent or by any other person under or in connection with any Finance Document, the transactions contemplated by any Finance Document
or any other agreement, arrangement or document entered into, made or executed in anticipation of, under or in connection with any Finance Document; and 

  

	 	(e)	the right or title of any person in or to, or the value or sufficiency of any part of the Charged Property, the priority of any of the Transaction Security or the existence of any Security affecting the Charged
Property, 

 and each Secured Party warrants to the Security Agent that it has not relied on and will not at any time rely on
the Security Agent in respect of any of these matters. 
  

	25.11	No responsibility to perfect Transaction Security 

 The Security Agent shall not be
liable for any failure to: 
  

	 	(a)	require the deposit with it of any deed or document certifying, representing or constituting the title of any Obligor to any of the Charged Property; 

 

	 	(b)	obtain any licence, consent or other authority for the execution, delivery, legality, validity, enforceability or admissibility in evidence of any of the Finance Documents or the Transaction Security; 

 

	 	(c)	register, file or record or otherwise protect any of the Transaction Security (or the priority of any of the Transaction Security) under any applicable laws in any jurisdiction or to give notice to any person of the
execution of any of the Finance Documents or of the Transaction Security; 

  

	 	(d)	take, or to require any of the Obligors to take, any steps to perfect its title to any of the Charged Property or to render the Transaction Security effective or to secure the creation of any ancillary Security under
the laws of any jurisdiction; or 

  

	 	(e)	require any further assurances in relation to any of the Transaction Security Documents. 

  
 78 

	25.12	Insurance by Security Agent 

  

	 	(a)	The Security Agent shall not be under any obligation to insure any of the Charged Property, to require any other person to maintain any insurance or to verify any obligation to arrange or maintain insurance contained in
the Finance Documents. The Security Agent shall not be responsible for any loss which may be suffered by any person as a result of the lack of or inadequacy of any such insurance. 

 

	 	(b)	Where the Security Agent is named on any insurance policy as an insured party, it shall not be responsible for any loss which may be suffered by reason of, directly or indirectly, its failure to notify the insurers of
any material fact relating to the risk assumed by such insurers or any other information of any kind, unless the Agent shall have requested it to do so in writing and the Security Agent shall have failed to do so within 14 days after receipt of that
request. 

  

	25.13	Custodians and nominees 

 The Security Agent may appoint and pay any person to act as a
custodian or nominee on any terms in relation to any assets of the trust or any assets over which Security has been created pursuant to Transaction Security as the Security Agent may determine, including for the purpose of depositing with a
custodian this Agreement or any document relating to the trust created under this Agreement and the Security Agent shall not be responsible for any loss, liability, expense, demand, cost, claim or proceedings incurred by reason of the misconduct,
omission or default on the part of any person appointed by it under this Agreement or be bound to supervise the proceedings or acts of any person. 
  

	25.14	Acceptance of title 

 The Security Agent shall be entitled to accept without enquiry, and
shall not be obliged to investigate, any right and title that any of the Obligors may have to any of the Charged Property and shall not be liable for or bound to require any Obligor to remedy any defect in its right or title. 

 

	25.15	Refrain from illegality 

 Notwithstanding anything to the contrary expressed or implied
in the Finance Documents, the Security Agent may refrain from doing anything which in its opinion will or may be contrary to any relevant law, directive or regulation of any jurisdiction and the Security Agent may do anything which is, in its
opinion, necessary to comply with any such law, directive or regulation. 
  

	25.16	Business with the Obligors 

 The Security Agent may accept deposits from, lend money to,
and generally engage in any kind of banking or other business with any of the Obligors. 
  

	25.17	Winding up of trust 

 If the Security Agent, with the approval of the Majority Lenders,
determines that all of the Secured Liabilities and all other liabilities secured by the Transaction Security Documents have been fully and finally discharged and none of the Secured Parties is under any commitment, obligation or liability (actual or
contingent) to make advances or provide other financial accommodation to any Obligor pursuant to the Finance Documents: 
  

	 	(a)	the trusts set out in this Agreement shall be wound up and the Security Agent shall release, without recourse or warranty, all of the Transaction Security and the rights of the Security Agent under each of the
Transaction Security Documents; and 

  

	 	(b)	any Retiring Security Agent shall release, without recourse or warranty, all of its rights under each of the Transaction Security Documents. 

  
 79 

	25.18	Powers supplemental 

 The rights, powers and discretions conferred upon the Security
Agent by this Agreement shall be supplemental to the Trustee Act 1925 and the Trustee Act 2000 and in addition to any which may be vested in the Security Agent by general law or otherwise. 

 

	25.19	Trustee division separate 

  

	 	(a)	In acting as trustee for the Secured Parties, the Security Agent shall be regarded as acting through its trustee division which shall be treated as a separate entity from any of its other divisions or departments.

  

	 	(b)	If information is received by another division or department of the Security Agent, it may be treated as confidential to that division or department and the Security Agent shall not be deemed to have notice of it.

  

	25.20	Disapplication 

 Section 1 of the Trustee Act 2000 shall not apply to the duties of
the Security Agent in relation to the trusts constituted by this Agreement. Where there are any inconsistencies between the Trustee Act 1925 or the Trustee Act 2000 and the provisions of this Agreement, the provisions of this Agreement shall, to the
extent allowed by law, prevail and, in the case of any inconsistency with the Trustee Act 2000, the provisions of this Agreement shall constitute a restriction or exclusion for the purposes of that Act. 

 

	25.21	Lenders’ indemnity to the Security Agent 

 Each Lender shall (in proportion to its
share of the Total Commitments or, if the Total Commitments are then zero, to its share of the Total Commitments immediately prior to their reduction to zero) indemnify the Security Agent and every Receiver and every Delegate, within three Business
Days of demand, against any cost, loss or liability incurred by any of them (otherwise than by reason of the Security Agent’s gross negligence or wilful misconduct) in acting as Security Agent, Receiver or Delegate under the Finance Documents
(unless the relevant Security Agent, Receiver or Delegate has been reimbursed by an Obligor pursuant to a Finance Document) and the Obligors shall jointly and severally indemnify each Lender against any payment made by it under this Clause 25.21.

  

	25.22	Conflict with the Transaction Security Documents 

  

	 	(a)	If there is any conflict between this Agreement and any Transaction Security Document with regard to instructions to, or other matters affecting, the Security Agent, this Agreement will prevail. 

 

	 	(b)	Each Lender shall deal with the Security Agent exclusively through the Agent. 

  

	25.23	Notification of prescribed events 

  

	 	(a)	If an Event of Default either occurs or ceases to be continuing the Agent shall, upon becoming aware of that occurrence or cessation, notify the Security Agent. 

  
 80 

	 	(b)	If the Security Agent enforces, or takes formal steps to enforce, any of the Transaction Security it shall notify each Party of that action. 

 

	 	(c)	If any Finance Party exercises any right it may have to enforce, or to take formal steps to enforce, any of the Transaction Security it shall notify the Security Agent and the Security Agent shall, upon receiving that
notification, notify each Party of that action. 

  

	 	(d)	If a prepayment under Clause 7 (Prepayment and Cancellation) is waived the Agent shall notify the Security Agent of the amount of the prepayment waived. 

 

	26.	CHANGE OF SECURITY AGENT AND DELEGATION 

  

	26.1	Resignation of the Security Agent 

  

	 	(a)	The Security Agent may resign and appoint one of its affiliates as successor by giving notice to the Borrower and the Majority Lenders. 

 

	 	(b)	Alternatively the Security Agent may resign by giving notice to the other Parties in which case the Majority Lenders may appoint a successor Security Agent. 

 

	 	(c)	If the Majority Lenders have not appointed a successor Security Agent in accordance with paragraph (b) above within 30 days after the notice of resignation was given, the Security Agent (after consultation with the
Agent) may appoint a successor Security Agent. 

  

	 	(d)	The retiring Security Agent (the “Retiring Security Agent”) shall, at its own cost, make available to the successor Security Agent such documents and records and provide such assistance as the successor
Security Agent may reasonably request for the purposes of performing its functions as Security Agent under the Finance Documents. 

  

	 	(e)	The Security Agent’s resignation notice shall only take effect upon (i) the appointment of a successor and (ii) the transfer of all of the Security Property to that successor. 

 

	 	(f)	Upon the appointment of a successor, the Retiring Security Agent shall be discharged from any further obligation in respect of the Finance Documents (other than its obligations under paragraph (b) of Clause 25.17
(Winding up of trust) and under paragraph (d) above) but shall, in respect of any act or omission by it whilst it was the Security Agent, remain entitled to the benefit of Clause 25 (The Security Agent), Clause 15.4
(Obligors’ indemnity to the Security Agent) and Clause 25.21 (Lenders’ indemnity to the Security Agent). Its successor and each of the other Parties shall have the same rights and obligations amongst themselves as they would
have had if that successor had been an original Party. 

  

	 	(g)	The Majority Lenders may, by notice to the Security Agent, require it to resign in accordance with paragraph (b) above. In this event, the Security Agent shall resign in accordance with paragraph (b) above but
the cost referred to in paragraph (d) above shall be for the account of the Borrower. 

  

	 	(h)	The Security Agent shall resign in accordance with paragraph (b) above and, to the extent applicable, shall use reasonable endeavours to appoint a successor Security Agent pursuant to paragraph (a) above if on
or after the date which is three months before the earliest FATCA Application Date relating to any payment to the Security Agent under the Finance Documents, either: 

 

	 	(i)	the Security Agent fails to respond to a request under Clause 12.8 (FATCA Information) and the Borrower or a Lender reasonably believes that the Security Agent will not be (or will have ceased to be) a FATCA
Exempt Party on or after that FATCA Application Date; 

  
 81 

	 	(ii)	the information supplied by the Security Agent pursuant to Clause 12.8 (FATCA Information) indicates that the Security Agent will not be (or will have ceased to be) a FATCA Exempt Party on or after that FATCA
Application Date; or 

  

	 	(iii)	the Security Agent notifies the Borrower and the Lenders that the Security Agent will not be (or will have ceased to be) a FATCA Exempt Party on or after that FATCA Application Date, 

 

	 	    	and (in each case) the Borrower or a Lender reasonably believes that a Party will be required to make a FATCA Deduction that would not be required if the Security Agent were a FATCA Exempt Party, and the Borrower or
that Lender, by notice to the Security Agent, requires it to resign. 

  

	26.2	Delegation 

  

	 	(a)	Each of the Security Agent, any Receiver and any Delegate may, at any time, delegate by power of attorney or otherwise to any person for any period, all or any of the rights, powers and discretions vested in it by any
of the Finance Documents. 

  

	 	(b)	That delegation may be made upon any terms and conditions (including the power to sub delegate) and subject to any restrictions that the Security Agent, that Receiver or that Delegate (as the case may be) may, in its
discretion, think fit in the interests of the Secured Parties and it shall not be bound to supervise, or be in any way responsible for any loss incurred by reason of any misconduct or default on the part of any such delegate or sub delegate.

  

	26.3	Additional Security Agents 

  

	 	(a)	The Security Agent may at any time appoint (and subsequently remove) any person to act as a separate trustee or agent or as a co-trustee or co agent jointly with it (i) if it
considers that appointment to be in the interests of the Secured Parties or (ii) for the purposes of conforming to any legal requirements, restrictions or conditions which the Security Agent deems to be relevant or (iii) for obtaining or
enforcing any judgment in any jurisdiction, and the Security Agent shall give prior notice to the Borrower and each of the Agents of that appointment. 

  

	 	(b)	Any person so appointed shall have the rights, powers and discretions (not exceeding those conferred on the Security Agent by this Agreement) and the duties and obligations that are conferred or imposed by the
instrument of appointment. 

  

	 	(c)	The remuneration that the Security Agent may pay to that person, and any costs and expenses (together with any applicable Indirect Tax) incurred by that person in performing its functions pursuant to that appointment
shall, for the purposes of this Agreement, be treated as costs and expenses incurred by the Security Agent. 

  
 82 

	27.	APPLICATION OF PROCEEDS 

  

	27.1	Order of application 

 Subject to Clause 27.2 (Prospective liabilities), all
amounts from time to time received or recovered by the Security Agent pursuant to the terms of any Finance Document or in connection with the realisation or enforcement of all or any part of the Transaction Security (for the purposes of this Clause
27, the “Recoveries”) shall be held by the Security Agent on trust or as agent to apply them at any time as the Security Agent (in its discretion) sees fit, to the extent permitted by applicable law (and subject to the provisions of
this Clause 27), in the following order: 
  

	 	(a)	in discharging any sums owing to the Security Agent, any Receiver or any Delegate under the Finance Documents; 

  

	 	(b)	in payment of all costs and expenses incurred by the Agent or any Secured Party in connection with any realisation or enforcement of the Transaction Security taken in accordance with the terms of this Agreement;

  

	 	(c)	in payment: 

  

	 	(i)	to the Agent on its own behalf and on behalf of the Lenders and the Arrangers; and 

  

	 	(ii)	for application towards the discharge of the Loan Debt; 

  

	 	(d)	if none of the Obligors is under any further actual or contingent liability under any Finance Document, in payment to any person to whom the Security Agent is obliged to pay in priority to any Obligor; and

  

	 	(e)	the balance, if any, in payment to the relevant Obligor. 

  

	27.2	Prospective liabilities 

 Following enforcement of any of the Transaction Security the
Security Agent may, in its discretion, hold any amount of the Recoveries in an interest bearing suspense or impersonal account(s) in the name of the Security Agent with such financial institution (including itself) and for so long as the Security
Agent shall think fit (the interest being credited to the relevant account) for later application under Clause 27.1 (Order of application) in respect of: 
  

	 	(a)	any sum payable to the Security Agent, any Receiver or any Delegate; and 

  

	 	(b)	any part of the Secured Liabilities, 

 that the Security Agent reasonably considers, in each
case, might become due or owing at any time in the future. 
  

	27.3	Investment of proceeds 

 Prior to the application of the Recoveries in accordance with
Clause 27.1 (Order of application) the Security Agent may, in its discretion, hold all or part of those proceeds in an interest bearing suspense or impersonal account(s) in the name of the Security Agent with such financial institution
(including itself) and for so long as the Security Agent shall think fit (the interest being credited to the relevant account) pending the application from time to time of those moneys in the Security Agent’s discretion in accordance with the
provisions of this Clause 27. 

  
 83 

	27.4	Currency Conversion 

  

	 	(a)	For the purpose of, or pending the discharge of, any of the Secured Liabilities the Security Agent may convert any moneys received or recovered by the Security Agent from one currency to another, at the Security
Agent’s Spot Rate of Exchange. 

  

	 	(b)	The obligations of any Obligor to pay in the due currency shall only be satisfied to the extent of the amount of the due currency purchased after deducting the costs of conversion. 

 

	27.5	Permitted Deductions 

 The Security Agent shall be entitled, in its discretion: 

 

	 	(a)	to set aside by way of reserve amounts required to meet, and to make and pay, any deductions and withholdings (on account of taxes or otherwise) which it is or may be required by any applicable law to make from any
distribution or payment made by it under this Agreement; and 

  

	 	(b)	to pay all Taxes which may be assessed against it in respect of any of the Charged Property, or as a consequence of performing its duties, or by virtue of its capacity as Security Agent under any of the Finance
Documents or otherwise (other than in connection with its remuneration for performing its duties under this Agreement). 

  

	27.6	Good Discharge 

  

	 	(a)	Any payment to be made in respect of the Secured Liabilities by the Security Agent 

  

	 	(i)	may be made to the Agent on behalf of the Finance Parties; and any payment made in that way shall be a good discharge, to the extent of that payment, by the Security Agent. 

 

	 	(b)	The Security Agent is under no obligation to make the payments to the Agent under paragraph (a) of this Clause 27.6 in the same currency as that in which the obligations and liabilities owing to the relevant
Finance Party are denominated. 

  

	28.	SHARING AMONG THE FINANCE PARTIES 

  

	28.1	Payments to Finance Parties 

 If a Finance Party (a “Recovering Finance
Party”) receives or recovers (whether by set-off or otherwise) any amount from an Obligor other than in accordance with Clause 29 (Bail-in) the
Recovering Finance Party shall, within three Business Days of demand by the Agent, pay to the Agent an amount (the “Sharing Payment”) equal to such receipt or recovery less any amount which the Agent determines may be retained by
the Recovering Finance Party as its share of any payment to be made, in accordance with Clause 30.5 (Partial payments). 
  

	28.2	Redistribution of payments 

 The Agent shall treat the Sharing Payment as if it had been
paid by the relevant Obligor and distribute it between the Finance Parties (other than the Recovering Finance Party) (the “Sharing Finance Parties”) in accordance with Clause 30.5 (Partial payments) towards the obligations of
that Obligor to the Sharing Finance Parties. 

  
 84 

	28.3	Recovering Finance Party’s rights 

  

	 	(a)	On a distribution by the Agent under Clause 28.2 (Redistribution of payments) of a payment received by a Recovering Finance Party from an Obligor, as between the relevant Obligor and the Recovering Finance Party,
an amount of the Recovered Amount equal to the Sharing Payment will be treated as not having been paid by that Obligor. 

  

	 	(b)	If and to the extent that the Recovering Finance Party is not able to rely on its rights under paragraph (a) above, the relevant Obligor shall be liable to the Recovering Finance Party for a debt equal to the
Sharing Payment which is immediately due and payable. 

  

	28.4	Reversal of redistribution 

 If any part of the Sharing Payment received or recovered by
a Recovering Finance Party becomes repayable and is repaid by that Recovering Finance Party, then: 
  

	 	(a)	each Sharing Finance Party shall, upon request of the Agent, pay to the Agent for the account of that Recovering Finance Party an amount equal to the appropriate part of its share of the Sharing Payment (together with
an amount as is necessary to reimburse that Recovering Finance Party for its proportion of any interest on the Sharing Payment which that Recovering Finance Party is required to pay) (the “Redistributed Amount”); and

  

	 	(b)	as between the relevant Obligor and each relevant Sharing Finance Party, an amount equal to the relevant Redistributed Amount will be treated as not having been paid by that Obligor. 

 

	28.5	Exceptions 

  

	 	(a)	This Clause 28 shall not apply to the extent that the Recovering Finance Party would not, after making any payment pursuant to this Clause, have a valid and enforceable claim against the relevant Obligor.

  

	 	(b)	A Recovering Finance Party is not obliged to share with any other Finance Party any amount which the Recovering Finance Party has received or recovered as a result of taking legal or arbitration proceedings, if:

  

	 	(i)	it notified that other Finance Party of the legal or arbitration proceedings; and 

  

	 	(ii)	that other Finance Party had an opportunity to participate in those legal or arbitration proceedings but did not do so as soon as reasonably practicable having received notice and did not take separate legal or
arbitration proceedings. 

  

	29.	BAIL-IN 

  

	29.1	Contractual recognition of bail-in 

Notwithstanding any other term of any Finance Document or any other agreement, arrangement or understanding between the Parties, each Party
acknowledges and accepts that any liability of any Party to any other Party under or in connection with the Finance Documents may be subject to Bail-In Action by the relevant Resolution Authority and
acknowledges and accepts to be bound by the effect of: 
  

	 	(a)	any Bail-In Action in relation to any such liability, including (without limitation): 

  

	 	(i)	a reduction, in full or in part, in the principal amount, or outstanding amount due (including any accrued but unpaid interest) in respect of any such liability; 

  
 85 

	 	(ii)	a conversion of all, or part of, any such liability into shares or other instruments of ownership that may be issued to, or conferred on, it; and 

 

	 	(iii)	a cancellation of any such liability; and 

  

	 	(b)	a variation of any term of any Finance Document to the extent necessary to give effect to any Bail-In Action in relation to any such liability.” 

 

	29.2	Definitions 

 For the purposes of this Clause 29: 

“Bail-In Action” means the exercise of any Write-down and Conversion Powers. 

“Bail-In Legislation” means: 

 

	 	(a)	in relation to an EEA Member Country which has implemented, or which at any time implements, Article 55 of Directive 2014/59/EU establishing a framework for the recovery and resolution of credit institutions and
investment firms, the relevant implementing law or regulation as described in the EU Bail-In Legislation Schedule from time to time; and 

 

	 	(b)	in relation to any other state, any analogous law or regulation from time to time which requires contractual recognition of any Write-down and Conversion Powers contained in that law or regulation. 

“EEA Member Country” means any member state of the European Union, Iceland, Liechtenstein and Norway. 

“EU Bail-In Legislation Schedule” means the document described as such and published
by the Loan Market Association (or any successor person) from time to time. 
 “Resolution Authority” means any body which
has authority to exercise any Write-down and Conversion Powers. 
 “Write-down and Conversion Powers” means: 

 

	 	(a)	in relation to any Bail-In Legislation described in the EU Bail-In Legislation Schedule from time to time, the powers described as such in
relation to that Bail-In Legislation in the EU Bail-In Legislation Schedule; and 

  

	 	(b)	in relation to any other applicable Bail-In Legislation: 

  

	 	(i)	any powers under that Bail-In Legislation to cancel, transfer or dilute shares issued by a person that is a bank or investment firm or other financial institution or affiliate of
a bank, investment firm or other financial institution, to cancel, reduce, modify or change the form of a liability of such a person or any contract or instrument under which that liability arises, to convert all or part of that liability into
shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the
powers under that Bail-In Legislation that are related to or ancillary to any of those powers; and 

  

	 	(ii)	any similar or analogous powers under that Bail-In Legislation. 

  
 86 

	30.	PAYMENT MECHANICS 

  

	30.1	Payments to the Agent 

  

	 	(a)	On each date on which an Obligor or a Lender is required to make a payment under a Finance Document, that Obligor or Lender shall make the same available to the Agent (unless a contrary indication appears in a Finance
Document) for value on the due date at the time and in such funds specified by the Agent as being customary at the time for settlement of transactions in the relevant currency in the place of payment. 

 

	 	(b)	Payment shall be made to such account in the principal financial centre of the country of that currency with such bank as the Agent specifies. 

 

	30.2	Distributions by the Agent 

  

	 	(a)	Each payment received by the Agent under the Finance Documents for another Party shall, subject to Clause 30.3 (Distributions to an Obligor) and Clause 30.4 (Clawback), be made available by the Agent
as soon as practicable after receipt to the Party entitled to receive payment in accordance with this Agreement (in the case of a Lender, for the account of its Facility Office), to such account as that Party may notify to the Agent by not less than
five Business Days’ notice with a bank in the principal financial centre of the country of that currency. 

  

	 	(b)	The Agent shall distribute payments received by it in relation to all or any part of the Loan to the Lender indicated in the records of the Agent as being so entitled on that date Provided that the Agent is authorised
to distribute payments to be made on the date on which any transfer becomes effective pursuant to Clause 22 (Changes to the Lenders)) to the Lender so entitled immediately before such transfer took place regardless of the period to which
such sums relate. 

  

	30.3	Distributions to an Obligor 

 The Agent may (with the consent of the Obligor or in
accordance with Clause 31 (Set-Off)) apply any amount received by it for that Obligor in or towards payment (in the currency and funds of receipt) of any amount due from that Obligor under the Finance
Documents or in or towards purchase of any amount of any currency to be so applied, provided such amount is due and unpaid. 
  

	30.4	Clawback 

  

	 	(a)	Where a sum is to be paid to the Agent or the Security Agent under the Finance Documents for another Party, the Agent or the Security Agent is not obliged to pay that sum to that other Party (or to enter into or perform
any related exchange contract) until it has been able to establish to its satisfaction that it has actually received that sum. 

  

	 	(b)	If the Agent pays an amount to another Party and it proves to be the case that the Agent had not actually received that amount, then the Party to whom that amount (or the proceeds of any related exchange contract) was
paid by the Agent shall on demand refund the same to the Agent together with interest on that amount from the date of payment to the date of receipt by the Agent, calculated by the Agent to reflect its cost of funds. 

  
 87 

	30.5	Partial payments 

  

	 	(a)	If the Agent receives a payment that is insufficient to discharge all the amounts then due and payable by an Obligor under the Finance Documents, the Agent shall apply that payment towards the obligations of that
Obligor under the Finance Documents in the following order: 

  

	 	(i)	first, in or towards payment pro rata of any unpaid fees, costs and expenses of, and other amounts owing to, the Agent, the Security Agent, any Receiver or any Delegate under the Finance Documents;

  

	 	(ii)	secondly, in or towards payment pro rata of any accrued interest, fee (other than as provided in (i) above) or commission due but unpaid under the Finance Documents (including, without limitation, any
periodic payments); 

  

	 	(iii)	thirdly, in or towards payment pro rata of any principal due but unpaid under this Agreement; and 

  

	 	(iv)	fourthly, in or towards payment pro rata of any other sum due but unpaid under the Finance Documents, 

  

	 	(b)	The Agent shall, if so directed by the Majority Lenders, vary the order set out in paragraphs (a)(ii) to (a)(iv) above. 

  

	 	(c)	Paragraphs (a) and (b) above will override any appropriation made by an Obligor. 

  

	30.6	No set-off by Obligors 

 All payments to be made
by an Obligor under the Finance Documents shall be calculated and be made without (and free and clear of any deduction for) set-off or counterclaim. 

 

	30.7	Business Days 

  

	 	(a)	Any payment which is due to be made on a day that is not a Business Day shall be made on the next Business Day in the same calendar month (if there is one) or the preceding Business Day (if there is not).

  

	 	(b)	During any extension of the due date for payment of any principal or Unpaid Sum under paragraph (a) above, interest is payable on the principal or Unpaid Sum at the rate payable on the original due date.

  

	30.8	Currency of account 

  

	 	(a)	Subject to paragraphs (b) and (c) below, U.S. dollars is the currency of account and payment for any sum due from an Obligor under any Finance Document. 

 

	 	(b)	Each payment in respect of costs, expenses or Taxes shall be made in the currency in which the costs, expenses or Taxes are incurred. 

 

	 	(c)	Any amount expressed to be payable in a currency other than U.S. dollars shall be paid in that other currency. 

  
 88 

	30.9	Change of currency 

  

	 	(a)	Unless otherwise prohibited by law, if more than one currency or currency unit are at the same time recognised by the central bank of any country as the lawful currency of that country, then: 

 

	 	(i)	any reference in the Finance Documents to, and any obligations arising under the Finance Documents in, the currency of that country shall be translated into, or paid in, the currency or currency unit of that country
designated by the Agent (after consultation with the Borrower); and 

  

	 	(ii)	any translation from one currency or currency unit to another shall be at the official rate of exchange recognised by the central bank for the conversion of that currency or currency unit into the other, rounded up or
down by the Agent (acting reasonably). 

  

	 	(b)	If a change in any currency of a country occurs, this Agreement will, to the extent the Agent (acting reasonably and after consultation with the Borrower) specifies to be necessary, be amended to comply with any
generally accepted conventions and market practice in the Relevant Interbank Market and otherwise to reflect the change in currency. 

  

	31.	SET-OFF 

 A Finance Party may set off any matured
obligation due from an Obligor under the Finance Documents (to the extent beneficially owned by that Finance Party) against any matured obligation owed by that Finance Party to that Obligor, regardless of the place of payment, booking branch or
currency of either obligation. If the obligations are in different currencies, the Finance Party may convert either obligation at a market rate of exchange in its usual course of business for the purpose of the
set-off. 
  

	32.	TURNOVER OF RECEIPTS 

  

	32.1	Turnover by the Lenders 

 Subject to Clause 32.2 (Permitted assurance and
receipts), if at any time prior to the date on which the Agent is satisfied that the Borrower is or may become under any actual or contingent liability under any Finance Document, any Lender receives or recovers: 

 

	 	(a)	any payment or distribution of, or on account of or in relation to, any of the Relevant Debt which is not made in accordance with Clause 27 (Application of Proceeds); 

 

	 	(b)	other than where Clause 31 (Set-Off) applies, any amount by way of set-off in respect of any of the Relevant Debt owed to it;

  

	 	(c)	notwithstanding paragraphs (a) and (b) above, and other than where Clause 31 (Set-Off) applies, any amount: 

 

	 	(i)	on account of, or in relation to, any of the Relevant Debt: 

  

	 	(A)	after the occurrence of a Distress Event; or 

  

	 	(B)	as a result of any other litigation or proceedings against the Borrower (other than after the occurrence of an Insolvency Event in respect of the Borrower or any Obligor); or 

 

	 	(ii)	by way of set-off in respect of any of the Relevant Debt owed to it after the occurrence of a Distress Event, 

  
 89 

	 	    	other than, in each case, any amount received or recovered in accordance with Clause 27 (Application of Proceeds); 

  

	 	(d)	the proceeds of any enforcement of any Transaction Security except in accordance with Clause 27 (Application of Proceeds); or 

 

	 	(e)	other than where Clause 31 (Set-Off) applies, any distribution in cash or in kind or payment of, or on account of or in relation to, any of the Relevant Debt owed by the
Borrower or any Obligor which is not in accordance with Clause 27 (Application of Proceeds) and which is made as a result of, or after, the occurrence of an Insolvency Event in respect of the Borrower, and any Obligor; 

that Lender will, in relation to receipts and recoveries not received or recovered by way of set-off:

  

	 	(x)	hold an amount of that receipt or recovery equal to the Relevant Debt (or if less, the amount received or recovered) on trust for the Security Agent and promptly pay that amount to the Security Agent for application in
accordance with the terms of this Agreement; and 

  

	 	(y)	promptly pay an amount equal to the amount (if any) by which the receipt or recovery exceeds the Relevant Debt to the Security Agent for application in accordance with the terms of this Agreement; and 

 

	 	(z)	in relation to receipts and recoveries received or recovered by way of set-off, promptly pay an amount equal to that recovery to the Security Agent for application in accordance
with the terms of this Agreement. 

  

	32.2	Permitted assurance and receipts 

 Nothing in this Agreement shall restrict the ability
of any Lender to: 
  

	 	(a)	arrange with any person which is not a member of the Group any assurance against loss in respect of, or reduction of its credit exposure to, the Borrower (including assurance by way of credit based derivative or sub-participation); or 

  

	 	(b)	make any assignment or transfer permitted by Clause 22 (Changes to the Lenders), 

 which
is not in breach of this Agreement, and that Lender shall not be obliged to account to any other Party for any sum received by it as a result of that action. 
  

	32.3	Sums received by the Borrower 

 If the Borrower receives or recovers any sum which, under
the terms of any of the Finance Documents, which should have been paid to the Security Agent, the Borrower will: 
  

	 	(a)	hold an amount of that receipt or recovery equal to the Relevant Debt (or if less, the amount received or recovered) on trust for the Security Agent and promptly pay that amount to the Security Agent for application in
accordance with the terms of this Agreement; and 

  

	 	(b)	promptly pay an amount equal to the amount (if any) by which the receipt or recovery exceeds the Relevant Debt to the Security Agent for application in accordance with the terms of this Agreement. 

  
 90 

	32.4	Saving provision 

 If, for any reason, any of the trusts expressed to be created in this
Clause 32 should fail or be unenforceable, the affected Lender, the Borrower will promptly pay an amount equal to that receipt or recovery to the Security Agent to be held on trust by the Security Agent for application in accordance with the terms
of this Agreement. 
  

	32.5	Definitions 

 For the purposes of this Clause 32: 

“Relevant Debt” means: 
  

	 	(a)	in the case of a Lender: 

  

	 	(i)	the Loan Debt owed to the Arrangers ranking (in accordance with the terms of this Agreement) pari passu with or in priority to that Lender; 

 

	 	(ii)	the Loan Debt owed to the Lenders ranking (in accordance with the terms of this Agreement) pari passu with or in priority to that; 

  

	 	(iii)	all Loan Debt owed to the Agent; and 

  

	 	(iv)	all Loan Debt owed to the Security Agent; and 

  

	 	(b)	in the case of the Borrower, all of the Loan Debt. 

  

	33.	NOTICES 

  

	33.1	Communications in writing 

 Any communication to be made under or in connection with the
Finance Documents shall be made in writing and, unless otherwise stated, may be made by electronic mail (“email”) (including scanned copies of executed documents and other attachments), fax or letter. 

 

	33.2	Addresses 

 The corporate email address, address and fax number (and the department or
officer, if any, for whose attention the communication is to be made) of each Party for any communication or document to be made or delivered under or in connection with the Finance Documents is: 

 

	 	(a)	in the case of the Borrower, that identified with its name below; 

  

			
	Borrower	  	
		
	Address:	  	Plant 10, Gate No. 4,
		  	Godrej and Boyce Complex,
		  	Pirojshanagar, LBS Marg,Vikhroli (West),
		  	Mumbai 400 079
		  	India
		
	E-mail Address:	  	anupama.pai@wns.com
	Fax:	  	+91 22 2518 8308
	Attention:	  	General Counsel

  

	 	(b)	in the case of the Agent and the Security Agent, that identified with its name below, 

  
 91 

			
	Agent	  	
		
	Address:	  	16/F, PCCW Tower, Taikoo Place,
		  	979 King’s Road, Quarry Bay,
		  	Hong Kong
		
	Email Address:	  	hk.csd.syndication@asia.bnpparibas.com
	Fax:	  	+852 3197 3066
	Attention:	  	CMLS – Clement Wong / Hugo Chan
		
	Security Agent	  	
		
	Address:	  	16/F, PCCW Tower, Taikoo Place,
		  	979 King’s Road, Quarry Bay,
		  	Hong Kong
		
	Email Address:	  	hk.csd.syndication@asia.bnpparibas.com
	Fax:	  	+852 3197 3066
	Attention:	  	CMLS – Clement Wong / Hugo Chan

 or any substitute corporate email address, address, fax number or department or officer as the Party may notify
to the Agent (or the Agent may notify to the other Parties, if a change is made by the Agent) by not less than five Business Days’ notice. 
  

	33.3	Delivery 

  

	 	(a)	Any communication or document made or delivered by one person to another under or in connection with the Finance Documents will be effective: 

 

	 	(i)	if by way of email, only when received in legible form by at least one of the relevant corporate email addresses of the person(s) to whom the communication is made; 

 

	 	(ii)	if by way of fax, only when received in legible form; or 

  

	 	(iii)	if by way of letter, only when it has been left at the relevant address or five Business Days after being deposited in the post postage prepaid in an envelope addressed to it at that address, 

 

	 	    	and, (in the case of paragraphs (ii) and (iii) above) if a particular department or officer is specified as part of its address details provided under Clause 33.2 (Addresses), if addressed to that department
or officer. 

  

	 	(b)	Any communication or document to be made or delivered to the Agent or the Security Agent will be effective only when actually received by the Agent or the Security Agent and then only if it is sent to the correct
corporate email address(es) or, in the case of a fax or a letter, expressly marked for the attention of the department or officer identified with the Agent’s or the Security Agent’s signature below (or any substitute department or officer
as the Agent or the Security Agent shall specify for this purpose). 

  

	 	(c)	All notices from or to an Obligor shall be sent through the Agent. 

  

	 	(d)	Any communication or document made or delivered to the Borrower in accordance with this Clause will be deemed to have been made or delivered to each of the Obligors. 

 

	 	(e)	Any communication or document which becomes effective, in accordance with paragraphs (a) to (d) above, after 5.00 p.m. in the place of receipt shall be deemed only to become effective on the following day.

  
 92 

	33.4	English language 

  

	 	(a)	Any notice given under or in connection with any Finance Document must be in English. 

  

	 	(b)	All other documents provided under or in connection with any Finance Document must be: 

  

	 	(i)	in English; or 

  

	 	(ii)	if not in English, and if so required by the Agent, accompanied by a certified English translation and, in this case, the English translation will prevail unless the document is a constitutional, statutory or other
official document. 

  

	34.	CALCULATIONS AND CERTIFICATES 

  

	34.1	Accounts 

 In any litigation or arbitration proceedings arising out of or in connection
with a Finance Document, the entries made in the accounts maintained by a Finance Party are prima facie evidence of the matters to which they relate. 
  

	34.2	Certificates and determinations 

 Any certification or determination by a Finance Party
of a rate or amount under any Finance Document is, in the absence of manifest error, conclusive evidence of the matters to which it relates. 
  

	34.3	Day count convention 

 Any interest, commission or fee accruing under a Finance Document
will accrue from day to day and is calculated on the basis of the actual number of days elapsed and a year of 360 days or, in any case where the practice in the Relevant Interbank Market differs, in accordance with that market practice. 

 

	35.	PARTIAL INVALIDITY 

 If, at any time, any provision of the Finance Documents is or
becomes illegal, invalid or unenforceable in any respect under any law of any jurisdiction, neither the legality, validity or enforceability of the remaining provisions nor the legality, validity or enforceability of such provision under the law of
any other jurisdiction will in any way be affected or impaired. 
  

	36.	REMEDIES AND WAIVERS 

 No failure to exercise, nor any delay in exercising, on the part
of any Finance Party, any right or remedy under the Finance Documents shall operate as a waiver of any such right or remedy or constitute an election to affirm any of the Finance Documents. No election to affirm any of the Finance Documents on the
part of any Finance Party shall be effective unless it is in writing. No single or partial exercise of any right or remedy shall prevent any further or other exercise or the exercise of any other right or remedy. The rights and remedies provided in
this Agreement are cumulative and not exclusive of any rights or remedies provided by law. 

  
 93 

	37.	AMENDMENTS AND WAIVERS 

  

	37.1	Required consents 

  

	 	(a)	Subject to Clause 37.2 (All lender matters) and any term of the Finance Documents may be amended or waived only with the consent of the Majority Lenders and the Obligors’ Agent (in accordance with Clause 2.3
(Obligors’ Agent) and paragraph (c) below) and any such amendment or waiver will be binding on all Parties. 

  

	 	(b)	The Agent may effect, on behalf of any Finance Party, any amendment or waiver permitted by this Clause 37. 

  

	 	(c)	Without prejudice to the other provisions of this Agreement, each Obligor agrees to any such amendment or waiver permitted by this Clause 37 which is agreed to by the Obligors’ Agent. This includes any amendment or
waiver which would, but for this paragraph (c) require the consent of all of the Obligors. 

  

	 	(d)	Without prejudice to the generality of paragraphs (c), (d) and (e) of Clause 24.6 (Rights and discretions of the Agent), the Agent may, whenever it deems appropriate, engage and rely on the advice of
external legal counsel in determining the level of consent required in respect of any amendment, waiver or consent under this Agreement. 

  

	37.2	All lender matters 

  

	 	(a)	An amendment or waiver that has the effect of changing or which relates to: 

  

	 	(i)	the definition of “Majority Lenders” in Clause 1.1 (Definitions); 

  

	 	(ii)	an extension to the date of payment of any amount under the Finance Documents; 

  

	 	(iii)	a reduction in the Margin or a reduction in the amount of any payment of principal, interest, fees or commission payable; 

  

	 	(iv)	an increase in the amount of any Commitment or an extension of the period of availability for utilisation of any Commitment or any requirement that a cancellation of Commitments reduces the Commitments of the Lenders
rateably under the Facility; 

  

	 	(v)	any provision which expressly requires the consent of all the Lenders; 

  

	 	(vi)	a change to the Borrower or the Parent Guarantor; 

  

	 	(vii)	Clause 2.2 (Finance Parties’ rights and obligations), Clause 22 (Changes to the Lenders) or this Clause 37; 

  

	 	(viii)	the nature or scope or release of the guarantee and indemnity granted under any Transaction Security Document unless: 

  

	 	(A)	permitted under any Finance Document; or 

  

	 	(B)	permitted under Clause 23.3 (Resignation and release of security on disposal); or 

  

	 	(ix)	the manner in which the proceeds of enforcement of the Transaction Security are distributed, 

  
 94 

	 	    	shall not be made without the prior consent of all the Lenders. 

  

	 	(b)	The Borrower and the Agent or Security Agent, as applicable, may amend or waive a term of a Fee Letter to which they are party. 

  

	 	(c)	An amendment or waiver which relates to the rights or obligations of any Administrative Party may not be effected without the consent of such Administrative Party. 

 

	37.3	Other exceptions 

 An amendment or waiver which relates to the rights or obligations of
the Agent or the Arranger or a Reference Bank (each in their capacity as such) may not be effected without the consent of the Agent, the Arranger or that Reference Bank, as the case may be. 

 

	38.	DISCLOSURE OF INFORMATION 

  

	38.1	Confidentiality 

 Each Finance Party agrees to keep all Confidential Information
confidential and not to disclose it to anyone, save to the extent permitted by Clause 38.2 (Disclosure of Confidential Information), and to ensure that all Confidential Information is protected with security measures and a degree of care that
would apply to its own confidential information 
  

	38.2	Disclosure of Confidential Information 

 Any Finance Party may disclose: 

 

	 	(a)	to any of its head office, other branches and regional offices, Affiliates and Related Funds and all its other affiliated companies and any of its or their officers, directors, employees, professional advisers,
auditors, partners and Representatives such Confidential Information as that Finance Party shall consider appropriate for any purposes as it thinks fit if any person to whom the Confidential Information is to be given pursuant to this paragraph
(a) is made aware in writing of its confidential nature and that some or all of such Confidential Information may be price-sensitive information except that there shall be no such requirement to so inform if the recipient is subject to
professional obligations to maintain the confidentiality of the information or is otherwise bound by requirements of confidentiality in relation to the Confidential Information; 

 

	 	(b)	to any person: 

  

	 	(i)	to (or through) whom it assigns or transfers (or may potentially assign or transfer) all or any of its rights and/or obligations under one or more Finance Documents and to any of that person’s Affiliates, Related
Funds, Representatives and professional advisers; 

  

	 	(ii)	with (or through) whom it enters into (or may potentially enter into), whether directly or indirectly, any sub-participation in relation to, or any other transaction under which
payments are to be made or may be made by reference to, one or more Finance Documents and/or one or more Obligors and to any of that person’s Affiliates, Related Funds, Representatives and professional advisers; 

 

	 	(iii)	appointed by any Finance Party or by a person to whom paragraph (a)(i) or (a)(ii) above applies to receive communications, notices, information or documents delivered pursuant to the Finance Documents on its behalf
(including, without limitation, any person appointed under paragraph (c) of Clause 24.14 (Relationship with the other Finance Parties)); 

  
 95 

	 	(iv)	who invests in or otherwise finances (or may potentially invest in or otherwise finance), directly or indirectly, any transaction referred to in paragraph (a)(i) or (a)(ii) above; 

 

	 	(v)	to whom information is required or requested to be disclosed by any court of competent jurisdiction or any governmental, banking, taxation or other regulatory authority or similar body, the rules of any relevant stock
exchange or pursuant to any applicable law or regulation; 

  

	 	(vi)	to whom information is required or requested to be disclosed in connection with, and for the purposes of, any litigation, arbitration, administrative or other investigations, proceedings or disputes; 

 

	 	(vii)	to whom or for whose benefit that Finance Party charges, assigns or otherwise creates Security (or may do so) pursuant to Clause 22.12 (Security over Lenders’ rights); 

 

	 	(viii)	who is a Party; or 

  

	 	(ix)	with the consent of the Borrower, 

 in each case, such Confidential Information as that Finance
Party shall consider appropriate if: 
  

	 	(A)	in relation to paragraphs (a)(i), (a)(ii) and (a)(iii) above, the person to whom the Confidential Information is to be given has entered into a Confidentiality Undertaking except that there shall be no requirement for a
Confidentiality Undertaking if the recipient is a professional adviser and is subject to professional obligations to maintain the confidentiality of the Confidential Information; 

 

	 	(B)	in relation to paragraph (a)(iv) above, the person to whom the Confidential Information is to be given has entered into a Confidentiality Undertaking or is otherwise bound by requirements of confidentiality in relation
to the Confidential Information they receive and is informed that some or all of such Confidential Information may be price-sensitive information; 

  

	 	(C)	in relation to paragraphs (a)(v), (a)(vi) and (a)(vii) above, the person to whom the Confidential Information is to be given is informed of its confidential nature and that some or all of such Confidential Information
may be price-sensitive information except that there shall be no requirement to so inform if, in the opinion of that Finance Party, it is not practicable so to do in the circumstances; 

 

	 	(c)	to any person appointed by that Finance Party or by a person to whom paragraph (a)(i) or (a)(ii) above applies to provide administration or settlement services in respect of one or more of the Finance Documents
including without limitation, in relation to the trading of participations in respect of the Finance Documents, such Confidential Information as may be required to be disclosed to enable such service provider to provide any of the services referred
to in this paragraph (c) if the service provider to whom the Confidential Information is to be given has entered into a confidentiality agreement substantially in the form of the LMA Master Confidentiality Undertaking for Use With
Administration/Settlement Service Providers or such other form of confidentiality undertaking agreed between the Borrower and the relevant Finance Party; or 

  

	 	(d)	to any rating agency (including its professional advisers) such Confidential Information as may be required to be disclosed to enable such rating agency to carry out its normal rating activities in relation to the
Finance Documents and/or the Obligors if the rating agency to whom the Confidential Information is to be given is informed of its confidential nature and that some or all of such Confidential Information may be price-sensitive information.

  
 96 

	38.3	Entire agreement 

 This Clause 38 constitutes the entire agreement between the Parties in
relation to the obligations of the Finance Parties under the Finance Documents regarding Confidential Information and supersedes any previous agreement, whether express or implied, regarding Confidential Information. 

 

	38.4	Inside information 

 Each of the Finance Parties acknowledges that some or all of the
Confidential Information is or may be price-sensitive information and that the use of such information may be regulated or prohibited by applicable legislation including securities law relating to insider dealing and market abuse and each of the
Finance Parties undertakes not to use any Confidential Information for any unlawful purpose. 
  

	38.5	Notification of disclosure 

 Each of the Finance Parties agrees (to the extent permitted
by law and regulation) to inform the Borrower: 
  

	 	(a)	of the circumstances of any disclosure of Confidential Information made pursuant to Clause 38.2 (Disclosure of Confidential Information) except where such disclosure is made to any of the persons referred to in
that paragraph during the ordinary course of its supervisory or regulatory function; and 

  

	 	(b)	upon becoming aware that Confidential Information has been disclosed in breach of this Clause 38. 

  

	38.6	Continuing obligations 

 The obligations in this Clause 38 are continuing and, in
particular, shall survive and remain binding on each Finance Party for a period of 24 months from the earlier of: 
  

	 	(a)	the date on which all amounts payable by the Obligors under or in connection with this Agreement have been paid in full and all Commitments have been cancelled or otherwise cease to be available; and 

 

	 	(b)	the date on which such Finance Party otherwise ceases to be a Finance Party. 

 For the avoidance
of doubt, the consent to disclosure authorised in this Clause 38 shall not replace or prejudice but shall be in addition to any other consent or right of disclosure which the Finance Party may have received or be entitled to (whether under law,
agreement or otherwise). 
 For the purpose of any banking secrecy obligation which may be imposed upon any Finance Party pursuant to any
applicable law, rule or regulation, the disclosure authorization given herein shall survive and continue in full force and effect for the benefit of that Finance Party notwithstanding the full repayment of all outstandings under the Finance
Documents and/or the cancellation or cessation of all Commitments. 

  
 97 

	38.7	Personal Data 

  

	 	(a)	If any Obligor provides the Finance Parties with personal data of any individual as required by, pursuant to, or in connection with the Finance Documents, that Obligor represents and warrants to the Finance Parties that
it has, to the extent required by law, (i) notified the relevant individual of the purposes for which data will be collected, processed, used or disclosed; and (ii) obtained such individual’s consent for, and hereby consents on behalf
of such individual to, the collection, processing, use and disclosure of his/her personal data by the Finance Parties, in each case, in accordance with or for the purposes of the Finance Documents, and confirms that it is authorised by such
individual to provide such consent on his/her behalf. 

  

	 	(b)	Each Obligor agrees and undertakes to notify the Agent promptly upon its becoming aware of the withdrawal by the relevant individual of its consent to the collection, processing, use and/or disclosure by any Finance
Party of any personal data provided by that Obligor to any Finance Party. 

  

	 	(c)	The Borrower shall be responsible for ensuring that the consent of any individual whose personal data is provided to any Finance Party by the Borrower has been obtained in compliance with any applicable laws.

  

	 	(d)	Any consent given pursuant to this agreement in relation to personal data shall, subject to all applicable laws and regulations, survive death, incapacity, bankruptcy or insolvency of any such individual and the
termination or expiration of this agreement. 

  

	39.	CONFIDENTIALITY OF FUNDING RATES AND REFERENCE BANK QUOTATIONS 

  

	39.1	Confidentiality and disclosure 

  

	 	(a)	The Agent and each Obligor agree to keep each Funding Rate (and, in the case of the Agent, each Reference Bank Quotation) confidential and not to disclose it to anyone, save to the extent permitted by paragraphs (b),
(c) and (d) below. 

  

	 	(b)	The Agent may disclose: 

  

	 	(i)	any Funding Rate (but not, for the avoidance of doubt, any Reference Bank Quotation) to the Borrower pursuant to Clause 8.3 (Notification of rates of interest); and 

 

	 	(ii)	any Funding Rate or any Reference Bank Quotation to any person appointed by it to provide administration services in respect of one or more of the Finance Documents to the extent necessary to enable such service
provider to provide those services if the service provider to whom that information is to be given has entered into a confidentiality agreement substantially in the form of the LMA Master Confidentiality Undertaking for Use With
Administration/Settlement Service Providers or such other form of confidentiality undertaking agreed between the Agent and the relevant Lender or Reference Bank, as the case may be. 

  
 98 

	 	(c)	The Agent may disclose any Funding Rate or any Reference Bank Quotation, and each Obligor may disclose any Funding Rate, to: 

  

	 	(i)	any of its Affiliates and any of its or their officers, directors, employees, professional advisers, auditors, partners and Representatives if any person to whom that Funding Rate or Reference Bank Quotation is to be
given pursuant to this paragraph (i) is informed in writing of its confidential nature and that it may be price-sensitive information except that there shall be no such requirement to so inform if the recipient is subject to professional
obligations to maintain the confidentiality of that Funding Rate or Reference Bank Quotation or is otherwise bound by requirements of confidentiality in relation to it; 

 

	 	(ii)	any person to whom information is required or requested to be disclosed by any court of competent jurisdiction or any governmental, banking, taxation or other regulatory authority or similar body, the rules of any
relevant stock exchange or pursuant to any applicable law or regulation if the person to whom that Funding Rate or Reference Bank Quotation is to be given is informed in writing of its confidential nature and that it may be price-sensitive
information except that there shall be no requirement to so inform if, in the opinion of the Agent or the relevant Obligor, as the case may be, it is not practicable to do so in the circumstances; 

 

	 	(iii)	any person to whom information is required to be disclosed in connection with, and for the purposes of, any litigation, arbitration, administrative or other investigations, proceedings or disputes if the person to whom
that Funding Rate or Reference Bank Quotation is to be given is informed in writing of its confidential nature and that it may be price-sensitive information except that there shall be no requirement to so inform if, in the opinion of the Agent or
the relevant Obligor, as the case may be, it is not practicable to do so in the circumstances; and 

  

	 	(iv)	any person with the consent of the relevant Lender or Reference Bank, as the case may be. 

  

	 	(d)	The Agent’s obligations in this Clause 39 relating to Reference Bank Quotations are without prejudice to its obligations to make notifications under Clause 8.1 (Calculation of interest) to Clause 8.3
(Notification of rates of interest) provided that (other than pursuant to paragraph (b)(i) above) the Agent shall not include the details of any individual Reference Bank Quotation as part of any such notification. 

 

	39.2	Related obligations 

  

	 	(a)	The Agent and each Obligor acknowledge that each Funding Rate (and, in the case of the Agent, each Reference Bank Quotation) is or may be price-sensitive information and that its use may be regulated or prohibited by
applicable legislation including securities law relating to insider dealing and market abuse and the Agent and each Obligor undertake not to use any Funding Rate or, in the case of the Agent, any Reference Bank Quotation for any unlawful purpose.

  

	 	(b)	The Agent and each Obligor agree (to the extent permitted by law and regulation) to inform the relevant Lender or Reference Bank, as the case may be: 

 

	 	(i)	of the circumstances of any disclosure made pursuant to paragraph (c)(ii) of Clause 39.1 (Confidentiality and disclosure) except where such disclosure is made to any of the persons referred to in that paragraph
during the ordinary course of its supervisory or regulatory function; and 

  

	 	(ii)	upon becoming aware that any information has been disclosed in breach of this Clause 39. 

  
 99 

	39.3	No Event of Default 

 No Event of Default will occur under Clause 21.3 (Other
obligations) by reason only of an Obligor’s failure to comply with this Clause 39. 
  

	40.	COUNTERPARTS 

 Each Finance Document may be executed in any number of counterparts, and
this has the same effect as if the signatures on the counterparts were on a single copy of the Finance Document. 
  

	41.	GOVERNING LAW 

 This Agreement, and all
non-contractual obligations arising from or in connection with this Agreement, are governed by English law. 
  

	42.	ENFORCEMENT 

  

	42.1	Jurisdiction of English courts 

  

	 	(a)	The courts of England have exclusive jurisdiction to settle any dispute arising out of or in connection with this Agreement (including any dispute relating to any non-contractual
obligation arising from or in connection with this Agreement and any dispute regarding the existence, validity or termination of this Agreement) or any non-contractual obligation arising out of or in
connection with this Agreement (a “Dispute”). 

  

	 	(b)	The Parties agree that the courts of England are the most appropriate and convenient courts to settle Disputes and accordingly no Party will argue to the contrary. 

 

	 	(c)	This Clause 42.1 is for the benefit of the Finance Parties only. As a result, to the extent allowed by law: 

  

	 	(i)	no Finance Party will be prevented from taking proceedings relating to a Dispute in any other courts with jurisdiction; and 

  

	 	(ii)	the Finance Parties may take concurrent proceedings in any number of jurisdictions. 

  

	42.2	Service of process 

 Without prejudice to any other mode of service allowed under any
relevant law, each Obligor (other than an Obligor incorporated in England and Wales): 
  

	 	(a)	irrevocably appoints WNS Global Services (UK) Limited as its agent for service of process in relation to any proceedings before the English courts in connection with any Finance Document at the address indicated below:

 WNS Global Services (UK) Limited 
  

			
	Address:	  	The Lodge, Harmondsworth Lane,
		  	West Drayton, Middlesex,
		  	UB7 0AB, United Kingdom
		
	E-mail Address:        	  	ritu.motashaw@wns.cm
	Fax:	  	+44 7768045342
	Attention:	  	Ritu Motashaw

  

	 	(b)	agrees that failure by a process agent to notify the relevant Obligor of the process will not invalidate the proceedings concerned. 

  
 100 

 Each Obligor expressly agrees and consents to the provisions of this Clause 42.2. 

 

	42.3	Waiver of immunities 

 Each Obligor irrevocably waives, to the extent permitted by
applicable law, with respect to itself and its revenues and assets (irrespective of their use or intended use), all immunity on the grounds of sovereignty or other similar grounds from: 

 

	 	(a)	suit; 

  

	 	(b)	jurisdiction of any court; 

  

	 	(c)	relief by way of injunction or order for specific performance or recovery of property; 

  

	 	(d)	attachment of its assets (whether before or after judgment); and 

  

	 	(e)	execution or enforcement of any judgment to which it or its revenues or assets might otherwise be entitled in any proceedings in the courts of any jurisdiction (and irrevocably agrees, to the extent permitted by
applicable law, that it will not claim any immunity in any such proceedings). 

 EACH PARTY WAIVES ANY RIGHTS IT MAY HAVE TO A JURY TRIAL
OF ANY CLAIM OR CAUSE OF ACTION BASED ON OR ARISING FROM THE FINANCE DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED BY THE FINANCE DOCUMENTS. IN THE EVENT OF LITIGATION, THE FINANCE DOCUMENTS MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT.

 THIS AGREEMENT has been entered into on the date stated at the beginning of this Agreement. 

  
 101 

 SCHEDULE 1 

THE ORIGINAL LENDERS 
  

					
	Name of Original Lender	  	Commitment (US$)	 
		
	 BNP Paribas, acting through its Hong Kong branch
	  	 	34,000,000	 
		
	 Total
	  	 	34,000,000	 

  
 102 

 SCHEDULE 2 

CONDITIONS 
 Part 1

 Conditions Precedent to Delivery of the Initial Utilisation Request 

 

	1.	BORROWER 

  

	1.1	A copy of the constitutional documents of the Borrower. 

  

	1.2	A copy of a resolution of the board of directors of the Borrower: 

  

	 	(a)	approving the terms of, and the transactions contemplated by, the Transaction Documents to which it is a party and resolving that it execute the Transaction Documents to which it is a party; 

 

	 	(b)	authorising a specified person or persons to execute, deliver and perform the Finance Documents to which it is a party on its behalf; and 

 

	 	(c)	authorising a specified person or persons, on its behalf, to sign and/or despatch all documents and notices (including, if relevant, any Utilisation Request) to be signed and/or despatched by it under or in connection
with the Finance Documents to which it is a party. 

  

	1.3	A specimen of the signature of each person authorised by the resolution referred to in paragraph 1.2 above. 

  

	1.4	A certificate of the Borrower (signed by a director or any other authorised signatory) confirming that borrowing or guaranteeing or securing, as appropriate, the Total Commitments would not cause any borrowing,
guarantee or security or similar limit binding on it to be exceeded. 

  

	1.5	A certificate of an authorised signatory of the Borrower certifying that each copy document relating to it specified in this Part 1 of Schedule 2 is correct, complete and in full force and effect as at a date no
earlier than the date of this Agreement. 

  

	1.6	A solvency certificate in respect of the Borrower, in form and substance satisfactory to the Agent. 

  

	1.7	A good standing certificate (or their equivalent) in respect of the Borrower. 

  

	2.	PARENT GUARANTOR 

  

	2.1	A copy of the constitutional documents of the Parent Guarantor. 

  

	2.2	A copy of a resolution of the board of directors of the Parent Guarantor: 

  

	 	(a)	approving the terms of, and the transactions contemplated by, the Transaction Documents to which it is a party and resolving that it execute the Transaction Documents to which it is a party; 

 

	 	(b)	authorising a specified person or persons to execute, deliver and perform the Finance Documents to which it is a party on its behalf; and 

 

	 	(c)	authorising a specified person or persons, on its behalf, to sign and/or despatch all documents and notices (including, if relevant, any Utilisation Request) to be signed and/or despatched by it under or in connection
with the Finance Documents to which it is a party. 

  
 103 

	2.3	A specimen of the signature of each person authorised by the resolution referred to in paragraph 1.2 above. 

  

	2.4	A certificate of the Parent Guarantor (signed by a director or authorised signatory) confirming that securing the Total Commitments would not cause any security or similar limit binding on it to be exceeded.

  

	2.5	A certificate of the Parent Guarantor (signed by a director or authorised signatory) certifying that each copy document relating to it specified in this Part 1 of Schedule 2 is correct, complete and in full force and
effect as at a date no earlier than the date of this Agreement. 

  

	2.6	A good standing certificate (or their equivalent) in respect of the Parent Guarantor. 

  

	3.	LEGAL OPINIONS 

  

	3.1	A legal opinion in relation to English law from Latham & Watkins addressed to the Finance Parties at the date of that opinion, substantially in the form distributed to the Original Lenders prior to the signing
of this Agreement. 

  

	3.2	A legal opinion in relation to New York law from Latham & Watkins addressed to the Finance Parties at the date of that opinion, substantially in the form distributed to the Original Lenders prior to the signing
of this Agreement. 

  

	3.3	A legal opinion in relation to Jersey law from Mourant Ozannes addressed to the Finance Parties at the date of that opinion, substantially in the form distributed to the Original Lenders prior to the signing of this
Agreement. 

  

	4.	OTHER DOCUMENTS AND EVIDENCE 

  

	4.1	Evidence that any process agent referred to in Clause 42.2 (Service of process) has accepted its appointment. 

  

	4.2	The Group Structure Chart which shows the Group assuming the Closing Date has occurred. 

  

	4.3	The Reports and any reliance letters in respect of the Reports. 

  

	4.4	The Original Financial Statements. 

  

	4.5	The audited annual financial statements of the Parent Guarantor for the period ending 31 March 2016. 

  

	4.6	Evidence satisfactory to the Agent that the fees, costs and expenses then due from the Borrower pursuant to Clause 11 (Fees) and Clause 16 (Costs and Expenses) have been paid in full or will be paid in
full by the first Utilisation Date. 

  

	4.7	The Funds Flow Statement in a form agreed by the Borrower and the Agent. 

  

	4.8	The Base Case Model in a form agreed by the Borrower and the Agent. 

  

	4.9	A certificate of the Borrower (signed by a director) detailing the estimated Acquisition Costs to be paid from the proceeds of Utilisation of the Loan. 

 

	4.10	A certificate of the Borrower (signed by a director) certifying that: 

  

	 	(a)	no material terms and conditions of the SPA have been, or will on or prior to the Closing Date be, amended or waived without the consent of the Lenders (other than those waivers already obtained and notified to the
Agent in writing prior to the date of this Agreement); 

  
 104 

	 	(b)	amounts to be drawn under the Facility, when aggregated with the available cash resources of the Borrower, are sufficient to pay the purchase price under the SPA, the Acquisition Costs and any other amounts to be paid
on the Closing Date under the Funds Flow Statement; 

  

	 	(c)	each of the conditions to closing as set out in Article VI (Conditions to Closing) of the SPA have been satisfied or waived; and 

 

	 	(d)	100% of the Target Shares shall be acquired by the Borrower on the Closing Date. 

  

	4.11	All necessary “know your customer” or other similar checks in relation to the Borrower, the Parent Guarantor under all applicable laws and regulations and internal policies having been completed by each
Lender. 

  

	4.12	All regulatory filings, permits, approvals and consents which are required for the purposes of the Acquisition. 

  

	4.13	A copy of any other Authorisation or other document, opinion or assurance which the Agent considers to be necessary or desirable (if it has notified the Borrower accordingly) in connection with the entry into and
performance of the transactions contemplated by any Finance Document or for the validity and enforceability of any Finance Document. 

  

	5.	TRANSACTION DOCUMENTS 

  

	5.1	A copy of the SPA executed by the parties thereto. 

  

	6.	FINANCE DOCUMENTS 

  

	6.1	This Agreement executed by the Borrower. 

  

	6.2	The Guarantee. 

  

	6.3	The Fee Letters executed by the Borrower. 

 Part 2 

Conditions Subsequent 
  

	1.	Within 120 days of the date of this Agreement: 

  

	 	(a)	The following Transaction Security Documents each duly entered into by the parties to it: 

  

			
	 Name of Obligor
	 	 Transaction Security Document

		
	Borrower	 	Stock Pledge Agreement governed by New York law in respect of all the shares held by the Borrower in the Target, in form and substance satisfactory to the Agent
		
	Borrower	 	All-asset Security Agreement governed by New York law in respect of all personal property of the Borrower, in form and substance satisfactory to the Agent

  
 105 

	 	(b)	Any notices or documents (including the relevant share certificates and share transfer forms in blank) required to be given or executed under the terms of the security documents referred to in paragraph (a) above.

  

	 	(c)	A legal opinion in relation to New York law from Latham & Watkins addressed to the Finance Parties at the date of that opinion. 

 

	2.	As soon as reasonably practicable but in any event within three Business Days of the execution of the Transaction Security Documents, Uniform Commercial Code filings, a Pledge Supplement (as defined in the Stock Pledge
Agreement) in the form annexed to the Stock Pledge Agreement executed by the Borrower in respect of all the shares held by the Borrower in the Target, and delivery of original stock certificates and stock powers and other perfection actions required
in respect of the Transaction Security Documents. 

  
 106 

 SCHEDULE 3 

UTILISATION REQUEST 
  

			
	From:	 	WNS NORTH AMERICA INC.
		
	To:	 	BNP PARIBAS
		
		 	16/F, PCCW Tower,
		 	Taikoo Place,
		 	979 King’s Road,
		 	Quarry Bay, Hong Kong
		
		 	Attention: CMLS – Clement Wong / Hugo Chan

 Dated: 

Dear Sirs, 
 WNS NORTH AMERICA INC. –
US$34,000,000 Facility Agreement 
 dated
[                    ] (the “Facility Agreement”) 
  

	1.	We refer to the Facility Agreement. This is an Utilisation Request. Terms defined in the Facility Agreement shall have the same meaning in this Utilisation Request. 

 

	2.	We wish to borrow a Loan on the following terms: 

  

			
	Proposed Utilisation Date:	 	[    ] (or, if that is not a Business Day, the next Business Day)
		
	Amount:	 	[    ] or, if less, the Available Facility
		
	First Interest Period:	 	[                ]

  

	3.	We confirm that each condition specified in Clause 4.2 (Further conditions precedent) is satisfied on the date of this Utilisation Request. 

 

	4.	The proceeds of this Loan should be credited to [account]. 

  

	5.	This Utilisation Request is irrevocable. 

  

	
	Yours faithfully
	
	  

	Director/Authorised Signatory of
	WNS NORTH AMERICA INC.

  
 107 

 SCHEDULE 4 

FORM OF TRANSFER CERTIFICATE 
  

			
	To:	 	BNP PARIBAS as Agent and Security Agent
		
	From:	 	[the Existing Lender] (the “Existing Lender”) and [the New Lender] (the “New Lender”)
		
	Dated:	 	

 WNS NORTH AMERICA INC. – US$34,000,000 Facility Agreement 

dated [                    ] (the
“Facility Agreement”) 
  

	1.	We refer to Clause 22.5 (Procedure for transfer) of the Facility Agreement. This is a Transfer Certificate. Terms used in the Facility Agreement shall have the same meaning in this Transfer Certificate.

  

	2.	The Existing Lender and the New Lender agree to the Existing Lender transferring to the New Lender by novation, and in accordance with Clause 22.5 (Procedure for transfer), all of the Existing Lender’s
rights and obligations under the Facility Agreement and the other Finance Documents which relate to that portion of the Existing Lender’s Commitment and participations in the Loan under the Facility Agreement as specified in the Schedule.

  

	3.	The proposed Transfer Date is [                    ]. 

 

	4.	The Facility Office and address, fax number and attention particulars for notices of the New Lender for the purposes of Clause 33.2 (Addresses) are set out in the Schedule. 

 

	5.	The New Lender expressly acknowledges: 

  

	 	(a)	the limitations on the Existing Lender’s obligations set out in paragraphs (a) and (c) of Clause 22.4 (Limitation of responsibility of Existing Lenders); and 

 

	 	(b)	that it is the responsibility of the New Lender to ascertain whether any document is required or any formality or other condition is required to be satisfied to effect or perfect the transfer contemplated by this
Transfer Certificate or otherwise to enable the New Lender to enjoy the full benefit of each Finance Document. 

  

	6.	The New Lender confirms that it is a “New Lender” within the meaning of Clause 22.1 (Assignments and transfers by the Lenders). 

 

	7.	The Existing Lender and the New Lender confirm that the New Lender is not an Obligor or an Affiliate of an Obligor. 

  

	8.	This Transfer Certificate may be executed in any number of counterparts and this has the same effect as if the signatures on the counterparts were on a single copy of this Transfer Certificate. 

 

	9.	This Transfer Certificate and all non-contractual obligations arising from or in connection with this Transfer Certificate are governed by English law. 

 

	10.	This Transfer Certificate has been entered into on the date stated at the beginning of this Transfer Certificate. 

Note: The execution of this Transfer Certificate may not transfer a proportionate share of the Existing Lender’s interest in the Transaction Security
in all jurisdictions. It is the responsibility of the New Lender to ascertain whether any other documents or other formalities are required to perfect a transfer of such a share in the Existing Lender’s Transaction Security in any jurisdiction
and, if so, to arrange for execution of those documents and completion of those formalities. 

  
 108 

 THE SCHEDULE 

Commitment/rights and obligations to be transferred, and other particulars 

 

			
	Commitment/participation(s) transferred:	 	
	 Drawn Loan(s) participation(s) amount(s):
	 	[        ]
	 Available Commitment amount:
	 	[        ]
		
	Administration particulars:	 	
	 New Lender’s receiving account:
	 	[        ]
	 Address:
	 	[        ]
	 Telephone:
	 	[        ]
	 Facsimile:
	 	[        ]
	 Attn/Ref:
	 	[        ]
		
	[the Existing Lender]	 	[the New Lender]

									
					
	By:	 	  
	 		 	By:	 	  

 This Transfer Certificate is executed by the Agent and the Transfer Date is confirmed as
[                ]. 
  

			
	BNP PARIBAS as Agent

			
		
	By:	 	  

  

	Note:	It is the New Lender’s responsibility to ascertain whether any other document is required, or any formality or other condition is required to be satisfied, to effect or perfect the transfer contemplated in
this Transfer Certificate or to give the New Lender full enjoyment of all the Finance Documents. 

  
 109 

 SCHEDULE 5 

FORM OF COMPLIANCE CERTIFICATE 
  

			
	To:	 	BNP PARIBAS as Agent and Security Agent
		
	From:	 	WNS NORTH AMERICA INC.
		
	Dated:	 	
	
	Dear Sirs

 WNS NORTH AMERICA INC. – US$34,000,000 Facility Agreement 

dated [                    ] (the
“Facility Agreement”) 
  

	1.	We refer to the Facility Agreement. This is a Compliance Certificate. Terms used in the Facility Agreement shall have the same meaning in this Compliance Certificate. 

 

	2.	We confirm that for the Relevant Period ending on [                    ]: 

 

	 	(a)	EBITDA was [        ] and Total [Net] Debt was [        ]; therefore, Leverage was [        ] to 1;

  

	 	(b)	EBITDA was [        ] and Debt Service was [        ]; therefore, the Debt Service Cover was
[        ] to 1;1 

  

	3.	We set out below calculations establishing the figures in paragraph 2 above: 

  

	    	[            ]. 

  

	4.	We confirm that no Default is continuing.* 

  

			
	Signed by:	 	  

		 	Director/Authorised Signatory of
		 	WNS (Holdings) Limited

  

	1 	Note: only include in respect of a Relevant Period coinciding with the end of each Financial Year. 

	*	If this statement cannot be made, the certificate should identify any Default that is continuing and the steps, if any, being taken to remedy it. 

  
 110 

 SCHEDULE 6 

FORM OF RESIGNATION LETTER 
  

			
	To:	 	BNP PARIBAS as Agent
		
	From:	 	[resigning Obligor] and WNS NORTH AMERICA INC.
		
	Dated:	 	
	
	Dear Sirs

 WNS NORTH AMERICA INC. – US$34,000,000 Facility Agreement 

dated [                    ] (the
“Facility Agreement”) 
  

	1.	We refer to the Facility Agreement. This is a Resignation Letter. Terms defined in the Facility Agreement have the same meaning in this Resignation Letter unless given a different meaning in this Resignation Letter.

  

	2.	Pursuant to Clause 23.2 (Resignation of the Parent Guarantor) of the Facility Agreement, we request that the Parent Guarantor be released from its obligations as a Guarantor under the Facility Agreement.

  

	3.	We confirm that: 

  

	 	(a)	no Default is continuing or would result from the acceptance of this request; and 

  

	 	(b)	[        ]*. 

  

	4.	This Resignation Letter, and all non-contractual obligations arising from or in connection with this Resignation Letter, are governed by English law. 

 

									
	WNS NORTH AMERICA INC.	  		  	[Subsidiary]

									
					
	By:	 	  
	  		 	By:  	 	  

  

	*	Insert any other conditions required by the Facility Agreement. 

  
 111 

 SCHEDULE 7 

EXISTING SECURITY 
  

							
	 Name of Obligor
	  	 Security
	  	Total Principal Amount of
Indebtedness Secured	 
	 WNS Global Services Private Limited
	  	 Fixed Deposit
	  	INR	250,000	 
	 WNS Global Services Private Limited
	  	 Fixed Deposit
	  	INR	100,000	 
	 Value Edge Research Services Private Limited
	  	 Fixed Deposit
	  	INR	670,000	 
	 Value Edge Research Services Private Limited
	  	 Fixed Deposit
	  	INR	 25,000	 
	 WNS North America Inc.
	  	 Fixed Deposit
	  	USD	21,222	 
	 WNS Global Services Philippines Inc.
	  	 Fixed Deposit
	  	PHP	3,961,741	 
	 WNS Global Services (Romania) S.R.L.
	  	 Fixed Deposit
	  	EUR	 165,547	 
	 WNS Global Services (Australia) Pty Ltd.
	  	 Fixed Deposit
	  	AUD	 10,698	 
	 WNS Global Services (Australia) Pty Ltd.
	  	 Fixed Deposit
	  	AUD	 21,000	 
	 WNS Global Services (UK) Limited
	  	 Fixed Deposit
	  	PLN	 25,000	 

  
 112 

 SCHEDULE 8 

TIMETABLES 
  

			
	Function	  	Day/Time
		
	 Delivery of a duly completed Utilisation Request (Clause 5.1 (Delivery of a Utilisation
Request))
	  	 U – 3
 11.00 a.m. Hong Kong
time

		
	 Agent notifies the Lenders of the Loan in accordance with Clause 5.4 (Lenders’
participations)
	  	 U – 2
 noon

		
	 LIBOR is fixed
	  	Quotation Day as of 11.00 a.m. London time

 “U” = date of utilisation 

“U – X” = X Business Days prior to date of utilisation 

  
 113 

 SIGNATORIES 
  

			
	The Borrower
	
	WNS NORTH AMERICA INC.
		
	By:	 	
	
	  

	Name:	 	
		
	Title:	 	

  
 Signature Page to
Facility Agreement 

			
	The Arranger
	
	BNP PARIBAS
		
	By:	 	
	
	  

	Name:	 	
		
	Title:	 	

  
 Signature Page to
Facility Agreement 

			
	The Original Lender
	
	BNP PARIBAS, acting through its Hong Kong branch
		
	By:	 	
	
	  

	Name:	 	
		
	Title:	 	
		
	By:	 	
	
	  

	Name:	 	
		
	Title:	 	

  
 Signature Page to
Facility Agreement 

			
	THE AGENT
	
	BNP PARIBAS, acting through its Hong Kong branch
		
	By:	 	
	
	  

	Name:	 	
		
	Title:	 	
		
	By:	 	
	
	  

	Name:	 	
		
	Title:	 	

  
 Signature Page to
Facility Agreement 

			
	THE SECURITY AGENT
	
	BNP PARIBAS, acting through its Hong Kong branch
		
	By:	 	
	
	  

	Name:	 	
		
	Title:	 	
		
	By:	 	
	
	  

	Name:	 	
		
	Title:	 	

  
 Signature Page to
Facility Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]